[House Report 118-965]
[From the U.S. Government Publishing Office]
Union Calendar No. 812
118th Congress, 2d Session - - - - - - - - - - - - House Report 118-965
ACTIVITY REPORT
of the
COMMITTEE ON ENERGY AND COMMERCE
of the
HOUSE OF REPRESENTATIVES
for the
ONE HUNDRED EIGHTEENTH CONGRESS
[GRAPHIC(S) NOT AVAILABLE IN TIFF FORMAT]
January 2, 2025.--Committed to the Committee of the Whole House on the
State of the Union and ordered to be printed
Union Calendar No. 812
118th Congress, 2d Session - - - - - - - - - - - - House Report 118-965
ACTIVITY REPORT
of the
COMMITTEE ON ENERGY AND COMMERCE
of the
HOUSE OF REPRESENTATIVES
for the
ONE HUNDRED EIGHTEENTH CONGRESS
[GRAPHIC(S) NOT AVAILABLE IN TIFF FORMAT]
January 2, 2025.--Committed to the Committee of the Whole House on the
State of the Union and ordered to be printed
_______
U.S. GOVERNMENT PUBLISHING OFFICE
57-857 WASHINGTON : 2025
LETTER OF TRANSMITTAL
----------
House of Representatives,
Committee on Energy and Commerce,
Washington, DC, January 2, 2025.
Hon. Kevin F. McCumber,
Acting Clerk, House of Representatives,
Washington, DC.
Dear Clerk McCumber: Pursuant to clause 1(d) of rule XI of
the Rules of the House of Representatives, I present herewith a
report on the activities of the Committee on Energy and
Commerce for the 118th Congress, including the Committee's
review and study of legislation within its jurisdiction and the
oversight activities undertaken by the Committee.
Sincerely,
Cathy McMorris Rodgers,
Chair.
C O N T E N T S
----------
Page
Jurisdiction..................................................... 1
Rules............................................................ 3
Membership and Organization...................................... 11
Full Committee................................................... 17
Subcommittee on Communications and Technology.................... 23
Subcommittee on Innovation, Data, and Commerce................... 49
Subcommittee on Energy, Climate, and Grid Security............... 81
Subcommittee on Environment, Manufacturing, and Critical
Materials...................................................... 113
Subcommittee on Health........................................... 123
Authorization and Oversight Plan................................. 261
Union Calendar No. 812
118th Congress } { Report
HOUSE OF REPRESENTATIVES
2d Session } { 118-965
======================================================================
ACTIVITY REPORT OF THE COMMITTEE ON ENERGY AND COMMERCE OF THE HOUSE OF
REPRESENTATIVES FOR THE ONE HUNDRED EIGHTEENTH CONGRESS
_______
January 2, 2025.--Committed to the Committee of the Whole House on the
State of the Union and ordered to be printed
_______
Mrs. Rodgers of Washington, from the Committee on Energy and Commerce,
submitted the following
R E P O R T
Jurisdiction
The jurisdiction of the Committee on Energy and Commerce,
as prescribed by Clause 1(f) of rule X of the Rules of the
House of Representatives, is as follows:
(1) Biomedical research and development.
(2) Consumer affairs and consumer protection.
(3) Health and health facilities (except health care
supported by payroll deductions).
(4) Interstate energy compacts.
(5) Interstate and foreign commerce generally.
(6) Exploration, production, storage, supply, marketing,
pricing, and regulation of energy resources, including all
fossil fuels, solar energy, and other unconventional or
renewable energy resources.
(7) Conservation of energy resources.
(8) Energy information generally.
(9) The generation and marketing of power (except by
Federally chartered or Federal regional power marketing
authorities); reliability and interstate transmission of, and
ratemaking for, all power; and siting of generation facilities
(except the installation of interconnections between Government
waterpower projects).
(10) General management of the Department of Energy and
management and all functions of the Federal Energy Regulatory
Commission.
(11) National energy policy generally.
(12) Public health and quarantine.
(13) Regulation of the domestic nuclear energy industry,
including regulation of research and development reactors and
nuclear regulatory research.
(14) Regulation of interstate and foreign communications.
(15) Travel and tourism.
The committee shall have the same jurisdiction with respect
to regulation of nuclear facilities and of use of nuclear
energy as it has with respect to regulation of nonnuclear
facilities and of use of nonnuclear energy.
In addition, clause 3(e) of rule X of the Rules of the
House of Representatives provides that the Committee on Energy
and Commerce shall review and study on a continuing basis laws,
programs, and Government activities relating to nuclear and
other energy and nonmilitary nuclear energy research and
development including the disposal of nuclear waste.
Rules
(Adopted January 31, 2023)
Rule 1. General Provisions
(a) Rules of the Committee. The Rules of the House are the
rules of the Committee on Energy and Commerce (the
``Committee'') and its subcommittees so far as is applicable.
(b) Rules of the Subcommittees. Each subcommittee of the
Committee is part of the Committee and is subject to the
authority and direction of the Committee and to its rules so
far as is applicable. Written rules adopted by the Committee,
not inconsistent with the Rules of the House, shall be binding
on each subcommittee of the Committee.
Rule 2. Meetings
(a) Regular Meeting Days. The Committee shall meet on the
fourth Tuesday of each month at 10 a.m., for the consideration
of bills, resolutions, and other business, if the House is in
session on that day. If the House is not in session on that day
and the Committee has not met during such month, the Committee
shall meet at the earliest practicable opportunity when the
House is again in session. The chair of the Committee may, at
his or her discretion, cancel, delay, or defer any meeting
required under this section, after consultation with the
ranking minority member.
(b) Additional Meetings. The chair may call and convene, as
he or she considers necessary, additional meetings of the
Committee for the consideration of any bill or resolution
pending before the Committee or for the conduct of other
Committee business. The Committee shall meet for such purposes
pursuant to that call of the chair.
(c) Notice. The date, time, place, and subject matter of
any meeting of the Committee (other than a hearing) shall be
announced at least 36 hours (exclusive of Saturdays, Sundays,
and legal holidays except when the House is in session on such
days) in advance of the commencement of such meeting. In no
event shall such meeting commence earlier than the third
calendar day (excluding Saturdays, Sundays, or legal holidays
except when the House is in session on such a day) on which
members have notice thereof.
(d) Agenda. The agenda for each Committee meeting, setting
out all items of business to be considered, shall be provided
to each member of the Committee at least 36 hours in advance of
such meeting.
(e) Availability of Texts. No bill, recommendation, or
other matter shall be considered by the Committee unless the
text of the matter, together with an explanation, has been
available to members of the Committee for three days (or 24
hours in the case of a substitute for introduced legislation).
Such explanation shall include a summary of the major
provisions of the legislation, an explanation of the
relationship of the matter to present law, and a summary of the
need for the legislation.
(f) Waiver. The requirements of subsections (c), (d), and
(e) may be waived by a majority of those present and voting (a
majority being present) of the Committee or by the chair with
the concurrence of the ranking member, as the case may be.
Rule 3. Hearings
(a) Notice. The date, time, place, and subject matter of
any hearing of the Committee shall be announced at least one
week in advance of the commencement of such hearing, unless a
determination is made in accordance with clause 2(g)(3) of rule
XI of the Rules of the House that there is good cause to begin
the hearing sooner.
(b) Memorandum. Each member of the Committee shall be
provided, except in the case of unusual circumstances, with a
memorandum at least 48 hours before each hearing explaining--
(1) the purpose of the hearing and
(2) the names of any witnesses.
(c) Witnesses. (1) Each witness who is to appear before the
Committee shall file with the clerk of the Committee, at least
two working days in advance of his or her appearance,
sufficient copies, as determined by the chair of the Committee
of a written statement of his or her proposed testimony to
provide to members and staff of the Committee, the news media,
and the general public. Each witness shall, to the greatest
extent practicable, also provide a copy of such written
testimony in an electronic format prescribed by the chair. Each
witness shall limit his or her oral presentation to a brief
summary of the argument. The chair of the Committee or the
presiding member may waive the requirements of this paragraph
or any part thereof.
(2) To the greatest extent practicable, the written
testimony of each witness appearing in a nongovernmental
capacity shall include a curriculum vitae and a disclosure of
any Federal grant or contract or foreign government contracts
and payments related to the subject matter of the hearing
received during the current calendar year or either of the two
preceding calendar years by the witness or by an entity
represented by the witness. The disclosure shall include--
(i) the amount and source of each Federal grant (or
subgrant thereof) or contract (or subcontract thereof) related
to the subject matter of the hearing; and
(ii) the amount and country of origin of any payment or
contract related to the subject matter of the hearing
originating with a foreign government.
(d) Questioning. (1) The right to interrogate the witnesses
before the Committee shall alternate between majority and
minority members. Each member shall be limited to 5 minutes in
the interrogation of witnesses until such time as each member
who so desires has had an opportunity to question witnesses. No
member shall be recognized for a second period of 5 minutes to
interrogate a witness until each member of the Committee
present has been recognized once for that purpose. The chair
shall recognize in order of appearance members who were not
present when the meeting was called to order after all members
who were present when the meeting was called to order have been
recognized in the order of seniority on the Committee or
relevant subcommittee, as the case may be.
(2) The chair, with the concurrence of the ranking minority
member, or the Committee by motion, may permit an equal number
of majority and minority members to question a witness for a
specified, total period that is equal for each side and not
longer than 30 minutes for each side. The chair, with the
concurrence of the ranking minority member, or the Committee by
motion, may also permit committee staff of the majority and
minority to question a witness for a specified, total period
that is equal for each side and not longer than 30 minutes for
each side.
(3) Each member may submit to the chair of the Committee
additional questions for the record, to be answered by the
witnesses who have appeared. Each member shall provide a copy
of the questions in an electronic format to the clerk of the
Committee no later than 10 business days following a hearing.
The chair shall transmit all questions received from members of
the Committee to the appropriate witness and include the
transmittal letter and the responses from the witnesses in the
hearing record. After consultation with the ranking minority
member, the chair is authorized to close the hearing record no
earlier than 120 days from the date the questions were
transmitted to the appropriate witness.
Rule 4. Vice Chair; Presiding Member
The chair shall designate a member of the majority party to
serve as vice chairman of the Committee, and shall designate a
majority member of each subcommittee to serve as vice chair of
each subcommittee. The vice chair of the Committee or
subcommittee, as the case may be, shall preside at any meeting
or hearing during the temporary absence of the chair. If the
chair and vice chair of the Committee or subcommittee are not
present at any meeting or hearing, the ranking member of the
majority party who is present shall preside at the meeting or
hearing.
Rule 5. Open Proceedings
Except as provided by the Rules of the House, each meeting
and hearing of the Committee for the transaction of business,
including the markup of legislation, and each hearing, shall be
open to the public, including to radio, television, and still
photography coverage, consistent with the provisions of rule XI
of the Rules of the House.
Rule 6. Quorum
Testimony may be taken and evidence received at any hearing
at which there are present not fewer than two members of the
Committee in question. A majority of the members of the
Committee shall constitute a quorum for those actions for which
the House Rules require a majority quorum. For the purposes of
taking any other action, one-third of the members of the
Committee shall constitute a quorum.
Rule 7. Official Committee Records
(a)(1) Documents reflecting the proceedings of the
Committee shall be made publicly available in electronic form
on the Committee's website and in the Committee office for
inspection by the public, as provided in rule XI, clause 2(e)
of the Rules of the House not more than 24 hours after each
meeting has adjourned, including a record showing those present
at each meeting; and a record of the vote on any question on
which a record vote is demanded, including a description of the
amendment, motion, order, or other proposition, the name of
each member voting for and each member voting against such
amendment, motion, order, or proposition, and the names of
those members of the committee present but not voting.
(2) Record Votes. A record vote may be demanded by one-
fifth of the members present or, in the apparent absence of a
quorum, by any one member. No demand for a record vote shall be
made or obtained except for the purpose of procuring a record
vote or in the apparent absence of a quorum.
(b) Postponement of Votes. In accordance with clause
2(h)(4) of rule XI of the Rules of the House, the chair of the
Committee or a subcommittee, after consultation with the
ranking minority member of the Committee or subcommittee, may--
(1) postpone further proceedings when a record vote is
ordered on the question of approving a measure or matter or on
adopting an amendment; and
(2) resume proceedings on a postponed question at any time
after reasonable notice. When proceedings resume on a postponed
question, notwithstanding any intervening order for the
previous question, an underlying proposition shall remain
subject to further debate or amendment to the same extent as
when the question was postponed.
(c) Archived Records. The records of the Committee at the
National Archives and Records Administration shall be made
available for public use in accordance with rule VII of the
Rules of the House. The chair shall notify the ranking minority
member of any decision, pursuant to clause 3(b)(3) or clause
4(b) of the Rule, to withhold a record otherwise available, and
the matter shall be presented to the Committee for a
determination on the written request of any member of the
Committee. The chair shall consult with the ranking minority
member on any communication from the Archivist of the United
States or the Clerk of the House concerning the disposition of
noncurrent records pursuant to clause 3(b) of the Rule.
Rule 8. Subcommittees
(a) Establishment. There shall be such standing
subcommittees with such jurisdiction and size as determined by
the majority party caucus of the Committee. The jurisdiction,
number, and size of the subcommittees shall be determined by
the majority party caucus prior to the start of the process for
establishing subcommittee chairmanships and assignments.
(b) Powers and Duties. Each subcommittee is authorized to
meet, hold hearings, receive testimony, mark up legislation,
and report to the Committee on all matters referred to it.
Subcommittee chairs shall set hearing and meeting dates only
with the approval of the chair of the Committee with a view
toward assuring the availability of meeting rooms and avoiding
simultaneous scheduling of Committee and subcommittee meetings
or hearings whenever possible.
(c) Ratio of Subcommittees. The majority caucus of the
Committee shall determine an appropriate ratio of majority to
minority party members for each subcommittee and the chair
shall negotiate that ratio with the minority party, provided
that the ratio of party members on each subcommittee shall be
no less favorable to the majority than that of the full
Committee, nor shall such ratio provide for a majority of less
than two majority members.
(d) Selection of Subcommittee Members. Prior to any
organizational meeting held by the Committee, the majority and
minority caucuses shall select their respective members of the
standing subcommittees.
(e) Ex Officio Members. The chair and ranking minority
member of the Committee shall be ex officio members with voting
privileges of each subcommittee of which they are not assigned
as members and may be counted for purposes of establishing a
quorum in such subcommittees.
Rule 9. Opening Statements
(a) Written Statements. All written opening statements at
hearings and business meetings conducted by the committee shall
be made part of the permanent record.
(b) Length.
(1) At full committee hearings, the chair and ranking
minority member shall be limited to 5 minutes each for an
opening statement, and may designate another member to give an
opening statement of not more than 5 minutes. At subcommittee
hearings, the subcommittee chair and ranking minority member of
the subcommittee shall be limited to 5 minutes each for an
opening statement. In addition, the full committee chair and
ranking minority member shall each be allocated 5 minutes for
an opening statement for themselves or their designees.
(2) At any business meeting of the Committee, statements
shall be limited to 5 minutes each for the chair and ranking
minority member (or their respective designee) of the Committee
or subcommittee, as applicable, and 3 minutes each for all
other members. The chair may further limit opening statements
for members (including, at the discretion of the chair, the
chair and ranking minority member) to one minute.
Rule 10. Reference of Legislation and Other Matters
All legislation and other matters referred to the Committee
shall be referred to the subcommittee of appropriate
jurisdiction within two weeks of the date of receipt by the
Committee unless--
(1) action is taken by the full Committee within those two
weeks, or
(2) by majority vote of the members of the Committee,
consideration is to be by the full Committee.
In the case of legislation or other matter within the
jurisdiction of more than one subcommittee, the chair of the
Committee may, in his discretion, refer the matter
simultaneously to two or more subcommittees for concurrent
consideration, or may designate a subcommittee of primary
jurisdiction and also refer the matter to one or more
additional subcommittees for consideration in sequence (subject
to appropriate time limitations), either on its initial
referral or after the matter has been reported by the
subcommittee of primary jurisdiction. Such authority shall
include the authority to refer such legislation or matter to an
ad hoc subcommittee appointed by the chair, with the approval
of the Committee, from the members of the subcommittees having
legislative or oversight jurisdiction.
Rule 11. Managing Legislation on the House Floor
The chair, in his or her discretion, shall designate which
member shall manage legislation reported by the Committee to
the House.
Rule 12. Committee Professional and Clerical Staff Appointments
(a) Delegation of Staff. Whenever the chair of the
Committee determines that any professional staff member
appointed pursuant to the provisions of clause 9 of rule X of
the House of Representatives, who is assigned to such chair and
not to the ranking minority member, by reason of such
professional staff member's expertise or qualifications will be
of assistance to one or more subcommittees in carrying out
their assigned responsibilities, he or she may delegate such
member to such subcommittees for such purpose. A delegation of
a member of the professional staff pursuant to this subsection
shall be made after consultation with subcommittee chairs and
with the approval of the subcommittee chair or chairs involved.
(b) Minority Professional Staff. Professional staff members
appointed pursuant to clause 9 of rule X of the House of
Representatives, who are assigned to the ranking minority
member of the Committee and not to the chair of the Committee,
shall be assigned to such Committee business as the minority
party members of the Committee consider advisable.
(c) Additional Staff Appointments. In addition to the
professional staff appointed pursuant to clause 9 of rule X of
the House of Representatives, the chair of the Committee shall
be entitled to make such appointments to the professional and
clerical staff of the Committee as may be provided within the
budget approved for such purposes by the Committee. Such
appointee shall be assigned to such business of the full
Committee as the chair of the Committee considers advisable.
(d) Sufficient Staff. The chair shall ensure that
sufficient staff is made available to each subcommittee to
carry out its responsibilities under the rules of the
Committee.
(e) Fair Treatment of Minority Members in Appointment of
Committee Staff. The chair shall ensure that the minority
members of the Committee are treated fairly in appointment of
Committee staff.
(f) Contracts for Temporary or Intermittent Services. Any
contract for the temporary services or intermittent service of
individual consultants or organizations to make studies or
advise the Committee or its subcommittees with respect to any
matter within their jurisdiction shall be deemed to have been
approved by a majority of the members of the Committee if
approved by the chair and ranking minority member of the
Committee. Such approval shall not be deemed to have been given
if at least one-third of the members of the Committee request
in writing that the Committee formally act on such a contract,
if the request is made within 10 days after the latest date on
which such chairman or chairmen, and such ranking minority
member or members, approve such contract.
Rule 13. Supervision, Duties of Staff
(a) Supervision of Majority Staff. The professional and
clerical staff of the Committee not assigned to the minority
shall be under the supervision and direction of the chair who,
in consultation with the chairs of the subcommittees, shall
establish and assign the duties and responsibilities of such
staff members and delegate such authority as they determine is
appropriate.
(b) Supervision of Minority Staff. The professional and
clerical staff assigned to the minority shall be under the
supervision and direction of the minority members of the
Committee, who may delegate such authority as they determine
appropriate.
Rule 14. Committee Budget
(a) Administration of Committee Budget. The chair of the
Committee, in consultation with the ranking minority member,
shall for the 118th Congress attempt to ensure that the
Committee receives necessary amounts for professional and
clerical staff, travel, investigations, equipment and
miscellaneous expenses of the Committee and the subcommittees,
which shall be adequate to fully discharge the Committee's
responsibilities for legislation and oversight.
(b) Monthly Expenditures Report. Committee members shall be
furnished a copy of each monthly report, prepared by the chair
for the Committee on House Administration, which shows
expenditures made during the reporting period and cumulative
for the year by the Committee and subcommittees, anticipated
expenditures for the projected Committee program, and detailed
information on travel.
Rule 15. Broadcasting of Committee Hearings
Any meeting or hearing that is open to the public may be
covered in whole or in part by radio or television or still
photography, subject to the requirements of clause 4 of rule XI
of the Rules of the House. The coverage of any hearing or other
proceeding of the Committee or any subcommittee thereof by
television, radio, or still photography shall be under the
direct supervision of the chairman of the Committee, the
subcommittee chairman, or other member of the Committee
presiding at such hearing or other proceeding and may be
terminated by such member in accordance with the Rules of the
House.
Rule 16. Subpoena Power
The power to authorize and issue subpoenas is delegated to
the chair of the full Committee, as provided for under clause
2(m)(3)(A)(i) of rule XI of the Rules of the House of
Representatives. The chair shall notify the ranking minority
member prior to issuing any subpoena under such authority. To
the extent practicable, the chair shall consult with the
ranking minority member at least 72 hours in advance of a
subpoena being issued under such authority. The chair shall
report to the members of the Committee on the issuance of a
subpoena as soon as practicable but in no event later than one
week after issuance of such subpoena.
Rule 17. Travel of Members and Staff
(a) Approval of Travel. Consistent with the primary expense
resolution and such additional expense resolutions as may have
been approved, travel to be reimbursed from funds set aside for
the Committee for any member or any staff member shall be paid
only upon the prior authorization of the chair. Travel may be
authorized by the chair for any member and any staff member in
connection with the attendance of hearings conducted by the
Committee or any subcommittee thereof and meetings,
conferences, and investigations which involve activities or
subject matter under the general jurisdiction of the Committee.
Before such authorization is given there shall be submitted to
the chair in writing the following--
(1) the purpose of the travel;
(2) the dates during which the travel is to be made and the
date or dates of the event for which the travel is being made;
(3) the location of the event for which the travel is to be
made; and
(4) the names of members and staff seeking authorization.
(b) Approval of Travel by Minority Members and Staff. In
the case of travel by minority party members and minority party
professional staff for the purpose set out in (a), the prior
approval, not only of the chair but also of the ranking
minority member, shall be required. Such prior authorization
shall be given by the chair only upon the representation by the
ranking minority member in writing setting forth those items
enumerated in (1), (2), (3), and (4) of paragraph (a).
Rule 18. Website
The chair shall maintain an official Committee website for
the purposes of furthering the Committee's legislative and
oversight responsibilities, including communicating information
about the Committee's activities to Committee members and other
members of the House. The ranking minority member may maintain
an official website for the purpose of carrying out official
responsibilities, including communicating information about the
activities of the minority members of the Committee to
Committee members and other members of the House.
Rule 19. Conferences
The chair of the Committee is directed to offer a motion
under clause 1 of rule XXII of the Rules of the House whenever
the chair considers it appropriate.
Membership and Organization
ONE HUNDRED EIGHTEENTH CONGRESS
COMMITTEE ON ENERGY AND COMMERCE
(Ratio 29-23)
CATHY McMORRIS RODGERS,
Washington, Chair
FRANK PALLONE, Jr., New Jersey, MICHAEL C. BURGESS, Texas
Ranking Member ROBERT E. LATTA, Ohio
ANNA G. ESHOO, California BRETT GUTHRIE, Kentucky
DIANA DeGETTE, Colorado H. MORGAN GRIFFITH, Virginia
JANICE D. SCHAKOWSKY, Illinois GUS M. BILIRAKIS, Florida
DORIS O. MATSUI, California LARRY BUCSHON, Indiana
KATHY CASTOR, Florida RICHARD HUDSON, North Carolina
JOHN P. SARBANES, Maryland TIM WALBERG, Michigan
PAUL TONKO, New York EARL L. ``BUDDY'' CARTER, Georgia
YVETTE D. CLARKE, New York JEFF DUNCAN, South Carolina
TONY CARDENAS, California GARY J. PALMER, Alabama
RAUL RUIZ, California NEAL P. DUNN, Florida
SCOTT H. PETERS, California JOHN R. CURTIS, Utah
DEBBIE DINGELL, Michigan DEBBIE LESKO, Arizona
MARC A. VEASEY, Texas GREG PENCE, Indiana
ANN M. KUSTER, New Hampshire DAN CRENSHAW, Texas
ROBIN L. KELLY, Illinois JOHN JOYCE, Pennsylvania
NANETTE DIAZ BARRAGAN, California KELLY ARMSTRONG, North Dakota,
LISA BLUNT ROCHESTER, Delaware Vice Chair
DARREN SOTO, Florida RANDY K. WEBER, SR., Texas
ANGIE CRAIG, Minnesota RICK W. ALLEN, Georgia
KIM SCHRIER, Washington TROY BALDERSON, Ohio
LORI TRAHAN, Massachusetts RUSS FULCHER, Idaho
LIZZIE FLETCHER, Texas AUGUST PFLUGER, Texas
DIANA HARSHBARGER, Tennessee
MARIANNETTE MILLER-MEEKS, Iowa
KAT CAMMACK, Florida
JAY OBERNOLTE, California
JOHN JAMES, Michigan*
*BILL JOHNSON, Ohio, resigned from Congress on January 21, 2024.
JOHN JAMES, Michigan, was elected to the Committee on Energy and
Commerce on March 12, 2024.
Subcommittee Memberships and Jurisdiction
Subcommittee on Communications and Technology
(Ratio 16-12)
ROBERT E. LATTA, Ohio, Chair
DORIS MATSUI, California Ranking MemberNDY K. WEBER, Sr., Texas, Vice
YVETTE D. CLARKE, New York Chair
MARC VEASEY, Texas GUS M. BILIRAKIS, Florida
DARREN SOTO, Florida TIM WALBERG, Michigan
ANNA ESHOO, California EARL L. ``BUDDY'' CARTER, Georgia
TONY CARDENAS, California NEAL P. DUNN, Florida
ANGIE CRAIG, Minnesota JOHN CURTIS, Utah
LIZZIE FLETCHER, Texas JOHN JOYCE, Pennsylvania
DEBBIE DINGELL, Michigan RICK ALLEN, Georgia
ANN KUSTER, New Hampshire RUSS FULCHER, Idaho
ROBIN KELLY, Illinois AUGUST PFLUGER, Texas
FRANK PALLONE, Jr., New Jersey DIANA HARSHBARGER, Tennessee
(Ex Officio) MARIANETTE MILLER-MEEKS, Iowa
KAT CAMMACK, Florida
JAY OBERNOLTE, California
CATHY McMORRIS RODGERS, Washington
(Ex Officio)
Jurisdiction: Electronic communications, both Interstate and
foreign, including voice, video, audio and data, whether transmitted by
wire or wirelessly, and whether transmitted by telecommunications,
commercial or private mobile service, broadcast, cable, satellite,
microwave, or other mode; technology generally; emergency and public
safety communications; cybersecurity, privacy, and data security; the
Federal Communications Commission, the National Telecommunications and
Information Administration, the Office of Emergency Communications in
the Department of Homeland Security; and all aspects of the above-
referenced jurisdiction related to the Department of Homeland Security.
Subcommittee on Innovation, Data, and Commerce
(Ratio 13-9)
GUS BILIRAKIS, Florida, Chair
JANICE SCHAKOWSKY, Illinois, Ranking MemberLBERG, Michigan, Vice Chair
KATHY CASTOR, Florida LARRY BUCSHON, Indiana
DEBBIE DINGELL, Michigan JEFF DUNCAN, South Carolina
ROBIN KELLY, Illinois NEAL DUNN, Florida
LISA BLUNT ROCHESTER, Delaware DEBBIE LESKO, Arizona
DARREN SOTO, Florida KELLY ARMSTRONG, North Dakota
LORI TRAHAN, Massachusetts RUSS FULCHER, Idaho
YVETTE CLARKE, New York DIANA HARSHBARGER, Tennessee
FRANK PALLONE, Jr., New Jersey KAT CAMMACK, Florida
(Ex Officio) JAY OBERNOLTE, California
JOHN JAMES, Michigan
CATHY McMORRIS RODGERS, Washington
(Ex Officio)
Jurisdiction: Interstate and foreign commerce, including all trade
matters within the jurisdiction of the full committee; regulation of
commercial practices (the Federal Trade Commission), including sports-
related matters; consumer affairs and consumer protection, including
privacy matters generally; data security; consumer product safety (the
Consumer Product Safety Commission); product liability; motor vehicle
safety; and regulation of travel, tourism, and time.
Subcommittee on Energy, Climate, and Grid Security
(Ratio 17-13)
JEFF DUNCAN, South Carolina, Chair
DIANA DeGETTE, Colorado, Ranking MemberHN CURTIS, Utah, Vice Chair
SCOTT PETERS, California MICHAEL BURGESS, Texas
LIZZIE FLETCHER, Texas ROBERT E. LATTA, Ohio
DORIS MATSUI, California BRETT GUTHRIE, Kentucky
PAUL TONKO, New York H. MORGAN GRIFFITH, Virginia
MARC VEASEY, Texas LARRY BUCSHON, Indiana
ANN KUSTER, New Hampshire TIM WALBERG, Michigan
KIM SCHRIER, Washington GARY PALMER, Alabama
KATHY CASTOR, Florida DEBBIE LESKO, Arizona
JOHN SARBANES, Maryland GREG PENCE, Indiana
TONY CARDENAS, California KELLY ARMSTRONG, North Dakota
LISA BLUNT ROCHESTER, Delaware RANDY WEBER, Texas
FRANK PALLONE, Jr., New Jersey RICK ALLEN, Georgia
(Ex Officio) TROY BALDERSON, Ohio
AUGUST PFLUGER, Texas
CATHY McMORRIS RODGERS, Washington
(Ex Officio)
Jurisdiction: National energy policy; fossil energy; renewable
energy; nuclear energy; nuclear facilities; the Department of Energy;
the Nuclear Regulatory Commission; the Federal Energy Regulatory
Commission; synthetic and alternative fuels; energy conservation;
energy information; utility issues; interstate energy compacts; energy
generation, marketing, reliability, transmission, siting, exploration,
production, efficiency, cybersecurity, and ratemaking for all generated
power; pipelines; all laws, programs, and government activities
affecting energy matters, including all aspects of the above-referenced
jurisdiction related to the Department of Homeland Security.
Subcommittee on Environment, Manufacturing, and Critical Materials
(Ratio 13-9)
EARL L. ``BUDDY'' CARTER, Georgia,
Chair
PAUL TONKO, New York, Ranking Member JOHN JOYCE, Pennsylvania, Vice
DIANA DeGETTE, Colorado Chairman
JANICE SCHAKOWSKY, Illinois GARY PALMER, Alabama
JOHN SARBANES, Maryland GREG PENCE, Indiana
YVETTE CLARKE, New York DAN CRENSHAW, Texas
RAUL RUIZ, California RANDY K. WEBER, Texas
SCOTT PETERS, California RICK ALLEN, Georgia
NANETTE DIAZ BARRAGAN, California TROY BALDERSON, Ohio
FRANK PALLONE, Jr., New Jersey RUSS FULCHER, Idaho
(Ex Officio) AUGUST PFLUGER, Texas
MARIANNETTE MILLER-MEEKS, Iowa
JOHN JAMES, Michigan
CATHY McMORRIS RODGERS, Washington
(Ex Officio)
Jurisdiction: All matters related to soil, air, and water
contamination, including Superfund and the Resource Conservation and
Recovery Act; the regulation of solid, hazardous, and nuclear wastes,
including mining, nuclear, oil, gas, and coal combustion waste; the
Clean Air Act and air emissions; emergency environmental response;
industrial plant security, including cybersecurity; the regulation of
drinking water (Safe Drinking Water Act), including underground
injection of fluids (e.g., deep well injection or hydrofracking); toxic
substances (Toxic Substances Control Act); noise; and all aspects of
the above-referenced jurisdiction related to the Department of Homeland
Security.
Subcommittee on Health
(Ratio 17-13)
BRETT GUTHRIE, Kentucky, Chair
ANNA ESHOO, California, Ranking MemberARRY BUCSHON, Indiana, Vice Chair
JOHN SARBANES, Maryland MICHAEL BURGESS, Texas
TONY CARDENAS, California ROBERT L. LATTA, Ohio
RAUL RUIZ, California H. MORGAN GRIFFITH, Virginia
DEBBIE DINGELL, Michigan GUS BILIRAKIS, Florida
ANN KUSTER, New Hampshire RICHARD HUDSON, North Carolina
ROBIN KELLY, Illinois EARL L. ``BUDDY'' CARTER, Georgia
NANETTE DIAZ BARRAGAN, California NEAL DUNN, Florida
LISA BLUNT ROCHESTER, Delaware GREG PENCE, Indiana
ANGIE CRAIG, Minnesota DAN CRENSHAW, Texas
KIM SCHRIER, Washington JOHN JOYCE, Pennsylvania
LORI TRAHAN, Massachusetts TROY BALDERSON, Ohio
FRANK PALLONE, Jr., New Jersey DIANA HARSHBARGER, Tennessee
(Ex Officio) MARIANNETTE MILLER-MEEKS, Iowa
JAY OBERNOLTE, California
CATHY McMORRIS RODGERS, Washington
(Ex Officio)
Jurisdiction: Public health and quarantine; hospital construction;
mental health; biomedical research and development; health information
technology, privacy, and cybersecurity; public health insurance
(Medicare, Medicaid) and private health insurance; medical malpractice
and medical malpractice insurance; the regulation of food, drugs, and
cosmetics; drug abuse; the Department of Health and Human Services; the
National Institutes of Health; the Centers for Disease Control; Indian
Health Service; and all aspects of the above-referenced jurisdiction
related to the Department of Homeland Security.
Subcommittee on Oversight and Investigations
(Ratio 10-7)
H. MORGAN GRIFFITH, Virginia,
Chair
KATHY CASTOR, Florida, Ranking MemberDEBBIE LESKO, Arizona, Vice Chair
DIANA DeGETTE, Colorado MICHAEL BURGESS, Texas
JANICE SCHAKOWSKY, Illinois BRETT GUTHRIE, Kentucky
PAUL TONKO, New York JEFF DUNCAN, South Carolina
RAUL RUIZ, California GARY PALMER, Alabama
SCOTT PETERS, California DAN CRENSHAW, Texas
FRANK PALLONE, Jr., New Jersey KELLY ARMSTRONG, North Dakota
(Ex Officio) KAT CAMMACK, Florida
CATHY McMORRIS RODGERS, Washington
(Ex Officio)
Jurisdiction: Responsibility for oversight of agencies,
departments, and programs related to the jurisdiction of the full
committee, and for conducting investigations.
COMMITTEE STAFF
Majority Committee Staff
Sarah Alexander, Professional
Staff Member
Alexander Aramanda, Professional
Staff Member
Sean Brebbia, Chief Counsel,
Oversight & Investigations
Jolie Brochin, Junior Professional
Staff Member
Anudeep Buddharaju, Senior Counsel
Sarah Burke, Deputy Staff Director
David Burns, Professional Staff
Member
Michael Cameron, Professional
Staff Member
Marjorie Connell, Director of
Archives
Gerald Couri, Deputy Chief Counsel
for Environment
Nick Crocker, Senior Advisor and
Director of Coalitions
Corey Ensslin, Senior Policy
Advisor
Kristin Fritsch, Professional
Staff Member
Theresa Gambo, Financial and
Office Administrator
Seth Gold, Professional Staff
Member
Grace Graham, Chief Counsel,
Health
Sydney Greene, Director of
Operations
Jay Gulshen, Senior Professional
Staff Member
Rebecca Hagigh, Staff Assistant
Christen Harsha, Senior Counsel
Jack Heretik, Press Secretary
Slate Herman, Counsel
Jessica Herron, Clerk
Nate Hodson, Staff Director
Calvin Huggins, Staff Assistant
Tara Hupman, Chief Counsel
Noah Jackson, Clerk
Daniel Kelly, Press Assistant
Patrick Kelly, Staff Assistant
Sean Kelly, Press Secretary
Lauren Kennedy, Clerk
Alexander Khlopin, Clerk
Peter Kielty, General Counsel
Emily King, Member Services
Director
Elise Krekorian, Counsel
Christopher Krepich, Press
Secretary
Timothy Kurth, Chief Counsel,
Innovation, Data, and Commerce
Giulia Leganski, Professional
Staff Member
John Lin, Senior Counsel
Drew Lingle, Professional Staff
Member
Molly Lolli, Professional Staff
Member
Peter Maris, Research Assistant
Mary Martin, Chief Counsel, Energy
and Environment
Jacob McCurdy, Professional Staff
Member
Brandon Mooney, Deputy Chief
Counsel of Energy
Catherine O'Connor, Chief Counsel,
Communications and Technology
Clare Paoletta, Professional Staff
Member
Kaitlyn Peterson, Clerk
Gavin Proffitt, Professional Staff
Member
Carla Rafael-Miranda, Senior Staff
Assistant
Brannon Rains, Professional Staff
Member
Katelyn Roberts, Digital Director
& Senior Communications Advisor
Jason Rogers, Shared Staff
Emma Schultheis, Clerk
Kristin Seum, Counsel
Olivia Shields, Communications
Director
Alan Slobodin, Chief Investigative
Counsel
Peter Spencer, Senior Professional
Staff Member
Lacey Strahm, Professional Staff
Member
John Strom, Counsel
Michael Taggart, Policy Director
Theodore Tanzer, Senior Counsel
Joanne Thomas, Counsel
Dray Thorne, Director of
Information Technology
Evan Viau, Professional Staff
Member
Johanna Wells, Staff Assistant
Caitlin Wilson, Counsel
Detailees
Wayne Laufert, GPO
Patricia Mangrum, GPO
Minority Committee Staff
Lydia Abma, Policy Analyst
Hannah Anton, Policy Analyst
Shana Beavin, Professional Staff
Member
Keegan Cardman, Staff Assistant
Timia Crisp McClain, Professional
Staff Member
Jennifer Epperson, Chief Counsel,
Communications and Technology
Austin Flack, Professional Staff
Member
Waverly Gordon, Deputy Staff
Director/General Counsel
Daniel Greene, Professional Staff
Member
Tiffany Guarascio, Staff Director
Anthony Gutierrez, Professional
Staff Member
Alicia Haberman, Staff Director,
Environment, Manufacturing, and
Critical Materials
Perry Hamilton, Member Services
and Outreach Manager
Stephen Holland, Senior Health
Counsel
Elizabeth Hone, Chief Counsel,
Innovation, Data, and Commerce
Saha Khaterzai, Professional Staff
Member
Mackenzie Kuhl, Digital Manager
Una Lee, Chief Counsel, Health
Gayle Mauser, Health Advisor
William McAuliffe, Chief Counsel,
Oversight and Investigations
Daniel Miller, Professional Staff
Member
Elysa Monfort Corl, Press
Secretary
Katarina Morgan, Health Assistant
Juan Negrete Bautista,
Professional Staff Member
Constance O'Connor, Senior
Oversight Counsel
Joseph Orlando, Junior
Professional Staff Member
Christina Parisi, Professional
Staff Member
Kristopher Pittard, Professional
Staff Member
Gregory Pugh, Staff Assistant
Caroline Rinker, Junior Press
Secretary
Emma Roehrig, Staff Assistant
Kylea Rogers, Policy Analyst
Harry Samuels, Oversight Counsel
Andrew Souvall, Director of
Communications, Outreach, and
Member Services
Medha Surampudy, Professional
Staff Member
Jacquelyn Bolen Sutter, Senior
Counsel
Johanna Thomas, Counsel
Rebecca Tomilchik, Professional
Staff Member
Richard Van Buren, Senior Health
Counsel
Edward Walker, Technology Director
Caroline Wood, Research Analyst
Joseph Wright, Staff Director,
Energy, Climate, and Grid Security
Clifford Young, Deputy
Communications Director
Detailees
Ian Barlow, FTC
Jennifer Black, FDA
Elizabeth Johns, GAO
Mary Koenen, GAO
Phoebe Rouge, FTC
Michael Scurato, FCC
FULL COMMITTEE
Oversight Activities
Antisemitism at NIH-Funded Institutions
Investigation into how HHS and NIH ensure NIH-funded
institutions are compliant with relevant civil rights
legislation related to antisemitism, as well as whether these
institutions are providing a safe environment. Letters have
been sent and a report was published.
Clean School Bus Program
Investigation into the Environmental Protection Agency's
(EPA's) Clean School Bus Program, which funded the conversion
of diesel school buses into ``clean'' models. The Committee
held a hearing, communicated with EPA and EPA Office of
Inspector General (OIG), surveyed participating school
districts, and produced a 51-page report.
CMS Budget Neutrality Changes
Oversight of the Center for Medicare and Medicaid Services'
(CMS's) adjustments to budget neutrality requirements for
Medicaid demonstrations. The Committee submitted letters to CMS
and the Government Accountability Office (GAO), emphasizing the
need for greater transparency and accountability. After follow-
ups and Committee pressure, CMS released an updated State
Medicaid Director letter regarding the budget neutrality
changes.
CMS Improper Payments
Investigation into improper Medicaid payments, particularly
those made on behalf of deceased beneficiaries and individuals
enrolled in multiple states. The Committee has corresponded
with Health and Human Services (HHS) OIG and CMS, urging audits
and stricter verification processes. The Committee conducted a
hearing on the subject, featuring testimonies from key
oversight officials. The investigation was ongoing at the end
of the 118th Congress.
COVID Origins
Oversight of risky research connected to the origin of the
COVID-19 pandemic (in partnership with the Select Subcommittee
on the Coronavirus Pandemic). The Committee and the Select
Subcommittee sent several letters and conducted transcribed
interviews with 12 witnesses (including with Dr. Anthony Fauci,
former National Institutes of Health Director Francis Collins,
and EcoHealth Alliance President Peter Daszak). Though the
oversight is going, these efforts in part led to HHS'
suspension and proposed debarment of EcoHealth Alliance and Dr.
Daszak.
COVID Origins NIH GenBank
Investigation into early SARS-CoV-2 sequences that may have
been submitted by a Chinese researcher to the NIH database for
genetic sequences. The Committee requested information and
documents from HHS, eventually confirming that the submission
included early SARS-CoV-2 sequences almost two weeks before the
public posting of the SARS-CoV-2. The Committee is awaiting a
follow-up response from HHS.
Department of Energy Loan Programs Office
Investigation into the Department of Energy's (DOE's) Loan
Program Office, including the Director's ethics issues and
efforts to assess the financial condition of applicants. In-
camera document reviews have yielded significant insights into
the loan agreement process. Staff continue to press for
completion of all requests.
Environmental Justice Grants
Investigation of the EPA's use of environmental justice
programs to fund special interest groups to promote the Biden
administration's agenda. The Committee produced a 51-page
report and continues to monitor how this money is spent.
EPA's Greenhouse Gas Reduction Fund
Inquiry into EPA's $20 billion ``green bank'' program,
including how recipients would be chosen, funding recipient
leadership, and how the EPA would conduct oversight. The
Committee sent letters, reviewed documents, monitored the use
of funding, and held a hearing. The Committee plans to seek
more information.
Eventbrite
Investigation into the online ticketing platform's removal
of conservative events, while continuing to platform speakers
who praised the attacks on Israel on October 7, 2023. The
Committee sent a letter and held multiple meetings with the
company.
FDA Foreign Drug Inspection Program
Oversight of the Food and Drug Administration's (FDA's)
inspections into foreign drug manufacturing plants, focusing on
the issues which have prevent the frequency of its inspections
returning to pre-pandemic levels. The Committee sent letters
and held a hearing on the subject.
Ford-CATL Battery Plant
Probe into Ford's plans to partner with Chinese company
CATL to establish an electric vehicle battery plant in
Michigan, originating from concerns the Chinese companies will
take advantage of Inflation Reduction Act incentives (in
partnership with the Foreign Affairs Committee, the Ways and
Means Committee, and the Select Committee on China). The
Committees sent letters to Ford and federal agencies, held in-
camera document review, and met with both Ford officials and
the Committee on Foreign Investments in the United States. The
investigation was ongoing at the end of the 118th Congress.
HHS's COVID-19 Public Health Campaign
Investigation into the failings of the HHS's COVID-19
public health campaign, as well as how the Biden
administration's pandemic response resulted in a collapse of
trust in public health messaging. The Committee reviewed
documents and produced a 113-page report.
Maui Fires and Electric Infrastructure
Investigation into the 2023 wildfires on the Hawaiian
island of Maui, focusing on the circumstances contributing the
deadly impact of the fires, preparations for wildfire events,
and lessons learned. The Committee sent letters, reviewed
documents, and held a hearing.
NIH Reappointments
Investigation into whether HHS followed the law and
internal policies when appointing and reappointing Institute
and Center Directors at NIH. Questions were asked at a hearing,
a press conference with Chair Rodgers, Health Subcommittee
Chair Guthrie, and Oversight and Investigations Chair Griffith
was held, and a report was produced.
Organ Procurement and Transplant Network
Examination of concerns about patient safety, data
transparency, cybersecurity failures, and potential conflicts
of interest within the Organ Procurement and Transplantation
Network, managed by the United Network for Organ Sharing. The
Committee coordinated efforts with HHS OIG, state-level
investigators, the Department of Justice, and whistleblowers.
The Committee conducted a hearing on the subject, as well as
highlighting concerns in letters.
PayPal User Agreement Change
Joint investigations into fines imposed by PayPal on users
for posting messages off-platform (in partnership Financial
Services Committee). Following meetings with the company's
general counsel, PayPal agreed to change its user agreement.
Risky MPVX Research
Investigation into risky research done involving the MPVX
virus (formerly known as ``monkeypox'') by Dr. Bernard Moss at
the National Institute of Allergy and Infectious Diseases
(NIAID). The Committee reviewed documents, continually
pressured HHS for more information, and published a 72-page
interim report. The investigation was ongoing at the end of the
118th Congress.
SafeSport
Bipartisan oversight into the Center for SafeSport,
following issues raised by multiple athletes raised issues with
the Center, including length of time to complete
investigations, lack of communication with victims, an
inordinate number of cases being administratively closed. The
Committee held multiple meetings with athletes and officials
from various National Governing Bodies about improving the
Center for SafeSport. The Committee also convened a hearing
with the SafeSport CEO and other panelists.
SAMHSA Spending
Examination of how the Substance Abuse and Mental Health
Services Administration (SAMHSA) managed COVID-19 supplemental
funding and 988 Suicide and Crisis Hotline funding, which found
that significant sums have not yet been spent. The Committee
requested the GAO to conduct a further examination on how the
SAMHSA COVID-19 supplemental funds and the 988 Program funds
were used by the states and other grantees.
Sexual Harassment at NIH-Funded Institutions
Investigation into how complaints of sexual harassment at
NIH-funded institutions are handled by HHS Office of Civil
Rights (OCR) and NIH. Committee staff sent numerous letters,
reviewed files at in-camera reviews, and resisted HHS
obstructions. An interim report on the investigation has been
drafted. The Committee sent a request letter for GAO to
continue the investigation into NIH's handling of sexual
harassment within its intramural research program.
TikTok
Joint bipartisan investigation into TikTok, related to its
platforming of antisemitism and sexually explicit materials, as
well as its connections to the Chinese Communist Party. The
Committee reviewed documents and convened multiple closed door
meetings with representatives from the company. The Committee
held a hearing that went into a classified executive session on
this topic.
Unaccompanied Children
Investigation into hazardous work conditions, deaths, and
overall mistreatment of migrant children in HHS custody. The
Committee held multiple meetings with the Office of Refugee
Resettlement (ORR) and private contractors responsible for the
safe release of migrant children. The Committee also convened a
hearing with HHS Secretary Xavier Becerra on the subject.
UnitedHealth Group's Cyberattack
Bipartisan investigation into the effects of a cyberattack
on UnitedHealth Group's subsidiary. The Committee met with
providers, insurance companies, competitor companies, as well
as reviewed relevant documents, including in camera. The
Committee convened a hearing with the CEO and continues to
review documents as they are produced. The investigation was
ongoing at the end of the 118th Congress.
World Anti-Doping Agency
Bipartisan inquiry into the World Anti-Doping Agency's
refusal to ban or suspend Chinese swimmers testing positive for
a banned substance. The Committee sent a letter, convened a
hearing with two Olympians and the U.S. Anti-Doping Agency
(WADA was invited but refused to attend) and met with
representatives and officials with the U.S. Olympic and
Paralympic Committee (USOPC) The Committee continues to have
regular meetings with USADA and USOPC.
Subcommittee on Communications and Technology
LEGISLATIVE ACTIVITIES
Foreign Adversary Communications Transparency Act
H.R. 820
To direct the Federal Communications Commission to publish
a list of entities that hold authorizations, licenses, or other
grants of authority issued by the Commission and that have
certain foreign ownership, and for other purposes.
Summary
H.R. 820 would require the Federal Communications
Commission to annually publish a list of entities that hold a
license or authorization granted by the FCC and have ties to
specific countries. An entity must be listed if the government
of China, Cuba, Iran, North Korea, Russia, or Venezuela (or an
organization subject to the jurisdiction of any of those
governments) owns an entity interest in the entity. The FCC may
list additional entities that do not meet these requirements
after consulting with an appropriate national security agency.
Legislative History
H.R. 820 was introduced by Representative Stefanik (R-NY)
on February 2, 2023, and was referred to the Committee on
Energy and Commerce.
On February 15, 2024, the Subcommittee on Communications
and Technology held a hearing on H.R. 820.
On March 12, 2024, the Subcommittee on Communications and
Technology favorably forwarded H.R. 820, as amended, to the
full committee by a vote of 22 to 0.
On March 20, 2024, the full committee favorably reported
H.R. 820 to the House by a vote of 44 to 0.
Future Uses of Technology Upholding Reliable and Enhanced (FUTURE)
Networks Act
H.R. 1513
To direct the Federal Communications Commission to
establish a task force to be known as the ``6G Task Force'',
and for other purposes.
Summary
H.R. 1513 would require the Federal Communications
Commission to establish a 6G Task Force to report on sixth-
generation wireless technology, including the status of
settling standards for and possible uses of such technology.
The task force would be composed of representatives of (1)
trusted companies in the communications industry; (2) trusted
public interest organizations or academic institutions; and (3)
federal, state, local, and tribal governments.
Legislative History
H.R. 1513 was introduced by Representative Matsui (CA-D) on
March 9, 2023, and referred to the Committee on Energy and
Commerce.
On February 15, 2024, the Subcommittee on Communications
and Technology held a hearing on H.R. 1513.
On March 12, 2024, the Subcommittee on Communications and
Technology favorably forwarded H.R. 1513 to the full committee
by a vote of 23 to 0.
On March 20, 2024, the full committee favorably reported
H.R. 1513 to the House by a vote of 44 to 0.
Countering CCP Drones Act
H.R. 2864
To amend the Secure and Trusted Communications Networks Act
of 2019 to provide for the addition of certain equipment and
services produced or provided by DJI Technologies to the list
of covered communications equipment or services published under
such Act
Summary
H.R. 2864 would require the inclusion of telecommunications
and video surveillance equipment or services produced or
provided by Shenzhen Da-Jiang Innovations Sciences and
Technologies Company Limited (a Chinese drone maker commonly
known as DJI Technologies) on a list of communications
equipment or services determined by the Federal Communications
Commission (FCC) to pose an unacceptable risk to U.S. national
security. Current law prohibits the use of federal funding
available through specified FCC programs for purchasing or
maintaining listed equipment or services.
Legislative History
H.R. 2864 was introduced by Representative Stefanik (NY-R)
on April 25, 2023, and referred to the Committee on Energy and
Commerce.
On February 15, 2024, the Subcommittee on Communications
and Technology held a hearing on H.R. 2864.
On March 12, 2024, the Subcommittee on Communications and
Technology favorably forwarded H.R. 2864 to the full committee
by a vote of 21 to 0.
On March 20, 2024, the full committee favorably reported
H.R. 2864 to the House by a vote of 43 to 0.
ROUTERS Act
H.R. 7589
To direct the Secretary of Commerce, acting through the
Assistant Secretary of Commerce for Communications and
Information, to conduct a study of the national security risks
posed by consumer routers, modems, and devices that combine a
modem and router, and for other purposes.
Summary
H.R. 7589 would require the Secretary of Commerce, through
the Assistant Secretary for Communications and Information, to
conduct a study of the national security risks posed by
routers, modems, or devices that combine both, that are
designed, developed, manufactured, or supplied by persons owned
by, controlled by or subject to the jurisdiction or direction
of the People's Republic of China, Iran, North Korea, or
Russia.
Legislative History
H.R. 7589 was introduced by Representative Latta (OH-R) on
March 8, 2024, and referred to the Committee on Energy and
Commerce.
On February 15, 2024, the Subcommittee on Communications
and Technology held a hearing on H.R. 7589.
On March 12, 2024, the Subcommittee on Communications and
Technology favorably forwarded H.R. 7589 to the full committee
by a vote of 23 to 0.
On March 20, 2024, the full committee favorably reported
H.R. 7589 to the House by a vote of 43 to 0.
Secure Space Act of 2023
H.R. 675
To amend the Secure and Trusted Communications Networks Act
of 2019 to prohibit the Federal Communications Commission from
granting a license or United States market access for a non-
geostationary orbit satellite system if the license or grant of
market access would be held or controlled by an entity that
produces or provides any covered communications equipment or
service or an affiliate of such an entity, and for other
purposes.
Summary
H.R. 675 would prohibit the Federal Communications
Commission (FCC) from granting licenses or access to U.S.
markets for geostationary or non-geostationary orbit satellite
systems or authorizations for related earth-based stations that
communicate with those systems to certain producers or
providers of communications equipment or services.
Specifically, the FCC may not grant a license, market access,
or authorization to an entity that produces or provides
equipment or a service that the FCC determines poses an
unacceptable risk to national security or the security and
safety of U.S. persons (e.g., Huawei Technologies Company and
China Mobile International USA Inc.).
Geostationary satellite systems include satellites that
stay in the same position relative to points on the Earth's
surface. Non-geostationary satellite systems are comprised of
satellites that do not maintain a stationary position but
rather move in relation to the Earth's surface. Both types of
systems may be used to provide broadband and other
telecommunications services.
Legislative History
H.R. 675 was introduced by Representative Pallone (NJ-D) on
January 31, 2023, and referred to the Committee on Energy and
Commerce.
On February 8, 2023, the Subcommittee on Communications and
Technology held a hearing on H.R. 675.
On March 8, 2023, the Subcommittee on Communications and
Technology favorably forwarded H.R. 675, as amended, to the
full Committee by a vote of 26 to 0.
On March 24, 2023, the full Committee on Energy and
Commerce favorably reported H.R. 675, as amended, to the House
by a vote of 46 to 0.
Launch Communications Act
H.R. 682
To facilitate access to electromagnetic spectrum for
commercial space launches and commercial space reentries.
Summary
H.R. 682 would require the Federal Communications
Commission (FCC) to facilitate access to specified broadband
spectrum frequencies for commercial space launches and
reentries.
Under current law, commercial missions launching from the
United States to space must use government-owned spectrum to
communicate with the rockets during launch, and private
companies must apply to the FCC to receive special temporary
authority to use such spectrum. On June 28, 2021, the FCC
issued a final rule adopting a nonfederal secondary allocation
of the 2200-2290 megahertz frequencies of the electromagnetic
spectrum for use during commercial space launches and
reentries.
The bill would require the FCC to adopt service rules for
access to additional frequencies for commercial space launches
and reentries and complete associated rulemaking activities
(e.g., those that set technical specifications and eligibility
requirements) to implement the allocation of the frequencies.
The FCC must also streamline the process for access
authorizations, providing for (1) authorizations to access
specified frequencies for multiple commercial space launches
and reentries from one or more launch or reentry sites, (2)
authorizations for multiple uses of such frequencies for a
commercial space launch or reentry, (3) automation of the FCC's
review process for access applications, and (4) increased
coordination between the FCC and the National
Telecommunications and Information Administration to speed the
review of such applications.
Legislative History
H.R. 682 was introduced by Representative Soto (FL-D) on
January 31, 2023, and referred to the Committee on Energy and
Commerce.
On February 8, 2023, the Subcommittee on Communications and
Technology held a hearing on H.R. 682.
On March 8, 2023, the Subcommittee on Communications and
Technology favorably forwarded H.R. 682, as amended, to the
full committee by a vote of 26 to 0.
On March 24, 2023, the full committee favorably reported
H.R. 682, as amended, to the House by a vote of 46 to 0.
On July 25, 2023, Representative Latta moved to suspend the
rules and pass H.R. 682, as amended. The House agreed to the
motion by a voice vote.
On July 26, 2023, H.R. 682 was received in the Senate and
referred to the Committee on Commerce, Science, and
Transportation.
Satellite and Telecommunications (SAT) Streamlining Act
H.R. 1338
To amend the Communications Act of 1934 to provide
authority for certain licenses, and for other purposes.
Summary
H.R. 1338 would direct the Federal Communications
Commission (FCC) to revise its regulations that govern licenses
and grants of U.S. market access for geostationary and non-
geostationary orbital satellites. Geostationary orbital
satellites maintain a stationary position in orbit while non-
geostationary satellites move in relation to the Earth's
surface; these satellites may be used to provide broadband and
other telecommunications services.
The bill would specify deadlines by which the FCC must
decide whether to approve an application for a license or grant
of market access. Generally, the FCC must make a decision on
(1) an initial application or a major modification of an
application within one year, (2) a renewal of an application
within 180 days, and (3) a minor modification of an application
within 90 days. The bill allows the FCC to extend the deadlines
in some instances, such as when an application raises national
security and law enforcement concerns.
The FCC regulations would include performance objectives
for space safety and orbital debris that are specific,
measurable, and technology-neutral.
The FCC would also include requirements related to the
sharing of the electromagnetic spectrum band by licensees and
grantees. For example, the FCC must (1) require licensees and
grantees to make a good faith effort to coordinate their use of
the spectrum with others, and (2) establish a quantifiable
level of protection from harmful interference for other
authorized users of the spectrum.
Legislative History
H.R. 1338 was introduced by Representative McMorris Rodgers
(WA-R) on March 3, 2023, and referred to the Committee on
Energy and Commerce.
On February 8, 2023, the Subcommittee on Communications and
Technology held a hearing on H.R. 1338.
On March 8, 2023, the Subcommittee on Communications and
Technology favorably forwarded H.R. 1338 to the full committee
by a vote of 23 to 0.
On March 24, 2023, the full committee favorably reported
H.R. 1338, as amended, to the House by a vote of 44 to 0.
On July 25, 2023, Representative Latta moved to suspend the
rules and pass H.R. 1338, as amended. The motion failed by a
vote of 250 to 163 to 1.
Advanced, Local Emergency Response Telecommunications (ALERT) Parity
Act
H.R. 1353
To direct the Federal Communications Commission to issue
rules for the provision of emergency connectivity service, and
for other purposes.
Summary
H.R. 1353 would require the Federal Communications
Commission (FCC) to facilitate the provision of emergency
communication services (e.g., 9-1-1 calls and emergency alerts)
in unserved areas. An unserved area is one that has no
commercial mobile service capable of providing emergency
services because of a lack of infrastructure, destruction of
infrastructure, a power outage, or other reason.
The FCC must establish a process for companies to apply for
approval to access the electromagnetic spectrum in order to
provide emergency services in unserved areas. To obtain
approval, a company must demonstrate that it (1) has a
technical proposal for providing services, (2) will not use the
spectrum to provide additional services, and (3) has the
capability to provide the services rapidly. The company must
also demonstrate that the services can withstand earthquakes,
hurricanes, and other major disasters. The FCC must publish a
list of approved providers online.
The bill would provide protections for authorized users of
the spectrum. For example, a provider with FCC approval to
provide emergency services to an area under this bill may only
access the spectrum if (1) the entity that is typically
authorized to use it expressly consents in writing to the
approved provider's use, and (2) the approved provider's use
does not interfere with the authorized entity's use. Authorized
entities that receive a request for consent must reasonably
engage with the provider submitting the request.
The bill would also limit the liability of an approved
provider for certain harms resulting from the transmission of
(or failure to transmit) emergency alerts or the release of
subscriber information when delivering an alert.
Legislative History
H.R. 1353 was introduced by Representative Bill Johnson
(OH-R) on March 3, 2023, and referred to the Committee on
Energy and Commerce.
On February 8, 2023, the Subcommittee on Communications and
Technology held a hearing on H.R. 1353.
On March 8, 2023, the Subcommittee on Communications and
Technology favorably forwarded H.R. 1353 to the full committee
by a vote of 27 to 0.
On March 24, 2023, the full committee favorably reported
H.R. 1353, as amended, to the House by a vote of 46 to 0.
On April 25, 2023, Representative Latta moved to suspend
the rules and pass H.R. 1353, as amended. The motion passed by
a vote of 422 to 1 (Roll no. 197) on April 26, 2023.
On April 27, 2023, H.R. 1353 was received in the Senate and
referred to the Committee on Commerce, Science, and
Transportation.
Protecting Americans From Foreign Adversary Controlled Applications Act
PUBLIC LAW 118-50 (H.R. 7521)
To protect the national security of the United States from
the threat posed by foreign adversary controlled applications,
such as TikTok and any successor application or service and any
other application or service developed or provided by ByteDance
Ltd. or an entity under the control of ByteDance Ltd.
Summary
H.R. 7521 prohibits distributing, maintaining, or providing
internet hosting services for a foreign adversary controlled
application (e.g., TikTok). However, the prohibition does not
apply to a covered application that executes a qualified
divestiture as determined by the President.
Under the bill, a foreign adversary controlled application
is directly or indirectly operated by (1) ByteDance, Ltd. or
TikTok (including subsidiaries or successors that are
controlled by a foreign adversary); or (2) a social media
company that is controlled by a foreign adversary and has been
determined by the President to present a significant threat to
national security. The prohibition does not apply to an
application that is primarily used to post product reviews,
business reviews, or travel information and reviews.
The bill authorizes the Department of Justice to
investigate violations of the bill and enforce the bill's
provisions. Entities that violate the bill are subject to civil
penalties based on the number of users.
The bill requires a covered application to provide a user
with all available account data (including posts, photos, and
videos) at the user's request before the prohibition takes
effect.
The bill gives the U.S. Court of Appeals for the District
of Columbia exclusive jurisdiction over any challenge to the
bill. Further, a challenge to the bill must be brought within
165 days after the bill's enactment date. A challenge to any
action, finding, or determination under the bill must be
brought with 90 days of the action, finding, or determination.
Legislative History
H.R. 7521 was introduced by Representative Gallagher (WI-R)
on March 5, 2024.
On March 7, 2024, the full committee held a hearing on H.R.
7521. During the hearing, the committee voted to go into closed
executive session to receive classified information. Following
the hearing, the full committee met in open markup session to
consider H.R. 7521. The committee favorably reported the bill
to the House by a vote of 50 to 0.
On March 13, 2024, Representative McMorris Rodgers moved to
suspend the rules and pass H.R. 7521, as amended. The motion
passed by a vote of 352 to 65 to 1.
On March 14, 2024, H.R. 7521 was received in the Senate and
referred to the Committee on Commerce, Science, and
Transportation.
The text of H.R. 7521 was included in H.R. 815.
On April 23, 2024, H.R. 815 passed the Senate by a vote of
79 to 18 (Record Vote Number 154). On April 24, 2024, President
Biden signed H.R. 815 into law (Public Law 118-50).
Broadband Incentives for Communities Act
H.R. 1241
To direct the Assistant Secretary of Commerce for
Communications and Information to establish a competitive grant
program to assist local governments in providing efficient
review and approval of zoning and permitting applications that
facilitate the deployment of broadband infrastructure, and for
other purposes.
Summary
H.R. 1241 would require the National Telecommunications and
Information Administration (NTIA) to establish a grant program
to assist local governments and Indian tribes with efficient
review and approval of zoning or permitting applications that
facilitate the deployment of broadband infrastructure.
Grant recipients must use awarded funds to build
application processing capacity or to purchase technology,
software, and equipment to facilitate the processing of
applications.
The NTIA must also establish the Local Broadband Advisory
Council to develop solutions to challenges faced by local
governments, Indian tribes, and infrastructure providers in
facilitating wireless and broadband deployment, including in
unserved and underserved communities.
Legislative History
H.R. 1241 was introduced by Representative Fletcher (TX-D)
on February 28, 2023, and referred to the Committee on Energy
and Commerce.
On April 19, 2023, the Subcommittee on Communications and
Technology held a hearing on H.R. 1241.
Community Broadband Act of 2023
H.R. 2552
To amend the Telecommunications Act of 1996 to preserve and
protect the ability of State and local governments, public-
private partnerships, and cooperatives to provide broadband
services.
Summary
H.R. 2552 would prohibit states from blocking the provision
of broadband by public providers, public-private partnership
providers, or cooperatively organized providers. Further,
public providers and state or local entities participating in a
partnership must administer applicable ordinances and rules
without discrimination against competing private providers.
Legislative History
H.R. 2552 was introduced by Representative Eshoo (CA-D) on
April 10, 2023, and referred to the Committee on Energy and
Commerce.
On April 19, 2023, the Subcommittee on Communications and
Technology held a hearing on H.R. 2552.
CABLE Expansion Act
H.R. 3330
To amend the Communications Act of 1934 to preserve cable
franchising authority, provide for faster deployment of cable
and other services, and for other purposes.
Summary
H.R. 3330 would modify the requirements governing decisions
about the placement, construction, or modification of equipment
and related facilities that are used in or attached to cable
communications systems.
Specifically, state or local governments, their
instrumentalities, or franchise authorities (state or local
entities that regulate certain aspects of cable operators) may
not regulate the placement, construction, or modification of
cable equipment or facilities in a manner that effectively
prohibits a cable operator from providing or enhancing its
service under a franchise granted by one of those entities.
Additionally, the bill would require those entities to
approve or deny a complete request to place, construct, or
modify cable equipment or facilities within specified time
frames. Failure to respond to the request within the specified
time frame deems it automatically approved. Further, the bill
would require that any denial of a request must be in writing,
supported by substantial evidence contained in a written
record, and publicly released at the same time as the decision
is made.
The bill would also permit an entity to charge fees for
considering requests provided that the fees are (1)
nondiscriminatory, (2) publicly disclosed in advance, and (3)
based on actual and direct costs.
The modifications concerning the time frames for decisions
and the fees apply retroactively to requests that are submitted
prior to the enactment of the bill but have not been approved
or denied.
Legislative History
H.R. 3330 was introduced by Representative Lesko (AZ-R) on
May 15, 2023, and referred to Committee on Energy and Commerce.
On April 19, 2023, the Subcommittee on Communications and
Technology held a hearing on H.R. 3330.
To Amend the Communications Act of 1934 To Extend the Authority of the
Federal Communications Commission To Grant a License or Construction
Permit Through a System of Competitive Bidding
H.R. 1108
Summary
H.R. 1108 would extend through May 19, 2023, the authority
of the Federal Communications Commission to conduct auctions
for electromagnetic spectrum licenses. (The authority currently
expires on March 9, 2023.)
Legislative History
H.R. 1108 was introduced by Representative McMorris Rodgers
(WA-R) on February 21, 2023, and referred to the Committee on
Energy and Commerce.
On February 27, 2023, H.R. 1108 was considered in the House
under a motion to suspend the Rules, and the bill, without
amendment, was passed by a voice vote.
On March 3, 2023, H.R. 1108 was received in the Senate,
read twice, and referred to the Committee on Commerce, Science,
and Transportation.
Understanding Cybersecurity of Mobile Networks Act
H.R. 1123
To direct the Assistant Secretary of Commerce for
Communications and Information to submit to Congress a report
examining the cybersecurity of mobile service networks, and for
other purposes.
Summary
H.R. 1123 would require the National Telecommunications and
Information Administration to examine and report on the
cybersecurity of mobile service networks and the vulnerability
of these networks and mobile devices to cyberattacks and
surveillance conducted by adversaries.
The report would include (1) an assessment of the degree to
which providers of mobile service have addressed certain
cybersecurity vulnerabilities; (2) a discussion of the degree
to which these providers have implemented cybersecurity best
practices and risk assessment frameworks; and (3) an estimate
of the prevalence and efficacy of encryption and authentication
algorithms and techniques used in mobile service and
communications equipment, mobile devices, and mobile operating
systems and software.
Legislative History
H.R. 1123 was introduced by Representative Eshoo (CA-D) on
February 21, 2023, and referred to the Committee on Energy and
Commerce.
On March 3, 2023, H.R. 1123 was considered in the House
under a motion to suspend the Rules, and the bill, as amended,
was passed by a vote of 393 to 22 (Roll no. 133).
On March 8, 2023, H.R. 1123 was received in the Senate,
read twice, and referred to the Committee on Commerce, Science,
and Transportation.
Open RAN Outreach Act
H.R. 1340
To provide outreach and technical assistance to small
providers regarding Open RAN networks, and for other purposes.
Summary
H.R. 1340 would require the National Telecommunications and
Information Administration (NTIA) to conduct outreach and
provide technical assistance to small communications network
providers to raise awareness of the benefits, uses, and
challenges of Open RAN networks and other open network
architectures. Open RAN networks are wireless networks that
follow the Open Radio Access Network approach to
standardization, promoting the use of open interface standards
in the portion of the telecommunications network that connects
wireless devices (e.g., mobile phones) to the core of the
network.
The NTIA would also be required to conduct outreach and
provide assistance regarding participation in the Wireless
Supply Chain Innovation Grant Program.
Legislative History
H.R. 1340 was introduced by Representative Allred (TX-D) on
March 3, 2023, and referred to the Committee on Energy and
Commerce.
On March 8, 2023, the Subcommittee on Communications and
Technology favorably forwarded H.R. 1340 to the full committee
by a vote of 26 to 0.
On March 23, 2023, the full committee favorably reported
H.R. 1340 to the House by a vote of 49 to 0.
Spectrum Coordination Act
H.R. 1341
To improve Federal coordination with respect to spectrum
management, and for other purposes.
Summary
H.R. 1341 would require periodic updates to the memorandum
of understanding (MOU) that guides federal efforts to
coordinate the efficient management and use of the
electromagnetic spectrum. It also requires documentation of
interagency coordination during spectrum actions.
Specifically, the Federal Communications Commission (FCC)
and the National Telecommunications and Information
Administration (NTIA) would be required to update the current
MOU within three years and then update subsequent MOUs at least
every four years thereafter.
Additionally, the NTIA and the FCC must document their
efforts to coordinate the identification and resolution of
technical, procedural, or policy concerns of federal entities
that are affected by a spectrum action (i.e., a proposed action
by the FCC to reallocate spectrum that is anticipated to result
in an auction or licensing that could potentially impact the
spectrum operations of a federal entity).
The NTIA must file specified information in the public
record during the period for submitting comments about the
spectrum action. The information must include (1) the date on
which the FCC notified the NTIA about the action, (2) a list of
federal entities that may be affected by the action, (3) the
date on which the NTIA notified those entities about the
action, and (4) a summary of concerns with the action raised by
affected entities.
The bill would also require the FCC to include in any final
rule for a spectrum action an interagency coordination summary
that describes (1) the date the FCC notified the NTIA about the
spectrum action, (2) whether federal entities raised concerns,
and (3) how any concerns were resolved.
Legislative History
H.R. 1341 was introduced by Representative Balderson (OH-R)
on March 3, 2023, and referred to the Committee on Energy and
Commerce.
On March 8, 2023, the Subcommittee on Communications and
Technology favorably forwarded H.R. 1341 to the full committee
by a vote of 27 to 0.
On March 23, 2023, the full committee favorably reported
H.R. 1341 to the House by a vote of 49 to 0.
Institute for Telecommunication Services (ITS)
Codification Act
H.R. 1343
To codify the Institute for Telecommunication Sciences and
to direct the Assistant Secretary of Commerce for
Communications and Information to establish an initiative to
support the development of emergency communication and tracking
technologies, and for other purposes.
Summary
H.R. 1343 would provide statutory authority for the
Institute for Telecommunication Sciences, which serves as the
telecommunications research and engineering arm of the National
Telecommunications and Information Administration.
In addition, the institute must establish an initiative to
support the development of emergency communication and tracking
technologies for use in locating trapped individuals in
confined spaces where conventional radio communication is
limited.
Legislative History
H.R. 1343 was introduced by Representative Carter (GA-R) on
March 3, 2023, and referred to the Committee on Energy and
Commerce.
On January 30, 2018, the Subcommittee on Communications
forwarded the bill to the full committee by a vote of 27 to 0.
On March 24, 2023, the full committee favorably reported
H.R. 1343 to the House by a vote of 49 to 0.
On April 25, 2023, H.R. 1343 was considered in the House
under a motion to suspend the Rules, and the bill was passed by
a voice vote.
On April 26, 2023, H.R. 1343 was received in the Senate,
read twice, and referred to the Committee on Commerce, Science,
and Transportation.
NTIA Policy and Cybersecurity Coordination Act
H.R. 1345
To amend the National Telecommunications and Information
Administration Organization Act to establish the Office of
Policy Development and Cybersecurity, and for other purposes.
Summary
H.R. 1345 would establish the Office of Policy Development
and Cybersecurity within the National Telecommunications and
Information Administration to analyze and develop policies
related to internet and communications technologies.
Specific activities of the office would include, for
example, developing policies that promote (1) innovation,
competition, and other elements of the communications, media,
and technology markets; (2) security and resilience to
cybersecurity incidents while fostering innovation; and (3)
commercialization of communications technologies.
Legislative History
H.R. 1345 was introduced by Representative Curtis (UT-R) on
March 3, 2023, and referred to the Committee on Energy and
Commerce.
On March 8, 2023, the Subcommittee on Communications and
Technology favorably forwarded H.R. 1345 to the full committee
by a vote of 26 to 0.
On March 24, 2023, the full committee favorably reported
H.R. 1345 to the House by a vote of 44 to 0.
On July 25, 2023, H.R. 1345 was considered in the House
under a motion to suspend the Rules, and the bill was passed by
voice vote.
On July 26, 2023, H.R. 1345 was received in the Senate,
read twice, and referred to the Committee on Commerce, Science,
and Transportation.
Information and Communication Technology Strategy Act
H.R. 1354
To require the Secretary of Commerce, acting through the
Assistant Secretary of Commerce for Communications and
Information, to report on and develop a whole-of-Government
strategy with respect to the economic competitiveness of the
information and communication technology supply chain, and for
other purposes.
Summary
H.R. 1354 would require the National Telecommunications and
Information Administration to report on the information and
communication technology supply chain and to develop a strategy
to ensure the economic competitiveness of trusted information
and communication technology vendors.
The report must include (1) an identification of technology
that is critical to U.S. economic competitiveness and the
industrial capacity of U.S. vendors and other trusted vendors
that produce such technology, (2) an assessment of whether and
to what extent there is a dependence by providers of advanced
telecommunications capability in the United States on
technology that is not trusted, and (3) an identification of
federal government actions and resources needed to support the
economic competitiveness of trusted vendors and reduce
dependence on companies that are not trusted.
Legislative History
H.R. 1354 was introduced by Representative Joyce (PA-R) on
March 3, 2023, and referred to the Committee on Energy and
Commerce.
On March 8, 2023, the Subcommittee on Communications and
Technology favorably forwarded H.R. 1354 to the full committee
by a vote of 28 to 0.
On March 24, 2023, the full committee favorably reported
H.R. 1354 to the House by a vote of 48 to 0.
American Cybersecurity Literacy Act
H.R. 1360
To establish a cybersecurity literacy campaign, and for
other purposes.
Summary
H.R. 1360 would require the National Telecommunications and
Information Administration to develop and conduct a
cybersecurity literacy campaign to increase knowledge and
awareness of best practices to reduce cybersecurity risks.
Legislative History
H.R. 1360 was introduced by Representative Obernolte (CA-R)
on March 3, 2023, and referred to the Committee on Energy and
Commerce.
On March 8, 2023, the Subcommittee on Communications and
Technology favorably forwarded H.R. 1360 to the full committee
by a vote of 26 to 0.
On March 24, 2023, the full committee favorably reported
H.R. 1360 to the House by a vote of 49 to 0.
Communications Security Act
H.R. 1370
To direct the Federal Communications Commission to
establish a council to make recommendations on ways to increase
the security, reliability, and interoperability of
communications networks, and for other purposes.
Summary
H.R. 1370 would provide statutory authority and set forth
membership requirements for a council that provides advice and
recommendations to the Federal Communications Commission (FCC)
regarding ways to increase the security, reliability, and
interoperability of communications networks.
The bill specifies that the council must include
representatives of companies in the communications industry;
public interest organizations or academic institutions; and
federal, state, tribal, and local governments (with at least
one member representing each level of government).
The FCC could designate an existing advisory committee to
serve as the council, provided that the committee's membership
is modified (if necessary) to comply with the requirements
specified in the bill.
Legislative History
H.R. 1370 was introduced by Representative Slotkin (MI-D)
on March 3, 2023, and referred to the Committee on Energy and
Commerce.
On March 8, 2023, the Subcommittee on Communications and
Technology favorably forwarded H.R. 1370 to the full committee
by a vote of 26 to 0.
On March 24, 2023, the full committee favorably reported
H.R. 1370 to the House by a vote of 49 to 0.
Promoting United States Wireless Leadership Act of 2023
H.R. 1377
To direct the Assistant Secretary of Commerce for
Communications and Information to take certain actions to
enhance the representation of the United States and promote
United States leadership in communications standards-setting
bodies, and for other purposes.
Summary
H.R. 1377 would require the Department of Commerce to
assist trusted companies (i.e., companies determined to pose no
national security threat) and relevant stakeholders with
participation in organizations that set standards for
telecommunications, wireless devices, and related equipment.
Legislative History
H.R. 1377 was introduced by Representative Walberg (MI-R)
on March 3, 2023, and referred to the Committee on Energy and
Commerce and in addition to the Committee on Foreign Affairs.
On March 8, 2023, the Subcommittee on Communications and
Technology favorably forwarded H.R. 1377 to the full committee
by a vote of 28 to 0.
On March 24, 2023, the full committee favorably reported
H.R. 1377 to the House by a vote of 50 to 0.
Artificial Intelligence Accountability Act
H.R. 3369
To direct the Assistant Secretary of Commerce for
Communications and Information to conduct a study and hold
public meetings with respect to artificial intelligence
systems, and for other purposes.
Summary
H.R. 3369 would require the National Telecommunications and
Information Administration (NTIA) to study and report on
accountability measures for artificial intelligence (AI)
systems. (Generally, AI refers to computerized systems that
work and react in ways commonly thought to require human
intelligence, such as certain systems that solve complex
problems in real-world situations.)
Specifically, the NTIA must study, solicit stakeholder
feedback about, and report to Congress concerning mechanisms
(e.g., audits, certifications, and assessments) to provide
assurances that an AI system is trustworthy. Among other
topics, the study, feedback, and report must address how the
various accountability measures are currently incorporated into
AI systems and how the measures may reduce risks related to AI
systems.
In addition, the NTIA must consult with stakeholders
through public meetings to develop recommendations about (1)
the information that should be available to individuals,
communities, and businesses that interact with, are affected
by, or study AI systems; and (2) the methods for making that
information available.
Legislative History
H.R. 3369 was introduced by Harder (CA-D) on May 16, 2023,
and referred to the Committee on Energy and Commerce.
On July 12, 2023, the Subcommittee on Communications and
Technology favorably forwarded H.R. 3369, as amended, to the
full committee by voice vote.
On July 27, 2023, the full committee favorably forwarded
H.R. 3369, as amended, to the House by a vote of 50 to 0.
Spectrum Relocation Enhancement Act
H.R. 3430
To amend the National Telecommunications and Information
Administration Organization Act to enhance Federal spectrum
relocation, and for other purposes.
Summary
H.R. 3430 would modify procedures related to the relocation
or sharing of federal portions of the electromagnetic spectrum,
including the uses of and requirements for the Spectrum
Relocation Fund (SRF), which is a funding mechanism through
which federal agencies can recover certain costs associated
with spectrum relocation or sharing. The bill permits the SRF
to more broadly cover those costs.
Currently, the SRF covers costs to achieve comparable
capabilities, while the bill permits it to cover costs to
deploy systems that satisfy operational requirements. Further,
the SRF may cover costs for more extensive operational
requirements than those being met before the relocation or
sharing provided that the more extensive costs do not
jeopardize an auction, sharing, or other nonfederal use of the
spectrum.
Additionally, the bill would expand planning and
coordination requirements. This includes (1) specifying more
detailed requirements for transition plans that federal
agencies must submit to receive SRF payments, and (2) requiring
agencies to coordinate with the National Telecommunications and
Information Administration (NTIA) on their transition plans and
other activities.
The bill would also fund administrative support for a
technical panel that reviews the plans for transitioning
federal use of spectrum to nonfederal or shared use.
Legislative History
H.R. 3430 was introduced by Representative Matsui (CA-D) on
May 17, 2023, and referred to the Committee on Energy and
Commerce.
On July 12, 2023, the Subcommittee on Communications and
Technology favorably forwarded H.R. 3430, as amended, to the
full committee by a voice vote.
American Broadband Deployment Act of 2023
H.R. 3557
To streamline Federal, State, and local permitting and
regulatory reviews to expedite the deployment of communications
facilities, and for other purposes.
Summary
H.R. 3557 would streamline federal, state, and local
permitting processes for broadband deployment by establishing
shot clocks for state and local permitting reviews, deemed
granted remedies for missed shot clocks, and exempt deployments
over certain previously disturbed lands from National
Environmental Protection Act (NEPA) and National Historic
Preservation Act (NHPA) reviews.
Legislative History
H.R. 3557 was introduced by Representative Carter (GA-R) on
May 22, 2023, and referred to the Committee on Energy and
Commerce and in addition to the Committee on Natural Resources
and the Committee on Transportation and Infrastructure.
On May 24, 2023, the full committee favorably reported H.R.
3557, as amended, to the House by a vote of 27 to 23.
On October 2, 2023, the Committee on Natural Resources and
the Committee on Transportation and Infrastructure discharged
H.R. 3557 and it was placed on the Union Calendar (Calendar No.
192).
NTIA Reauthorization Act of 2024
H.R. 4510
To reauthorize the National Telecommunications and
Information Administration, to update the mission and functions
of the agency, and for other purposes.
Summary
H.R. 4510 would reauthorize the National Telecommunications
and Information Administration (NTIA) through FY2025 and
modifies its structure and functions.
The bill would promote the head of the NTIA to an Under
Secretary of the Department of Commerce. It would also provide
statutory authority for two NTIA offices focused on public
safety communications and international telecommunications
policy, respectively.
The bill would provide statutory authority for the NTIA
Office of Spectrum Management and otherwise revises the
management of spectrum resources (electromagnetic frequencies
used to transmit signals and data, including wireless
internet). The bill would expand the role of the NTIA with
respect to cybersecurity.
Legislative History
H.R. 4510 was introduced by Representative Latta (OH-R) on
July 10, 2023, and referred to the Committee on Energy and
Commerce.
On July 12, 2023, the Subcommittee on Communications and
Technology favorably forwarded H.R. 4510 to the full committee
by voice vote.
On July 27, 2023, the full committee favorably reported
H.R. 4510, as amended, to the House by a vote of 48-0.
On May 14, 2024, H.R. 4510, as amended, was considered in
the House under a motion to suspend the Rules. On May 15, 2024,
H.R. 4510, as amended, was passed by a vote of 374 to 36 (Roll
no. 205).
On May 16, 2024, the bill was received in the Senate, read
twice, and referred to the Committee on Commerce, Science, and
Transportation.
On July 26, 2023, H.R. 1345 was received in the Senate,
read twice, and referred to the Committee on Commerce, Science,
and Transportation.
5G SALE Act
H.R. 5677
To authorize the Federal Communications Commission to
process applications for spectrum licenses from applicants who
were successful bidders in an auction before the authority of
the Commission to conduct auctions expired on March 9, 2023.
Summary
H.R. 5677 would temporarily authorize the Federal
Communications Commission (FCC) to process applications for
licenses or permits for the use of specified bands of the
electromagnetic spectrum that were auctioned on or before March
9, 2023. The authorization would terminate 90 days after the
enactment of the bill.
The FCC has not processed the licenses or permits for the
previously auctioned spectrum because its authority to conduct
auctions lapsed on March 9, 2023.
Legislative History
H.R. 5677 was introduced by Representative Joyce (PA-R) on
September 22, 2023, and referred to the Committee on Energy and
Commerce.
On December 5, 2023, the full committee favorably reported
H.R. 5677 to the House by a vote of 40 to 0.
TRUSTED Broadband Networks Act
H.R. 3280
To provide that a project to remove and replace
communications equipment or services listed under the Secure
and Trusted Communications Networks Act of 2019 is not subject
to requirements to prepare certain environmental or historical
preservation reviews.
Summary
H.R. 3280 would exclude from specified environmental and
historic preservation reviews a project to permanently remove
and replace communications equipment or services that the
Federal Communications Commission has determined pose a threat
to national security.
Legislative History
On May 15, 2023, Representative Guthrie (KY-R) introduced
H.R. 3280. It was referred to the Committee on Energy and
Commerce, and in addition to the Committee on Natural
Resources.
On May 17, 2023, the Subcommittee on Communications and
Technology favorably forwarded H.R. 3280 to the full committee
by voice vote.
Broadband Competition and Efficient Deployment Act
H.R. 3288
To provide that a project for the collocation of a
telecommunications service facility is not subject to
requirements to prepare certain environmental or historical
preservation reviews.
Summary
H.R. 3288 would remove the requirement to prepare an
environmental or historic preservation review in order to add
or upgrade wireline facilities.
Legislative History
On May 15, 2023, Representative Joyce (PA-R) introduced
H.R. 3288. It was referred to the Committee on Energy and
Commerce, and in addition to the Committee on Natural
Resources.
On May 17, 2023, the Subcommittee on Communications and
Technology favorably forwarded H.R. 3288 to the full committee
by voice vote.
Expediting Federal Broadband Deployment Reviews Act
H.R. 3293
To require the Assistant Secretary of Commerce for
Communications and Information to establish an interagency
strike force to ensure that certain Federal land management
agencies, including the organizational units of such agencies,
prioritize the review of requests for communications use
authorizations, and for other purposes.
Summary
H.R. 3293 would establish an interagency strike force to
support federal land management agencies' review of requests
for communications use authorizations. (A communications use
authorization is required to modify or locate communications
facilities on public lands.)
The strike force must (1) conduct periodic calls with
strike force members to ensure that each agency prioritizes the
review of requests for communications use authorizations, (2)
establish goals for the review of the requests, and (3) monitor
and facilitate agency accountability for meeting the
established goals.
The bill specifies that the strike force must include the
head of the National Telecommunications and Information
Administration, the head of each federal land management
agency, and other members designated by the Department of
Agriculture and the Department of the Interior. The bill also
requires the strike force to report to Congress regarding its
effectiveness.
Legislative History
On May 15, 2023, Representative Duncan (SC-R) introduced
H.R. 3293. It was referred to the Committee on Energy and
Commerce, and in addition to the Committee on Natural Resources
and the Committee on Agriculture.
On May 17, 2023, the Subcommittee on Communications and
Technology favorably forwarded H.R. 3293 to the full committee
by a voice vote.
On May 24, 2023, the full committee favorably reported H.R.
3293 to the House by a vote of 51-0.
Standard FEES Act
H.R. 3309
To amend the Middle Class Tax Relief and Job Creation Act
of 2012 to establish a uniform fee schedule applicable to the
processing of forms for the consideration of applications for
the placement of communications facilities on certain buildings
and other property owned by the Federal Government, and for
other purposes.
Summary
H.R. 3309 would require the General Services Administration
(GSA) to establish, and federal agencies to adopt, a common
schedule of fees for processing certain applications to use
buildings or property owned or managed by the federal
government for locating or modifying transmitting devices,
support structures, or other communications facilities.
The fees must be competitively neutral and based on direct
and actual costs. GSA may provide exceptions to the fees if the
exceptions (1) are competitively neutral with respect to the
categories of individuals or entities that are granted
exceptions, and (2) serve a public benefit and the interest of
expanding broadband deployment. The bill would limit an
agency's use of the fees to amounts made available in advance
through appropriations acts.
Legislative History
On May 15, 2023, Representative Palmer (AL-R) introduced
H.R. 3309. It was referred to the Committee on Transportation
and Infrastructure, and in addition to the Committee on Energy
and Commerce.
On May 17, 2023, the Subcommittee on Communications and
Technology favorably forwarded H.R. 3309 to the full committee
by voice vote.
On May 24, 2023, the full committee favorably reported H.R.
3309 to the House by a vote of 50 to 0.
OVERSIGHT ACTIVITIES
Satellite Innovation and Security
On February 2, 2023, the Subcommittee on Communications and
Technology held a hearing entitled ``Launching into the State
of the Satellite Marketplace.'' The purpose of the hearing was
understand how the satellite communications marketplace has
changed in recent years, discuss the FCC's role in licensing
satellite communications systems, and examine how the U.S. can
encourage innovation and maintain leadership in the satellite
communications marketplace. The Subcommittee received testimony
from Tom Stroup, President, Satellite Industry Association;
Julie Zoller, Head of Global Regulatory Affairs, Project Kuiper
at Amazon; Jennifer Manner, Senior Vice President of Regulatory
Affairs, EchoStar Corporation; Margo Deckard, Co-Founder and
Chief Operating Officer, Lynk Global, Inc.; Kari Bingen,
Director, Aerospace Security Project and Senior Fellow,
International Security Program, Center for Strategic and
International Studies.
On February 8, 2023, the Subcommittee on Communications and
Technology held a hearing entitled ``Liftoff: Unleashing
Innovation in Satellite Communication Technologies.'' The
purpose of the hearing was to understand the challenges that
exist in the FCC's regulatory process for licensing commercial
satellite communications services, discuss how Congress can
encourage innovation, competition, and U.S. leadership in the
commercial satellite marketplace, and to review 5 pieces of
legislation. The Subcommittee received testimony from William
Richardson, Deputy Associate General Counsel for Agenda Review,
Federal Communications Commission; Charles Glass, Chief,
International Spectrum Policy Division, National
Telecommunications and Information Administration; David
Goldman, Senior Director of Satellite Policy, SpaceX; Peter
Davidson, Vice President of Global Government Affairs & Policy,
Intelsat; Whitney Q. Lohmeyer, Professor of Engineering, Olin
College of Engineering; Danielle Pineres, Vice President of
Regulatory Affairs & Compliance, Planet Labs.
American Wireless Leadership
On March 10, 2023, the Subcommittee on Communications and
Technology held a hearing entitled ``Defending America's
Wireless Leadership.'' The purpose of the hearing was to
understand the role of licensed and unlicensed spectrum in our
economy, discuss how FCC and NTIA coordinate spectrum
management activities, and discover the negative impact of
ceding leadership for spectrum policy. The Subcommittee
received testimony from Brad Gillen, Executive Vice President,
CTIA--The Wireless Association; James Assey, Executive Vice
President, NCTA--The Internet and Television Association; Clete
Johnson, Senior Fellow, Center for Strategic and International
Studies; Monisha Ghosh, Professor, Department of Electrical
Engineering at the University of Notre Dame.
Defending Free Speech From Censorship
On March 28, 2023, the Subcommittee on Communications and
Technology held a hearing entitled ``Preserving Free Speech and
Reining in Big Tech Censorship.'' The purpose of the hearing
was understanding the effect of Big Tech censorship on freedom
of expression, examining the role of Section 230 in
facilitating censorship, and determining Big Tech's role in
upholding the spirit of the First Amendment. The Subcommittee
received testimony from Seth Dillon, CEO, The Babylon Bee; Dr.
Jay Bhattacharya, M.D., Ph.D., Professor of Health Policy,
Stanford University; Mr. Michael Shellenberger, Founder and
President of Environmental Progress; Spencer Overton, Patricia
Roberts Harris Research Professor, George Washington University
Law School; President, The Joint Center for Political and
Economic Studies.
Rural Broadband
On September 21, 2023, the Subcommittee on Communications
and Technology held a hearing entitled ``Connecting Every
American: The Future of Rural Broadband Funding.'' The purpose
of the hearing was to discuss the future of the USF program,
how to eliminate waste, fraud, and abuse in the Lifeline
program, and examine IIJA. The Subcommittee received testimony
from Jonathan Spalter, President & CEO, USTelecom--The
Broadband Association; Justin Forde, Vice President, Vice
President of Government Relations, MidCo; Scott Wallsten,
President and Senior Fellow, Technology Policy Institute; Sara
Nichols Senior Planner, Land of Sky Regional Council of
Government.
On May 10, 2024, the Subcommittee on Communications and
Technology held a field hearing entitled ``Perspectives from
the Fields: The State of Rural Broadband in America.'' The
purpose of the hearing was to understand how connectivity
benefits rural agriculture communities, hear how precision
agriculture technology is impacted from high-speed broadband
connectivity, and determine what equities the FCC should
consider when rolling out the 5G Fund. The Subcommittee
received testimony from Don Cameron, Vice President/General
Manager, Terranova Ranch; Troy Klinger, Director of Network
Operation, Unwired Broadband, LLC.; Morgan Trembush, Integrated
Solutions Manager, Kern Machinery; Eric Votaw, CEO, Varcomm
Holdings, Inc.
Artificial Intelligence
On November 14, 2023, the Subcommittee on Communications
and Technology held a hearing entitled ``Leveraging AI to
Enhance American Communications.'' The purpose of the hearing
was to understand how companies use AI to scale businesses and
optimize productivity, examine challenges and opportunities for
telecommunications, and ensure datasets used to train AI are
fair and protect American's data privacy. The Subcommittee
received testimony from Courtney Lang, Vice President of
Policy, Trust, Data, and Technology, The Information Technology
Industry Council; Mr. Sam Rubin, Vice President, Global Head of
Operations, Unit 42, Palo Alto Networks; Dr. Sameh Yamany,
Chief Technology Officer, VIAVI Solutions; Dr. Nicol Turner
Lee, Ph.D., Senior Fellow in Governance Studies and Director,
Center for Technology Innovation, Brookings Institution.
Broadband Takeover
On November 30, 2023, the Subcommittee on Communications
and Technology held a hearing entitled ``Oversight of President
Biden's Broadband Takeover.'' The purpose of the hearing was to
examine why necessary to impose heavy regulations on broadband
networks, hear how the FCC plans to enforce its new digital
discrimination rules and whether the FCC will impose more
regulations. The Subcommittee received testimony from the
Honorable Jessica Rosenworcel, Chairwoman, Federal
Communications Commission; the Honorable Brendan Carr,
Commissioner, Federal Communications Commission; the Honorable
Geoffrey Starks, Commissioner, Federal Communications
Commission; the Honorable Nathan Simington, Commissioner,
Federal Communications Commission; the Honorable Anna Gomez,
Commissioner, Federal Communications Commission.
On September 10, 2024, the Subcommittee on Communications
and Technology held a hearing entitled, ``From Introduction to
Implementation: A BEAD Program Progress Report.'' The purpose
of the hearing was to determine whether NTIA is allowing states
to deploy the best technology and examine the rules that are
preventing deployment. The Subcommittee received testimony from
Misty Ann Giles, Director and Chief Operating Officer, Montana
Department of Administration; Basil Alwan, Chief Executive
Officer, Tarana Wireless; Shirely Bloomfield, Chief Executive
Officer, NTCA--The Rural Broadband Association; Blair Levin,
Policy Analyst, New Street Research; Non-Resident Fellow,
Metropolitan Policy Project, Brookings Institution.
Communication Cybersecurity
On January 11, 2024, the Subcommittee on Communications and
Technology held a hearing entitled ``Safeguarding Americans'
Communications: Strengthening Cybersecurity in a Digital Era.''
The purpose of the hearing was to examine the most prevalent
cybersecurity vulnerabilities in telecommunications networks,
determine best practices and frameworks in the event of
cybersecurity incidents, and hear whether there are specific
emerging threats or attack vectors that experts believe pose
risks to the industry in the future. The Subcommittee received
testimony from Jim Richberg, Head of Cyber Policy, Fortinet;
Tobin Richardson, President and CEO, Connectivity Standards
Alliance; Clete Johnson, Senior Fellow, Center for Strategic &
International Studies; Alan Butler, Executive Director and
President, Electronic Privacy Information Center.
Strengthening Open Radio Access Networks
On January 17, 2024, the Subcommittee on Communications and
Technology held a hearing entitled ``Strengthening American
Communications Leadership with Open Radio Access Networks.''
The purpose of the hearing was to discuss how O-RAN networks
are being deployed, the future of O-Ran technology, and how O-
RAN and V-RAN can promote greater supply chain security. The
Subcommittee received testimony from John Baker, Senior Vice
President of Ecosystem Business Development, Mavenir; Jeff
Blum, Executive Vice President, External & Government Affairs,
DISH; Diane Rinaldo, Executive Director, Open RAN Policy
Coalition; Kristian Toivo, Executive Director, Telecom Infra
Project.
Examining Sports Media Rights
On January 31, 2024, the Subcommittee on Communications and
Technology held a hearing entitled ``TV Timeout: Understanding
Sports Media Rights.'' The purpose of the hearing was to
understand how sports media rights evolved over the years and
what trends have shaped the landscape, examine how leagues
negotiate and structure their media rights deals, and discuss
the impact of transitioning to streaming services has had on
the acquisition and distribution of sports media rights. The
Subcommittee received testimony from Brian Lawlor, President,
Scripps Sports; John Ourand, Sports Correspondent, Puck News;
Rob Thun, Chief Content Officer, DirecTV; John Bergmayer, Legal
Director, Public Knowledge.
Section 230
On April 11, 2024, the Subcommittee on Communications and
Technology held a hearing entitled ``Where Are We Now: Section
230 of the Communications Decency Act of 1996.'' The purpose of
the hearing was to provide background and education around
Section 230. The Subcommittee received testimony from Dr. Mary
Anne Franks, Professor of Intellectual Property, Technology,
and Civil Rights Law, George Washington University Law School;
Ms. Mary Graw Leary, Professor of Law, The Catholic University
of America School of Law, and Visiting Professor of Law, The
University of Georgia School of Law; Dr. Allison Stanger,
Professor of International Politics and Economics, Middlebury
College.
On May 22, 2024, the Subcommittee on Communications and
Technology held a hearing entitled ``Legislative Proposal to
Sunset Section 230 of the Communications Decency Act.'' The
purpose of the hearing was to understand how the landscape of
online content and user behavior evolved and has shaped the
responsibilities and liabilities of Big Tech, examine the
benefits and drawbacks of different reform proposals to amend
Section 230, and consider a discussion draft to provide a
sunset to the legislation. The Subcommittee received testimony
from Carrie Goldberg, Founding Attorney, C.A. Goldberg, PLLC;
Marc Berkman, CEO, Organization for Social Media Safety; Kate
Tummarello, Executive Director, Engine.
Oversight of the National Telecommunications and Information
Administration
On December 5, 2023, the Subcommittee on Communications and
Technology held a hearing entitled ``Oversight of the National
Telecommunications and Information Administration.'' The
purpose of the hearing was to review legislation that will
prevent waste, fraud, and abuse, oversight of public safety
activities, and improve the coordination and management of
Federal spectrum. The Subcommittee received testimony from the
Honorable Alan Davidson, Assistant Secretary of Commerce for
Communications and Information and Administrator at the
National Telecommunications and Information Administration.
On May 15, 2024, the Subcommittee on Communications and
Technology held a hearing entitled ``The Fiscal Year 2025
National Telecommunications and Information Administration
Budget.'' The purpose of the hearing was to understand the
biggest challenges to deployment with BEAD funding, examine
what steps NTIA is taking to conduct oversight on public safety
activity, and identify if the right technologies are being
deployed to stretch BEAD funding. The Subcommittee received
testimony from the Honorable Alan Davidson, Assistant Secretary
of Commerce for Communications and Information and
Administrator at the National Telecommunications and
Information Administration.
Oversight of the Federal Communications Commission
On June 21, 2023, the Subcommittee on Communications and
Technology held a hearing entitled ``Oversight of the Federal
Communications Commission.'' The purpose of the hearing was to
examine the future of the USF fund and the FCC's broadband maps
and understand how the FCC is preventing waste, fraud, and
abuse in the ACP. The Subcommittee received testimony from the
Honorable Jessica Rosenworcel, Chairwoman, Federal
Communications Commission; the Honorable Brendan Carr,
Commissioner, Federal Communications Commission; the Honorable
Geoffrey Starks, Commissioner, Federal Communications
Commission; the Honorable Nathan Simington, Commissioner,
Federal Communications Commission.
On July 9, 2024, the Subcommittee on Communications and
Technology held a hearing entitled ``The Fiscal Year 2025
Federal Communications Commission Agency Budget.'' The purpose
of the hearing was to examine the FCC's regulations on
broadband service providers, and its digital discrimination
rules. The Subcommittee received testimony from the Honorable
Jessica Rosenworcel, Chairwoman, Federal Communications
Commission; the Honorable Brendan Carr, Commissioner, Federal
Communications Commission; the Honorable Geoffrey Starks,
Commissioner, Federal Communications Commission; the Honorable
Nathan Simington, Commissioner, Federal Communications
Commission; and the Honorable Anna Gomez, Commissioner, Federal
Communications Commission
Subcommittee on Innovation, Data, and Commerce
LEGISLATIVE ACTIVITIES
Informing Consumers About Smart Devices Act
H.R. 538
To require the disclosure of a camera or recording
capability in certain internet-connected devices.
Summary
H.R. 538 requires manufacturers of internet-connected
devices (e.g., smart appliances) that are equipped with a
camera or microphone to disclose to consumers that a camera or
microphone is part of the device.
The bill does not apply to mobile phones, laptops, or other
devices that a consumer would reasonably expect to include a
camera or microphone.
Legislative History
H.R. 538 was introduced by Representative Curtis on January
26, 2023, and referred to the Committee on Energy and Commerce.
On February 27, 2023, Representative Bilirakis moved to
suspend the rules and pass H.R. 538. The House agreed to the
motion by a recorded vote of 406-12.
On February 28, 2023, H.R. 548 was received in the Senate
and read twice and referred to the Committee on Commerce,
Science, and Transportation.
Telling Everyone the Location of Data Leaving the U.S. Act (TELL Act)
H.R. 742
To require that any person that maintains an internet
website or that sells or distributes a mobile application that
stores and maintains information collected from such website or
application in the People's Republic of China to disclose that
such information is stored and maintained in the People's
Republic of China and whether the Chinese Communist Party or a
Chinese State-owned entity has access to such information.
Summary
H.R. 742 requires any person that maintains a website or
that sells or distributes a mobile application that maintains
and stores information in China to conspicuously disclose
certain information to individuals who download or otherwise
use the website or application. The disclosures must specify
(1) that such information is stored and maintained inChina, and
(2) whether the information is accessible by the Chinese
Communist Party or a Chinese state-owned entity.
The bill also provides for enforcement of these
requirements by the Federal Trade Commission.
Legislative History
H.R. 742 was introduced by Representative Duncan (R-SC) on
February 2, 2023, and was referred to the Committee on Energy
and Commerce.
On February 1, 2023, the Subcommittee on Innovation, Data,
and Commerce held a hearing on H.R. 742.
On February 7, 2023, the Subcommittee on Innovation, Data,
and Commerce met in open markup session and forwarded H.R. 742,
without amendment, to the full Committee by a voice vote.
On March 9, 2023, the full Committee on Energy and Commerce
met in open markup session and ordered H.R. 742, as amended,
favorably reported to the House by a recorded vote of 28 yeas
and 22 nays.
Chinese-Owned Applications Using the Information of Our Nation Act of
2023 (CAUTION Act of 2023)
H.R. 750
To require any person that sells or distributes a mobile
application that the Federal Government has prohibited for
Government-owned devices to disclose that fact to any
individual who downloads, updates, or otherwise uses such
application, and for other purposes.
Summary
H.R. 750 This bill requires any person who sells or
distributes the social media application TikTok (or any
successor application or service developed or provided by
ByteDance Limited) to disclose, prior to download, that the use
of the application is prohibited on devices owned by the
federal government.
The bill provides the Federal Trade Commission with
authority to enforce this requirement.
Legislative History
H.R. 750 was introduced by Representative Cammack (R-FL) on
February 2, 2023, and was referred to the Committee on Energy
and Commerce.
On February 1, 2023, the Subcommittee on Innovation, Data,
and Commerce held a hearing on H.R. 750.
On February 7, 2023, the Subcommittee on Innovation, Data,
and Commerce met in open markup session and forwarded H.R. 750,
as amended, to the full Committee by a voice vote.
On March 9, 2023, the full Committee on Energy and Commerce
met in open markup session and ordered H.R. 750, as amended,
favorably reported to the House by a recorded vote of 47 yeas
and 1 nay.
Securing Semiconductor Supply Chains Act of 2023
H.R. 752
To require SelectUSA to coordinate with State-level
economic development organizations to increase foreign direct
investment in semiconductor-related manufacturing and
production.
Summary
H.R. 752 requires the SelectUSA program to solicit comments
from state economic development organizations regarding federal
efforts to increase foreign direct investment in semiconductor-
related manufacturing and production. SelectUSA must then
report to Congress on such comments and the strategies that
SelectUSA may employ to increase such investment and to secure
the U.S. semiconductor supply chain. SelectUSA is a Department
of Commerce program established to coordinate federal efforts
to attract and retain business investment in the United States.
Legislative History
H.R. 752 was introduced by Representative Eshoo (D-CA) on
February 2, 2023, and was referred to the Committee on Energy
and Commerce.
On February 7, 2023, the Subcommittee on Innovation, Data,
and Commerce met in open markup session and forwarded H.R. 752,
without amendment, to the full Committee by a recorded vote of
19 yeas and 0 nays.
On March 9, 2023, the full Committee on Energy and Commerce
met in open markup session and ordered H.R. 752, without
amendment, favorably reported to the House by a recorded vote
of 49 yeas and 0 nay.
On July 25, 2023, Representative Bucshon moved to suspend
the rules and pass H.R. 752, as amended. The House agreed to
the motion by voice vote.
On July 26, 2023, H.R. 752 was received in the Senate.
Internet Application I.D. Act
H.R. 784
To require any person that maintains an internet website or
that sells or distributes a mobile application that is owned,
wholly or partially, by the Chinese Communist Party or by a
non-state-owned entity located in the People's Republic of
China, to disclose that fact to any individual who downloads or
otherwise uses such website or application.
Summary
H.R. 784 requires websites and sellers or distributors of
mobile applications that are owned by the Chinese Communist
Party or by a non-state-owned entity domiciled in China to
conspicuously disclose that ownership to users.
The bill also provides for enforcement by the Federal Trade
Commission.
Legislative History
H.R. 784 was introduced by Representative Fulcher (R-ID) on
February 2, 2023, and was referred to the Committee on Energy
and Commerce.
On February 1, 2023, the Subcommittee on Innovation, Data,
and Commerce held a hearing on H.R. 784.
On February 7, 2023, the Subcommittee on Innovation, Data,
and Commerce met in open markup session and forwarded H.R. 784,
without amendment, to the full Committee by a voice vote.
On March 9, 2023, the full Committee on Energy and Commerce
met in open markup session and ordered H.R. 784, as amended,
favorably reported to the House by a recorded vote of 28 yeas
and 22 nays.
Global Investment in American Jobs Act of 2023
H.R. 813
To direct the Secretary of Commerce, in coordination with
the heads of other relevant Federal departments and agencies,
to conduct an interagency review of and report to Congress on
ways to increase the global competitiveness of the United
States in attracting foreign direct investment.
Summary
H.R. 813 requires the Department of Commerce to conduct an
interagency review of the global competitiveness of the United
States in attracting foreign direct investment from responsible
private-sector entities based in trusted countries and
addressing foreign trade barriers that firms in advanced
technology sectors face in the global digital economy.
Among other elements, the review shall include an
assessment of (1) the economic impact of foreign direct
investment in the United States, (2) trends in global cross-
border investment and data flows, (3) federal government
policies that facilitate foreign direct investment, and (4) the
adequacy of federal government efforts to encourage and
facilitate foreign direct investment in the United States.
Commerce must report the findings of such review to
Congress and the Government Accountability Office (GAO) and
include recommendations for increasing the global
competitiveness of the United States in attracting foreign
direct investment. The GAO must submit a review and assessment
of the report to Congress.
Legislative History
H.R. 813 was introduced by Representative Pence (R-IN) on
February 2, 2023, and was referred to the Committee on Energy
and Commerce.
On February 7, 2023, the Subcommittee on Innovation, Data,
and Commerce met in open markup session and forwarded H.R. 813,
without amendment, to the full Committee by a voice vote.
On March 9, 2023, the full Committee on Energy and Commerce
met in open markup session and ordered H.R. 813, as amended,
favorably reported to the House by a recorded vote of 50 yeas
and 0 nays.
Right to Equitable and Professional Auto Industry Repair (REPAIR) Act
H.R. 906
To ensure consumers have access to data relating to their
motor vehicles, critical repair information, and tools, and to
provide them choices for the maintenance, service, and repair
of their motor vehicles, and for other purposes.
Summary
H.R. 906 requires a motor vehicle manufacturer to provide
to a vehicle's owner certain direct, real-time, in-vehicle data
generated by the operation of the vehicle that is related to
diagnostics, repair, service, wear, and calibration or
recalibration of parts and systems of the vehicle.
Specifically, a vehicle manufacturer may not impair an
owner's access to such vehicle-generated data or impair an
aftermarket parts manufacturer from producing or offering
compatible aftermarket parts. A manufacturer also must make
available to the vehicle's owner, and designees, vehicle-
generated data through a standardized access platform. Outside
of recall and warranty repairs, a manufacturer may not mandate
the use of a particular brand or manufacturer of parts, tools,
or equipment.
The National Highway Traffic Safety Administration must
issue standards for access to vehicle data through the
standardized access platform.
The Federal Trade Commission must establish an advisory
committee to (1) provide recommendations on the implementation
of this bill, and (2) assess and report on existing and
emerging barriers to vehicle repair and vehicle owners' control
over their vehicle-generated data.
This bill provides authority for the commission to enforce
these requirements.
Legislative History
H.R. 906 was introduced by Representative Dunn (R-FL) on
February 9, 2023, and was referred to the Committee on Energy
and Commerce.
On September 29, 2023, the Subcommittee on Innovation,
Data, and Commerce held a hearing on H.R. 906.
On November 2, 2023, the Subcommittee on Innovation, Data,
and Commerce met in open markup session and forwarded H.R. 906,
without amendment, to the full Committee by a voice vote.
Securing and Enabling Commerce Using Remote and Electronic Notarization
Act of 2023 (SECURE) Notarization Act of 2023
H.R. 1059
To authorize notaries public to perform, and to establish
minimum standards for, electronic notarizations and remote
notarizations that occur in or affect interstate commerce, to
require any Federal court to recognize notarizations performed
by a notarial officer of any State, to require any State to
recognize notarizations performed by a notarial officer of any
other State when the notarization was performed under or
relates to a public Act, record, or judicial proceeding of the
notarial officer's State or when the notarization occurs in or
affects interstate commerce, and for other purposes.
Summary
H.R. 1059 allows a notary public commissioned under state
law to remotely notarize electronic records and perform
notarizations for remotely located individuals. The bill
provides technical requirements for the notarizations,
including the creation and retention of video and audio
recordings and the use of communication technologies (i.e.,
video chat).
Additionally, the bill requires U.S. courts and states to
recognize notarizations--including remote notarizations of
electronic records and notarizations of remotely-located
individuals--that occur in or affect interstate commerce and
are performed by a notary public commissioned under the laws of
other states.
The bill also allows a notary public to remotely notarize
electronic records involving an individual located outside of
the United States, subject to certain requirements.
Legislative History
H.R. 1059 was introduced by Representative Curtis (R-UT) on
February 17, 2023, by and referred to the Committee on Energy
and Commerce.
On February 27, 2023, Representative Bilirakis moved to
suspend the rules and pass H.R. 1059. The House agreed to the
motion by voice vote.
On February 28, 2023, H.R. 1059 was received in the Senate
and read twice and referred to the Committee on the Judiciary.
Gas Stove Protection and Freedom Act
H.R. 1615
To prohibit the use of Federal funds to ban gas stoves.
Summary
H.R. 1615 prohibits the Consumer Product Safety Commission
from using federal funds to (1) regulate gas stoves as a banned
hazardous product; or (2) issue or enforce a product safety
standard that prohibits the use or sale of gas stoves,
substantially increases the price of gas stoves, or makes a
type of product unavailable based on the kind of fuel it
consumes.
Legislative History
H.R. 1615 was introduced by Representative Armstrong (R-ND)
on March 13, 2023, and was referred to the Committee on Energy
and Commerce.
On May 24, 2023, the full Committee on Energy and Commerce
met in open markup session and ordered H.R. 1615, without
amendment, favorably reported to the House by a recorded vote
of 29 yeas and 19 nays.
On June 13, 2023, the House agreed to the Boebert amendment
(H. Amdt. 186) to H.R. 1615 by a recorded vote of 222-210. On
passage, the House agreed by a recorded vote of 248-180.
On June 14, 2023, H.R. 1615 was received in the Senate,
read the first time, and placed on the Senate Legislative
Calendar under Read the First Time.
On June 15, 2023, H.R. 1615, in the Senate, was read the
second time, placed on the Senate Legislative Calendar under
General Orders. Calendar No. 102.
Setting Consumer Standards for Lithium Ion Batteries Act
H.R. 1797
To require the Consumer Product Safety Commission to
promulgate a consumer product safety standard with respect to
rechargeable lithium-ion batteries used in micromobility
devices, and for other purposes.
Summary
H.R. 1797 requires the Consumer Product Safety Commission
to issue a consumer product safety standard for rechargeable
lithium-ion batteries used in micromobility devices, such as
electric bicycles and scooters, to protect against the risk of
fires.
The safety standard must include requirements with respect
to the equipment related to rechargeable lithium-ion batteries
used in micromobility devices, including battery chargers,
charging cables, external terminals on battery packs, external
terminals on micromobility devices, and free-standing stations
used for recharging.
Legislative History
H.R. 1797 was introduced by Representative Torres (D-NY) on
March 24, 2023, and was referred to the Committee on Energy and
Commerce.
On September 27, 2023, the Subcommittee on Innovation,
Data, and Commerce held a hearing on H.R. 1797.
On November 2, 2023, the Subcommittee on Innovation, Data,
and Commerce met in open markup session and forwarded H.R.
1797, as amended, to the full Committee by a record vote of 20
yeas and 0 nays.
On December 6, 2023, the full Committee on Energy and
Commerce met in open markup session and ordered H.R. 1797,
without amendment, favorably reported to the House by a record
vote of 42 yeas and 0 nays.
On May 14, 2024, Representative Bilirakis moved to suspend
the rules and pass H.R. 1797, as amended. The House agreed to
the motion by a recorded vote of 378-34.
On May 16, 2024, H.R. 1797 was received in the Senate, read
twice, and referred to the Committee on Commerce, Science, and
Transportation.
Wastewater Infrastructure Pollution Prevention and Environmental Safety
(WIPPES) Act
H.R. 2964
To require the Federal Trade Commission to issue
regulations requiring certain products to have ``Do Not Flush''
labeling, and for other purposes.
Summary
H.R. 2964 requires the Federal Trade Commission to issue
regulations requiring entities responsible for the labeling or
retail packaging of certain premoistened, nonwoven wipes (e.g.,
baby wipes, cleaning wipes, or personal care wipes) to label
such products clearly and conspicuously with the phrase Do Not
Flush and accompanying symbol as depicted under specified
industry guidelines. The commission is authorized to enforce
this requirement.
Legislative History
H.R. 2964 was introduced by Representative McClain (R-MI)
on April 27, 2023, and was referred to the Committee on Energy
and Commerce.
On September 27, 2023, the Subcommittee on Innovation,
Data, and Commerce held a hearing on H.R. 2964.
On November 2, 2023, the Subcommittee on Innovation, Data,
and Commerce met in open markup session and forwarded H.R.
2964, without amendment, to the full Committee by a voice vote.
On December 5 and 6, 2023, the full Committee on Energy and
Commerce met in open markup session and ordered H.R. 2964, as
amended, favorably reported to the House by a record vote of 42
yeas and 0 nays.
On June 11, 2024. Representative Bilirakis moved to suspend
the rules and pass H.R. 2964, as amended. The House agreed to
the motion by a recorded vote of 351-56.
On June 12, 2024, H.R. 2964 was received in the Senate and
read twice and referred to the Committee on Commerce, Science,
and Transportation.
Transparency in Charges for Key Events Ticketing
(TICKET) Act
H.R. 3950
To require sellers of event tickets to disclose
comprehensive information to consumers about ticket prices and
related fees, and for other purposes.
Summary
H.R. 3950 requires ticket sellers (including sellers on the
secondary market) for concerts, performances, sporting events,
and similar activities to clearly and prominently disclose at
the beginning of the transaction, and prior to the selection of
a ticket, the total ticket price for the event and an itemized
list of the base ticket price and each fee (e.g., service fee,
processing fee, delivery fee, facility charge fee, tax, or
other charge). The total ticket price must also be disclosed in
any advertisement, marketing, or price list. Currently, ticket
sellers generally disclose fees at the checkout stage.
Additionally, ticket sellers that are offering to sell a
ticket that the seller does not have in their actual or
constructive possession must clearly and prominently disclose
that the ticket is not in their possession before an individual
selects a ticket to purchase.
The Federal Trade Commission must enforce these
requirements.
Legislative History
H.R. 3950 was introduced by Representative Bilirakis (R-FL)
on June 9, 2023, and was referred to the Committee on Energy
and Commerce.
On September 27, 2023, the Subcommittee on Innovation,
Data, and Commerce held a hearing on H.R. 3950.
On November 2, 2023, the Subcommittee on Innovation, Data,
and Commerce met in open markup session and forwarded H.R.
3950, without amendment, to the full Committee by voice vote.
On December 5 and 6, 2023, the full Committee on Energy and
Commerce met in open markup session and ordered H.R. 3950, as
amended, favorably reported to the House by a record vote of 45
yeas and 0 nays.
On May 14, 2024, Rep. Bilirakis moved to suspend the rules
and pass H.R. 3950, as amended. The House agreed to the motion
by a recorded vote of 388-24.
On May 16, 2024, H.R. 3950 was received in the Senate and
read twice and referred to the Committee on Commerce, Science
and Transportation.
Youth Poisoning Protection Act
H.R. 4310
To ban the sale of products with a high concentration of
sodium nitrite to individuals, and for other purposes.
Summary
H.R. 4310 makes a consumer product with a concentration of
sodium nitrite of 10% or greater a banned hazardous product.
Legislative History
H.R. 4310 was introduced by Representative Trahan (D-MA) on
June 22, 2023, and was referred to the Committee on Energy and
Commerce.
On September 27, 2023, the Subcommittee on Innovation,
Data, and Commerce held a hearing on H.R. 4310.
On November 2, 2023, the Subcommittee on Innovation, Data,
and Commerce met in open markup session and forwarded H.R.
4310, without amendment, to the full Committee by a voice vote.
On December 5 and 6, 2023, the full Committee on Energy and
Commerce met in open markup session and ordered H.R. 4310,
without amendment, favorably reported to the House by a
recorded vote of 42 yeas and 0 nays.
On May 14, 2024, Representative Bilirakis moved to suspend
the rules and pass H.R. 4310. The House agreed to the motion by
a recorded vote of 376-33.
On May 16, 2024, H.R. 4310 was received in the Senate and
read twice and referred to the Committee on Commerce, Science,
and Transportation.
Data Elimination and Limiting Extensive Tracking and Exchange (DELETE)
Act
H.R. 4311
To establish a centralized system to allow individuals to
request the simultaneous deletion of their personal information
across all data brokers, and for other purposes.
Summary
H.R. 4311 would establish a centralized system to allow
individuals to request the simultaneous deletion of their
personal information across all data brokers. Violations of
this bill would be enforced as an ``unfair or deceptive act or
practice'' by the FTC.
Legislative History
H.R. 4311 was introduced by Representative Trahan (D-MA) on
June 22, 2023, and was referred to the Committee on Energy and
Commerce.
On April 17, 2024, the Subcommittee on Innovation, Data,
and Commerce held a hearing on H.R. 4311.
Terms-of-Service Labeling, Design, and Readability
(TLDR) Act
H.R. 4568
To require covered entities to issue a short-form terms of
service summary statement, and for other purposes.
Summary
H.R. 4568 would require covered entities to issue a short-
form terms of service summary statement which would be placed
at the top of the permanent terms of service page of the
covered entity. Violations of this bill would be enforced as an
``unfair or deceptive act or practice'' by the FTC, and the
legislation also provides enforcement authority to state
attorneys general.
Legislative History
H.R. 4658 was introduced by Representative Trahan (D-MA) on
July 11, 2023, and was referred to the Committee on Energy and
Commerce.
On April 17, 2024, the Subcommittee on Innovation, Data,
and Commerce held a hearing on H.R. 4568.
Consumer Safety Technology Act
H.R. 4814
To direct the Consumer Product Safety Commission to
establish a pilot program to explore the use of artificial
intelligence in support of the mission of the Commission and to
direct the Secretary of Commerce and the Federal Trade
Commission to study and report on the use of blockchain
technology and digital tokens, respectively.
Summary
H.R. 4814 establishes a pilot program to explore the use of
artificial intelligence to support the Consumer Product Safety
Commission (CPSC).
Specifically, the CPSC must consult with relevant
stakeholders, such as data scientists and product
manufacturers, and use artificial intelligence for a least one
of the following purposes: (1) tracking trends in injuries
involving consumer products, (2) identifying consumer product
hazards, (3) monitoring the sale of recalled consumer products,
or (4) identifying consumer products that do not meet specified
importation requirements related to product safety.
The bill also requires (1) the Department of Commerce to
report on existing and emerging uses of blockchain technology
for consumer protection, and (2) the Federal Trade Commission
to report on its efforts to prevent unfair or deceptive
practices relating to digital tokens.
Legislative History
H.R. 4814 was introduced by Representative Soto (D-FL) on
July 20, 2023, and was referred to the Committee on Energy and
Commerce.
On September 27, 2023, the Subcommittee on Innovation,
Data, and Commerce held a hearing on H.R. 4814.
On November 2, 2023, the Subcommittee on Innovation, Data,
and Commerce met in open markup session and forwarded H.R.
4814, without amendment, to the full Committee by a voice vote.
On December 5 and 6, 2023, the full Committee on Energy and
Commerce met in open markup session and ordered H.R. 4814,
without amendment, favorably reported to the House by a
recorded vote of 45 yeas and 0 nays.
On May 14, 2024, Representative Bilirakis moved to suspend
the rules and pass H.R. 4814. The House agreed to the motion by
voice vote.
On May 15, 2024, H.R. 4814 was received in the Senate and
read twice and referred to the Committee on Commerce, Science,
and Transportation.
Advancing Gig Economy Act
H.R. 5146
To require the Secretary of Commerce to conduct a study on
the gig economy and the impact the gig economy has on the
United States overall economy, including the impact that State
laws have had on the gig economy.
Summary
H.R. 5146 requires the Department of Commerce to study and
report on the impact of the gig economy on U.S. businesses
conducting interstate commerce. The gig economy includes
businesses that maintain an online application or platform to
facilitate the exchange of goods or services by users of the
application or platform.
The study shall involve, among other things, (1) outreach
to participating entities to establish a list of industry
sectors that take part in the gig economy, (2) surveying
federal activity on the gig economy to develop a list of
agencies asserting jurisdiction over entities in and sectors of
the gig economy, and (3) surveying state laws regulating the
gig economy to determine their impact on both the gig economy
and the U.S. economy.
Commerce must report to Congress the results of such study
and any recommendations to promote the growth of the gig
economy.
Legislative History
H.R. 5146 was introduced by Representative Joyce (R-PA) on
August 4, 2023, and was referred to the Committee on Energy and
Commerce.
On September 20, 2023, the Subcommittee on Innovation,
Data, and Commerce held a hearing on H.R. 5146.
On November 2, 2023, the Subcommittee on Innovation, Data,
and Commerce met in open markup session and forwarded H.R.
5146, without amendment, to the full Committee by a recorded
vote of 12 yeas to 9 nays.
On December 5 and 6, 2023, the full Committee on Energy and
Commerce met in open markup session and ordered H.R. 5146, as
amended, favorably reported to the House by a recorded vote of
27 yeas and 20 nays.
Virginia Graeme Baker Pool and Spa Safety
Reauthorization Act
H.R. 5202
To reauthorize the Virginia Graeme Baker Pool and Spa
Safety Act, and for other purposes.
Summary
H.R. 5202, the Virginia Graeme Baker Pool and Spa Safety
Reauthorization Act, first authorized in 2008, would extend the
Consumer Product Safety Commission's authority to improve the
safety of all pools and spas by increasing the layers of
protection and promoting uninterrupted supervision to prevent
child drowning and entrapment. The law has three principal
elements: (1) requires every public pool in the U.S. to install
safe drain covers that prevent suction entrapment; (2) a grant
program for states, localities, and Indian Tribes to enforce
standards and educate communities about drowning and entrapment
dangers; and (3) a national public education campaign, ``Pool
Safely,'' that raises awareness about drowning prevention.
Legislative History
H.R. 5202 was introduced by Representative Wasserman
Schultz (D-FL) on August 11, 2023, and was referred to the
Committee on Energy and Commerce.
On September 27, 2023, the Subcommittee on Innovation,
Data, and Commerce held a hearing on H.R. 5202.
On November 2, 2023, the Subcommittee on Innovation, Data,
and Commerce met in open markup session and forwarded H.R.
5202, as amended, to the full Committee by a recorded vote of
20 yeas to 0 nays.
On December 5 and 6, 2023, the full Committee on Energy and
Commerce met in open markup session and ordered H.R. 5202, as
amended, favorably reported to the House by a recorded vote of
40 yeas, 0 nays, and 1 abstention.
Critical Infrastructure Manufacturing Feasibility Act
H.R. 5390
To direct the Secretary of Commerce to conduct a study on
the feasibility of manufacturing in the United States products
for critical infrastructure sectors, and for other purposes.
Summary
H.R. 5390 requires the Department of Commerce to study and
report on products that are in high demand across the critical
infrastructure sectors. Critical infrastructure sectors are
those whose assets, systems, and networks are vital to national
security, the economy, public health or safety, or any
combination of those matters.
The study must (1) identify the products in high demand
across those sectors that are being imported due to
manufacturing, material, or supply chain constraints; and (2)
analyze the costs, benefits, and feasibility of manufacturing
those products in the United States.
Legislative History
H.R. 5390 was introduced by Representative Miller-Meeks (R-
IA) on September 12, 2023, and was referred to the Committee on
Energy and Commerce.
On September 20, 2023, the Subcommittee on Innovation,
Data, and Commerce held a hearing on H.R. 5390.
On November 2, 2023, the Subcommittee on Innovation, Data,
and Commerce met in open markup session and forwarded H.R.
5390, without amendment, to the full Committee by a voice vote.
On December 5 and 6, 2023, the full Committee on Energy and
Commerce met in open markup session and ordered H.R. 5390, as
amended, favorably reported to the House by a recorded vote of
45 yeas and 0 nays.
On May 14, 2024, Representative Bilirakis moved to suspend
the rules and pass H.R. 5390. The House agreed to the motion by
voice vote.
On May 15, 2024, H.R. 5390 was received in the Senate and
read twice and referred to the Committee on Commerce, Science,
and Transportation.
Advancing Tech Startups Act
H.R. 5398
To require the Secretary of Commerce to conduct a study on
tech startups, and for other purposes.
Summary
H.R. 5398 requires the Department of Commerce to study and
report on the impact of technology startup companies on the
U.S. economy.
Such study shall involve, among other things, (1)
describing the activities of identified locations that are
dedicated to the creation, development, and growth of
technology startup companies; (2) establishing a list of
federal agencies asserting jurisdiction over entities and
industry sectors dedicated to technology startup companies; and
(3) assessing risks and trends in relevant marketplaces and
supply chains that impact technology startup companies in the
United States.
Commerce must report to Congress the results of such study
and any recommendations to promote the creation, development,
and growth of technology startup companies.
Legislative History
H.R. 5398 was introduced by Representative Bill Johnson (R-
OH) on September 12, 2023, and was referred to the Committee on
Energy and Commerce.
On September 20, 2023, the Subcommittee on Innovation,
Data, and Commerce held a hearing on H.R. 5398.
On November 2, 2023, the Subcommittee on Innovation, Data,
and Commerce met in open markup session and forwarded H.R.
5398, without amendment, to the full Committee by a recorded
vote of 21 yeas to 0 nays.
On December 5 and 6, 2023, the full Committee on Energy and
Commerce met in open markup session and ordered H.R. 5398,
without amendment, favorably reported to the House by a
recorded vote of 46 yeas and 0 nays.
Banning Surveillance Advertising Act of 2023
H.R. 5534
To prohibit targeted advertising by advertisers and
advertising facilitators, and for other purposes.
Summary
H.R. 5534 would prohibit targeted advertising by
advertisers and advertising facilitators. This legislation
would be enforced by the FTC, state attorneys general (or other
authorized state officials), and individuals.
Legislative History
H.R. 5534 was introduced by Representative Eshoo (D-CA) on
September 18, 2023, and was referred to the Committee on Energy
and Commerce.
On April 17, 2024, the Subcommittee on Innovation, Data,
and Commerce held a hearing on H.R. 5534.
Reinforcing American-Made Products Act
H.R. 5556
To make exclusive the authority of the Federal Government
to regulate the labeling of products made in the United States
and introduced in interstate or foreign commerce, and for other
purposes.
Summary
H.R. 5556 specifies that the Federal Trade Commission's
regulation of the labeling of products as Made in the U.S.A. or
Made in America supersedes any conflicting state laws.
Legislative History
H.R. 5556 was introduced by Representative Curtis (R-UT) on
September 19, 2023, and was referred to the Committee on Energy
and Commerce.
On September 27, 2023, the Subcommittee on Innovation,
Data, and Commerce held a hearing on H.R. 5556.
On November 2, 2023, the Subcommittee on Innovation, Data,
and Commerce met in open markup session and forwarded H.R.
5556, without amendment, to the full Committee by a voice vote.
Algorithmic Accountability Act of 2023
H.R. 5628
To direct the Federal Trade Commission to require impact
assessments of automated decision systems and augmented
critical decision processes, and for other purposes.
Summary
H.R. 5628 would direct the FTC to require impact
assessments of automated decision systems and augmented
critical decision processes. Further, this bill would require
the FTC to publish an annual anonymized aggregate report and
establish a publicly accessible repository of information that
could be used to study the use of automated decision systems
and augmented critical decision processes, among other
purposes. Additionally, this bill would establish a Bureau of
Technology to enforce this legislation and support the FTC in
the technological aspects of its functions.
Legislative History
H.R. 5628 was introduced by Representative Clarke (D-NY) on
September 21, 2023, and was referred to the Committee on Energy
and Commerce.
On April 17, 2024, the Subcommittee on Innovation, Data,
and Commerce held a hearing on H.R. 5628.
Sammy's Law of 2023
H.R. 5778
To require large social media platform providers to create,
maintain, and make available to third-party safety software
providers a set of real-time application programming
interfaces, through which a child or a parent or legal guardian
of a child may delegate permission to a third-party safety
software provider to manage the online interactions, content,
and account settings of such child on the large social media
platform on the same terms as such child, and for other
purposes.
Summary
H.R. 5778 would require large social media platform
providers to create, maintain, and make available to third-
party safety software providers a set of real-time application
programming interfaces, through which a child or a parent or
legal guardian of a child may delegate permission to a third-
party safety software provider to manage the online
interactions, content, and account settings of such child on
the large social media platform on the same terms as such
child. Large social media platform providers would be required
to establish and implement reasonable policies, practices, and
procedures regarding the secure transfer of user data from the
large social media platform to a third-party safety software
provider in order to mitigate any risks related to user data,
among other things. Third-party safety software providers would
be required to register with the FTC as a condition of
accessing an application programming interface and other
information defined in the bill.
Violations of this bill would be enforced as an ``unfair or
deceptive act or practice'' by the FTC.
Legislative History
H.R. 5778 was introduced by Representative Wasserman
Schultz (D-FL) on September 28, 2023, and was referred to the
Committee on Energy and Commerce.
On April 17, 2024, the Subcommittee on Innovation, Data,
and Commerce held a hearing on H.R. 5778.
Cleaning Product Ingredient Communication Act
H.R. 5978
To amend the Fair Packaging and Labeling Act to establish a
Federal standard relating to ingredient disclosure in cleaning
products, and for other purposes.
Summary
H.R. 5978 would amend the Fair Packaging and Labeling Act
to enact a federal standard for the communication of cleaning
product ingredients to consumers. It would require
manufacturers to provide information efficiently and clearly
across the country in a uniform way and enhance the
accessibility of cleaning product ingredient information for
consumers by requiring both online and on label ingredient
communication.
Legislative History
H.R. 5978 was introduced by Representative Bucshon (R-IN)
on October 26, 2023, and was referred to the Committee on
Energy and Commerce.
On September 27, 2024, the Subcommittee on Innovation,
Data, and Commerce held a hearing on H.R. 5978.
Online Dating Safety Act of 2023
H.R. 6125
To require online dating service providers to provide fraud
ban notifications to online dating service members, and for
other purposes.
Summary
H.R. 6125 requires online dating service providers (i.e.,
mobile applications or websites) to provide users with a fraud
ban notification if the user has established an account with
the service and received a message through the service from a
banned user of the service.
The fraud ban notification must include (1) the username or
other profile identifier of the banned user and the most recent
time when the user who is receiving the notification sent or
received a message through the service to or from the banned
user, (2) a statement that the banned user may have been using
a false identity or attempting to defraud other users, (3) a
statement that the user should not send money or personal
financial information to another user, (4) a link to additional
information about avoiding online fraud, and (5) contact
information for the provider's customer service department.
The bill provides for enforcement of these requirements by
the Federal Trade Commission.
Legislative History
H.R. 6125 was introduced by Representative Valadao (R-CA)
on October 30, 2023, and was referred to the Committee on
Energy and Commerce.
On September 27, 2023, the Subcommittee on Innovation,
Data, and Commerce held a hearing on H.R. 6125.
On November 2, 2023, the Subcommittee on Innovation, Data,
and Commerce met in open markup session and forwarded H.R.
6125, without amendment, to the full Committee by a recorded
vote of 11 yeas to 8 nays.
On December 5 and 6, 2023, the full Committee on Energy and
Commerce met in open markup session and ordered H.R. 6125, as
amended, favorably reported to the House by a recorded vote of
44 yeas and 0 nays.
On September 23, 2024, Representative Bilirakis moved to
suspend the rules and pass H.R. 6125. The House agreed to the
motion by voice vote.
On September 24, 2024, H.R. 6125 was received in the Senate
and read twice and referred to the Committee on Commerce,
Science, and Transportation.
Awning Safety Act of 2023
H.R. 6132
To require the Consumer Product Safety Commission to
promulgate a mandatory consumer product safety standard with
respect to retractable awnings.
Summary
H.R. 6132 requires the Consumer Product Safety Commission
(CPSC) to issue a consumer product safety standard for fixed
and freestanding retractable awnings. Specifically, the CPSC
must issue a standard to protect against the risk of death or
serious injury associated with the awnings, including the risk
of death or serious injury related to the awning unexpectedly
opening and striking a person while removing the bungee tie-
downs for the cover of the awning.
Legislative History
H.R. 6132 was introduced by Representative Balderson (R-OH)
on November 1, 2023, and was referred to the Committee on
Energy and Commerce.
On September 27, 2023, the Subcommittee on Innovation,
Data, and Commerce held a hearing on H.R. 6132.
On November 2, 2023, the Subcommittee on Innovation, Data,
and Commerce met in open markup session and forwarded H.R.
6132, without amendment, to the full Committee by a voice vote.
On December 5 and 6, 2023, the full Committee on Energy and
Commerce met in open markup session and ordered H.R. 6132, as
amended, favorably reported to the House by a recorded vote of
43 yeas and 0 nays.
On May 14, 2024, Representative Bilirakis moved to suspend
the rules and pass H.R. 6132. The House agreed to the motion by
voice vote.
On May 15, 2024, H.R. 6132 was received in the Senate and
read twice and referred to the Committee on Commerce, Science,
and Transportation.
Protecting Kids on Social Media Act
H.R. 6149
To require that social media platforms verify the age of
their users, prohibit the use of algorithmic recommendation
systems on individuals under age 18, require parental or
guardian consent for social media users under age 18, and
prohibit users who are under age 13 from accessing social media
platforms.
Summary
H.R. 6149 requires social media platforms to verify the age
of account holders and limits access to such platforms by
children.
Specifically, social media platforms (1) must verify the
age of account holders, (2) may not allow an individual to
create or continue to use an account unless the individual's
age has been verified, and (3) must limit access to the
platform for children under the age of 13. Social media
platforms may not use or retain any information collected
during the age verification process for any other purpose.
Further, platforms must take reasonable steps to (1)
require affirmative consent from the parent or guardian of a
minor who is at least 13 years old to create an account for the
minor on the platform, and (2) provide the parent or guardian
with the ability to revoke such consent.
Social media platforms may not use the personal data of an
individual in an algorithmic recommendation system unless the
individual is at least 18 years old according to the platform's
age verification process.
The bill requires the Department of Commerce to establish a
voluntary pilot program to provide secure digital
identification credentials for individuals to use when
verifying their age on social media platforms. Commerce may
issue rules for social media companies to enroll in the
program.
The bill provides for enforcement by the Federal Trade
Commission and state attorneys general (or other authorized
state officials).
Legislative History
H.R. 6149 was introduced by Representative James (R-MI) on
November 1, 2023, and was referred to the Committee on Energy
and Commerce.
On April 17, 2024, the Subcommittee on Innovation, Data,
and Commerce held a hearing on H.R. 6149.
SCREEN Act
H.R. 6429
To require certain interactive computer services to adopt
and operate technology verification measures to ensure that
users of the platform are not minors, and for other purposes.
Summary
H.R. 6429 would require all commercial pornographic
websites to adopt and operate applicable technology
verification measures to ensure that a child cannot access its
pornographic content. Platforms would have the option to
contract a third party to comply with the provisions of this
bill. Additionally, the legislation establishes data security
requirements and prohibits companies from collecting data
beyond what is minimally necessary to verify a user's age and
from retraining information longer than is necessary to
demonstrate compliance, among other things. Violations of
section 4 of this bill would be enforced as an ``unfair or
deceptive act or practice'' by the FTC.
Legislative History
H.R. 6429 was introduced by Representative Mary Miller (R-
IL) on November 15, 2023, and was referred to the Committee on
Energy and Commerce.
On April 17, 2024, the Subcommittee on Innovation, Data,
and Commerce held a hearing on H.R. 6429.
No Hidden FEES Act of 2023
H.R. 6543
To prohibit unfair and deceptive advertising of prices for
hotel rooms and other places of short-term lodging, and for
other purposes.
Summary
H.R. 6543 requires providers of short-term lodging (e.g.,
hotels, motels, inns, and short-term rentals) to include each
mandatory fee when displaying or advertising the price for a
reservation.
The requirement does not apply to providers that offer
short-term lodging for purchase pursuant to a corporate,
government, or institutional travel management program.
The bill provides for enforcement by the Federal Trade
Commission and state attorneys general.
Legislative History
H.R. 6543 was introduced by Representative Kim (R-CA) on
December 1, 2023, and was referred to the Committee on Energy
and Commerce.
On September 27, 2023, the Subcommittee on Innovation,
Data, and Commerce held a hearing on H.R. 6543.
On November 2, 2023, the Subcommittee on Innovation, Data,
and Commerce met in open markup session and forwarded H.R.
6543, without amendment, to the full Committee by a voice vote.
On December 5 and 6, 2023, the full Committee on Energy and
Commerce met in open markup session and ordered H.R. 6543,
without amendment, favorably reported to the House by a
recorded vote of 43 yeas and 0 nays.
On June 11, 2024, Representative Bilirakis moved to suspend
the rules and pass H.R. 6543. The House agreed to the motion by
a recorded vote of 384 yeas to 25 nays.
On June 12, 2024, H.R. 6543 was received in the Senate and
read twice and referred to the Committee on Commerce, Science,
and Transportation.
STOP Act of 2023
H.R. 6568
To prohibit speculative ticketing as an unfair or deceptive
act or practice, and for other purposes.
Summary
H.R. 6568 bans the sale of speculative tickets, a ticket
where an issuer or secondary market ticket issuer does not have
actual or constructive possession of an event ticket. This
would not prohibit any services associated for procuring the
ticket once the tickets go on sale. The discussion draft would
authorize the FTC to enforce its requirements under 15 U.S.C.
57a(a)(1)(B).
Legislative History
H.R. 6568 was introduced by Representative Armstrong (R-ND)
on December 4, 2023, and was referred to the Committee on
Energy and Commerce.
On September 27, 2023, the Subcommittee on Innovation,
Data, and Commerce held a hearing on H.R. 6568.
On November 2, 2023, the Subcommittee on Innovation, Data,
and Commerce met in open markup session and forwarded H.R.
6568, without amendment, to the full Committee by a voice vote.
On December 5 and 6, 2023, the full Committee on Energy and
Commerce met in open markup session and ordered H.R. 3950, as
amended, with the inclusion of H.R. 6568 in the amendment,
favorably reported to the House by a recorded vote of 45 yeas
to 0 nays.
This topic is discussed in greater detail under H.R. 3950,
the Transparency in Charges for Key Events Ticketing (TICKET)
Act.
Promoting Resilient Supply Chains Act of 2023
H.R. 6571
To establish a critical supply chain resiliency and crisis
response program in the Department of Commerce, and to secure
American leadership in deploying emerging technologies, and for
other purposes.
Summary
H.R. 6571 requires the Industry and Analysis office of the
International Trade Administration of the Department of
Commerce to monitor and respond to disruptions in critical
industries and supply chains.
Specifically, the office must establish a critical supply
chain resiliency program to (1) map, monitor, and model
critical supply chains; (2) identify high-priority supply chain
gaps and vulnerabilities in critical industries; (3) identify
and evaluate the effect of potential supply chain disruptions
on U.S. economic security; and (4) collaborate with other
governmental bodies and key international partners to identify
opportunities to reduce supply chain gaps and vulnerabilities.
The office also must establish a unified coordination group to
oversee the interagency response to supply chain shocks and the
office must designate critical industries, critical supply
chains, and critical goods.
Additionally, the office must facilitate the development of
guidelines and best practices to reduce the risk of critical
supply chain disruption.
The bill includes various program evaluation and reporting
requirements.
Legislative History
H.R. 6571 was introduced by Representative Bucshon (R-IN)
on December 4, 2023, and was referred to the Committee on
Energy and Commerce.
On September 20, 2023, the Subcommittee on Innovation,
Data, and Commerce held a hearing on H.R. 6571.
On December 5 and 6, 2023, the full Committee on Energy and
Commerce met in open markup session and ordered H.R. 6571, as
amended, favorably reported to the House by a recorded vote of
44 yeas and 0 nays.
On May 14, 2024, Representative Bilirakis moved to suspend
the rules and pass H.R. 6571. The House agreed to the motion by
a recorded vote of 390 yeas to 19 nays.
On May 16, 2024, H.R. 6571 was received in the Senate and
read twice and referred to the Committee on Commerce, Science,
and Transportation.
Deploying American Blockchains Act of 2023
H.R. 6572
To direct the Secretary of Commerce to take actions
necessary and appropriate to promote the competitiveness of the
United States related to the deployment, use, application, and
competitiveness of blockchain technology or other distributed
ledger technology, and for other purposes.
Summary
H.R. 6572 requires the Department of Commerce to support
the leadership of the United States in the use of blockchain
technology and other distributed ledger technology, tokens, and
tokenization. Generally, blockchain technology is a distributed
digital ledger that uses cryptography to share verified
information across a network of computers. Tokens refer to the
transferrable, digital representation of information recorded
on blockchain technology and tokenization is the process of
creating a token.
Specifically, Commerce must advise the President on
policies related to the deployment and use of blockchain
technology and other distributed ledger technology,
applications built on blockchain technology or other
distributed ledger technology, tokens, and tokenization.
Commerce also must establish advisory committees to support the
adoption of blockchain technology to facilitate the development
of best practices with respect to blockchain technology,
applications built on blockchain technology, tokens, and
tokenization.
Commerce must report annually on the activities under this
bill and provide any recommendations for additional legislation
to strengthen U.S. competitiveness with respect to blockchain
technology.
Legislative History
H.R. 6572 was introduced by Representative Bucshon (R-IN)
on December 4, 2023, and was referred to the Committee on
Energy and Commerce.
On June 7, 2023, the Subcommittee on Innovation, Data, and
Commerce held a hearing on H.R. 6572.
On December 5 and 6, 2023, the full Committee on Energy and
Commerce met in open markup session and ordered H.R. 6572, as
amended, favorably reported to the House by a recorded vote of
46 yeas and 0 nays.
On May 14, 2024, Representative Bilirakis moved to suspend
the rules and pass H.R. 6572. The House agreed to the motion by
a recorded vote of 334 yeas to 79 nays.
On May 16, 2024, H.R. 6572 was received in the Senate and
read twice and referred to the Committee on Commerce, Science,
and Transportation.
Protecting Americans' Data From Foreign Adversaries
Act of 2024
H.R. 7520
To prohibit data brokers from transferring sensitive data
of United States individuals to foreign adversaries, and for
other purposes.
Summary
H.R. 7520 makes it unlawful for a data broker to sell,
license, rent, trade, transfer, release, disclose, or otherwise
make available specified personally identifiable sensitive data
of individuals who reside in the United States to North Korea,
China, Russia, or Iran or an entity controlled by such a
country (e.g., headquartered in or owned by a person in the
country).
Sensitive data includes government-issued identifiers
(e.g., Social Security numbers), financial account numbers,
biometric information, genetic information, precise geolocation
information, and private communications (e.g., texts or
emails).
A data broker generally includes an entity that sells or
otherwise provides data of individuals that the entity did not
collect directly from the individuals. A data broker does not
include an entity that transmits an individual's data or
communications at the request or direction of the individual or
an entity that makes news or information available to the
general public.
The bill provides for enforcement by the Federal Trade
Commission.
Legislative History
H.R. 7520 was introduced by Representative Pallone (D-NJ)
on March 5, 2024, and was referred to the Committee on Energy
and Commerce.
On March 7, 2024, the Committee on Energy and Commerce held
a full committee hearing to review H.R. 7520. The title of the
hearing was ``Legislation to Protect Americans from the
National Security Threats Posed by Foreign Adversary Controlled
Applications.'' The Committee met in executive session pursuant
to a motion by Chair Rodgers, which was adopted by a record
vote of 43 yeas and 0 nays.
On March 7, 2024, the full Committee on Energy and Commerce
met in open markup session and ordered H.R. 7520, without
amendment, favorably reported to the House by a recorded vote
of 50 yeas and 0 nays.
On March 19, 2024, Representative McMorris Rodgers moved to
suspend the rules and pass H.R. 7520. The House agreed to the
motion by a recorded vote of 414 yeas to 0 nays.
On March 21, 2024, H.R. 7520 was received in the Senate and
read twice and referred to the Committee on Commerce, Science,
and Transportation.
On April 17, 2024, H.R. 8038, the 21st Century Peace
Through Strength Act, which included H.R. 7520, was introduced
by Representative McCaul.
On April 19, 2024, the House agreed to H. Res. 1160 by a
recorded vote of 316 yeas to 94 nays.
On April 20, 2024, the House agreed on passage of H.R.
8038, as amended, by a recorded vote of 360 yeas to 58 nays.
On April 20, 2024, pursuant to the provisions of H. Res.
1160, the House took from the Speaker's table the bill H.R. 815
with the Senate amendment and agreed to the Senate amendment
with the amendment described in section 6. The House agreed to
an amendment, which included H.R. 8038, to the Senate amendment
without objection.
On April 23, 2024, the message on House action was received
in the Senate at the desk: House amendment to Senate amendment.
Senator Schumer moved to concur in the House amendment to the
Senate amendment to H.R. 815. The Senate agreed to the motion
by a recorded vote of 79 yeas to 18 nays. A message on Senate
action was sent to the House.
On April 24, 2024, the House presented H.R. 815 to the
President. It was signed by the President and became Public Law
No: 118-50.
Children and Teens Online Privacy Protection Act
H.R. 7890
To amend the Children's Online Privacy Protection Act of
1998 to strengthen protections relating to the online
collection, use, and disclosure of personal information of
children and teens, and for other purposes.
Summary
H.R. 7890 would amend the Children's Online Privacy
Protection Act of 1998 to strengthen protections relating to
the online collection, use, and disclosure of personal
information of children and teens, among other things.
Specifically, this bill would prohibit internet companies from
collecting personal information from users who are 13 to 16
years old without their consent. Additionally, the bill would
ban targeted advertising to kids and teens and require direct
notice if data is being stored or transferred outside of the
U.S. The legislation would also create an eraser mechanism for
parents and kids by requiring companies to permit users to
delete information when technologically feasible. This
legislation would be enforced by the FTC.
Legislative History
H.R. 7890 was introduced by Representative Walberg (R-MI)
on April 9, 2024, and was referred to the Committee on Energy
and Commerce.
On April 17, 2024, the Subcommittee on Innovation, Data,
and Commerce held a hearing on H.R. 7890.
On September 18, 2024, the full Committee on Energy and
Commerce met in open markup session and ordered H.R. 7890, as
amended, favorably reported to the House by a voice vote.
Kids Online Safety Act
H.R. 7891
To protect the safety of children on the internet.
Summary
H.R. 7891 would require high impact online and video game
companies to take reasonable measures in the design and
operation of products or services used by minors to prevent and
mitigate certain harms that may arise from that use, like
sexual exploitation and online bullying. Covered platforms
would be required to provide minors with certain safeguards.
Further, covered platforms would be required to provide parents
or guardians with tools to supervise minors' use of a platform,
such as control of account settings.
Additionally, covered platforms would have to disclose
specified information, including details regarding the use of
personalized recommendation systems. It would allow parents,
guardians, minors, and schools to report certain harms. Covered
platforms would be prevented from facilitating advertising of
age-restricted products or services to minors, and they would
also be required to annually report on foreseeable risks of
harm to minors from using the platform.
Finally, this bill also requires guidance for market and
product research focused on minors and an evaluation of options
to verify a user's age.
Legislative History
H.R. 7891 was introduced by Representative Bilirakis (R-FL)
on April 9, 2024, and was referred to the Committee on Energy
and Commerce.
On April 17, 2024, the Subcommittee on Innovation, Data,
and Commerce held a hearing on H.R. 7891.
On May 23, 2024, the Subcommittee on Innovation, Data, and
Commerce met in open markup session and forwarded H.R. 7891,
without amendment, to the full Committee by a voice vote.
On September 18, 2024, the full Committee on Energy and
Commerce met in open markup session and ordered H.R. 7891, as
amended, favorably reported to the House by a voice vote.
AM Radio for Every Vehicle Act of 2024
H.R. 8449
To require the Secretary of Transportation to issue a rule
requiring access to AM broadcast stations in motor vehicles,
and for other purposes.
Summary
H.R. 8449 would direct the Department of Transportation
(DOT), in consultation with the Federal Emergency Management
Agency (FEMA) and the Federal Communications Commission (FCC),
to issue a rule that requires automakers to maintain AM
broadcast radio devices as standard equipment in their vehicles
in a way that is easily accessible for consumers, and without a
separate or additional payment, fee, or surcharge, while also
providing extra compliance time for small manufacturers. It
would require any automaker that sells vehicles without access
to AM broadcast radio before the effective date of the rule to
clearly disclose to consumers that the vehicle lacks access to
AM broadcast radio. The bill would also direct the Government
Accountability Office (GAO) to conduct a comprehensive study on
disseminating emergency alerts and warnings to the public.
Legislative History
H.R. 8449 was introduced by Representative Bilirakis (R-FL)
on May 17, 2024, and was referred to the Committee on Energy
and Commerce.
On April 30, 2024, the Subcommittee on Innovation, Data,
and Commerce held a hearing on H.R. 8449.
On May 23, 2024, the Subcommittee on Innovation, Data, and
Commerce met in open markup session and forwarded H.R. 8449,
without amendment, to the full Committee by a voice vote.
On September 18, 2024, the full Committee on Energy and
Commerce met in open markup session and ordered H.R. 8449, as
amended, favorably reported to the House by a recorded vote of
45 yeas to 2 nays.
American Privacy Rights Act
H.R. 8818
To provide Americans with foundational data privacy rights,
create strong oversight mechanisms, and establish meaningful
enforcement, and for other purposes.
Summary
H.R. 8818 would establish a preemptive national consumer
data privacy and security standard to govern how certain
entities can collect, process, retain, and transfer Americans'
personal information. The bill would require certain entities
to be transparent about how they use consumer data and give
consumers the right to access, correct, delete, and export
their data, and to opt out of targeted advertising. The bill
would establish a data minimization standard that would limit
how companies can collect, process, retain, and transfer
information. The Federal Trade Commission (FTC), State
attorneys general, and consumers could enforce against
violations of the Act. The bill would also amend the Children's
Online Privacy Protection Act.
Legislative History
H.R. 8818 was introduced by Representative McMorris Rodgers
(R-WA) on June 25, 2024, and was referred to the Committee on
Energy and Commerce.
On April 17, 2024, the Subcommittee on Innovation, Data,
and Commerce held a hearing on a discussion draft of H.R. 8818.
On May 23, 2024, the Subcommittee on Innovation, Data, and
Commerce met in open markup session and forwarded the
discussion draft of H.R. 8818, without amendment, to the full
Committee by a voice vote.
OVERSIGHT ACTIVITIES
Competition With China
On February 1, 2023, the Subcommittee on Innovation, Data,
and Commerce held a hearing entitled ``Economic Danger Zone:
How America Competes to Win the Future Versus China.'' The
purpose of the hearing was to examine the threats China poses
to the U.S., particularly the Chinese challenge to U.S. global
leadership in emerging technologies such as Artificial
Intelligence (AI), autonomous vehicles (AVs), supply chain
security, blockchain technology, and to American data privacy
and security. The Subcommittee received testimony from Brandon
Pugh, Policy Director and Resident Senior Fellow, R Street
Institute; Jeff Farrah, Executive Director, Autonomous Vehicle
Industry Association (AVIA); Samm Sacks, Cyber Policy Fellow,
International Security Program, New America; and Marc Jarsulic,
Senior Fellow and Chief Economist, Center for American
Progress.
A National Standard for U.S. Data Privacy and Efforts To Protect Kids
Online
On March 1, 2023, the Subcommittee on Innovation, Data, and
Commerce held a hearing entitled ``Promoting U.S. Innovation
and Individual Liberty through a National Standard for Data
Privacy.'' The purpose of the hearing was to examine how
personal data was being treated and handled during the current
digital ecosystem and the dangers facing the U.S. if
Congressional inaction continued. The Subcommittee received
testimony from Alexandra Reeve Givens, President and CEO,
Center for Democracy & Technology; Graham Mudd, Founder and
Chief Product Officer, Anonym; and Jessica Rich, Of Counsel and
Senior Policy Advisor for Consumer Protection, Kelley Drye &
Warren, LLP.
On April 27, 2023, the Subcommittee on Innovation, Data,
and Commerce held a hearing entitled ``Addressing America's
Data Privacy Shortfalls: How a National Standard Fills Gaps to
Protect Americans' Personal Information.'' The purpose of the
hearing was to provide an opportunity for Members to analyze
where the gaps in protections for consumers' personal
information are, how businesses navigate the compliance of
sectoral laws, and why Congress must enact a comprehensive
privacy and data security law to fill these gaps. The
Subcommittee received testimony from Morgan Reed, President,
ACT|The App Association; Donald Codling, Senior Advisor for
Cybersecurity and Privacy, REGO Payment Architectures, Inc.;
Edward Britan, Head of Global Privacy, Salesforce, Inc.; Amelia
Vance, Founder and President, Public Interest Privacy Center.
On October 18, 2023, the Subcommittee on Innovation, Data,
and Commerce held a hearing entitled ``Safeguarding Data and
Innovation: Building the Foundation for the Use of Artificial
Intelligence.'' The purpose of the hearing was to examine the
need for comprehensive federal data privacy legislation to
safeguard U.S. citizens' data as a foundation for the safe
emergence of artificial intelligence (AI). The Subcommittee
received testimony from Victoria Espinel, President and Chief
Executive Officer, BSA The Software Alliance; Raffi Krikorian,
Chief Technology Officer, Emerson Collective; Amba Kak,
Executive Director, AI Now Institute; Clark Gregg, Actor and
Screenwriter, SAG AFTRA; and Jon Leibowitz--Former Chair and
Commissioner, Federal Trade Commission.
On April 17, 2024, the Subcommittee on Innovation, Data,
and Commerce held a hearing entitled ``Legislative Solutions to
Protect Kids Online and Ensure Americans' Data Privacy
Rights.'' The purpose of the hearing was to provide an
opportunity for Members to discuss the need for Congress to
enact a strong preemptive national data privacy and security
standard while at the same time establish strong data privacy
and design protections for children and their safety online.
The Subcommittee received testimony from Ms. Ava Smithing,
Director of Advocacy, Young People's Alliance; The Honorable
Maureen K. Ohlhausen, Co-chair, 21 Century Privacy Coalition;
Ms. Katherine Kuehn, Member, Board of Directors and CISO-in-
Residence, National Technology Security Coalition; Ms. Kara
Frederick, Director, Tech Policy Center, The Heritage
Foundation; Mr. Samir C. Jain, Vice President of Policy, Center
for Democracy & Technology; and Mr. David Brody, Managing
Attorney, Digital Justice Initiative, Lawyers' Committee for
Civil Rights Under Law.
College Athletes and Their Name, Image, and Likeness (NIL)
On March 29, 2023, the Subcommittee on Innovation, Data,
and Commerce held a hearing entitled ``Taking the Buzzer Beater
to the Bank: Protecting College Athletes'' NIL Dealmaking
Rights.'' The purpose of the hearing was to examine the NCAA's
restrictions on athletes' NIL, and to address Congressional
areas of concern and potential actions. The Subcommittee
received testimony from Jennifer Heppel, Commissioner, Patriot
League; Dr. Makola M. Abdullah, Ph.D., President, Virginia
State University; Trey Burton, Former National Football League
player; Kaley Mudge, Student Athlete, Florida State University;
Pat Chun, Director of Athletics, Washington State University;
and Jason Stahl, Executive Director and Founder, College
Football Players Association.
On January 18, 2024, the Subcommittee on Innovation, Data,
and Commerce held a hearing entitled ``NIL Playbook: Proposal
to Protect Student Athletes'' Dealmaking Rights.'' The purpose
of the hearing was to examine the state of the NIL landscape,
with its pay-for-play unfair competition, regulatory
uncertainty causing harm to student athletes, and the need for
Federal action and the establishment of a preemptive national
standard to protect student athletes. The Subcommittee received
testimony from the Honorable Charlie Baker, President, National
Collegiate Athletic Association (NCAA); Jeff Jackson,
Commissioner, the Missouri Valley Conference; Meredith Page,
Student Athlete, Radford University Volleyball; Chase Griffin,
Student Athlete, UCLA Football; Kaitlin ``Keke'' Tholl, Student
Athlete, University of Michigan Softball; Dr. Victoria Jackson,
Associate Clinical Professor of History, Arizona State
University.
Building Blockchains
On June 7, 2023, the Subcommittee on Innovation, Data, and
Commerce held a hearing entitled ``Building Blockchains:
Exploring Web3 and Other Applications for Distributed Ledger
Technologies.'' The purpose of the hearing was to explore and
examine the importance of U.S. leadership in the emerging
blockchain and distributed ledger technologies, particularly in
the context of new advancements, former Committee action, and
strategic competition with China. The Subcommittee received
testimony from Carla L. Reyes, Associate Professor of Law, SMU
Dedman School of Law; Hasshi Sudler, Professor and Chief
Executive Officer, Villanova University College of Engineering
and Internet Think Tank, Inc.; Ryan Wyatt, President, Polygon
Labs; and Ross Schulman, Senior Fellow, Decentralization,
Electronic Frontier Foundation.
National Standards for Autonomous Vehicles
On July 24, 2023, the Subcommittee on Innovation, Data, and
Commerce held a hearing entitled ``Self-Driving Vehicle
Legislative Framework: Enhancing Safety, Improving Lives and
Mobility, and Beating China.'' The purpose of the hearing was
to give Members the opportunity to discuss the importance of
enacting a preemptive national framework allowing the U.S. to
lead in the broad deployment of these safe and life
transforming vehicles, particularly in competition for global
leadership against China. The Subcommittee received testimony
from Mr. Mark Riccobono, President, National Federation of the
Blind; Mr. John Bozzella, President and CEO, Alliance For
Automotive Innovation; Mr. Gary Shapiro, President and CEO,
Consumer Technology Association; and Dr. Philip Koopman, Ph.D.,
Associate Professor, Carnegie Mellon University.
Securing America's Supply Chains
On September 20, 2023, the Subcommittee on Innovation,
Data, and Commerce held a hearing entitled ``Mapping America's
Supply Chains: Solutions to Unleash Innovation, Boost Economic
Resilience, and Beat China.'' The purpose of the hearing was to
provide Members the opportunity to examine legislation to map,
monitor, and secure U.S. supply chains for emerging
technologies, encourage growth and opportunities for key
economic sectors, and determine pathways to onshore critical
manufacturing industries inside the U.S., particularly in the
context of U.S. competition with China. The Subcommittee
received testimony from Chris Griswold, Policy Director,
American Compass; Deena Ghazarian, Found and CEO, Austere;
Justin Slaughter, Policy Director, Paradigm; and Scott Paul,
President, Alliance for American Manufacturing.
Enhancing Product Safety and Transparency for Americans
On September 27, 2023, the Subcommittee on Innovation,
Data, and Commerce held a hearing entitled ``Proposals to
Enhance Product Safety and Transparency for Americans.'' The
purpose of the hearing was to examine legislative proposals to
enhance product safety and transparency enforceable by the
Federal Trade Commission and the Consumer Product Safety
Commission, with focuses on the protections consumers have on
event ticketing and hotel lodging, safety of products in homes
and communities, disclosures of where products are made and
what they do, fraud prevention in online dating, and the
accessibility and availability of repairing our automobiles.
The Subcommittee received testimony from Ms. Kathleen Callahan,
Owner, Xpertech Auto Repair; Mr. Scott Benavidez, Chairman,
Automotive Service Association; Mr. Steven Michael Gentine,
Counsel, Arnold & Porter, LLP; Mr. John Breyault, Vice
President of Public Policy, Telecommunications and Fraud,
National Consumers League; and Mr. David Touhey, Certified
Venue Expert, Principal, Connett Consulting (IAVM, Fix the Tix
Coalition member, former president of venues, Monumental
Sports), and Adjunct Professor of sports management, Georgetown
University and George Washington University.
Preserving Americans' Access to AM Radio
On April 30, 2024, the Subcommittee on Innovation, Data,
and Commerce held a hearing entitled ``Preserving Americans''
Access to AM Radio.'' The purpose of the hearing was to discuss
the importance of AM Radio in vehicles as certain automakers
prepare to remove the service from newer vehicles, and to
consider Congressional action on preserving Americans' access
to the free, accessible service. The Subcommittee received
testimony from Mr. John Bozzella, President and CEO, Alliance
for Automotive Innovation; Mr. Gary Shapiro, President and CEO,
Consumer Technology Association; Melody Spann-Cooper, Chair and
CEO, Midway Broadcasting Corporation; and Justin Ahasteen,
Executive Director, Navajo Nation.
Oversight of the Federal Trade Commission
On April 18, 2023, the Subcommittee on Innovation, Data,
and Commerce held a hearing entitled ``Fiscal Year 2024 Federal
Trade Commission Budget.'' The purpose of the hearing was to
conduct oversight of the Federal Trade Commission and examine
their budget request for Fiscal Year 2024, per the Committee's
authorizing authority over the Commission. The Subcommittee
received testimony from the Honorable Lina Khan, Chair; the
Honorable Rebecca Kelly Slaughter, Commissioner; and the
Honorable Alvaro Bedoya, Commissioner.
On July 9, 2024, the Subcommittee on Innovation, Data, and
Commerce held a hearing entitled ``The Fiscal Year 2025 Federal
Trade Commission Budget.'' The purpose of the hearing was to
conduct oversight of the Federal Trade Commission and examine
their budget request for Fiscal Year 2025, per the Committee's
authorizing authority over the Commission. The Subcommittee
received testimony from the Honorable Lina M. Khan, Chair; the
Honorable Rebecca Kelly Slaughter, Commissioner; the Honorable
Alvaro Bedoya, Commissioner; the Honorable Melissa Holyoak,
Commissioner; and the Honorable Andrew N. Ferguson,
Commissioner.
On September 19, 2024, the Subcommittee on Innovation,
Data, and Commerce held a hearing entitled ``Federal Trade
Commission Practices: A Discussion on Past Versus Present.''
The purpose of the hearing was to examine the current practices
of the Federal Trade Commission under Chair Lina Khan and the
Commission's departure from vetted and respected norms and
practices the Commission held in past Administrations, both
Democrat and Republican. The Subcommittee received testimony
from Ms. Shane Tews, Non-Resident Senior Scholar, American
Enterprise Institute; Dr. J. Howard Beales III, Emeritus
Professor of Strategic Management and Public Policy, George
Washington School of Business; Mr. Neil Chilson, Head of AI
Policy, Abundance Institute; and Mr. John Davisson, Director of
Litigation, Electronic Privacy Information Center.
Oversight of the Department of Commerce
On June 26, 2024, the Subcommittee on Innovation, Data, and
Commerce held a hearing entitled ``The Fiscal Year 2025
Department of Commerce Budget.'' The purpose of the hearing was
to conduct oversight of the Department of Commerce and examine
their budget request for Fiscal Year 2025, per the Committee's
authorizing authority over the Department. The Subcommittee
received testimony from the Honorable Gina Raimondo, Secretary
of Commerce.
Oversight of the Consumer Product Safety Commission
On July 23, 2024, the Subcommittee on Innovation, Data, and
Commerce held a hearing entitled ``The Fiscal Year 2025
Consumer Product Safety Commission Budget.'' The purpose of the
hearing was to conduct oversight of the Consumer Product Safety
Commission and examine their budget request for Fiscal Year
2025, per the Committee's authorizing authority over the
Commission. The Subcommittee received testimony from the
Honorable Alexander Hoehn-Saric, Chair; the Honorable Peter A.
Feldman, Commissioner; the Honorable Richard L. Trumka, Jr.,
Commissioner; the Honorable Mary T. Boyle, Commissioner; and
the Honorable Douglas Dziak, Commissioner.
Subcommittee on Energy, Climate, and Grid Security
LEGISLATIVE ACTIVITIES
Pipeline Safety, Modernization, and Expansion Act of 2024
H.R. 7655
To amend title 49, United States Code, to improve the
safety of pipeline transportation, and for other purposes.
Summary
H.R. 7655 would reauthorize the Pipeline and Hazardous
Materials Safety Administration's (PHMSA) Pipeline Safety
Regulations (PSR).
Legislative History
H.R. 7655 was introduced by Representative Duncan (SC-3) on
March 13, 2024, and referred to the Committee on Transportation
and Infrastructure, and in addition to the Committee on Energy
and Commerce.
On March 20, 2024, the full committee favorably reported
H.R. 7655, as amended, to the House, by a vote of 27 to 18.
Protecting American Energy Production Act
H.R. 150
To prohibit a moratorium on the use of hydraulic
fracturing.
Summary
H.R. 150 would prohibit the President from declaring a
moratorium on the use of hydraulic fracturing unless Congress
authorizes the moratorium. The bill also expresses the sense of
Congress that states should maintain primacy for the regulation
of hydraulic fracturing for oil and natural gas production on
state and private lands.
Legislative History
H.R. 150 was introduced by Representative Duncan (SC-R) on
January 9, 2023, and referred to the Committee Natural
Resources, and in addition to the Committee on Energy and
Commerce.
On February 7, 2023, the Subcommittee on Energy, Climate,
and Grid Security held a hearing on H.R. 150.
Natural Gas Tax Repeal Act
H.R. 484
To repeal the natural gas tax.
Summary
H.R. 484 would eliminate a program administered by the
Environmental Protection Agency (EPA) that provides incentives
for petroleum and natural gas systems to reduce their emissions
of methane and other greenhouse gases. It would also repeal a
charge on methane emissions from specific types of facilities
that are required to report their greenhouse gas emissions to
the EPA's Greenhouse Gas Emissions Reporting Program.
Legislative History
On January 24, 2023, Representative Pfluger (TX-R)
introduced H.R. 484.
On February 7, 2023, the Subcommittee on Energy, Climate,
and Grid Security held a hearing on H.R. 484.
Natural Gas Tax Repeal Act
H.R. 1141
To repeal the natural gas tax.
Summary
H.R. 1141 would eliminate a program administered by the
Environmental Protection Agency (EPA) that provides incentives
for petroleum and natural gas systems to reduce their emissions
of methane and other greenhouse gases. It would also repeal a
charge on methane emissions from specific types of facilities
that are required to report their greenhouse gas emissions to
the EPA's Greenhouse Gas Emissions Reporting Program.
Legislative History
H.R. 1141 was introduced by Representative Pfluger (TX-R)
on February 21, 2023, and referred to the Committee on Energy
and Commerce.
On February 28, 2023, the Subcommittee Energy, Climate, and
Grid Security favorably forwarded H.R. 1141 to the full
committee by a vote of 13 to 7.
On March 9, 2023, the full committee favorably reported
H.R. 1141 to the House by a vote of 26 to 21.
Global Nuclear Energy Assessment and Cooperation Act
H.R. 995
To direct the Secretary of Energy to conduct a study on the
global status of the civilian nuclear energy industry.
Summary
H.R. 995 would establish requirements concerning
international nuclear energy cooperation and safety.
Specifically, the Department of Energy (DOE) must develop and
carry out a program to train foreign nuclear energy experts and
standardize safety practices. DOE must also study the global
status of the civilian nuclear energy industry and its supply
chain. In addition, the bill would prohibit any person from
possessing or owning enriched uranium from Russian or China
unless specifically authorized by the Nuclear Regulatory
Commission (NRC).
NRC may not issue a license to possess or own such fuel if
DOE and the Department of State determine that the possession
or ownership would pose a threat to national security. NRC must
establish an International Nuclear Reactor Export and
Innovation Branch within its Office of International Programs
to carry out and coordinate certain nuclear reactor export and
innovation activities. NRC must also identify in its annual
budget justification such activities.
Legislative History
H.R. 995 was introduced by Representative Carter (GA-R) on
February 14, 2023, and referred to the Committee on Energy and
Commerce.
On July 18, 2023, the Subcommittee on Energy, Climate, and
Grid Security held a hearing on H.R. 995.
On October 25, 2023, the Subcommittee Energy, Climate, and
Grid Security favorably forwarded H.R. 995, as amended, to the
full committee by a voice vote.
Strengthening the NRC Workforce Act of 2023
H.R. 4528
To amend the Atomic Energy Act of 1954 to address the
insufficient compensation and recruitment of employees and
other personnel of the Nuclear Regulatory Commission.
Summary
H.R. 4528 would authorize the Nuclear Regulatory Commission
(NRC) to address insufficient compensation of its personnel
without regard to civil service laws. The NRC must consult with
the Office of Personnel Management when making a determination
of the appropriate compensation for its personnel. It would
allow the NRC to respond to a severe shortage of candidates or
a critical hiring need for certain positions by using direct
hiring to carry out the NRC's responsibilities and activities.
Legislative History
H.R. 4528 was introduced by Representative DeGette (CO-D)
on July 11, 2023, and referred to the Committee on Energy and
Commerce.
On July 18, 2023, the Subcommittee on Energy, Climate, and
Grid Security held a hearing on H.R. 4528.
On October 25, 2023, the Subcommittee Energy, Climate, and
Grid Security favorably forwarded H.R. 4528 to the full
committee by a voice vote.
NRC Office of Public Engagement and Participation
Act of 2023
H.R. 4530
To establish an Office of Public Engagement and
Participation within the Nuclear Regulatory Commission.
Summary
H.R. 4530 would establish an independent office within the
Nuclear Regulatory Commission (NRC) to advocate for the public
within NRC jurisdiction and support public participation in NRC
proceedings and activities.
Legislative History
H.R. 4530 was introduced by Representative Levin (CA-D) on
July 11, 2023, and referred to the Committee on Energy and
Commerce.
On July 18, 2023, the Subcommittee on Energy, Climate, and
Grid Security held a hearing on H.R. 4530.
Nuclear Fuel Security Act of 2023
H.R. 5718
To require the Secretary of Energy to establish a Nuclear
Fuel Security Program, expand the American Assured Fuel Supply
Program.
Summary
H.R. 5718 would require the Secretary of Energy to
establish a Nuclear Fuel Security Program and would expand the
existing American Assured Fuel Supply Program.
Legislative History
H.R. 5718 was introduced by Representative Latta (OH-R) on
September 29, 2023, and referred to the Committee on Energy and
Commerce.
On July 18, 2023, the Subcommittee on Energy, Climate, and
Grid Security held a hearing on the subject matter of H.R.
5718.
On October 25, 2023, the Subcommittee Energy, Climate, and
Grid Security favorably forwarded H.R. 5718 to the full
committee by a voice vote.
On December 5, 2023, the full committee favorably reported
H.R. 5718 to the House by a vote of 48 to 0.
Nuclear Licensing Efficiency Act
H.R. 6236
To streamline nuclear technology regulatory permitting and
licensing.
Summary
H.R. 6236 would amend the Atomic Energy Act of 1954 to make
licensing reviews for nuclear construction and control more
streamlined. It would also amend the Nuclear Energy Innovation
and Modernization Act to require periodic updates on metrics
and schedules.
Legislative History
H.R. 6236 was introduced by Representative Allen (GA-R) on
November 6, 2023, and referred to the Committee on Energy and
Commerce.
On July 18, 2023, the Subcommittee on Energy, Climate, and
Grid Security held a hearing on the subject matter of H.R.
6236.
Modernize Nuclear Reactor Environmental Reviews Act
H.R. 6252
To direct the Nuclear Regulatory Commission to submit a
report and conduct a rulemaking on facilitating efficient,
timely environmental reviews of nuclear reactor applications.
Summary
H.R. 6252 would require the Nuclear Regulatory Commission
(NRC) to report to Congress on potential ways to streamline
environmental reviews for nuclear reactor applications.
Legislative History
H.R. 6252 was introduced by Representative Weber (TX-R) on
November 6, 2023, and referred to the Committee on Energy and
Commerce.
On July 18, 2023, the Subcommittee on Energy, Climate, and
Grid Security held a hearing on the subject matter of H.R.
6252.
Advanced Nuclear Reactor Prize Act
H.R. 6253
To authorize the Secretary of Energy to make awards to
cover regulatory costs relating to licensing certain first-of-
a-kind advanced nuclear reactors.
Summary
H.R. 6253 would amend the Nuclear Energy Innovation and
Modernization Act to include prizes for advanced nuclear
reactor licensing to non-federal entities.
Legislative History
H.R. 6253 was introduced by Representative Curtis (UT-R) on
November 7, 2023, and referred to the Committee on Energy and
Commerce.
On July 18, 2023, the Subcommittee on Energy, Climate, and
Grid Security held a hearing on the subject matter of H.R.
6253.
NRC Mission Alignment Act
H.R. 6265
To direct the Nuclear Regulatory Commission to update the
mission statement of the Commission to ensure licensing and
regulation is efficient and is in alignment with the policies
stated in the Atomic Energy Act of 1954.
Summary
H.R. 6265 would direct the Nuclear Regulatory Commission
(NRC) to update the mission statement of the NRC to include
that licensing and regulation of nuclear energy activities be
conducted in a manner that is efficient and does not
unnecessarily limit the potential of nuclear energy.
Legislative History
H.R. 6265 was introduced by Representative Duncan (SC-R) on
November 7, 2023, and referred to the Committee on Energy and
Commerce.
On July 18, 2023, the Subcommittee on Energy, Climate, and
Grid Security held a hearing on the subject matter of H.R.
6265.
Nuclear for Brownfield Site Preparation Act
H.R. 6268
To enable timely licensing reviews for nuclear reactor
facilities at brownfield sites and retired fossil fuel sites.
Summary
H.R. 6268 would require the Nuclear Regulatory Commission
(NRC) to evaluate modifications, regulations, guidance, or
policy that could improve licensing reviews for nuclear
projects on brownfield sites.
Legislative History
H.R. 6268 was introduced by Representative Guthrie (KY-R)
on November 7, 2023, and referred to the Committee on Energy
and Commerce.
On July 18, 2023, the Subcommittee on Energy, Climate, and
Grid Security held a hearing on the subject matter of H.R.
6268.
Strengthening American Nuclear Competitiveness Act
H.R. 6303
To assess and improve the competitiveness of United States
nuclear commerce, to expedite Department of Energy review of
certain nuclear technology exports.
Summary
H.R. 6303 would require the Secretary of Energy to report
to Congress on nuclear commerce, legal and regulatory
requirements, domestic and foreign nuclear issues, and the role
of emerging technologies, among other things.
Legislative History
H.R. 6303 was introduced by Representative Johnson (OH-R)
on November 8, 2023, and referred to the Committee on Energy
and Commerce.
On July 18, 2023, the Subcommittee on Energy, Climate, and
Grid Security held a hearing on the subject matter of H.R.
6303.
Advanced Reactor Fee Reduction Act
H.R. 6326
To amend the Nuclear Energy Innovation and Modernization
Act to reduce regulatory costs for advanced nuclear reactor
application reviews.
Summary
H.R. 6326 would require the Nuclear Regulatory Commission
(NRC) to review and modernize applications for advanced nuclear
reactors.
Legislative History
H.R. 6326 was introduced by Representative Bucshon (IN-R)
on November 9, 2023, and referred to the Committee on Energy
and Commerce.
On July 18, 2023, the Subcommittee on Energy, Climate, and
Grid Security held a hearing on the subject matter of H.R.
6326.
Advancing Nuclear Regulatory Oversight Act
H.R. 6346
To update oversight and inspection practices of the Nuclear
Regulatory Commission.
Summary
H.R. 6346 would require the Nuclear Regulatory Commission
to report to Congress about (1) changes to its regulation of
nuclear reactors and materials during the COVID-19 public
health emergency, and (2) actions (e.g., the use of risk-
informed, performance-based procedures) that may be implemented
to enhance the efficiency of oversight and inspection programs.
The Government Accountability Office would conduct a review of
the commission's office and other facility space requirements
and recommend ways to reduce office and facility costs.
Legislative History
H.R. 6346 was introduced by Representative Lesko (AZ-R) on
November 9, 2023, and referred to the Committee on Energy and
Commerce.
On July 18, 2023, the Subcommittee on Energy, Climate, and
Grid Security held a hearing on the subject matter of H.R.
6346.
Efficient Nuclear Licensing Hearings Act
H.R. 6464
To amend the Atomic Energy Act of 1954 to provide for more
efficient hearings on nuclear facility construction
applications.
Summary
H.R. 6464 would update the processes for hearings and
judicial review of nuclear facility construction applications
and for uranium enrichment facilities.
Legislative History
H.R. 6464 was introduced by Representative Griffith (VA-R)
on November 21, 2023, and referred to the Committee on Energy
and Commerce.
On July 18, 2023, the Subcommittee on Energy, Climate, and
Grid Security held a hearing on the subject matter of H.R.
6346.
Advanced Nuclear Deployment Act
H.R. 6526
To facilitate the efficient licensing and deployment of
advanced civilian nuclear technologies.
Summary
H.R. 6526 would enable preparations for advanced nuclear
reactor demonstrations on federal sites and update regulatory
requirements for micro-reactors. It would also establish a
pilot program for nuclear power purchase agreements.
Legislative History
H.R. 6526 was introduced by Representative Hudson (NC-R) on
November 30, 2023, and referred to the Committee on Energy and
Commerce.
On July 18, 2023, the Subcommittee on Energy, Climate, and
Grid Security held a hearing on the subject matter of H.R.
6526.
Atomic Energy Advancement Act
H.R. 6544
To advance the benefits of nuclear energy by enabling
efficient, timely, and predictable licensing, regulation, and
deployment of nuclear energy technologies.
Summary
H.R. 1141 would establish various requirements to
accelerate the deployment of nuclear energy technologies, such
as advanced nuclear reactors. The bill sets forth requirements
that direct the Nuclear Regulatory Commission (NRC) to
efficiently license and regulate nuclear energy activities. The
bill would revise the NRC's hiring process to enable the NRC to
respond to a severe shortage of candidates or a critical hiring
need by using direct hiring for certain positions to carry out
NRC's responsibilities and activities in a timely, efficient,
and effective manner.
It would reduce certain licensing fees charged by the NRC
for advanced nuclear reactors. It would authorize the
Department of Energy (DOE) to make awards that pay for certain
licensing fees. It would direct the NRC to promulgate a final
rule that implements a process to facilitate efficient and
timely environmental reviews of nuclear reactor applications.
The NRC must also develop and implement strategies to enable
efficient and timely licensing reviews for, and to support the
oversight of, nuclear facilities at brownfield sites, including
sites with retired fossil fuel facilities.
The bill would set requirements for expediting certain
licensing decisions for new nuclear reactors that will use a
previously licensed design and will be on or adjacent to a site
on which a nuclear reactor already operates or previously
operated. It would authorize DOE to establish a pilot program
under which DOE may make certain long-term power purchase
agreements for power generated by commercial nuclear reactors.
Finally, the bill would establish requirements concerning
international nuclear energy cooperation and safety.
Legislative History
H.R. 6544 was introduced by Representative Duncan (SC-R) on
December 1, 2023, and referred to the Committee on Energy and
Commerce.
On July 18, 2023, the Subcommittee on Energy, Climate, and
Grid Security held a hearing on the subject matter of H.R.
6544.
On October 24, 2023, the Subcommittee held a markup on
several bills that later formed H.R. 6544.
On December 5, 2023, the full committee favorably reported
H.R. 6544, as amended, to the House by a vote of 47 to 2.
On February 28, 2023, H.R. 6544 passed the House under
suspension of the rules by a vote of 365 to 36, 1 present.
On February 29, 2023, H.R. 6544 was received in the Senate
and referred to the Committee on Environment and Public Works.
Protecting America's Distribution Transformer
Supply Chain Act
H.R. 4167
To prohibit the Secretary of Energy from changing energy
conservation standards for distribution transformers for a
certain period.
Summary
H.R. 4167 would prohibit the Department of Energy (DOE)
from revising existing energy conservation standards for
distribution transformers in electric power systems for the
next five years. During that time, DOE may not propose,
finalize, implement, administer, or enforce any rule under the
Energy Policy and Conservation Act that establishes
requirements that are different than the requirements for
distribution transformers under the 2013 final rule titled
Energy Conservation Program: Energy Conservation Standards for
Distribution Transformers.
Legislative History
H.R. 4167 was introduced by Representative Hudson (NC-R) on
June 15, 2023, and referred to the Committee on Energy and
Commerce.
On June 13, 2023, the Subcommittee on Energy, Climate, and
Grid Security held a hearing on the subject matter of H.R.
4167.
On October 25, 2023, the Subcommittee on Energy, Climate,
and Grid Security favorably forwarded H.R. 4167 to the full
committee by a vote of 17 to 13.
On December 5, 2023, the full committee favorably reported
H.R. 4167 to the House by a vote of 24 to 22.
Hydropower Clean Energy Future Act
H.R. 4045
To modernize the hydropower licensing process and to
promote next-generation hydropower projects.
Summary
H.R. 4045 would modify the definition of ``renewable
energy'' to include hydropower. It would protect and promote
small and next-generation hydropower projects. It would
expedite licensing of next-generation hydropower projects. It
would identify and remove market barriers to hydropower. It
would modernize hydropower licensing under the Federal Power
Act.
Legislative History
H.R. 4045 was introduced by Representative McMorris Rodgers
(WA-R) on June 12, 2023, and referred to the Committee on
Energy and Commerce.
On October 25, 2023, the Subcommittee on Energy, Climate,
and Grid Security favorably forwarded H.R. 4045, as amended, to
the full committee by a vote of 16 to 12.
On December 5, 2023, the full committee favorably reported
H.R. 4045 to the House by a vote of 28 to 19.
Grid Act
H.R. 6185
To require coordination among Federal agencies on
regulatory actions that affect the reliable operation of the
bulk-power system.
Summary
H.R. 6185 would require coordination of processes to
protect electric grid reliability.
Legislative History
H.R. 6185 was introduced by Representative Duncan (SC-R) on
September 8, 2023, and referred to the Committee on Energy and
Commerce.
On October 24, 2023, the Subcommittee on Energy, Climate,
and Grid Security held a hearing on the bill.
On October 25, 2023, the Subcommittee on Energy, Climate,
and Grid Security favorably forwarded H.R. 6185 to the full
committee by a vote of 15 to 12.
On December 5, 2023, the full committee favorably reported
H.R. 6185 to the House by a vote of 24 to 21.
Prohibiting Russian Uranium Imports Act
H.R. 1042
To prohibit the importation into the United States of
unirradiated low-enriched uranium that is produced in the
Russian Federation.
Summary
H.R. 1042 would limit the importation of uranium from
Russia. Specifically, it bans unirradiated low-enriched uranium
(i.e., uranium that has not been in a reactor) that is produced
in Russia or by a Russian entity from being imported into the
United States. The bill would prohibit the importation of
unirradiated low-enriched uranium that has been swapped for the
banned uranium or otherwise obtained in a manner designed to
circumvent the ban's restrictions.
However, the Department of Energy (DOE) could waive this
ban if DOE determines that (1) no alternative viable source of
low-enriched uranium is available to sustain the continued
operation of a nuclear reactor or a U.S. nuclear energy
company, or (2) importation of the uranium is in the national
interest. Any waiver issued must terminate by January 1, 2028.
The ban terminates on December 31, 2040.
Legislative History
H.R. 1042 was introduced by Representative McMorris Rodgers
(WA-R) on February 14, 2023, and referred to the Committee on
Energy and Commerce.
On May 12, 2023, the Subcommittee Energy, Climate, and Grid
Security favorably forwarded H.R. 1042, as amended to the full
committee by a vote of 18 to 12.
On May 24, 2023, the full committee favorably reported H.R.
1042 to the House by a vote of 29 to 21.
On December 11, 2023, the House passed H.R. 1042 under
suspension of the rules by voice vote.
On April 30, 2024, the Senate passed H.R. 1042 by unanimous
consent.
H.R. 1042 was presented to the President on May 9, 2024,
and became Public Law 118-62 on May 13, 2024.
Promoting Cross Border Energy Infrastructure Act
H.R. 1058
To establish a more uniform, transparent, and modern
process to authorize the construction, connection, operation,
and maintenance of international border-crossing facilities for
the import and export of oil and natural gas and the
transmission of electricity.
Summary
H.R. 1058 would establish a new process for approving or
revoking the construction and operation of energy
infrastructure across an international border of the United
States. It would replace the existing process established under
specified executive orders.
It would require a person to obtain a certificate of
crossing before constructing, connecting, operating, or
maintaining a border-crossing facility for the import or export
of oil, natural gas, or electricity across a U.S. border
between Canada or Mexico. A certificate must be obtained from
the Federal Energy Regulatory Commission (FERC) for a facility
consisting of oil or natural gas pipelines or the Department of
Energy (DOE) for an electric transmission facility. As a
condition of issuing a certificate, DOE must require that an
electric transmission facility be constructed, connected,
operated, or maintained consistent with specified policies and
standards. FERC and DOE must meet a deadline for issuing a
certificate as set forth by this bill. The bill also requires
FERC to meet a deadline for approving applications to import or
export natural gas to or from Canada or Mexico.
The bill would require the President to obtain the approval
of Congress before revoking a permit issued under executive
orders for constructing, connecting, operating, or maintaining
an oil or natural gas pipeline, an electric transmission
facility, or a border-crossing facility.
Legislative History
H.R. 1058 was introduced by Representative Armstrong (ND-R)
on February 17, 2023, and referred to the Committee on Energy
and Commerce.
On February 28, 2023, the Subcommittee Energy, Climate, and
Grid Security favorably forwarded H.R. 1058, as amended, to the
full committee by a vote of 17 to 10.
On March 9, 2023, the full committee favorably reported
H.R. 1058 to the House by a vote of 28 to 20.
Prohibiting Russian Uranium Imports Act
H.R. 1042
To prohibit the importation into the United States of
unirradiated low-enriched uranium that is produced in the
Russian Federation.
Summary
H.R. 1042 would limit the importation of uranium from
Russia. Specifically, it bans unirradiated low-enriched uranium
(i.e., uranium that has not been in a reactor) that is produced
in Russia or by a Russian entity from being imported into the
United States. The bill would prohibit the importation of
unirradiated low-enriched uranium that has been swapped for the
banned uranium or otherwise obtained in a manner designed to
circumvent the ban's restrictions.
However, the Department of Energy (DOE) could waive this
ban if DOE determines that (1) no alternative viable source of
low-enriched uranium is available to sustain the continued
operation of a nuclear reactor or a U.S. nuclear energy
company, or (2) importation of the uranium is in the national
interest. Any waiver issued must terminate by January 1, 2028.
The ban terminates on December 31, 2040.
Legislative History
H.R. 1042 was introduced by Representative McMorris Rodgers
(WA-R) on February 14, 2023, and referred to the Committee on
Energy and Commerce.
On May 12, 2023, the Subcommittee Energy, Climate, and Grid
Security favorably forwarded H.R. 1042, as amended, to the full
committee by a vote of 18 to 12.
On May 24, 2023, the full committee favorably reported H.R.
1042 to the House by a vote of 29 to 21.
On December 11, 2023, the House passed H.R. 1042 under
suspension of the rules by voice vote.
On April 30, 2024, the Senate passed H.R. 1042 by unanimous
consent.
H.R. 1042 was presented to the President on May 9, 2024,
and became Public Law 118-62 on May 13, 2024.
Securing America's Critical Minerals Supply Act
H.R. 1068
To amend the Department of Energy Organization Act to
secure the supply of critical energy resources, including
critical minerals and other materials.
Summary
H.R. 1068 would require the Department of Energy (DOE) to
secure the supply of critical energy resources that are
essential to the energy security of the United States.
Legislative History
H.R. 1068 was introduced by Representative Bucshon (IN-R)
on February 17, 2023, and referred to the Committee on Energy
and Commerce.
On February 28, 2023, the Subcommittee Energy, Climate, and
Grid Security favorably forwarded H.R. 1068 to the full
committee by a vote of 15 to 8.
On March 9, 2023, the full committee favorably reported
H.R. 1068, as amended, to the House by a vote of 26 to 22.
REFINER Act
H.R. 1085
To require the Secretary of Energy to direct the National
Petroleum Council to issue a report with respect to
petrochemical refineries in the United States.
Summary
H.R. 1085 would require the Department of Energy to direct
the National Petroleum Council to publish a report on
petrochemical refineries located in the United States. The
report must include information concerning (1) the
contributions of such refineries to U.S. energy security, (2) a
projection for expanding the capacities of the refineries, (3)
any federal or state executive actions that have contributed to
a decline in their capacities, and (4) any recommendations to
increase such capacities.
However, the Department of Energy (DOE) could waive this
ban if DOE determines that (1) no alternative viable source of
low-enriched uranium is available to sustain the continued
operation of a nuclear reactor or a U.S. nuclear energy
company, or (2) importation of the uranium is in the national
interest. Any waiver issued must terminate by January 1, 2028.
The ban would terminate on December 31, 2040.
Legislative History
H.R. 1085 was introduced by Representative Latta (OH-R) on
February 17, 2023, and referred to the Committee on Energy and
Commerce.
On February 28, 2023, the Subcommittee Energy, Climate, and
Grid Security favorably forwarded H.R. 1085 to the full
committee by a vote of 17 to 11.
On March 9, 2023, the full committee favorably reported
H.R. 1085 to the House by a vote of 30 to 18.
Expressing Disapproval of the Revocation by President Biden of the
Presidential Permit for the Keystone XL Pipeline
H. CON. RES. 14
Expressing disapproval of the revocation by President Biden
of the Presidential permit for the Keystone XL pipeline.
Summary
This concurrent resolution expresses congressional
disapproval of the revocation of the presidential permit for
the Keystone XL pipeline. The permit authorized the TransCanada
Keystone Pipeline to construct, connect, operate, and maintain
the pipeline facilities in Phillips County, Montana, for the
import of oil from Canada to the United States.
Legislative History
H. Con. Res. 14 was introduced by Representative Lesko (AZ-
R) on February 7, 2023, and referred to the Committee on
Transportation and Infrastructure, and in addition to the
Committees on Energy and Commerce and on Natural Resources.
On February 28, 2023, the Subcommittee Energy, Climate, and
Grid Security favorably forwarded H. Con. Res. 14 to the full
committee by a vote of 15 to 11.
On March 9, 2023, the full committee favorably reported H.
Con. Res. 14 to the House by a vote of 28 to 21.
Expressing the Sense of Congress That the Federal Government Should Not
Impose Any Restrictions on the Export of Crude Oil or Other Petroleum
Products
H. CON. RES. 17
Expressing the sense of Congress that the Federal
Government should not impose any restrictions on the export of
crude oil or other petroleum products.
Summary
This concurrent resolution expresses the sense of Congress
that the federal government should not impose (1) overly
restrictive regulations on the exploration, production, or
marketing of energy resources; or (2) any restrictions on the
export of crude oil or other petroleum products under the
Energy Policy and Conservation Act, except with respect to the
export of such products to a foreign person or foreign
government subject to sanctions.
Legislative History
H. Con. Res. 17 was introduced by Representative Guthrie
(KY-R) on February 17, 2023, and referred to the Committee on
Energy and Commerce.
On February 28, 2023, the Subcommittee Energy, Climate, and
Grid Security favorably forwarded H. Con. Res. 17 to the full
committee by a vote of 14 to 10.
On March 9, 2023, the full committee favorably reported H.
Con. Res. 17 to the House by a vote of 29 to 19.
Promoting Interagency Coordination for Review of Natural Gas Pipelines
Act
H.R. 1115
To provide for Federal and State agency coordination in the
approval of certain authorizations under the Natural Gas Act.
Summary
H.R. 1115 would expand the authority of the Federal Energy
Regulatory Commission (FERC) to act as the only lead agency for
the purpose of coordinating the environmental review process
under the National Environmental Policy Act of 1969 (NEPA) of
natural gas pipeline project applications under the Natural Gas
Act. FERC must invite and designate the other participating
agencies involved in the authorization process by deadlines
established by the bill. In addition, FERC must consult with
the Transportation Security Administration regarding pipeline
infrastructure security, pipeline cybersecurity, pipeline
personnel security, and other pipeline security measures.
The bill establishes a deadline for agencies to complete
NEPA reviews of pipeline projects and requires concurrent
reviews when multiple federal or state agencies are involved.
Applicants for gas pipeline projects do not have to obtain a
certification under Section 401 of the Clean Water Act.
Instead, FERC must incorporate the water quality certification
into its NEPA review.
Legislative History
H.R. 1115 was introduced by Representative Burgess (TX-R)
on February 21, 2023, and referred to the Committee on Energy
and Commerce.
On February 28, 2023, the Subcommittee Energy, Climate, and
Grid Security favorably forwarded H.R. 1115, as amended, to the
full committee by a vote of 13 to 8.
On March 9, 2023, the full committee favorably reported
H.R. 1115 to the House by a vote of 27 to 23.
Protecting American Energy Production Act
H.R. 1121
To prohibit a moratorium on the use of hydraulic
fracturing.
Summary
H.R. 1121 would prohibit the President from declaring a
moratorium on the use of hydraulic fracturing unless Congress
authorizes the moratorium. The bill also expresses the sense of
Congress that states should maintain primacy for the regulation
of hydraulic fracturing for oil and natural gas production on
state and private lands.
Legislative History
H.R. 1121 was introduced by Representative Duncan (SC-R) on
February 21, 2023, and referred to the Committee on Natural
Resources and in addition to the Committee on Energy and
Commerce.
On February 28, 2023, the Subcommittee Energy, Climate, and
Grid Security favorably forwarded H.R. 1121 to the full
committee by a vote of 16 to 11.
On March 9, 2023, the full committee favorably reported
H.R. 1121 to the House by a vote of 29 to 19.
On November 8, 2023, the Committee on Natural Resources
favorably reported H.R. 1121 to the House by a vote of 21 to
17.
On March 19, 2024, the Rules Committee reported H. Res.
1085 to the House, providing for consideration of H.R. 1121.
On March 20, 2023, the House passed H.R. 1121 by a vote of
229 to 118.
On March 21, 2024, the bill was received in the Senate and
referred to the Committee on Energy and Natural Resources.
Unlocking Our Domestic LNG Potential Act of 2023
H.R. 1130
To repeal restrictions on the export and import of natural
gas.
Summary
H.R. 1130 would repeal certain restrictions on the import
and export of natural gas under the Natural Gas Act, including
restrictions related to free trade agreements.
In addition, the bill grants the Federal Energy Regulatory
Commission the exclusive authority to approve or deny
applications for the siting, construction, expansion, or
operation of facilities (e.g., liquefied natural gas terminals)
to export natural gas to foreign countries or import natural
gas from foreign countries.
Legislative History
H.R. 1130 was introduced by Representative Johnson (OH-R)
on February 21, 2023, and referred to the Committee on Energy
and Commerce.
On February 28, 2023, the Subcommittee Energy, Climate, and
Grid Security favorably forwarded H.R. 1130, as amended, to the
full committee by a vote of 16 to 9.
On March 9, 2023, the full committee favorably reported
H.R. 1130 to the House by a vote of 27 to 21.
On September 19, 2023, the Rules Committee reported H. Res.
699 to the House, providing for the consideration of H.R. 1130.
On September 21, 2023, the Rules Committee reported H. Res.
712 to the House, providing for the consideration of H.R. 1130.
Critical Electric Infrastructure Cybersecurity Incident Reporting Act
H.R. 1160
To direct the Secretary of Energy to promulgate regulations
to facilitate the timely submission of notifications regarding
cybersecurity incidents and potential cybersecurity incidents
with respect to critical electric infrastructure.
Summary
H.R. 1160 would require the Department of Energy (DOE) to
issue regulations about reporting cybersecurity incidents with
respect to critical electric infrastructure. The regulations
must require federal agencies as well as the owners, operators,
and users of critical electric infrastructure to report
cybersecurity incidents or potential cybersecurity incidents to
DOE within 24 hours of their discovery.
Legislative History
H.R. 1160 was introduced by Representative Walberg (MI-R)
on February 24, 2023, and referred to the Committee on Energy
and Commerce.
On February 28, 2023, the full committee favorably reported
H.R. 1160, as amended, to the House by a vote of 49 to 1.
Lower Energy Costs Act
H.R. 1
To lower energy costs by increasing American energy
production, exports, infrastructure, and critical minerals
processing, by promoting transparency, accountability,
permitting, and production of American resources, and by
improving water quality certification and energy projects, and
for other purposes.
Summary
H.R. 1 includes provisions to increase American energy
production, exports, infrastructure, and critical minerals
processing; to provide transparency, accountability,
permitting, and production of American resources; to streamline
energy permitting; to provide for permitting for mining needs;
federal land use planning; ensuring competitiveness on federal
lands; energy revenue sharing; and water quality certification
and energy project improvement.
Legislative History
H.R. 1 was introduced by Representative Scalise (LA-R) on
March 14, 2023, and referred to the Committee on Natural
Resources, and in addition to the Committees on Energy and
Commerce, Agriculture, Transportation and Infrastructure, and
Budget.
On March 28, 2023, the Rules Committee reported H. Res. 260
to the House, providing for consideration of H.R. 1.
On March 28 through 30, 2023, the House met in the
Committee of the Whole for debate and consideration of
amendments to H.R. 1.
On March 30, 2023, the House passed H.R. 1, as amended, by
a vote of 225 to 204.
Homeowner Energy Freedom Act
H.R. 1603
To repeal provisions of Public Law 117-169 relating to
taxpayer subsidies for home electrification, and for other
purposes.
Summary
H.R. 1603 would repeal provisions of the Deficit Reduction
Act of 2022 relating to (1) the high-efficiency electric home
rebate program, (2) state-based home energy efficiency
contractor training grants, and (3) assistance for latest and
zero building energy code adoption. It also rescinds any
unobligated balances available for such programs.
Legislative History
H.R. 1603 was introduced by Representative McMorris Rodgers
(WA-R) on March 14, 2023, and referred to the Committee on
Energy and Commerce.
On March 24, 2023, the full committee favorably reported
H.R. 1603 to the House by a vote of 27 to 22.
Save Our Gas Stoves Act
H.R. 1640
To prohibit the Secretary of Energy from finalizing,
implementing, or enforcing the proposed rule titled ``Energy
Conservation Program: Energy Conservation Standards for
Consumer Conventional Cooking Products.''
Summary
H.R. 1640 would place limits on energy conservation
standards for kitchen ranges or ovens under the Energy Policy
and Conservation Act.
The Department of the Energy (DOE) may not prescribe or
amend energy conservation standards for kitchen ranges or ovens
unless DOE (1) determines that such standards will not likely
result in the unavailability of a product on account of the
type of fuel the range or oven uses; and (2) discloses certain
stakeholder meetings with entities that have ties to China or
the Chinese Communist Party.
In addition, DOE may not finalize, implement, or enforce
the proposed rule titled Energy Conservation Program: Energy
Conservation Standards for Consumer Conventional Cooking
Products issued on February 1, 2023, or any substantially
similar rule. The proposed rule prescribes energy conservation
standards for consumer conventional cooking tops, including
electric cooking tops, gas cooking tops, electrical ovens, and
gas ovens.
Legislative History
H.R. 1640 was introduced by Representative Lesko (AZ-R) on
March 17, 2023, and referred to the Committee on Energy and
Commerce.
On May 12, 2023, the Subcommittee Energy, Climate, and Grid
Security favorably forwarded H.R. 1640 to the full committee by
a vote of 20 to 10.
On May 24, 2023, the full committee favorably reported H.R.
1640 to the House by a vote of 31 to 18.
On June 5, 2023, the Rules Committee reported H. Res. 463
to the House, providing for the consideration of H.R. 1640;
passage of H. Res. 463 failed.
On June 12, 2023, the Rules Committee reported H. Res. 495
to the House, providing for the consideration of H.R. 1640.
On June 13 and 14, 2023, the House met in the Committee of
the Whole to debate and consider amendments to H.R. 1640.
On June 14, 2023, the House passed H.R. 1640, as amended,
by a vote of 249 to 181.
On June 15, 2023, H.R. 1640 was received in the Senate and
referred to the Committee on Energy and Natural Resources.
Hands Off Our Home Appliances Act
H.R. 6192
To amend the Energy Policy and Conservation Act to prohibit
the Secretary of Energy from prescribing any new or amended
energy conservation standard for a product that is not
technologically feasible and economically justified.
Summary
H.R. 1042 would modify the process by which the Department
of Energy (DOE) amends, revokes, or implements energy
conservation standards for certain consumer products (other
than automobiles), such as household appliances.
It would eliminate the requirement under the Energy Policy
and Conservation Act for DOE, within six years of issuing a
final rule establishing or amending such standard, to issue a
new proposed rule or publish a notice that the standard does
not need to be amended. Instead, the bill allows DOE to publish
a notice of proposed rulemaking for prescribing a new or
amended energy conservation standard for a consumer product at
any time.
It would specify that DOE may grant a petition to revoke or
amend energy conservation standards if it finds that the
standards (1) result in additional costs to consumers, (2) do
not result in significant conservation of energy or water, (3)
are not technologically feasible, and (4) result in a product
(e.g., gas stoves) not being commercially available in the
United States to all consumers.
It would modify the criteria used to prescribe new or
amended energy conservation standards. For example, new energy
conservation standards must be technologically feasible and
economically justified.
Legislative History
H.R. 6192 was introduced by Representative Lesko (AZ-R) on
November 2, 2023, and referred to the Committee on Energy and
Commerce.
On October 24, 2023, the Subcommittee Energy, Climate, and
Grid Security favorably forwarded a draft version of H.R. 6192
to the full committee by a vote of 15 to 12.
On December 5, 2023, the full committee favorably reported
H.R. 6192 to the House by a vote of 26 to 20.
On May 6, 2024, the Rules Committee reported H. Res. 1194
to the House, providing for consideration of H.R. 6192.
On May 7, 2024, the House met in the Committee of the Whole
to debate and consider amendments to H.R. 6192.
On May 7, 2024, the House passed H.R. 6192, as amended, by
a vote of 212 to 195.
On May 8, 2024, H.R. 6192 was received in the Senate and
referred to the Committee on Energy and Natural Resources.
Affordable HOMES Act
H.R. 6421
To prohibit the Secretary of Energy from enforcing energy
efficiency standards applicable to manufactured housing.
Summary
H.R. 6421 would repeal the Department of Energy's authority
to establish standards for manufactured housing.
Legislative History
H.R. 6421 was introduced by Representative Bucshon (IN-R)
on November 15, 2023, and referred to the Committee on Energy
and Commerce.
On December 5, 2023, the full committee favorably reported
H.R. 6421 to the House by a vote of 24 to 20.
Affordable Air Conditioning Act
H.R. 7626
To prohibit the Secretary of Energy from prescribing or
enforcing energy conservation standards for room air
conditioners that are not cost-effective or technologically
feasible.
Summary
H.R. 7626 would place limits on the authority of the
Department of Energy (DOE) to prescribe or enforce energy
conservation standards for room air conditioners. Specifically,
the bill prohibits DOE from prescribing or enforcing such
standards unless they (1) are technologically feasible and
economically justified, (2) are not likely to result in
additional net costs to the consumer, and (3) will result in
significant conservation of energy.
Legislative History
H.R. 7626 was introduced by Representative Crenshaw (TX-R)
on March 12, 2023, and referred to the Committee on Energy and
Commerce.
On March 20, 2023, the full committee favorably reported
H.R. 7626 to the House by a vote of 24 to 21.
Prohibiting Russian Uranium Imports Act
H.R. 7637
To prohibit the Secretary of Energy from prescribing or
enforcing energy conservation standards for refrigerators,
refrigerator-freezers, and freezers that are not cost-effective
or technologically feasible.
Summary
H.R. 7637 would place limits on the authority of the
Department of Energy (DOE) to prescribe or enforce energy
conservation standards for refrigerators, refrigerator-
freezers, and freezers. Specifically, the bill prohibits DOE
from prescribing or enforcing such standards unless they (1)
are technologically feasible and economically justified, (2)
are not likely to result in additional net costs to the
consumer, and (3) will result in significant conservation of
energy.
Legislative History
H.R. 7637 was introduced by Representative Miller-Meeks
(IA-R) on March 12, 2023, and referred to the Committee on
Energy and Commerce.
On March 20, 2023, the full committee favorably reported
H.R. 7637 to the House by a vote of 25 to 21.
On July 9, 2024, the Rules Committee reported H. Res. 1341
to the House, providing for the consideration of H.R. 7637.
On July 9, 2023, the House passed H.R. 7637 by a vote of
212 to 192.
On July 10, 2024, H.R. 7637 was received in the Senate and
referred to the Committee on Energy and Natural Resources.
Clothes Dryer Reliability Act
H.R. 7645
To prohibit the Secretary of Energy from prescribing or
enforcing energy conservation standards for clothes dryers that
are not cost-effective or technologically feasible.
Summary
H.R. 7645 would place limits on the authority of the
Department of Energy (DOE) to prescribe or enforce energy
conservation standards for clothes dryers. Specifically, the
bill prohibits DOE from prescribing or enforcing such standards
unless they (1) are technologically feasible and economically
justified, (2) are not likely to result in additional net costs
to the consumer, and (3) will result in significant
conservation of energy.
Legislative History
H.R. 7645 was introduced by Representative Ezell (MS-R) on
March 13, 2023, and referred to the Committee on Energy and
Commerce.
On March 20, 2023, the full committee favorably reported
H.R. 7645 to the House by a vote of 25 to 20.
Liberty in Laundry Act
H.R. 7673
To prohibit the Secretary of Energy from prescribing or
enforcing energy conservation standards for clothes washers
that are not cost-effective or technologically feasible.
Summary
H.R. 7673 would place limits on the authority of the
Department of Energy (DOE) to prescribe or enforce energy
conservation standards for clothes washers. Specifically, the
bill prohibits DOE from prescribing or enforcing such standards
unless they (1) are technologically feasible and economically
justified, (2) are not likely to result in additional net costs
to consumers, and (3) will result in significant conservation
of energy.
Legislative History
H.R. 7673 was introduced by Representative Ogles (TN-R) on
March 13, 2023, and referred to the Committee on Energy and
Commerce.
On March 20, 2023, the full committee favorably reported
H.R. 7673 to the House by a vote of 22 to 19.
On December 10, 2024, the Rules Committee reported H. Res.
1612 to the House, providing for consideration of H.R. 7673.
On December 10, 2024, the House passed H.R. 7673 by a vote
of 215 to 200.
Stop Unaffordable Dishwasher Standards Act
H.R. 7700
To prohibit the Secretary of Energy from prescribing or
enforcing energy conservation standards for dishwashers that
are not cost-effective or technologically feasible.
Summary
H.R. 7700 would place limits on the authority of the
Department of Energy (DOE) to prescribe or enforce energy
conservation standards for dishwashers. Specifically, the bill
prohibits DOE from prescribing or enforcing such standards
unless they (1) are technologically feasible and economically
justified, (2) are not likely to result in additional net costs
to the consumer, and (3) will result in significant
conservation of energy.
Legislative History
H.R. 7700 was introduced by Representative Langworthy (NY-
R) on March 15, 2023, and referred to the Committee on Energy
and Commerce.
On March 20, 2023, the full committee favorably reported
H.R. 7700 to the House by a vote of 25 to 21.
On July 9, 2024, the Rules Committee reported H. Res. 1341
to the House, providing for consideration of H.R. 7700.
On July 9, 2024, the House passed H.R. 7700 by a vote of
214 to 192.
On July 10, 2024, H.R. 7700 was received in the Senate and
referred to the Committee on Energy and Natural Resources.
OVERSIGHT ACTIVITIES
American Energy Expansion: Strengthening Economic, Environmental, and
National Security
On January 31, 2023, the Committee on Energy and Commerce
held a hearing entitled ``American Energy Expansion:
Strengthening Economic, Environmental, and National Security.''
The purpose of the hearing was to explore the benefits,
opportunities, and approaches to expanding American energy and
energy technologies. The Committee received testimony from The
Honorable Paul Dabbar, Former Under Secretary of Energy,
Distinguished Visiting Fellow at the Center on Global Energy
Policy, Columbia University, CEO of Bohr Quantum Technology;
Robert McNally, President of Rapidan Energy Group; Donna
Jackson, National Advisory Council, Project 21; and Dr. Ana
Unruh Cohen, Former Majority Staff Director, U.S. House Select
Committee on the Climate Crisis.
Unleashing American Energy, Lowering Energy Costs, and Strengthening
Supply Chains
On February 7, 2023, the Subcommittee on Energy, Climate,
and Grid Security and the Subcommittee on Environment,
Manufacturing, and Critical Materials held a joint legislative
hearing entitled ``Unleashing American Energy, Lowering Energy
Costs, and Strengthening Supply Chains.'' The purpose of this
hearing was to review the following legislation:
H.R. 150, Protecting American Energy
Production Act;
H.R. 484, Natural Gas Tax Repeal Act;
H.R. ___, Promoting Cross-border Energy
Infrastructure Act;
H. Con. Res. ___, a resolution expressing
disapproval of the revocation by President Biden of the
Presidential permit for the Keystone XL pipeline;
H.R. ___, Promoting Interagency Coordination
for Review of Natural Gas Pipelines Act;
H.R. ___,, Unlocking Our Domestic LNG
Potential Act of 2023;
H.R. ___, Securing America's Critical
Minerals Supply Act;
H.R. ___, Critical Electric Infrastructure
Cybersecurity Incident Reporting Act;
H.R. ___, a bill to require the Secretary of
Energy to direct the National Petroleum Council to
issue a report with respect to petrochemical refineries
in the United States, and for other purposes;
H.R. ___, a bill to amend the Clean Air Act
to prohibit the phase out of gasoline and prevent
higher prices for consumers and for other purposes;
H. Con. Res. ___, a resolution expressing
the sense of Congress that the Federal Government
should not impose any restrictions on the export of
crude oil or other petroleum products;
H.R. ___, a bill to repeal section 134 of
the Clean Air Act, relating to the greenhouse gas
reduction fund;
H.R. ___, a bill to authorize the
Administrator of the Environmental Protection Agency to
waive application of certain requirements, sanctions,
or fees, with respect to processing or refining of
critical energy resources at a critical energy resource
facility, and for other purposes;
H.R. ___, a bill to amend the Toxic
Substances Control Act with respect to critical energy
resources, and for other purposes;
H.R. ___, a bill to amend the Solid Waste
Disposal Act to treat the owner or operator of a
critical energy resource facility as having been issued
an interim permit for the treatment, storage, and
disposal, of hazardous waste, and for other purposes;
H.R. ___, a bill to require the
Administrator of the Environmental Protection Agency to
authorize the use of flexible air permitting with
respect to certain critical energy resource facilities,
and for other purposes; and
H.R. ___, a bill to prohibit the importation
into the United States of unirradiated low-enriched
uranium that is produced in the Russian Federation, and
for other purposes.
The Subcommittee received testimony from The Honorable Mark
Menezes, Former United States Deputy Secretary of Energy; The
Honorable Bernard McNamee, Former Commissioner of the Federal
Energy Regulatory Commission; Jeffrey Eshelman II, President
and Chief Executive Officer of the Independent Petroleum
Association of America; Katie Sweeney, Executive Vice President
and Chief Operating Officer of the National Mining Association;
Raul Garcia, Legislative Director for Healthy Communities at
Earthjustice; and Tyson Slocum, Director of the Energy Program
at Public Citizen. The U.S. Environmental Protection Agency
(EPA), the U.S. Department of Energy (DOE), and the Federal
Energy Regulatory Commission (FERC) were invited to provide
witnesses to testify at this hearing but all declined the
invitation to appear.
American Energy Expansion: Improving Local Economies and Communities'
Way of Life
On February 16, 2023, the Subcommittee on Energy, Climate,
and Grid Security held a field hearing in Midland, Texas
entitled ``American Energy Expansion: Improving Local Economies
and Communities' Way of Life.'' The purpose of this field
hearing was to examine the benefits, opportunities, and
challenges to expanding American energy from the local energy
community perspective. The Subcommittee received testimony from
The Honorable Lori Blong, Mayor of Midland, Texas, and
President of Octane Energy; Adrian Carrasco, Chairman of the
Midland Hispanic Chamber of Commerce and President of Premier
Energy Services; Steven Pruett, President and CEO of Elevation
Resources and Chairman of the Board for Independent Petroleum
Association of America; and Dr. Maria A. Reyes, Deputy Director
of Commission Shift.
American Nuclear Energy Expansion: Powering a Clean and Secure Future
On April 18, 2023, the Subcommittee on Energy, Climate, and
Grid Security held a hearing entitled ``American Nuclear Energy
Expansion: Powering a Clean and Secure Future.'' The purpose of
this hearing was to examine issues associated with expanding
nuclear energy for power generation and industrial use and for
international competition and security, including issues
concerning advanced reactor deployment and licensing,
industrial infrastructure, and fuel supply chains. The
Subcommittee received testimony from Dr. Jess C. Gehin,
Associate Laboratory Director, Nuclear Science and Technology,
Idaho National Laboratory; Regis Repko, Senior Vice President,
Generation and Transmission Strategy, Duke Energy;
The Fiscal Year 2024 Department of Energy Budget
On May 11, 2023, the Subcommittee on Energy, Climate, and
Grid Security held a hearing entitled ``The Fiscal Year 2024
Department of Energy Budget.'' The purpose of the hearing was
to examine the Fiscal Year 2024 budget request for the
Department of Energy. The Subcommittee received testimony from
The Honorable Jennifer M. Granholm, Secretary, United States
Department of Energy.
Oversight of FERC: Adhering to a Mission of Affordable and Reliable
Energy for America
On June 13, 2023, the Subcommittee on Energy, Climate, and
Grid Security held a hearing entitled ``Oversight of FERC:
Adhering To A Mission Of Affordable And Reliable Energy For
America.'' The purpose of this hearing was to examine the work
of the Federal Energy Regulatory Commission (FERC) to ensure
affordable, reliable electricity and natural gas service
throughout the country, as well as its adherence to its core
mission of ensuring just and reasonable rates for energy
services. The Subcommittee received testimony from the
Honorable Willie L. Phillips, Chairman, Federal Energy
Regulatory Commission; The Honorable James P. Danly,
Commissioner, Federal Energy Regulatory Commission; The
Honorable Mark C. Christie, Commissioner, Federal Energy
Regulatory Commission; and, The Honorable Allison Clements
Commissioner, Federal Energy Regulatory Commission.
Oversight of the NRC: Ensuring Efficient and Predictable Nuclear Safety
Regulation for a Prosperous America
On June 14, 2023, the Subcommittee on Energy, Climate, and
Grid Security held a hearing entitled ``Oversight of the NRC:
Ensuring Efficient and Predictable Nuclear Safety Regulation
for a Prosperous America.'' The purpose of this hearing was to
examine the Nuclear Regulatory Commission's (NRC) role in
regulating and licensing commercial power plants, advanced
nuclear technologies, and other uses of nuclear materials. The
Subcommittee received testimony from The Honorable Christopher
T. Hanson, Chairman, Nuclear Regulatory Commission; The
Honorable Jeff Baran, Commissioner, Nuclear Regulatory
Commission; The Honorable David A. Wright, Commissioner,
Nuclear Regulatory Commission; The Honorable Annie Caputo,
Commissioner, Nuclear Regulatory Commission; and The Honorable
Bradley R. Crowell, Commissioner, Nuclear Regulatory
Commission.
Enhancing America's Grid Security and Resilience
On June 16, 2023, the Subcommittee on Energy, Climate, and
Grid Security held a field hearing in Moore County, North
Carolina entitled ``Enhancing America's Grid Security and
Resilience.'' The purpose of this hearing was to examine the
physical and cybersecurity considerations for the electric
grid, with focus on the attack on an electrical substation that
occurred in Moore County, North Carolina on December 3, 2022.
The Subcommittee received testimony from William Ray, Director
and Deputy Homeland Security Advisor, Division of Emergency
Management, North Carolina Department of Public Safety; Mark
Aysta, Managing Director, Enterprise Security, Duke Energy; Tim
Ponseti, Vice President of Operations, SERC Reliability
Corporation; and Dr. Jordan Kern, Assistant Professor, North
Carolina State University, Department of Industrial and Systems
Engineering.
American Nuclear Energy Expansion: Updating Policies for Efficient,
Predictable Licensing and Deployment
On July 18, 2023, the Subcommittee on Energy, Climate, and
Grid Security held a legislative hearing entitled ``American
Nuclear Energy Expansion: Updating Policies for Efficient,
Predictable Licensing and Deployment.'' The purpose of this
hearing was to review the following legislation:
H.R. ___, NRC Mission Alignment Act
H.R. ___, Modernize Nuclear Reactor
Environmental Reviews Act
H.R. ___, Nuclear Licensing Efficiency Act
H.R. ___, Nuclear Advisory Committee Reform
Act
H.R. ___, Efficient Nuclear Licensing
Hearings Act
H.R. ___, Advanced Reactor Fee Reduction Act
H.R. ___, Advanced Nuclear Reactor Prize Act
H.R. ___, Advancing Nuclear Regulatory
Oversight Act
H.R. ___, Nuclear for Brownfields Site
Preparation Act
H.R. 995, Global Nuclear Energy Assessment
and Cooperation Act
H.R. ___, Strengthening American Nuclear
Competitiveness Act
H.R. ___, Advanced Nuclear Deployment Act
H.R. ___, Nuclear Fuel Security Act of 2023
H.R. 4528, Strengthening the NRC Workforce
Act of 2023
H.R. 4530, NRC Office of Public Engagement
and Participation Act of 2023
The Subcommittee received testimony from Dan Dorman,
Executive Director of Operations, Nuclear Regulatory
Commission; Dr. Michael Goff, Principal Deputy Assistant
Secretary, Office of Nuclear Energy, U.S. Department of Energy;
Maria Korsnick, President and CEO, Nuclear Energy Institute;
Jeffrey S. Merrifield, Chairman, Advanced Nuclear Working
Group, Nuclear Industry Council; Ted Nordhaus, Founder and
Executive Director, the Breakthrough Institute; and Jackie
Toth, Deputy Director, Good Energy Collective.
Keeping the Lights on: Enhancing Reliability and Efficiency to Power
American Homes
On September 13, 2023, the Subcommittee on Energy, Climate,
and Grid Security held a legislative hearing entitled ``Keeping
the Lights On: Enhancing Reliability and Efficiency to Power
American Homes.'' The purpose of this hearing was to review the
following legislation:
H.R. 4167, the ``Protecting America's
Distribution Transformer Supply Chain Act''
H.R. ___, the ``DOE Appliance and Equipment
Standards Reform and Consumer Protection Act''
H.R. ___, the ``GRID Act''
The Subcommittee received testimony from Gene Rodrigues,
Assistant Secretary for Electricity, Office of Electricity,
U.S. Department of Energy; David Ortiz, Office of Electric
Reliability, Federal Energy Regulatory Commission; Kevin
Messner, Executive Vice President and Chief Policy Officer,
Association of Home Appliance Manufacturers; B. Robert ``Bob''
Paulling, President and CEO, Mid-Carolina Electric Cooperative,
on behalf of the National Rural Electric Cooperatives
Association; Ben Lieberman, Senior Fellow, Competitive
Enterprise Institute; and Andrew deLaski, Executive Director,
Appliance Standards Awareness Project.
American Hydropower: Unleashing Reliable, Renewable, Clean Power Across
the U.S.
On September 20, 2023, the Subcommittee on Energy, Climate,
and Grid Security held a legislative hearing entitled
``American Hydropower: Unleashing Reliable, Renewable, Clean
Power Across the U.S.'' The purpose of the hearing was to
review the following legislation:
H.R. 4045, the ``Hydropower Clean Energy
Future Act''
The Subcommittee received testimony from Terry Turpin,
Director of the Office of Energy Projects, Federal Energy
Regulatory Commission; John Hairston, Administrator, Bonneville
Power Administration; Thomas P. Smith, Chief of Operations and
Regulatory Division, Army Corps of Engineers; and Matt Lee-
Ashley, Chief of Staff, Council on Environmental Quality.
Powering America's Economy, Security, and Our Way of Life: Examining
the State of Grid Reliability
On September 28, 2023, the Subcommittee on Energy, Climate,
and Grid Security held a hearing entitled ``Powering America's
Economy, Security, and our Way of Life: Examining the State of
Grid Reliability.'' The purpose of this hearing was to examine
how grid operators are navigating the changing energy landscape
and the impact the evolving energy portfolio has had on their
core mission of ensuring the reliability of the Bulk Power
System in their respective markets. The Subcommittee received
testimony from Gordon van Welie, President and Chief Executive
Officer, ISO New England; Paul Suskie, Executive Vice
President, Regulatory Policy and General Counsel, Southwest
Power Pool; Richard J. Dewey, President and Chief Executive
Officer, ISO New York; Todd Ramey, Senior Vice President,
Markets and Digital Strategy, Midcontinent ISO; Woody
Rickerson, Senior Vice President and Chief Operating Officer,
ERCOT; Neil Millar, Vice President for Infrastructure and
Operations Planning, California ISO; and Frederick S. Bresler
III, Senior Vice President of Market Services, PJM
Interconnection, LLC.
The Role of Artificial Intelligence in Powering America's Energy Future
On October 19, 2023, the Subcommittee on Energy, Climate,
and Grid Security held a hearing entitled ``The Role of
Artificial Intelligence in Powering America's Energy Future.''
The purpose of the hearing was to examine how America can
harness AI technology to expand and secure American energy. The
Subcommittee received testimony from Edward Abbo, President and
Chief Technology Officer, C3 AI; The Honorable Paul Dabbar,
former Under Secretary for Science, U.S. Department of Energy;
Jeremy Renshaw, Senior Technical Executive for AI, Quantum, and
Innovation, Electric Power Research Institute; and Sreedhar
Sistu, Vice President, Artificial Intelligence, Schneider
Electric.
America's Future: Leading a New Era of Energy Dominance, Security, and
Environmental Stewardship
On December 5, 2023, the Subcommittee on Energy, Climate,
and Grid Security held a hearing entitled ``America's Future:
Leading a New Era of Energy Dominance, Security, and
Environmental Stewardship.'' The purpose of this hearing was to
examine opportunities to expand access to affordable, reliable,
and clean energy. The Subcommittee received testimony from Dr.
Edmund O. Schweitzer III, Founder, President, and Chief
Technology Officer, Schweitzer Engineering Laboratories; Anne
Bradbury, Chief Executive Officer, American Exploration &
Production Council; Dr. David Gattie, Associate Professor of
Engineering and Senior Fellow, Center for International Trade
and Security, University of Georgia; and Dr. Noah Kaufman,
Senior Research Scholar, Center for Global Energy Policy at
Columbia University.
Fueling America's Economy: Legislation To Improve Safety and Expand
U.S. Pipeline Infrastructure
On January 18, 2024, the Subcommittee on Energy, Climate,
and Grid Security held a legislative hearing entitled ``Fueling
America's Economy: Legislation to Improve Safety and Expand
U.S. Pipeline Infrastructure.'' The purpose of the hearing was
to examine the following legislation:
H.R. ___, the ``Pipeline Safety,
Modernization, and Expansion Act''
The Subcommittee received testimony from Tristan Brown,
Deputy Administrator, Pipeline and Hazardous Materials Safety
Administration; Andrew Black, President and CEO, Liquid Energy
Pipeline Association; Robin Rorick, Vice President of Midstream
Policy, American Petroleum Institute, Dave Schryver, President
and CEO of American Public Gas Association; and Bill Caram,
Executive Director, Pipeline Safety Trust.
Exposing President Biden's Plan To Dismantle the Snake River Dams and
the Negative Impacts to the United States
On January 30, 2024, the Subcommittee on Energy, Climate,
and Grid Security held a hearing entitled ``Exposing President
Biden's Plan to Dismantle the Snake River Dams and the Negative
Impacts to the United States.'' The purpose of this hearing was
to examine the management and operations of federal dams on the
Columbia River and its tributaries, and actions taken by the
Biden administration to plan for the removal of the Lower Snake
River dams. The Subcommittee received testimony from The
Honorable Brenda Mallory, Chair, Council on Environmental
Quality; John Hairston, Administrator and CEO, Bonneville Power
Administration; The Honorable Michael L. Connor, Assistant
Secretary of the Army (Civil Works), U.S. Army; Janet Coit,
Assistant Administrator for Fisheries, National Oceanic and
Atmospheric Administration; Jeremiah Baumann, Senior Advisor,
Director of Policy and Implementation, Office of the Secretary,
U.S. Department of Energy; The Honorable Jim Matheson, CEO,
National Rural Electric Cooperative Association; Casey Chumrau,
CEO, Washington Grain Commission; Neil Maunu, Executive
Director, Pacific Northwest Waterways Association; and Jeremy
Takala, Member, Yakama Nation's Tribal Council.
Politics Over People: How Biden's LNG Export Ban Threatens America's
Energy and Economic Security
On February 6, 2024, the Subcommittee on Energy, Climate,
and Grid Security held a hearing entitled ``Politics over
People: How Biden's LNG Export Ban Threatens America's Energy
and Economic Security.'' The purpose of this hearing was to
examine the Biden administration's announced ban on issuing
permits to export liquified natural gas (LNG), and the
implications of this decisions on the U.S. economy and energy
security. The Subcommittee received testimony from Toby Z.
Rice, President and CEO, EQT Corporation; Brigham McCown,
Senior Fellow and Director, Initiative on American Energy
Security, the Hudson Institute; Eric Cormier, Senior Vice
President of Entrepreneurship and Strategic Initiatives,
Southwest Louisiana Chamber Economic Development Alliance; and
Gillian Giannetti, Senior Attorney, Natural Resources Defense
Council.
Powered Up: State Utility Regulators on Challenges to Reliable,
Affordable Electricity
On February 14, 2024, the Subcommittee on Energy, Climate,
and Grid Security held a hearing entitled ``Powered Up: State
Utility Regulators on Challenges to Reliable, Affordable
Electricity.'' The purpose of this hearing was to examine the
perspectives of State commissioners on threats to affordable
and reliable electricity. The Subcommittee received testimony
from Jim Huston, Chairman, Indiana Utility Regulatory
Commission; Nick Myers, Commissioner, Arizona Corporation
Commission; Tricia Pridemore, Commissioner, Georgia Public
Service Commission; and Keith Hay, Senior Director of Policy,
Colorado Energy Office.
Biden's LNG Export Ban: How Rush to Green Politics Hurts Local
Communities and U.S. Energy Security
On April 8, 2024, the Subcommittee on Energy, Climate, and
Grid Security held a field hearing in Port Arthur, Texas
entitled ``Biden's LNG Export Ban: How Rush-to-Green Politics
Hurts Local Communities and U.S. Energy Security.'' The purpose
of this hearing was to examine the Biden administration's
announced ban on issuing permits to export liquified natural
gas (LNG), and the negative implications of this decision on
local economies, jobs, and educational opportunities. The
Subcommittee received testimony from Mayor of Port Arthur
Thurman Bill Bartie; Dr. Betty J. Reynard, President, Lamar
State College Port Arthur; Larry Kelly, Executive Port Director
and CEO, Port of Port Arthur; and John Beard, Jr., Founder and
CEO, Port Arthur Community Action Network.
American Nuclear Energy Expansion: Spent Fuel Policy and Innovation
On April 10, 2024, the Subcommittee on Energy, Climate, and
Grid Security held a hearing entitled ``American Nuclear Energy
Expansion: Spent Fuel Policy and Innovation.'' The purpose of
this hearing was to examine federal responsibility for
permanent disposal of spent nuclear fuel and opportunities for
mitigating disposal challenges, such as through reprocessing
and recycling fuel, to advance nuclear energy for the nation.
The Subcommittee received testimony from Dr. John C. Wagner,
Laboratory Director, Idaho National Laboratory; Lake H.
Barrett, former Principal Deputy Director, Office of Civilian
Radioactive Waste Management, U.S. Department of Energy; Daniel
T. Stetson, Chair, SONGS Community Engagement Panel; and Greg
R. White, Executive Director, National Association of
Regulatory Utility Commissioners.
The Fiscal Year 2025 Department of Energy Budget
On May 1, 2024, the Subcommittee on Energy, Climate, and
Grid Security held a hearing entitled ``The Fiscal Year 2025
Department of Energy Budget.'' The purpose of this hearing was
to examine the Fiscal Year 2025 budget request for the
Department of Energy. The Subcommittee received testimony from
The Honorable Jennifer M. Granholm, Secretary, United States
Department of Energy.
Green Building Policies: Jeopardizing the American Dream of
Homeownership
On May 22, 2024, the Subcommittee on Energy, Climate, and
Grid Security held a hearing entitled ``Green Building
Policies: Jeopardizing the American Dream of Homeownership.''
The purpose of this hearing was to examine the impact of green
building policies on housing affordability, including building
energy codes, performance standards, and fossil fuel-use
restrictions. The Subcommittee received testimony from Phil
Bonnell, President, PABCO Building Products; Shawn Woods,
President, Ashlar Homes LLC, on behalf of National Association
of Home Builders; Mike Casper, President and CEO, Jo-Carroll
Energy Inc., on behalf of American Public Gas Association; and
Rob Howard, President of Howard Building Science.
Powering AI: Examining America's Energy and Technology Future
On June 4, 2024, the Subcommittee on Energy, Climate, and
Grid Security held a hearing entitled ``Powering AI: Examining
America's Energy and Technology Future.'' The purpose of this
hearing was to examine the economic, energy, regulatory, and
geopolitical considerations of electricity demand growth,
including from creasing data center and artificial intelligence
usage. The Subcommittee received testimony from Philip J. Dion,
Senior Vice President, Customer Solutions, Edison Electric
Institute; Tony Clark, Senior Advisor, Wilkinson Barker Knauer,
LLP; Tom Hassenboehler, Chair, Advisory Committee, Electricity
Customer Alliance; and Melissa C. Lott, Professor, Climate
School, Columbia University.
The Fiscal Year 2025 Nuclear Regulatory Commission Budget
On July 23, 2024, the Subcommittee on Energy, Climate, and
Grid Security held a hearing entitled ``The Fiscal Year 2025
Nuclear Regulatory Commission Budget.'' The purpose of this
hearing was to examine the Fiscal Year 2025 budget request for
the Nuclear Regulatory Commission. The Subcommittee received
testimony from The Honorable Christopher T. Hanson, Chairman,
Nuclear Regulatory Commission; The Honorable David A. Wright,
Commissioner, Nuclear Regulatory Commission; The Honorable
Annie Caputo, Commissioner, Nuclear Regulatory Commission; and
the Honorable Bradley R. Crowell, Commissioner, Nuclear
Regulatory Commission.
The Fiscal Year 2025 Federal Energy Regulatory Commission Budget
On July 24, 2024, the Subcommittee on Energy, Climate, and
Grid Security held a hearing entitled ``The Fiscal Year 2025
Federal Energy Regulatory Commission Budget.'' The purpose of
this hearing was to examine the Fiscal Year 2025 budget request
for the Federal Energy Regulatory Commission. The Subcommittee
received testimony from The Honorable Willie L. Phillips,
Chairman, Federal Energy Regulatory Commission; The Honorable
Mark C. Christie, Commissioner, Federal Energy Regulatory
Commission; The Honorable David Rosner, Commissioner, Federal
Energy Regulatory Commission; The Honorable Lindsey S. See,
Commissioner, Federal Energy Regulatory Commission; and The
Honorable Judy W. Chang, Commissioner, Federal Energy
Regulatory Commission.
From Gas to Groceries: Americans Pay the Price of the Biden Harris
Energy Agenda
On September 11, 2024, the Subcommittee on Energy, Climate,
and Grid Security held a hearing entitled ``From Gas to
Groceries: Americans Pay the Price of the Biden-Harris Energy
Agenda.'' The purpose of this hearing was to examine the broad
impacts of the elevated price levels for energy and power over
the past four years, the ramifications of those elevated price
levels, and what may be done to address them. The Subcommittee
received testimony from Linda Pryor, Hilltop Farm WNC, on
behalf of the American Farm Bureau Federation; Patrice Onwuka,
Director, Center for Economic Opportunity, Independent Women's
Forum; Travis Fisher, Director of Energy and Environmental
Policy Studies, Cato Institute; and Trevor Higgins, Senior Vice
President, Energy and Environment, Center for American
Progress.
Subcommittee on Environment, Manufacturing, and Critical Materials
LEGISLATIVE ACTIVITIES
Air Quality Standards Implementation Act of 2024
H.R. 7650
To facilitate efficient State implementation of national
ambient air quality standards.
Summary
H.R. 7650 would facilitate state implementation of national
ambient air quality standards and set a timeline for review of
state plans. It would adjust the composition of the Independent
Scientific Review Committee.
Legislative History
On March 13, 2024, Representative Carter (GA-R) introduced
H.R. 7650, and it was referred to the Committee on Energy and
Commerce.
On March 20, 2024, the full committee favorably reported
H.R. 7650 to the House by a vote of 26 to 21.
Preserving Choice in Vehicle Purchases Act
H.R. 1435
To amend the Clean Air Act to prevent the elimination of
the sale of internal combustion engines.
Summary
H.R. 1435 would modify the waiver process under the Clean
Air Act related to state emission control standards for new
motor vehicles (or new motor vehicle engines).
The bill would provide that state standards that directly
or indirectly limit the sale or use of new motor vehicles with
internal combustion engines are not eligible for waivers. The
bill also prohibits the EPA from determining that any state
standards amended after the bill's enactment are within the
scope of an existing waiver.
The bill would require the EPA to revoke waivers granted
between January 1, 2022, and the date of enactment of this bill
if the standards directly or indirectly limit the sale or use
of new motor vehicles with internal combustion engines.
Legislative History
On March 8, 2023, Representative Joyce (PA-R) introduced
H.R. 1435, and it was referred to the Committee on Energy and
Commerce.
On July 12, 2023, the Subcommittee on Environment,
Manufacturing, and Critical Materials favorably forwarded H.R.
1435 to the full committee by a vote of 13 to 8.
On July 27, 2023, the full committee favorably reported
H.R. 1435, as amended, to the House by a vote of 26 to 22.
On September 13, 2023, the Rules Committee reported H. Res.
680 to the House, providing for consideration of H.R. 1435.
On September 14, 2023, the House passed H.R. 1435 by a vote
of 222 to 190.
On September 18, 2023, H.R. 1435 was received in the Senate
and referred to the Committee on Environment and Public Works.
Choice in Automobile Retail Sales Act of 2023
H.R. 4468
To prohibit the Administrator of the Environmental
Protection Agency from finalizing, implementing, or enforcing a
proposed rule with respect to emissions from vehicles.
Summary
H.R. 4468 would limit the authority of the Environmental
Protection Agency (EPA) with regard to regulating emissions
standards for new motor vehicles. Specifically, the EPA is
prohibited from prescribing a regulation related to new motor
vehicle emissions standards that (1) mandates the use of any
specific technology, or (2) results in limited availability of
new motor vehicles based on the type of new motor vehicle
engine.
Additionally, the bill prohibits the EPA from finalizing,
implementing, or enforcing the proposed rule titled Multi-
Pollutant Emissions Standards for Model Years 2027 and Later
Light-Duty and Medium-Duty Vehicles. Among other purposes, the
proposed rule includes more stringent greenhouse gas standards
for both light-duty and medium duty vehicles starting with
model year 2027.
Legislative History
On July 6, 2023, Representative Walberg (MI-R) introduced
H.R. 4468, and it was referred to the Committee on Energy and
Commerce.
On July 12, 2023, the Subcommittee on Environment,
Manufacturing, and Critical Materials favorably forwarded H.R.
4468 to the full committee by a vote of 12 to 7.
On July 27, 2023, the full committee favorably reported
H.R. 4468 to the House by a vote of 27 to 23.
On December 4, 2023, the Rules Committee reported H. Res.
906 to the House, providing for consideration of H.R. 4468.
On December 6, 2023, the House met in the Committee of the
Whole to consider amendments on H.R. 4468.
On December 6, 2023, the House passed H.R. 4468, as
amended, by a vote of 221 to 197.
On December 7, 2023, H.R. 4468 was received in the Senate
and referred to the Committee on Environment and Public Works.
No Fuel Credits for Batteries Act of 2023
H.R. 4469
To clarify that eRINs are not authorized for purposes of
satisfying the volume of renewable fuel that needs to be
contained in transportation fuel for purposes of the Renewable
Fuel Program.
Summary
H.R. 4469 would prohibit the Environmental Protection
Agency from authorizing the generation of credits--called
renewable identification numbers or eRINs--for electricity
generated from renewable fuel for purposes of satisfying the
volume of renewable fuel that needs to be contained in
transportation fuel under the Renewable Fuel Standard program.
Further, it prohibits the use or transfer of such credits that
were generated before the enactment of this bill.
Legislative History
On July 6, 2023, Representative Pence (IN-R) introduced
H.R. 4469, and it was referred to the Committee on Energy and
Commerce.
On July 12, 2023, the Subcommittee on Environment,
Manufacturing, and Critical Materials favorably forwarded H.R.
4469 to the full committee by a vote of 12 to 7.
On July 27, 2023, the full committee favorably reported
H.R. 4469 to the House by a vote of 26 to 22.
Cutting Green Corruption and Taxes Act
H.R. 1023
To repeal section 134 of the Clean Air Act, relating to the
greenhouse gas reduction fund.
Summary
H.R. 1023 would repeal the Greenhouse Gas Reduction Fund,
which provides financial and technical assistance to states and
other eligible recipients to help communities reduce greenhouse
gas emissions.
The bill would also eliminate a program administered by the
Environmental Protection Agency (EPA) that provides incentives
for petroleum and natural gas systems to reduce their emissions
of methane and other greenhouse gases. It would also repeal a
charge on methane emissions from specific types of facilities
that are required to report their greenhouse gas emissions to
the EPA's Greenhouse Gas Emissions Reporting Program.
Legislative History
On February 14, 2023, Representative Palmer (AL-R)
introduced H.R. 1023, and it was referred to the Committee on
Energy and Commerce.
On February 28, 2023, the Subcommittee on Environment,
Manufacturing, and Critical Materials favorably forwarded H.R.
1023 to the full committee by a vote of 11 to 6.
On March 9, 2023, the full committee favorably reported
H.R. 1023 to the House by a vote of 27 to 21.
On March 22, 2023, the Rules Committee reported H. Res.
1085 to the House, providing for consideration of H.R. 1023.
On March 22, 2023, the House passed H.R. 1023, as amended,
by a vote of 209 to 204.
To Amend the Solid Waste Disposal Act To Provide the Owner or Operator
of a Critical Energy Resource Facility an Interim Permit Under Subtitle
C That is Subject to Final Approval by the Administrator of the
Environmental Protection Agency
H.R. 1070
Summary
H.R. 1070 would give a facility that processes or refines a
critical energy resource an interim status permit under the
Resource Conservation and Recovery Act until (1) the final
administrative disposition of its permit application, or (2) it
is proven that the facility failed to provide information
needed to process the permit application.
Legislative History
On February 17, 2023, Representative Carter (AL-R)
introduced H.R. 1070, and it was referred to the Committee on
Energy and Commerce.
On February 28, 2023, the Subcommittee on Environment,
Manufacturing, and Critical Materials favorably forwarded H.R.
1070, as amended, to the full committee by a vote of 13 to 6.
On March 9, 2023, the full committee favorably reported
H.R. 1070, as amended, to the House by a vote of 27 to 22.
To Require the Administrator of the Environmental Protection Agency To
Authorize the Use of Flexible Air Permitting With Respect to Certain
Critical Energy Resource Facilities
H.R. 1131
Summary
H.R. 1131 would require the Environmental Protection Agency
(EPA) to revise its Title V operating permit regulations under
the Clean Air Act. Such permits set forth compliance
requirements related to air pollution for certain facilities
(i.e., sources).
Specifically, the bill requires the EPA to revise
regulations to authorize the owner or operator of a critical
energy resource facility to utilize flexible air permitting, as
described in the final rule titled Operating Permit Programs;
Flexible Air Permitting Rule published on October 6, 2009. The
bill also requires the regulations to facilitate flexible,
market-responsive operations (as described in the final rule)
with respect to critical energy resource facilities.
Legislative History
On February 21, 2023, Representative Joyce (PA-R)
introduced H.R. 1131, and it was referred to the Committee on
Energy and Commerce.
On February 28, 2023, the Subcommittee on Environment,
Manufacturing, and Critical Materials favorably forwarded H.R.
1131 to the full committee by a vote of 13 to 6.
On March 9, 2023, the full committee favorably reported
H.R. 1131 to the House by a vote of 26 to 20.
To Authorize the Administrator of the Environmental Protection Agency
To Waive Application of Certain Requirements With Respect To Processing
and Refining a Critical Energy Resource at a Critical Energy Resource
Facility
H.R. 1140
Summary
H.R. 1140 would allow the Environmental Protection Agency
(EPA) to issue a temporary waiver of requirements under the
Clean Air Act or the Solid Waste Disposal Act for a critical
energy resource facility if the EPA finds that the processing
or refining of a critical energy resource at the facility is
necessary to meet national security or energy security needs.
Further, the EPA may issue such waiver with or without notice,
hearing, or other report.
Legislative History
On February 21, 2023, Representative Pence (IN-R)
introduced H.R. 1140, and it was referred to the Committee on
Energy and Commerce.
On February 28, 2023, the Subcommittee on Environment,
Manufacturing, and Critical Materials favorably forwarded H.R.
1140 to the full committee by a vote of 13 to 6.
On March 9, 2023, the full committee favorably reported
H.R. 1140 to the House by a vote of 28 to 21.
Keeping America's Refineries Act
H.R. 1155
To prohibit the phase out of gasoline and prevent higher
prices for consumers.
Summary
H.R. 1155 would revise the EPA's Risk Management program to
exempt a petroleum (e.g., gasoline) refinery that uses a
hydrofluoric acid alkylation unit from certain hazard
assessment requirements. Petroleum refineries use the acid
during the gasoline production process. Hydrofluoric acid is
hazardous and corrosive. If it is accidently released, it can
form a toxic vapor cloud.
Currently, petroleum refineries are required to include in
a hazard assessment an evaluation of safer technology and
alternative risk management measures for a hydrofluoric acid
alkylation unit. This bill eliminates that requirement if the
petroleum refinery (1) has obtained a construction permit or
operating permit under the program, or (2) demonstrates that it
will conform to the most recent version of American Petroleum
Institute Recommended Practice 751. This practice provides
guidance on the safe operation of such a unit.
Legislative History
On February 24, 2023, Representative Crenshaw (TX-R)
introduced H.R. 1155, and it was referred to the Committee on
Energy and Commerce.
On February 28, 2023, the Subcommittee on Environment,
Manufacturing, and Critical Materials favorably forwarded H.R.
1155 to the full committee by a vote of 10 to 6.
On March 9, 2023, the full committee favorably reported
H.R. 1140 to the House by a vote of 26 to 19.
OVERSIGHT ACTIVITIES
Government Response to East Palestine: Ensuring Safety and Transparency
for the Community
On March 28, 2023, the Subcommittee on Environment,
Manufacturing, and Critical Materials held a hearing entitled
``Government Response to East Palestine: Ensuring Safety and
Transparency for the Community.'' The purpose of this hearing
was to examine the federal, state, and local response to the
train derailment in East Palestine, Ohio that occurred on
February 3, 2023. The Subcommittee received testimony from The
Honorable Debra Shore, Regional Administrator for Region 5,
U.S. Environmental Protection Agency; The Honorable Anne Vogel,
Director, Ohio Environmental Protection Agency; and Wesley J.
Vins, Health Commissioner, Columbiana County General Health
District.
Exposing the Environmental, Human Rights, and National Security Risks
of the Biden Administration's Rush to Green Policies
On April 26, 2023, the Subcommittee on Environment,
Manufacturing, and Critical Materials held a hearing entitled
``Exposing the Environmental, Human Rights, and National
Security Risks of the Biden Administration's Rush to Green
Policies.'' The purpose of this hearing was to examine the
whole-of-government approach by the Biden administration to
advance green policies without considering the long-term
impacts on national security, supply chains, and the economy.
The Subcommittee received testimony from Mark Mills, Senior
Fellow, Manhattan Institute; Ashley Nunes, Director of Federal
Policy, Climate and Energy, the Breakthrough Institute; Daniel
Simmons, Vice President for Policy, Institute for Energy
Research; and Trevor Higgins, Senior Vice President, Energy and
Environment, Center for American Progress.
The Fiscal Year 2024 Environmental Protection Agency Budget
On May 10, 2023, the Subcommittee on Environment,
Manufacturing, and Critical Materials held a hearing entitled
``The Fiscal Year 2024 Environmental Protection Agency
Budget.'' The purpose of this hearing was to examine the Fiscal
Year 2024 Environmental Protection Agency budget request. The
Subcommittee received testimony from The Honorable Michael S.
Regan, Administrator, U.S. Environmental Protection Agency.
Clean Power Plan 2.0: EPA's Latest Attack on Electric Reliability
On June 6, 2023, the Subcommittee on Environment,
Manufacturing, and Critical Materials held a hearing entitled
``Clean Power Plan 2.0: EPA's Latest Attack on Electric
Reliability.'' The purpose of this hearing was to examine the
preliminary observations concerning the Environmental
Protection Agency's proposed greenhouse gas emissions standards
for the power sector and the reliable delivery of electricity.
The Subcommittee received testimony from Patrick O'Loughlin,
President and CEO, Buckeye Power Inc. and Ohio Rural Electric
Cooperatives; Todd Snitcher, President and CEO, Electric Power
Supply Association; Michael J. Nasi, Partner, Jackson Walker;
and Jay Duffy, Litigation Director, Clean Air Task Force.
Driving Affordability: Preserving People's Freedom To Buy Affordable
Vehicles and Fuel
On June 22, 2023, the Subcommittee on Environment,
Manufacturing, and Critical Materials held a legislative
hearing entitled ``Driving Affordability: Preserving People's
Freedom to Buy Affordable Vehicles and Fuel.'' The purpose of
this hearing was to examine the following pieces of
legislation:
H.R. 1435, Preserving Choice in Vehicle
Purchases Act
H.R. 3337, Fuels Parity Act
H.R. ___, No Fuel Credits for Batteries Act
H.R. ___, Choice in Automobile Retail Sales
(CARS) Act
The Subcommittee received testimony from Joseph Goffman,
Principal Deputy Administrator, Office of Air and Radiation,
U.S. Environmental Protection Agency; Chet Thompson, President
and CEO, American Fuel and Petrochemical Manufacturers; Neil
Caskey, CEO, National Corn Growers Association; and Genevieve
Cullen, President, Electric Drive Transportation Association.
Protecting American Manufacturing: Examining EPA's Proposed PM2.5
Rule
On September 19, 2023, the Subcommittee on Environment,
Manufacturing, and Critical Materials held a hearing entitled
``Protecting American Manufacturing: Examining EPA's Proposed
PM2.5 Rule.'' The purpose of this hearing was to
examine issues surrounding the U.S. Environmental Protection
Agency's reconsideration of air quality standards for fine
particulate matter, including potential implementation
challenges and impacts on manufacturing and economic
development. The Subcommittee received testimony from Bryce
Bird, Director, Division of Air Quality, Utah Department of
Environmental Quality; Glenn Hamer, President and CEO, Texas
Association of Business; Tim Hunt, Senior Director, Air Quality
Programs, American Forest & Paper Association and American Wood
Council; and Almeta E. Cooper, National Manager, Health Equity,
Moms Clean Air Force.
Revitalizing American Communities: Ensuring the Reauthorization of
EPA's Brownfields Program
On September 27, 2023, the Subcommittee on Environment,
Manufacturing, and Critical Materials held a legislative
hearing entitled ``Revitalizing American Communities: Ensuring
the Reauthorization of EPA's Brownfields Program.'' The purpose
of the hearing was to consider the following legislation:
H.R. ___, the Revitalization Through
Brownfields Act of 2023
The Subcommittee received testimony from Barry Breen,
Principal Deputy Assistant Administrator, Office of Land and
Emergency Management, U.S. Environmental Protection Agency;
Christian Bollwage, Mayor of Elizabeth, New Jersey, on behalf
of the Conference of Mayors and the National League of Cities;
Tammy Shifflett Tincher, Greenbrier County Commission, on
behalf of National Association of Counties; Lesly Melendez,
Executive Director, Groundwork Lawrence, on behalf of the
National Brownfields Coalition; and Pat Ford, Director of
External Affairs & Business Development, Frontier Group of
Companies, Buffalo, New York.
Exposing EPA Efforts To Limit Chemicals Needed for Life Saving Medical
Devices and Other Essential Products
On October 18, 2023, the Subcommittee on Environment,
Manufacturing, and Critical Materials held a hearing entitled
``Exposing EPA Efforts to Limit Chemical Needed for Life-Saving
Medical Devices and Other Essential Products.'' The purpose of
this hearing was to focus on the importance of chemicals for
modern life and the American economy, as well as examine how
the Environmental Protection Agency is undercutting these needs
with over-regulation and pushing the manufacturing of chemicals
to countries such as China. The Subcommittee received testimony
from Peter Huntsman, President and CEO, Huntsman Corporation;
Chris Jahn, President and CEO, American Chemistry Council;
Scott Whitaker, President and CEO, Advanced Medical Technology
Association; and Dr. Tracey Woodruff, Professor and Director,
University of California San Fransisco, Program on Reproductive
Health and the Environment.
Clean Power Plan 2.0: EPA's Effort To Jeopardize Reliable and
Affordable Energy for States
On November 14, 2023, the Subcommittee on Environment,
Manufacturing, and Critical Materials held a hearing entitled
``Clean Power Plan 2.0: EPA's Effort to Jeopardize Reliable and
Affordable Energy for States.'' The purpose of this hearing was
to examine State perspectives concerning the Environmental
Protection Agency's proposed greenhouse gas emissions standards
for the power sector and the reliable delivery of electricity.
The Subcommittee received testimony from L. David Glatt,
Director, North Dakota Department of Environmental Quality;
Chris Parker, Director, Utah Department of Commerce, Division
of Public Utilities; Michelle Walker Owenby, Director, Division
of Air Pollution Control, Tennessee Department of Environment
and Conservation; and Serena McIlwain, Secretary of the
Environment, State of Maryland.
America Leads the Way: Our History as the Global Leader at Reducing
Emissions
On November 29, 2023, the Subcommittee on Environment,
Manufacturing, and Critical Materials held a hearing entitled
``America Leads the Way: Our History as the Global Leader at
Reducing Emissions.'' The purpose of this hearing was to
examine lessons of America's experience and success in reducing
emissions of air pollutants and greenhouse gases, among other
environmental advances, while focusing on expanding the
benefits of affordable, secure energy domestically and around
the world. The Subcommittee received testimony from The
Honorable Mark W. Menezes, President and CEO, United States
Energy Association; Amanda Eversole, Executive Vice President
and Chief Advocacy Officer, American Petroleum Institute; Mark
P. Mills, Senior Fellow, Manhattan Institute; and Dr. Karl
Hausker, Senior Fellow, World Resources Institute.
Subcommittee on Health
LEGISLATIVE ACTIVITIES
Securing the U.S. Organ Procurement and Transplantation Network Act
PUBLIC LAW 118-14 (H.R. 2544)
To improve the Organ Procurement and Transplantation
Network, and for other purposes.
Summary
H.R. 2544 amends the Public Health Service Act to allow for
competition within the Organ Procurement and Transplantation
Network (OPTN) contract process. The legislation also makes
technical changes and requires the Comptroller General to
conduct a review of the OPTN and submit its findings to the
House Energy and Commerce Committee and the Senate Health,
Education, Labor, and Pensions committee.
Legislative History
H.R. 2544 was introduced by Representative Bucshon (IN-R)
on April 10, 2023, and referred to the Committee on Energy and
Commerce.
On April 19, 2023, the Subcommittee on Health held a
hearing on H.R. 2544.
On May 17, 2023, the Subcommittee on Health favorably
forwarded H.R. 2544, without amendment, to the full committee
by a vote of 28 yeas and 0 nays.
On May 24, 2023, the full committee favorably reported H.R.
2544, without amendment, to the House by a vote of 49 yeas and
0 nays.
On July 11, 2023, the Committee on Energy and Commerce
reported H.R. 2544, without amendment, to the House (H. Rept.
118-140), and the bill was placed on the Union Calendar
(Calendar No. 111).
On July 25, 2023, Representative Bucshon moved to suspend
the rules and pass H.R. 2544, without amendment. The House
agreed to the motion by a voice vote.
On July 26, 2023, H.R. 2544 was received in the Senate and
read twice.
On July 27, 2023, H.R. 2544 was considered in the Senate,
and the bill, without amendment, was passed by unanimous
consent.
On September 14, 2023, H.R. 2544 was presented to the
President, and the President signed the bill on September 22,
2023 (Public Law 118-14).
Dr. Emmanuel Bilirakis and Honorable Jennifer Wexton National Plan To
End Parkinson's Act
PUBLIC LAW 118-66 (H.R. 2365)
To direct the Secretary of Health and Human Services to
carry out a national project to prevent, diagnose, treat, and
cure Parkinson's, to be known as the National Parkinson's
Project, and for other purposes.
Summary
H.R. 2365 requires the Department of Health and Human
Services (HHS) to carry out the National Parkinson's Project to
prevent, diagnose, treat, and cure Parkinson's disease and
other neurodegenerative related diseases. The Secretary must
provide an annual assessment of the nation's progress in
preparing for and responding to the increased burden of
Parkinson's; provide information, facilitate collaboration, and
encourage development of innovative approaches to prevent,
diagnose, treat, and cure Parkinson's and related diseases; and
coordinate and avoid duplication of related research activities
across involved entities; among other things.
The bill also establishes an Advisory Council, comprised of
federal and nonfederal stakeholders, to advise HHS on
Parkinson's related issues, including providing an annual
report outlining current activities, recommendations, and
priority actions to improve efforts related to the prevention,
diagnosis, treatment, and curing of Parkinson's and related
diseases. The provisions of the bill terminate at the end of
calendar year 2025.
Legislative History
H.R. 2365 was introduced by Representative Bilirakis (FL-R)
on March 29, 2023, and referred to the Committee on Energy and
Commerce.
On June 14, 2023, the Subcommittee on Health held a hearing
on H.R. 2365.
On July 13, 2023, the Subcommittee on Health favorably
forwarded H.R. 2365, without amendment, to the full committee
by voice vote.
On December 5 and 6, 2023, the full committee favorably
reported H.R. 2365, as amended, to the House by a vote of 47
yeas and 0 nays.
On December 12, 2023, the Committee on Energy and Commerce
reported H.R. 2365, as amended, to the House (H. Rept. 118-
313), and the bill was placed on the Union Calendar (Calendar
No. 253).
On December 13, 2023, Representative Bilirakis moved to
suspend the rules and pass H.R. 2365, as amended. The House
agreed to the motion by a vote of 407 yeas and 9 nays.
On December 14, 2023, H.R. 2365 was received in the Senate,
read twice, and referred to the Committee on Health, Education,
Labor, and Pensions.
On May 23, 2024, the Committee on Health, Education, Labor,
and Pensions discharged H.R. 2365, by unanimous consent.
On May 23, 2024, the Dr. Emmanuel Bilirakis National Plan
to End Parkinson's Act Senate Committee on Health, Education,
Labor, and Pensions discharged by unanimous consent. H.R. 2365
passed the Senate, without amendment, by voice vote.
On June 28, 2024, H.R. 2365 was presented to the President,
and the President signed the bill on July 2, 2024 (Public Law
118-66).
Maternal and Child Health Stillbirth Prevention
Act of 2024
PUBLIC LAW 118-69 (H.R. 4581)
To amend title V of the Social Security Act to support
stillbirth prevention and research, and for other purposes.
Summary
H.R. 4581 clarifies that evidence-based activities and
research focused on reducing the incidence of stillbirth are
permissible uses of the Maternal and Child Health Services
Block Grant funding in Title V of the Social Security Act.
Legislative History
H.R. 4581 was introduced by Representative Hinson (IA-R) on
July 12, 2023, and referred to the Committee on Energy and
Commerce.
On February 14, 2024, the Subcommittee on Health held a
hearing on H.R. 4581.
On March 12, 2024, the Subcommittee on Health favorably
forwarded H.R. 4581, as amended, to the full committee by a
vote of 25 yeas and 0 nays.
On May 7, 2024, the Committee on Energy and Commerce
reported H.R. 4581, as amended, to the House (H. Rept. 118-
490), and the bill was placed on the Union Calendar (Calendar
No. 406).
On March 20, 2024, the full committee favorably reported
H.R. 4581, without amendment, to the House by a vote of 44 yeas
and 0 nays.
On May 14, 2024, Representative Bucshon moved to suspend
the rules and pass H.R. 4581, as amended. The House agreed to
the motion by a vote of 408 yeas and 3 nays.
On May 16, 2024, H.R. 4581 was received in the Senate and
read twice.
On June 11, 2024, the Maternal and Child Health Stillbirth
Prevention Act of 2024 passed the Senate, without amendment, by
unanimous consent.
On July 8, 2024, H.R. 4581 was presented to the President,
and the President signed the bill on July 12, 2024 (Public Law
118-69).
Supporting and Improving Rural EMS Needs (SIREN) Reauthorization Act
PUBLIC LAW 118-84 (S. 265, H.R. 4646)
To reauthorize the rural emergency medical service training
and equipment assistance program.
Summary
H.R. 4646 would reauthorize and modify the rural emergency
medical services (EMS) training and equipment assistance
program through 2029.
Legislative History
H.R. 4646 was introduced by Representative Joyce (OH-R) on
July 14, 2023, and referred to the Committee on Energy and
Commerce.
On February 14, 2024, the Subcommittee on Health held a
hearing on H.R. 4646.
On March 12, 2024, the Subcommittee on Health favorably
forwarded H.R. 4646, as amended, to the full committee by a
vote of 24 yeas and 0 nays.
On March 20, 2024, the full committee favorably reported
H.R. 4646, as amended, to the House by a vote of 46 yeas and 0
nays.
On May 31, 2024, the Committee on Energy and Commerce
reported H.R. 4646, as amended, to the House (H. Rept. 118-
532), and the bill was placed on the Union Calendar (Calendar
No. 443).
No further action was taken on the bill.
S. 265 was introduced by Senator Durbin (IL-D) on February
2, 2023, read twice, and referred to the Committee on Health,
Education, Labor, and Pensions.
On June 15, 2023, the Committee on Health, Education,
Labor, and Pensions ordered S. 265 to be reported favorably,
with an amendment in the nature of a substitute.
On July 26, 2023, Senator Sanders (VT-D) reported S. 265,
with an amendment in the nature of a substitute, to the Senate
without a written report, and the bill was placed on the Senate
Legislative Calendar under General Orders (Calendar No. 173).
On December 13, 2023, S. 265 passed Senate, without
amendment, by unanimous consent.
On December 15, 2023, S. 265 was received in the House.
On September 17, 2024, Representative McMorris Rodgers
moved to suspend the rules and pass the bill. The House agreed
to the motion by voice vote.
On September 24, 2024, S. 265 was presented to the
President, and the President signed the bill on September 26,
2024 (Public Law 118-84).
Poison Control Centers Reauthorization Act of 2024
PUBLIC LAW 118-86 (S. 4351, H.R. 7251)
To amend the Public Health Service Act to reauthorize
certain poison control programs.
Summary
H.R. 7251 reauthorizes certain poison control programs.
These programs include the maintenance of the national toll-
free phone number, the promotion of poison control center
utilization, and the maintenance of a program that awards
grants to accredited poison control centers.
Legislative History
H.R. 7251 was introduced by Representative Chavez-DeRemer
(OR-R) on February 6, 2024, and referred to the Committee on
Energy and Commerce.
On February 14, 2024, the Subcommittee on Health held a
hearing on H.R. 7251.
On March 12, 2024, the Subcommittee on Health favorably
forwarded H.R. 7251, as amended, to the full committee by a
vote of 23 yeas and 0 nays.
On March 20, 2024, the full committee favorably reported
H.R. 7251, as amended, to the House by a vote of 47 yeas and 0
nays.
On May 17, 2024, the Committee on Energy and Commerce
reported H.R. 7251, as amended, to the House (H. Rept. 118-
512), and the bill was placed on the Union Calendar (Calendar
No. 425).
No further action was taken on the bill.
S. 4351 was introduced by Senator Murray (WA-D) on May 15,
2024, read twice, and referred to the Committee on Health,
Education, Labor, and Pensions.
On May 23, 2024, the Committee on Health, Education, Labor,
and Pensions ordered S. 4351 to be reported, without amendment,
favorably.
On June 18, 2024, Senator Sanders (VT-D) reported S. 4351,
without amendment, to the Senate without a written report, and
the bill was placed on the Senate Legislative Calendar under
General Orders (Calendar No. 428).
On July 11, 2024, S. 4351 passed the Senate, without
amendment, by unanimous consent.
On July 15, 2024, S. 4351 was received in the House.
On September 17, 2024, Representative McMorris Rodgers
moved to suspend the rules and pass the bill. The House agreed
to the motion by voice vote.
On September 24, 2024, S. 4351 was presented to the
President, and the President signed the bill on September 26,
2024 (Public Law 118-86).
NAPA Reauthorization Act
PUBLIC LAW 118-92 (S. 133, H.R. 619)
To extend the National Alzheimer's Project.
Summary
H.R. 619 would reauthorize the National Alzheimer's Project
through 2035 and make certain modifications to the Project,
including updating the Project's purpose and revising the
Advisory Council on Alzheimer's Research, Care and Services by
expanding the membership and its reporting requirements.
Legislative History
H.R. 619 was introduced by Representative Tonko (NY-D) on
January 30, 2023, and referred to the Committee on Energy and
Commerce.
On February 14, 2024, the Subcommittee on Health held a
hearing on H.R. 619.
On March 12, 2024, the Subcommittee on Health favorably
forwarded H.R. 619, as amended, to the full committee by a vote
of 26 yeas and 0 nays.
On March 20, 2024, the full committee favorably reported
H.R. 619, as amended, to the House by a vote of 43 yeas and 0
nays.
On May 24, 2024, the Committee on Energy and Commerce
reported H.R. 619, as amended, to the House (H. Rept. 118-526),
and the bill was placed on the Union Calendar (Calendar No.
438).
No further action was taken on the bill.
S. 133 was introduced by Senator Collins (ME-R) on January
30, 2023, read twice, and referred to the Committee on Health,
Education, Labor, and Pensions.
On June 15, 2023, the Committee on Health, Education,
Labor, and Pensions ordered S. 133 to be reported, without
amendment, favorably.
On June 18, 2024, Senator Sanders (VT-D) reported S. 133,
without amendment, to the Senate without a written report, and
the bill was placed on the Senate Legislative Calendar under
General Orders (Calendar No. 182).
On July 30, 2024, S. 133 passed Senate, as amended, by
voice vote.
On August 2, 2024, S. 133 was received in the House.
On September 23, 2024, Representative Bucshon moved to
suspend the rules and pass the bill. The House agreed to the
motion by voice vote.
On September 26, 2024, S. 133 was presented to the
President, and the President signed the bill on October 1, 2024
(Public Law 118-92).
Alzheimer's Accountability and Investment Act
PUBLIC LAW 118-93 (S. 134, H.R. 620)
To require an annual budget estimate for the initiatives of
the National Institutes of Health pursuant to reports and
recommendations made under the National Alzheimer's Project
Act.
Summary
H.R. 620 requires the National Institutes of Health (NIH)
to continue to submit an annual budget estimate to Congress to
achieve the initiatives and goals included in the National Plan
to Address Alzheimer's Disease.
Legislative History
H.R. 620 was introduced by Representative Smith (NJ-R) on
January 30, 2023, and referred to the Committee on Energy and
Commerce.
On February 14, 2024, the Subcommittee on Health held a
hearing on H.R. 620.
On March 12, 2024, the Subcommittee on Health favorably
forwarded H.R. 620, without amendment, to the full committee by
a vote of 26 yeas and 0 nays.
On March 20, 2024, the full committee favorably reported
H.R. 620, without amendment, to the House by a vote of 43 to 0.
On May 31, 2024, the Committee on Energy and Commerce
reported H.R. 620, without amendment, to the House (H. Rept.
118-531), and the bill was placed on the Union Calendar
(Calendar No. 442).
No further action was taken on the bill.
S. 134 was introduced by Senator Collins (ME-R) on January
30, 2023, read twice, and referred to the Committee on Health,
Education, Labor, and Pensions.
On June 15, 2023, the Committee on Health, Education,
Labor, and Pensions ordered S. 134 to be reported favorably,
without amendment.
On July 27, 2024, Senator Sanders (VT-D) reported S. 134,
without amendment, to the Senate without a written report, and
the bill was placed on the Senate Legislative Calendar under
General Orders (Calendar No. 183).
On July 30, 2024, S. 134 passed Senate, without amendment,
by unanimous consent.
On August 2, 2024, S. 134 was received in the House.
On September 23, 2024, Representative Bucshon moved to
suspend the rules and pass the bill. The House agreed to the
motion by voice vote.
On September 26, 2024, S. 134 was presented to the
President, and the President signed the bill on October 1, 2024
(Public Law 118-93).
Congenital Heart Futures Reauthorization Act of 2024
PUBLIC LAW 118-107 (H.R. 7189)
To amend the Public Health Service Act to reauthorize a
national congenital heart disease research, surveillance, and
awareness program.
Summary
H.R. 7189 reauthorizes the national congenital heart
disease research, surveillance, and awareness program at the
Centers for Disease Control and Prevention (CDC). The bill also
requires the Secretary to issue a report and strategy for
improvement to Congress on activities related to congenital
heart disease for both the public and health care providers, as
well as the current workforce capacity of health care providers
who treat adult patients living with congenital heart disease
(CHD). The bill reauthorizes the program for five fiscal years
from 2025 through 2029.
Legislative History
H.R. 7189 was introduced by Representative Bilirakis (FL-R)
on February 1, 2024, and referred to the Committee on Energy
and Commerce.
On February 14, 2024, the Subcommittee on Health held a
hearing on H.R. 7189.
On March 12, 2024, the Subcommittee on Health favorably
forwarded H.R. 7189, as amended, to the full committee by a
vote of 24 to 0.
On March 20, 2024, the full committee favorably reported
H.R. 7189, as amended to the House by a vote of 43 to 0.
On September 23, 2024, Representative Bilirakis moved to
suspend the rules and pass H.R. 7189, as amended. The House
agreed to the motion by a voice vote.
On September 24, 2024, H.R. 7189 was received in the
Senate.
On September 25, 2024, the Congenital Heart Futures
Reauthorization Act of 2024 passed the Senate by unanimous
consent.
On November 15, 2024, H.R. 7189 was presented to the
President, and the President signed the bill on November 21,
2024 (Public Law 118-107).
BOLD Infrastructure for Alzheimer's Reauthorization
Act of 2024
PUBLIC LAW 118-142 (H.R. 7218)
To amend title III of the Public Health Service Act to
extend the program for promotion of public health knowledge and
awareness of Alzheimer's disease and related dementias.
Summary
H.R. 7218 would reauthorize programs to support states,
local public health departments, and other entities that
educate and support early detection and diagnosis, support
patients and caregivers needs, and promote public health
knowledge and awareness of Alzheimer's disease and related
dementias, among other activities, for fiscal years 2025
through 2029.
Legislative History
H.R. 7218 was introduced by Representative Guthrie (KY-R)
on February 5, 2024, and referred to the Committee on Energy
and Commerce.
On February 14, 2024, the Subcommittee on Health held a
hearing on H.R. 7218.
On March 12, 2024, the Subcommittee on Health favorably
forwarded H.R. 7218 to the full committee by a vote of 25 to 0.
On March 20, 2024, the full committee favorably reported
H.R. 7218 to the House by a vote of 44 to 0.
On September 17, 2024, Representative Miller-Meeks moved to
suspend the rules and pass H.R. 7218. The House agreed to the
motion by a voice vote.
On September 18, 2024, H.R. 7218 was received in the
Senate.
On November 21, 2024, the BOLD Infrastructure for
Alzheimer's Reauthorization Act of 2024 passed the Senate,
without amendment, by voice vote.
On December 5, 2024, H.R. 7218 was presented to the
President, and the President signed the bill on December 11,
2024 (Public Law 118-142).
Firefighter Cancer Registry Reauthorization Act of 2023
PUBLIC LAW 118-147 (H.R. 3821)
To reauthorize the Firefighter Cancer Registry Act of 2018.
Summary
H.R. 3821 reauthorizes funding for the voluntary registry
for firefighter cancer incidents under the Centers for Disease
Control and Prevention (CDC) for fiscal years 2024 through
2028.
Legislative History
H.R. 3821 was introduced by Representative Pascrell (NJ-D)
on June 5, 2023, and referred to the Committee on Energy and
Commerce.
On June 14, 2023, the Subcommittee on Health held a hearing
on H.R. 3821.
On July 13, 2023, the Subcommittee on Health favorably
forwarded H.R. 3821 to the full committee by a vote of 28 to 0.
On July 19, 2023, the full committee favorably reported
H.R. 3821 to the House by a vote of 51 to 0.
On March 6, 2024, Representative Guthrie moved to suspend
the rules and pass H.R. 3821. The House agreed to the motion by
a vote of 413 to 7.
On March 7, 2024, H.R. 3821 was received in the Senate and
referred to the Committee on Health, Education, Labor, and
Pensions.
On December 4, 2024, the Firefighter Cancer Registry
Reauthorization Act of 2023 passed the Senate, without
amendment, by voice vote.
On December 10, 2024, H.R. 3821 was presented to the
President, and the President signed the bill on December 12,
2024 (Public Law 118-147).
No Taxpayer Funding for Abortion and Abortion Insurance Full Disclosure
Act of 2023
H.R. 7
To prohibit taxpayer funded abortions.
Summary
H.R. 7 would prohibit the use of federal funds, including
funds in the budget of the District of Columbia, for abortion
or health coverage that includes abortion. The prohibitions do
not apply to abortions in cases of rape or incest, or where a
physical condition endangers a woman's life unless an abortion
is performed. In addition, abortions may not be provided in a
federal health care facility or by a federal employee.
Legislative History
H.R. 7 was introduced by Representative Smith (NJ-R) on
January 9, 2023, and referred to the Committee on Energy and
Commerce, and in addition to the Committee on the Judiciary and
the Committee on Ways and Means.
Byron Nash Renal Medullary Carcinoma
Awareness Act of 2023
H.R. 124
To amend title XIX of the Social Security Act to provide
incentives for education on the risk of renal medullary
carcinoma in individuals who are receiving medical assistance
under such title and who have sickle cell disease.
Summary
This legislation would support education on the risk of
renal medullary carcinoma for individuals who are eligible to
receive medical assistance for sickle cell disease under
Medicaid.
Legislative History
H.R. 124 was introduced by Representative Green (TX-D) on
January 9, 2023, and referred to the Committee on Energy and
Commerce.
On April 30, 2024, the Subcommittee on Health held a
hearing on H.R. 124.
Mandating Exclusive Review of Individual Treatments
(MERIT) Act
H.R. 133
To amend title XVIII of the Social Security Act to clarify
the use of the national coverage determination process under
the Medicare program.
Summary
H.R. 133 would ensure that prospectively, any national
coverage decision that the Centers for Medicare and Medicaid
(CMS) makes will only apply to that specific therapy and not an
entire class of drugs. Medicare includes several pathways to
coverage for items and services, including for drugs and
breakthrough medical devices. The national coverage
determination (NCD) process provides coverage of an item or
service nationally. Currently, CMS makes NCDs an entire class
of drugs. This legislation would ensure that the agency must
make NCDs on individual drugs.
Legislative History
H.R. 133 was introduced by Representative Buchanan (FL-R)
on January 9, 2023, and referred to the Committee on Energy and
Commerce, and in addition to the Committee on Ways and Means.
On September 19, 2023, the Subcommittee on Health held a
hearing on H.R. 133.
On November 15, 2023, the Subcommittee on Health favorably
forwarded H.R. 133, as amended, to the full committee by voice
vote.
On December 5, 2023, the full committee favorably reported
H.R. 133, as amended, to the House by a vote of 42 to 0.
To Amend Title XVIII of the Social Security Act To Remove Geographic
Requirements and Expand Originating Sites for Telehealth Services
H.R. 134
To amend title XVIII of the Social Security Act to remove
geographic requirements and expand originating sites for
telehealth services.
Summary
This legislation would allow any location in the United
States, including the home of a beneficiary, to be considered
an originating site for the purpose of furnishing telehealth
services under Medicare.
Legislative History
H.R. 134 was introduced by Representative Buchanan (FL-R)
on January 9, 2023, and referred to the Committee on Energy and
Commerce, and in addition to the Committee on Ways and Means.
On April 10, 2024, the Subcommittee on Health held a
hearing on H.R. 134.
No further action was taken on the bill. The provisions of
H.R. 134 were included in H.R. 7623, which is discussed
elsewhere in this report.
Patient Access To Urgent-Use Pharmacy
Compounding Act of 2023
H.R. 167
To amend the Federal Food, Drug, and Cosmetic Act to ensure
patients have access to certain urgent-use compounded
medications, and for other purposes.
Summary
H.R. 167 would allow 503A facilities to compound drugs when
a licensed prescriber certifies to the pharmacist that such
prescriber has made reasonable attempts to obtain but has not
been able to obtain, a drug to address an urgent medical need,
so long as other conditions are met. It would also expand when
a compounded drug does not meet the definition of ``essentially
a copy of a commercially available drug product'' to include
drugs on both the Food and Drug Administration (FDA) Drug
Shortages Database or the American Society of Hospital
Pharmacists Drug Shortages List.
Legislative History
H.R. 167 was introduced by Representative Griffith (VA-R)
on January 9, 2023, and referred to the Committee on Energy and
Commerce.
On September 14, 2023, the Subcommittee on Health held a
hearing on H.R. 167.
To Terminate the Requirement Imposed by the Director of the Centers for
Disease Control and Prevention for Proof of COVID-19 Vaccination for
Foreign Travelers, and for Other Purposes.
H.R. 185
To terminate the requirement imposed by the Director of the
Centers for Disease Control and Prevention for proof of COVID-
19 vaccination for foreign travelers, and for other purposes.
Summary
H.R. 185 would terminate the air travel vaccination
requirement for foreign travelers that was imposed through the
order issued by the Director of the Centers for Disease Control
and Prevention entitled ``Amended Order Implementing
Presidential Proclamation on Advancing the Safe Resumption of
Global Travel During the COVID-19 Pandemic.''
Legislative History
H.R. 185 was introduced by Representative Massie (KY-R) on
January 9, 2023, and referred to the Committee on Energy and
Commerce.
On February 8, 2023, H.R. 185 was considered in the House
pursuant to the provisions of H. Res. 97, and the bill, as
amended, was passed by a recorded vote of 227 yeas and 201
nays.
On February 13, 2023, H.R. 185 was read twice and placed on
Senate Legislative Calendar under General Orders (Calendar No.
14).
Pandemic is Over Act
H.R. 382
To terminate the public health emergency declared with
respect to COVID-19.
Summary
H.R. 382 would terminate the public health emergency
declared by the Secretary of Health and Human Services (HHS) on
January 31, 2022, entitled ``Determination that a Public Health
Emergency Exists Nationwide as the Result of the 2019 Novel
Coronavirus.''
Legislative History
H.R. 382 was introduced by Representative Guthrie (KY-R) on
January 17, 2023, and referred to the Committee on Energy and
Commerce.
On January 31, 2023, H.R. 382 was considered in the House
pursuant to the provisions of H. Res. 75, and the bill, without
amendment was passed by a recorded vote of 220 yeas and 210
nays.
On February 1, 2023, H.R. 382 was received in the Senate,
read twice, and referred to the Committee on Health, Education,
Labor, and Pensions.
To Amend the Controlled Substances Act To Fix a Technical Error in the
Definitions
H.R. 455
To amend the Controlled Substances Act to fix a technical
error in the definitions.
Summary
This legislation would make technical corrections to the
definitions section of the Controlled Substances Act.
Legislative History
H.R. 455 was introduced by Representative Burchett (TN-R)
on January 24, 2023, and referred to the Committee on Energy
and Commerce, and in addition to the Committee on the
Judiciary.
On June 21, 2024, the Subcommittee on Health held a hearing
on H.R. 455.
On May 16, 2024, the Subcommittee on Health favorably
forwarded H.R. 455, without amendment, to the full committee by
a vote of 24 yeas and 0 nays.
On June 12, 2024, the full committee favorably reported
H.R. 455, without amendment, to the House by a vote of 44 yeas
and 0 nays.
On September 17, 2024, the Committee on Energy and Commerce
reported H.R. 455, without amendment, to the House (H. Rept.
118-681), and the bill was placed on the Union Calendar
(Calendar No. 576).
No further action was taken on the bill.
S. 223 was introduced by Senator Grassley (IA-R) on
February 1, 2023, read twice, considered, read the third time,
and passed without amendment by unanimous consent.
On February 2, 2023, S. 223 was received in the House. On
December 16, 2024, Representative Bucshon moved to suspend the
rules and pass S. 223. The House agreed to the motion by voice
vote.
Halt All Lethal Trafficking of Fentanyl (HALT) Act
H.R. 467, H.R. 171
To amend the Controlled Substances Act with respect to the
scheduling of fentanyl-related substances, and for other
purposes.
Summary
This legislation would place fentanyl-related substances
(FRS) permanently into Schedule I of the Controlled Substances
Act. The bill would also simplify the registration processes
for certain research with Schedule I substances.
Legislative History
H.R. 171 was introduced by Representative Griffith (VA-R)
on January 9, 2023, and referred to the Committee on Energy and
Commerce, and in addition to the Committee on the Judiciary.
No further action was taken on the bill.
H.R. 467 was introduced by Representative Griffith (VA-R)
on January 24, 2023, and referred to the Committee on Energy
and Commerce, and in addition to the Committee on the
Judiciary. H.R. 467 was similar to H.R. 171.
On February 1, 2023, the Subcommittee on Health held a
hearing on H.R. 467.
On March 8, 2023, the Subcommittee on Health favorably
forwarded H.R. 467, as amended, to the full committee by a vote
of 17 yeas and 10 nays.
On March 23, 2023, the full committee favorably reported
H.R. 467, as amended, to the House by a vote of 27 yeas and 19
nays.
On May 17, 2023, the Committee on Energy and Commerce
reported H.R. 467, as amended, to the House (H. Rept. 118-67),
and the bill was placed on the Union Calendar (Calendar No.
47).
On May 25, 2023, Representative Griffith moved to suspend
the rules and pass H.R. 467, as amended. The House agreed to
the motion by a vote of 289 yeas and 133 nays.
On May 30, 2023, H.R. 467 was received in the Senate, read
twice, and referred to the Committee on the Judiciary.
Protecting Health Care for all Patients Act of 2023
H.R. 485
To amend title XI of the Social Security Act to prohibit
the use of quality-adjusted life years and similar measures in
coverage and payment determinations under Federal health care
programs.
Summary
This legislation would prohibit all federal health care
programs, including the Federal Employees Health Benefits
Program, and federally funded state health care programs (e.g.,
Medicaid) from using prices that are based on quality-adjusted
life years, or other similar measures that discount the value
of a life based on disability, to determine relevant thresholds
for coverage, reimbursements, or incentive programs.
Legislative History
H.R. 485 was introduced by Representative McMorris Rodgers
(WA-R) on January 24, 2023, and referred to the Committee on
Energy and Commerce, and in addition to the Committee on Ways
and Means.
On February 1, 2023, the Subcommittee on Health held a
hearing on H.R. 485.
On March 8, 2023, the Subcommittee on Health favorably
forwarded H.R. 485, as amended, to the full committee by voice
vote.
On March 23, 2023, the full committee favorably reported
H.R. 485, as amended, to the House by a vote of 27 yeas and 20
nays.
On May 17, 2023, the Committee on Energy and Commerce
reported H.R. 485, as amended, to the House (H. Rept. 118-65),
and the bill was placed on the Union Calendar (Calendar No.
45).
On February 7, 2024, H.R. 465 was considered in the House
pursuant to the provisions of H. Res. 996, and the bill, as
amended, was passed by a recorded vote of 211 yeas and 208
nays.
On February 8, 2024, H.R. 485 was received in the Senate,
read twice, and referred to the Committee on Finance.
Freedom for Health Care Workers Act
H.R. 497
To eliminate the COVID-19 vaccine mandate on health care
providers furnishing items and services under certain Federal
health care programs.
Summary
H.R. 497 would prohibit the Secretary of HHS from
implementing, enforcing, or otherwise give effect to the rule
entitled ``Medicare and Medicaid Programs; Omnibus COVID-19
Health Care Staff Vaccination''. This rule established COVID-19
immunization requirements for Medicare and Medicaid certified
providers and suppliers.
Legislative History
H.R. 497 was introduced by Representative Duncan (SC-R) on
January 25, 2023, and referred to the Committee on Energy and
Commerce, and in addition to the Committee on Ways and Means.
On January 31, 2023, H.R. 497 was considered in the House
pursuant to the provisions of H. Res. 75, and the bill, without
amendment, was passed by a recorded vote of 227 yeas and 203
nays.
On February 1, 2023, H.R. 497 was received in the Senate,
read twice, and referred to the Committee on Finance.
9-8-8 Lifeline Cybersecurity Responsibility Act
H.R. 498
To amend title V of the Public Health Service Act to secure
the suicide prevention lifeline from cybersecurity incidents,
and for other purposes.
Summary
H.R. 498 amends title V of the Public Health Service Act to
require the Assistant Secretary for Substance Abuse and Mental
Health Services Administration (SAMHSA) to coordinate 9-8-8
lifeline cybersecurity protections with the Chief Information
Security Officer of the Department of Health and Human Services
(HHS). It also requires the 9-8-8 lifeline administrator and
local call centers to report cybersecurity vulnerabilities and
incidents to SAMHSA immediately.
Legislative History
H.R. 498 was introduced by Representative Obernolte (CA-R)
on January 25, 2023, and referred to the Committee on Energy
and Commerce.
On February 1, 2023, the Subcommittee on Health held a
hearing on H.R. 498.
On March 8, 2023, the Subcommittee on Health favorably
forwarded H.R. 498, as amended, to the full committee by a vote
of 27 to 0.
On March 23, 2023, the full committee favorably reported
H.R. 498, as amended, to the House by a vote of 46 yeas and 0
nays.
On May 11, 2023, the Committee on Energy and Commerce
reported H.R. 498, as amended, to the House (H. Rept. 118-52),
and the bill was placed on the Union Calendar (Calendar No.
35).
On March 5, 2024, Representative Guthrie moved to suspend
the rules and pass H.R. 498, as amended. The House agreed to
the motion by a voice vote.
On March 6, 2024, H.R. 498 was received in the Senate, read
twice, and referred to the Committee on Health, Education,
Labor, and Pensions.
Block, Report, and Suspend Suspicious Shipments Act
H.R. 501
To amend the Controlled Substances Act to require
registrants to decline to fill certain suspicious orders, and
for other purposes.
Summary
H.R. 501 amends the Controlled Substances Act to require
Drug Enforcement Administration (DEA) registrants to either
decline to fill a suspicious order or to practice due diligence
and either decline to fill a suspicious order or fill it, if
all indicators have been dispelled. This requirement applies to
all controlled substances.
Legislative History
H.R. 501 was introduced by Representative Harshbarger (TN-
R) on January 25, 2023, and referred to the Committee on Energy
and Commerce, and in addition to the Committee on the
Judiciary.
On February 1, 2023, the Subcommittee on Health held a
hearing on H.R. 501.
On March 8, 2023, the Subcommittee on Health favorably
forwarded H.R. 501, without amendment, to the full committee by
a vote of 28 yeas and 0 nays.
On March 23, 2023, the full committee favorably reported
H.R. 501, as amended, to the House by a vote of 44 yeas and 0
nays.
On May 17, 2023, the Committee on Energy and Commerce
reported H.R. 501, as amended, to the House (H. Rept. 118-66),
and the bill was placed on the Union Calendar (Calendar No.
46).
Think Differently Database Act
H.R. 670
To amend title IV of the Public Health Service Act to
direct the Secretary of Health and Human Services to establish
a clearinghouse on intellectual disabilities, and for other
purposes.
Summary
H.R. 670 would require the Department of Health and Human
Services to establish a publicly available website that is
focused on improving the accessibility of health service
information and resources for individuals with disabilities.
Legislative History
H.R. 670 was introduced by Representative Molinaro (NY-R)
on January 31, 2023, and referred to the Committee on Energy
and Commerce.
On April 30, 2024, the Subcommittee on Health held a
hearing on H.R. 670.
On May 16, 2024, the Subcommittee on Health favorably
forwarded H.R. 670, as amended, to the full committee by a vote
of 20 yeas and 0 nays.
On September 18, 2024, the full committee favorably
reported H.R. 670, as amended, to the House by a vote of 41 to
0.
On December 17, 2024, the House passed H.R. 670 under
suspension of the rules.
On December 21, 2024, the Senate passed H.R. 670 by
unanimous consent.
Fair Access in Residency (FAIR) Act
H.R. 751
To amend title XVIII of the Social Security Act to require
as a condition of satisfying the definition of an approved
medical residency training program for purposes of payments
under Medicare for costs related to graduate medical education
for hospitals operating such a program to submit information to
encourage more equitable treatment of osteopathic and
allopathic candidates in the residency application and review
process, and for other purposes.
Summary
H.R. 751 would extend funding for the Teaching Health
Center Graduate Medical Education program for three years.
Legislative History
H.R. 751 was introduced by Representative Harshbarger (TN-
R) on February 2, 2023, and referred to the Committee on Ways
and Means, and in addition to the Committee on Energy and
Commerce.
On April 19, 2023, the Subcommittee on Health held a
hearing on H.R. 751.
Securing the Border for Public Health Act of 2023
H.R. 801
To amend title III of the Public Health Service Act to
provide for suspension of entries and imports from designated
countries to prevent the spread of communicable diseases and
import into the United States of certain controlled substances.
Summary
This bill allows the Secretary of the Department of Health
and Human Services, after consultation with the Attorney
General, to restrict the entry of persons or property from
foreign countries to prevent the introduction of certain
controlled substances into the United States.
Legislative History
H.R. 801 was introduced by Representative Lesko (AZ-R) on
February 2, 2023, and referred to the Committee on Energy and
Commerce.
On February 15, 2023, the Subcommittee on Health held a
hearing on H.R. 801.
On March 8, 2023, the Subcommittee on Health favorably
forwarded H.R. 801, without amendment, to the full committee by
a vote of 17 to 12.
On March 23, 2024, the full committee favorably reported
H.R. 801, without amendment, to the House by a vote of 24 yeas
and 19 nays.
On May 11, 2023, the Committee on Energy and Commerce
reported H.R. 801, without amendment, to the House (H. Rept.
118-53), and the bill was placed on the Union Calendar
(Calendar No. 36).
Telehealth Benefit Expansion for Workers Act of 2023
H.R. 824
To amend title XXVII of the Public Health Service Act, the
Employee Retirement Income and Security Act of 1974, and the
Internal Revenue Code of 1986 to treat benefits for telehealth
services offered under a group health plan or group health
insurance coverage as excepted benefits.
Summary
The bill would expand upon a COVID-19 flexibility
provisions offered by the Department of Health and Human
Services (HHS), the Department of Labor, and the Department of
the Treasury that increases the ability of employers to offer
stand-alone coverage of telehealth-only services to employees.
Legislative History
H.R. 824 was introduced by Representative Walberg (MI-D) on
February 2, 2023, and referred to the Committee on Energy and
Commerce, and in addition to the Committee on Education and the
Workforce and the Committee on Ways and Means.
On June 21, 2023, the Subcommittee on Health held a hearing
on H.R. 824.
On July 13, 2023, the Subcommittee on Health favorably
forwarded H.R. 824, as amended, to the full committee by a vote
of 16 yeas and 11 nays.
On July 19, 2023, the full committee favorably reported
H.R. 824, as amended, to the House by a vote of 29 to 20.
Patient Access to Higher Quality Health Care Act of 2023
H.R. 977
To repeal changes made by health care reform laws to the
Medicare exception to the prohibition on certain physician
referrals for hospitals.
Summary
H.R. 977 would repeal provisions in the Stark Law that
prohibit physician self-referrals to new or expanded physician-
owned hospitals.
Legislative History
H.R. 977 was introduced by Representative Burgess (TX-R) on
February 10, 2023, and referred to the Committee on Energy and
Commerce, and in addition to the Committee on Ways and Means.
On April 26, 2023, the Subcommittee on Health held a
hearing on H.R. 977.
Better Empowerment Now To Enhance Framework and Improve Treatments Act
of 2023 (BENEFIT Act of 2023)
H.R. 1092
To strengthen the use of patient-experience data within the
benefit-risk framework for approval of new drugs.
Summary
This legislation would modify the new drug approval process
by requiring the Food and Drug Administration (FDA) to utilize
relevant patient-experience data as part of the benefit-risk
assessment framework.
Legislative History
H.R. 1092 was introduced by Representative Matsui (CA-D) on
February 17, 2023, and referred to the Committee on Energy and
Commerce.
On February 29, 2024, the Subcommittee on Health held a
hearing on H.R. 1092.
Knowing the Efficiency and Efficacy of Permanent (KEEP) TElehealth
Options Act of 2023
H.R. 1110
To direct the Secretary of Health and Human Services, the
Medicare Payment Advisory Commission, and the Medicaid and CHIP
Payment and Access Commission to conduct studies and report to
Congress on actions taken to expand access to telehealth
services under the Medicare, Medicaid, and Children's Health
Insurance programs during the COVID-19 emergency.
Summary
This legislation would require the Secretary of the
Department of Health and Human Services (HHS) to publish a
comprehensive report on the provision of telehealth services
under Medicare, Medicaid, and the Children's Health Insurance
Program (CHIP) during the COVID-19 emergency. In addition, the
Medicare Payment Advisory Commission (MedPAC) and the Medicaid
and CHIP Payment and Access Commission (MACPAC) shall study the
increased risk of fraudulent activities related to expansion of
telehealth, as well as potential improvements to telehealth
services.
Legislative History
H.R. 1110 was introduced by Representative Balderson (OH-R)
on February 21, 2023, and referred to the Committee on Energy
and Commerce, and in addition to the Committee on Ways and
Means.
On April 10, 2024, the Subcommittee on Health held a
hearing on H.R. 1110.
The provisions of H.R. 1110 were included in H.R. 7623,
which is discussed elsewhere in this report.
Facilitating Innovative Nuclear Diagnostics Act of 2023
H.R. 1199
To amend title XVIII of the Social Security Act to ensure
equitable payment for, and preserve Medicare beneficiary access
to, diagnostic radiopharmaceuticals under the Medicare hospital
outpatient prospective payment system.
Summary
This legislation would change the Medicare reimbursement
structure from being bundled with other imaging services by
establishing separate payment requirements for diagnostic
radiopharmaceuticals under the Medicare prospective payment
system for hospital outpatient department services. These
requirements would apply to diagnostic radiopharmaceuticals
that have an average daily cost of $500 or more in 2024 and as
adjusted based on a specified fee schedule factor in each year
thereafter.
Legislative History
H.R. 1199 was introduced by Representative Dunn (FL-R) on
February 27, 2023, and referred to the Committee on Energy and
Commerce, and in addition to the Committee on Ways and Means.
On September 19, 2023, the Subcommittee on Health held a
hearing on H.R. 1199.
On May 16, 2024, the Subcommittee on Health favorably
forwarded H.R. 1199, without amendment, to the full committee
by voice vote.
Stop Institutional Child Abuse Act
S. 1352
To study and prevent child abuse in youth residential
programs, and for other purposes.
Summary
S. 1352 requires the Department of Health and Human
Services to contract with the National Academies of Sciences,
Engineering, and Medicine to study and make recommendations
about various aspects of youth residential programs.
Specifically, the National Academies must identify the nature,
prevalence, severity, and scope of child abuse, neglect, and
deaths in youth residential programs.
Legislative History
S. 1351 was introduced by Senator Merkley (OR-D) on April
27, 2023, read twice and referred to the Committee on Health,
Education, Labor, and Pensions.
On December 11, 2024, the Senate Committee on Health,
Education, Labor, and Pensions discharged by unanimous consent.
On December 11, 2024, the Senate passed S. 1351, as
amended, by unanimous consent.
On December 12, 2024, S. 1351 was received in the House.
On December 17, 2024, Representative Guthrie moved to
suspend the rules and pass S. 1351 The House agreed to the
motion by a vote of 373 to 33.
Increasing Access to Biosimilars Act of 2023
H.R. 1352
To require the Secretary of Health and Human Services to
establish a demonstration project to increase access to
biosimilar biological products under the Medicare program.
Summary
H.R. 1352 would promote patient access to biosimilars by
establishing a demonstration project to evaluate the benefits
of providing a shared savings payment for biosimilar biological
products under the Medicare program. The demonstration project
would be implemented for three years, and participation would
be voluntary.
Legislative History
H.R. 1352 was introduced by Representative Hudson (NC-R) on
March 3, 2023, and referred to the Committee on Energy and
Commerce, and in addition to the Committee on Ways and Means.
On October 19, 2023, the Subcommittee on Health held a
hearing on H.R. 1352.
On November 15, 2023, the Subcommittee on Health favorably
forwarded H.R. 1352, without amendment, to the full committee
by voice vote.
On December 5, 2023, the full committee favorably reported
H.R. 1352, as amended, to the House by a vote of 44 to 0.
Sustainable Cardiopulmonary Rehabilitation Services in the Home Act
H.R. 1406
To amend title XVIII of the Social Security Act to
permanently extend certain in-home cardiopulmonary
rehabilitation flexibilities established in response to COVID-
19, and for other purposes.
Summary
This legislation would permanently allow cardiopulmonary
rehabilitation services to be furnished via telehealth at a
beneficiary's home under Medicare.
Legislative History
H.R. 1406 was introduced by Representative Joyce (PA-R) on
March 7, 2023, and referred to the Committee on Energy and
Commerce, and in addition to the Committee on Ways and Means.
On October 19, 2023, the Subcommittee on Health held a
hearing on H.R. 1406.
On May 16, 2024, the Subcommittee on Health favorably
forwarded H.R. 1406, as amended, to the full committee by voice
vote.
The provisions of H.R. 1406 were included in H.R. 7623,
which is discussed elsewhere in this report.
Animal Drug and Animal Generic Drug User Fee Amendments of 2023
H.R. 1418
To amend the Federal Food, Drug, and Cosmetic Act to
reauthorize user fee programs relating to new animal drugs and
generic new animal drugs.
Summary
H.R. 1418 reauthorizes provisions of the Animal Drug User
Fee Act (ADUFA) and the Animal Generic Animal Drug User Fee Act
(AGDUFA) through fiscal year (FY) 2028. Specifically, the bill
would allow the Food and Drug Administration (FDA) to continue
to collect and obligate user fees, paid by regulated industry
to supplement Congressional appropriations, for the review of
animal drugs and animal generic drugs. It also includes
provisions that improve upon the review and development of
animal health products and support activities regarding the
development and stewardship of animal antimicrobials.
Legislative History
H.R. 1418 was introduced by Representative Pence (IN-R) on
March 7, 2023, and referred to the Committee on Energy and
Commerce.
On March 30, 2023, the Subcommittee on Health held a
hearing on H.R. 1418.
On May 17, 2023, the Subcommittee on Health favorably
forwarded H.R. 1418, as amended, to the full committee by a
vote of 29 yeas and 0 nays.
On May 25, 2023, the full committee favorably reported H.R.
1418, as amended, to the House by a vote of 49 to 0.
On July 17, 2023, Representative Bilirakis moved to suspend
the rules and pass H.R. 1418, as amended. The House agreed to
the motion by a voice vote.
On September 20, 2023, H.R. 1418 was read twice, and placed
on Senate Legislative Calendar under General Orders.
The provisions of H.R. 1418 were included in H.R. 5860.
On September 30, 2023, the House agreed to suspend the
rules and pass H.R. 5860 by a vote of 335 to 91.
On September 30, 2023 the Senate passed H.R. 5860 by a vote
of 88 to 9.
The President signed H.R. 5860 on September 30, 2024
(Public Law 118-15).
Access to Prescription Digital Therapeutics Act of 2023
H.R. 1458
To amend titles XVIII and XIX of the Social Security Act to
provide for coverage of prescription digital therapeutics under
such titles, and for other purposes.
Summary
This legislation would provide for Medicare and Medicaid
coverage of prescription digital therapeutics.
Legislative History
H.R. 1458 was introduced by Representative Hern (OK-R) on
March 8, 2023, and referred to the Committee on Energy and
Commerce, and in addition to the Committee on Ways and Means.
On September 19, 2023, the Subcommittee on Health held a
hearing on H.R. 1458.
Defending Against Imitations and Replacements of Yogurt, Milk, and
Cheese To Promote Regular Intake of Dairy Everyday (DAIRY PRIDE) Act
H.R. 1462
To require enforcement against misbranded milk
alternatives.
Summary
This legislation would prohibit the sale of any food that
uses the market name of a dairy product (such as milk, yogurt,
or cream cheese) unless the food is the milk of a hooved
animal, is derived from such milk, or contains such milk as a
primary ingredient.
Legislative History
H.R. 1462 was introduced by Representative Joyce (PA-R) on
March 8, 2023, and referred to the Committee on Energy and
Commerce.
On September 10, 2024, the Subcommittee on Health held a
hearing on H.R. 1462.
Comprehensive Opioid Recovery Centers
Reauthorization Act of 2023
H.R. 1502
To amend title V of the Public Health Service Act to
reauthorize comprehensive opioid recovery centers, and for
other purposes.
Summary
H.R. 1502 would reauthorize competitive grants for
comprehensive opioid recovery centers for fiscal years 2024
through 2028.
Legislative History
H.R. 1502 was introduced by Representative Guthrie (KY-R)
on March 9, 2023, and referred to the Committee on Energy and
Commerce.
On June 21, 2023, the Subcommittee on Health held a hearing
on H.R. 1502.
The provisions of H.R. 1502 were included in H.R. 4531,
which is discussed elsewhere in this report.
Drug Price Transparency in Medicaid Act of 2023
H.R. 1613
To amend title XIX of the Social Security Act to improve
transparency and prevent the use of abusive spread pricing and
related practices in the Medicaid program.
Summary
H.R. 1613 would require pass-through pricing and prohibit
spread-pricing for payment arrangements with pharmacy benefit
managers under Medicaid.
Legislative History
H.R. 1613 was introduced by Representative Carter (GA-R) on
March 17, 2023, and referred to the Committee on Energy and
Commerce.
On April 26, 2023, the Subcommittee on Health held a
hearing on H.R. 1613.
The provisions of H.R. 1613 were included in H.R. 3561,
which is discussed elsewhere in this report.
Generic Animal Drug Advancement Act
H.R. 1683
To amend the Federal Food, Drug, and Cosmetic Act to make
certain changes with respect to the approval of abbreviated
applications for the approval of new animal drugs, and for
other purposes.
Summary
H.R. 1683 would amend section 512(n) of Federal Food, Drug,
and Cosmetic Act (FFDCA) concerning labeling requirements to
allow a generic animal drug application to gain approval for
fewer species than on the reference listed drug's labeling. The
bill would also amend section 512(d) of FFDCA to allow new
generic animal drugs to gain approval as combination products.
Legislative History
H.R. 1683 was introduced by Representative Mace (SC-R) on
March 21, 2023, and referred to the Committee on Energy and
Commerce.
On March 30, 2023, the Subcommittee on Health held a
hearing on H.R. 1683.
Ensuring Patient Access to Critical Breakthrough
Products Act of 2023
H.R. 1691
To amend title XVIII of the Social Security Act to ensure
prompt coverage of breakthrough devices under the Medicare
program, and for other purposes.
Summary
This legislation would provide temporary or transitional
Medicare coverage of medical breakthrough devices for four
years while CMS works to make a permanent coverage
determination. The legislation also enables a process whereby
the Secretary would assign coding for approved products in a
timely manner.
Legislative History
H.R. 1691 was introduced by Representative Wenstrup (OH-R)
on March 22, 2023, and referred to the Committee on Ways and
Means, and in addition to the Committee on Energy and Commerce.
On September 19, 2023, the Subcommittee on Health held a
hearing on H.R. 1691.
Defending Domestic Orange Juice Production Act of 2023
H.R. 1750
To modify the minimum required weight of orange juice
soluble solids.
Summary
This legislation would require finished pasteurized orange
juice to contain at least 10 percent by weight of orange juice
soluble solids (currently 10.5 percent), exclusive of the
solids of any added optional sweetening ingredients.
Legislative History
H.R. 1750 was introduced by Representative Franklin (FL-R)
on March 23, 2023, and referred to the Committee on Energy and
Commerce.
On September 10, 2024, the Subcommittee on Health held a
hearing on H.R. 1750.
Codifying Useful Regulatory Definitions (CURD) Act
H.R. 1803
To amend the Federal Food, Drug, and Cosmetic Act to define
the term natural cheese.
Summary
This legislation would establish a statutory definition for
``natural cheese'' as cheese (ripened or unripened soft, semi-
soft, or hard) that is produced from animal milk or certain
dairy ingredients and is produced in accordance with
established cheese-making standards. The definition excludes
pasteurized process cheeses, cheese foods, and cheese spreads.
Legislative History
H.R. 1803 was introduced by Representative Gallagher/Steil
(WI-R) on March 27, 2023, and referred to the Committee on
Energy and Commerce.
On September 10, 2024, the Subcommittee on Health held a
hearing on H.R. 1803.
Combating Illicit Xylazine Act
H.R. 1839
To prohibit certain uses of xylazine, and for other
purposes.
Summary
H.R. 1839 creates a definition for the illicit use and
distribution of xylazine and subjects individuals who illicitly
distribute the substance to penalties associated with Schedule
III of the Controlled Substances Act.
Legislative History
H.R. 1839 was introduced by Representative Panetta (CA-D)
on March 28, 2023, and referred to the Committee on Energy and
Commerce, and in addition to the Committee on the Judiciary.
On June 21, 2023, the Subcommittee on Health held a hearing
on H.R. 1839.
The provisions of H.R. 1839 were included in H.R. 4531,
which is discussed elsewhere in this report.
Saving Access to Laboratory Services Act
H.R. 2377
To amend title XVIII of the Social Security Act to improve
the accuracy of market-based Medicare payment for clinical
diagnostic laboratory services, to reduce administrative
burdens in the collection of data, and for other purposes.
Summary
This legislation would require CMS to use statistical
sampling of private-payer rates in establishing Medicare
reimbursement amounts for widely available clinical diagnostic
tests.
Legislative History
H.R. 2377 was introduced by Representative Hudson (NC-R) on
March 29, 2023, and referred to the Committee on Energy and
Commerce, and in addition to the Committee on Ways and Means.
On October 19, 2023, the Subcommittee on Health held a
hearing on H.R. 2377.
Reentry Act of 2023
H.R. 2400
To amend title XIX of the Social Security Act to allow
States to make medical assistance available to inmates during
the 30-day period preceding their release.
Summary
H.R. 2400 would allow for state Medicaid programs to
provide Medicaid coverage for eligible individuals who are
incarcerated and are set to be released from prison within 30
days. Current law prohibits Medicaid from covering individuals
who are incarcerated, whether in pre-trial detention or post-
adjudication, thus leaving such costs up to the jail or prison
in question.
Legislative History
H.R. 2400 was introduced by Representative Tonko (NY-D) on
March 30, 2023, and referred to the Committee on Energy and
Commerce.
On June 21, 2023, the Subcommittee on Health held a hearing
on H.R. 2400.
Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening
Coverage Act
H.R. 2407
To amend title XVIII of the Social Security Act to provide
for Medicare coverage of multi-cancer early detection screening
tests.
Summary
This legislation would allow for Medicare coverage and
payment for FDA cleared or approved multi-cancer early
detection screening tests.
Legislative History
H.R. 2407 was introduced by Representative Arrington (TX-R)
on March 30, 2023, and referred to the Committee on Energy and
Commerce, and in addition to the Committee on Ways and Means.
On September 19, 2023, the Subcommittee on Health held a
hearing on H.R. 2407.
Access To Innovative Treatments Act of 2023
H.R. 2408
To amend title XVIII of the Social Security Act to provide
a review process for adverse national coverage determinations
with respect to drug coverage under the Medicare program.
Summary
This legislation would amend the Social Security Act (SSA)
to provide for a review process for adverse National Coverage
Determinations (NCDs) with respect to drug and biologics
coverage. The legislation would also prohibit existing NCDs
from denying or limiting coverage to subsequently FDA-approved
drugs or biologics, which would effectively prohibit CMS from
limiting coverage to an entire class of drugs.
Legislative History
H.R. 2408 was introduced by Representative Barragan (CA-D)
on March 30, 2023, and referred to the Committee on Ways and
Means, and in addition to the Committee on Energy and Commerce.
On September 19, 2023, the Subcommittee on Health held a
hearing on H.R. 2408.
National Nursing Workforce Center Act of 2023
H.R. 2411
To amend the Public Health Service Act to support and
stabilize the existing nursing workforce, establish programs to
increase the number of nurses, and for other purposes.
Summary
H.R. 2411 would authorize the Secretary of the Department
of Health and Human Services (HHS) to carry out a pilot program
to establish new or enhance existing State-based nursing
workforce centers. The legislation also allows for a technical
assistance center through a competitive grant.
Legislative History
H.R. 2411 was introduced by Representative Blunt Rochester
(DE-D) on March 30, 2023, and referred to the Committee on
Energy and Commerce.
On April 19, 2023, the Subcommittee on Health held a
hearing on H.R. 2411.
To Amend the Public Health Service Act To Reauthorize a Military and
Civilian Partnership for Trauma Readiness Grant Program
H.R. 2416
To amend the Public Health Service Act to reauthorize a
military and civilian partnership for trauma readiness grant
program.
Summary
H.R. 2416 would reauthorize the ``Military Injury Surgical
Systems Integrated Operationally Nationwide to Achieve ZERO
Preventable Deaths'' Act, or ``Mission ZERO'' Act, a military
and civilian partnership for trauma readiness grant program,
for fiscal years 2024 through 2028. The program provides grants
for eligible trauma systems and centers to incorporate full
military trauma teams or individual military trauma providers
into their hospitals.
Legislative History
H.R. 2416 was introduced by Representative Burgess (TX-R)
on March 30, 2023, and referred to the Committee on Energy and
Commerce.
On June 13, 2023, the Subcommittee on Health held a hearing
on H.R. 2416.
The provisions of H.R. 2416 were included in H.R. 4421,
which is discussed elsewhere in this report.
Special Diabetes Program for Indians Reauthorization Act of 2023
H.R. 2547
To amend title III of the Public Health Service Act to
extend funding for special diabetes programs for Indians.
Summary
This legislation would extend funding for the Special
Diabetes for Indians program.
Legislative History
H.R. 2547 was introduced by Representative Cole (OK-R) on
April 10, 2023, and referred to the Committee on Energy and
Commerce.
On April 19, 2023, the Subcommittee on Health held a
hearing on H.R. 2547.
The provisions of H.R. 2547 were included in H.R. 5378,
which is discussed elsewhere in this report.
The provisions of H.R. 2547 were included in H.R. 10545.
On December 21, 2024, the House agreed to suspend the rules
and pass H.R. 10545 by a vote of 366 to 34.
On December 21, 2024 the Senate passed H.R. 10545 by a vote
of 85 to 11.
Special Diabetes Program Reauthorization Act of 2023
H.R. 2550
To extend funding for Special Diabetes Programs for Type I
diabetes.
Summary
H.R. 2550 would extend funding for the Special Diabetes
Program for five years.
Legislative History
H.R. 2550 was introduced by Representative DeGette (CO-D)
on April 10, 2023, and referred to the Committee on Energy and
Commerce.
On April 19, 2023, the Subcommittee on Health held a
hearing on H.R. 2550.
The provisions of H.R. 2550 were included in H.R. 3561,
which is discussed elsewhere in this report.
Certain provisions of H.R. 2550 were included in H.R.
10545.
On December 21, 2024, the House agreed to suspend the rules
and pass H.R. 10545 by a vote of 366 to 34.
On December 21, 2024 the Senate passed H.R. 10545 by a vote
of 85 to 11.
Strengthening Community Care Act of 2023
H.R. 2559
To extend funding for community health centers and the
National Health Service Corps, and for other purposes.
Summary
H.R. 2559 would extend funding for the Community Health
Center Fund and National Health Service Corps for five years.
Legislative History
H.R. 2559 was introduced by Representative Joyce (PA-R) on
April 10, 2023, and referred to the Committee on Energy and
Commerce.
On April 19, 2023, the Subcommittee on Health held a
hearing on H.R. 2559.
The provisions of H.R. 2559 were included in H.R. 3561,
which is discussed elsewhere in this report.
The provisions of H.R. 2559 were included in H.R. 10545.
On December 21, 2024, the House agreed to suspend the rules
and pass H.R. 10545 by a vote of 366 to 34.
On December 21, 2024, the Senate passed H.R. 10545 by a
vote of 85 to 11.
Doctors of Community (DOC) Act
H.R. 2569
To amend the Public Health Service Act to reauthorize the
program of payments to teaching health centers that operate
graduate medical education programs.
Summary
H.R. 2569 would make the Teaching Health Center Graduate
Medical Education program permanent and increase its funding to
$582.7 million by Fiscal Year 2033.
Legislative History
H.R. 2569 was introduced by Representative Pallone (NJ-D)
on April 10, 2023, and referred to the Committee on Energy and
Commerce.
On April 19, 2023, the Subcommittee on Health held a
hearing on H.R. 2569.
Increasing Access to Quality Cardiac Rehabilitation Care Act of 2023
H.R. 2583
To amend title XVIII of the Social Security Act to expand
and expedite access to cardiac rehabilitation programs and
pulmonary rehabilitation programs under the Medicare program,
and for other purposes.
Summary
This legislation would allow nurse practitioners, clinical
nurse specialists, and physician assistants, to supervise and
administer cardiac rehabilitation care programs under Medicare.
Legislative History
H.R. 2583 was introduced by Representative Blunt Rochester
(DE-D) on April 13, 2023, and referred to the Committee on
Energy and Commerce, and in addition to the Committee on Ways
and Means.
On October 19, 2023, the Subcommittee on Health held a
hearing on H.R. 2583.
Supporting Safety Net Hospitals Act
H.R. 2665
To amend title XIX of the Social Security Act to delay
certain disproportionate share hospital payment reductions
under the Medicaid program.
Summary
H.R. 2665 would eliminate the disproportionate share
hospital payment reductions under the Medicaid program for
Fiscal Years 2024 and 2025.
Legislative History
H.R. 2665 was introduced by Representative Clarke (NY-D) on
April 18, 2023, and referred to the Committee on Energy and
Commerce.
On April 26, 2023, the Subcommittee on Health held a
hearing on H.R. 2665.
The provisions of H.R. 2665 were included in H.R. 3561,
which is discussed elsewhere in this report.
Certain provisions of H.R. 2665 were included in H.R.
10545.
On December 21, 2024, the House agreed to suspend the rules
and pass H.R. 10545 by a vote of 366 to 34.
On December 21, 2024 the Senate passed H.R. 10545 by a vote
of 85 to 11.
Medicaid VBPs for Patients (MVP) Act
H.R. 2666
To amend title XIX of the Social Security Act to codify
value-based purchasing arrangements under the Medicaid program
and reforms related to price reporting under such arrangements,
and for other purposes.
Summary
H.R. 2666 codifies Medicaid rules that permit the use of
varying best price points under value-based purchasing
arrangements such as gene therapies.
Legislative History
H.R. 2666 was introduced by Representative Guthrie (KY-R)
on April 18, 2023, and referred to the Committee on Energy and
Commerce, and in addition to the Committee on Ways and Means.
On April 26, 2023, the Subcommittee on Health held a
hearing on H.R. 2666.
On May 17, 2023, the Subcommittee on Health favorably
forwarded H.R. 2666, as amended, to the full committee by a
vote of 16 yeas and 11 nays.
On May 24, 2023, the full committee favorably reported H.R.
2666, as amended, to the House by a vote of 31 to 19.
Pharmacy Benefits Accountability Act
H.R. 2679
To amend the Public Health Service Act, the Employee
Retirement Income Security Act, and the Internal Revenue Code
of 1984 to increase oversight of pharmacy benefits manager
services, and for other purposes.
Summary
H.R. 2679 would require pharmacy benefit managers (PBMs)
regularly to furnish employers with detailed data on
prescription drug spending, including the cost of drugs, total
out-of-pocket spending, formulary placement rationale, and
aggregate rebate information. Additionally, the Comptroller
General of the United States would be required to submit a
report to Congress on pharmacy networks of group health plans,
health insurance issuers, and entities providing pharmacy
management services under such group health plans or group or
individual health insurance coverage.
Legislative History
H.R. 2679 was introduced by Representative Kuster (NH-D) on
April 18, 2023, and referred to the Committee on Energy and
Commerce, and in addition to the Committee on Education and the
Workforce, and the Committee on Ways and Means.
On April 26, 2023, the Subcommittee on Health held a
hearing on H.R. 2679.
The provisions of H.R. 2679 were included in H.R. 7623,
which is discussed elsewhere in this report.
Charlotte Woodward Organ Transplant Discrimination Prevention Act
H.R. 2706
To prohibit discrimination on the basis of mental or
physical disability in cases of organ transplants.
Summary
H.R. 2706 prohibits health care providers and other
entities from denying or restricting an individual's access to
organ transplants solely on the basis of the individual's
disability, except in limited circumstances.
Legislative History
H.R. 2706 was introduced by Representative Cammack (FL-R)
on April 19, 2023, and referred to the Committee on Energy and
Commerce.
On February 14, 2024, the Subcommittee on Health held a
hearing on H.R. 2706.
On March 12, 2024, the Subcommittee on Health favorably
forwarded H.R. 2706, as amended, to the full committee by voice
vote.
On March 20, 2024, the full committee favorably reported
H.R. 2706, as amended, to the House by a vote of 46 yeas and 0
nays.
On May 14, 2024, the Committee on Energy and Commerce
reported H.R. 2706, as amended, to the House (H. Rept. 118-
507), and the bill was placed on the Union Calendar (Calendar
No. 422).
On September 23, 2024, Representative Bucshon moved to
suspend the rules and pass H.R. 2706, as amended. The House
agreed to the motion by a voice vote.
On September 24, 2024, H.R. 2706 was received in the
Senate, read twice, and referred to the Committee on Health,
Education, Labor, and Pensions.
Protecting Patients Against PBM Abuses Act
H.R. 2880
To amend title XVIII of the Social Security Act to
establish certain requirements for pharmacy benefit managers
under Part D of the Medicare program.
Summary
This legislation would establish new requirements for
pharmacy benefit managers (PBMs) under Medicare Part D,
including a policy to de-link PBM compensation from the cost of
medications, while also prohibiting the use of spread pricing
in which a PBM charges a sponsor a different amount for the
drug's ingredient cost or dispensing fee than the amount the
PBM reimburses the pharmacy for such ingredient cost or
dispensing fee. The legislation also prohibits PBMs from
compensating a network pharmacy less than affiliated pharmacies
and includes transparency provisions related to the PBM rebates
and administrative fees.
Legislative History
H.R. 2880 was introduced by Representative Carter (GA-R) on
April 26, 2023, and referred to the Committee on Energy and
Commerce, and in addition to the Committee on Ways and Means.
On September 19, 2023, the Subcommittee on Health held a
hearing on H.R. 2880.
On November 15, 2023, the Subcommittee on Health favorably
forwarded H.R. 2880, without amendment, to the full committee
by voice vote.
On December 5, 2023, the full committee favorably reported
H.R. 2880, as amended, to the House by a vote of 46 to 0.
Food Labeling Modernization Act of 2023
H.R. 2901
To amend the Federal Food, Drug, and Cosmetic Act to
strengthen requirements related to nutrient information on food
labels.
Summary
This legislation would update front-of-package food
labeling requirements to highlight certain nutritional
information, require updates to the ingredient list on packaged
food, and impose certain restrictions on how food can be
labeled.
Legislative History
H.R. 2901 was introduced by Representative Pallone (NJ-D)
on April 26, 2023, and referred to the Committee on Energy and
Commerce.
On September 10, 2024, the Subcommittee on Health held a
hearing on H.R. 2901.
Drug Shortage Prevention Act of 2023
H.R. 3008
To amend the Federal Food, Drug, and Cosmetic Act to
provide for notification by manufacturers of critical essential
medicines of increased demand of such drugs.
Summary
H.R. 3008 would expand existing drug shortage notification
requirements by requiring drug manufacturers to notify the FDA
of permanent discontinuance or interruption in the manufacture
of an excipient (inactive ingredient in a drug), or API that is
likely to result in meaningful disruption in supply. The
legislation would also expand the requirement so manufacturers
would be required to notify the FDA when that manufacturer
experiences an increase in demand of the finished dosage form,
API, excipient, or any other input such that it is likely to
lead to a shortage of the drug, API, excipient, or any other
input. The bill would require the FDA to issue guidance on such
notifications, through consultation with industry and public
health officials, not later than 180 days after the enactment
of the bill.
Legislative History
H.R. 3008 was introduced by Representative Jacobs (CA-D) on
April 28, 2023, and referred to the Committee on Energy and
Commerce.
On September 14, 2023, the Subcommittee on Health held a
hearing on H.R. 3008.
Due Process Continuity of Care Act
H.R. 3074
To amend title XIX of the Social Security Act to remove the
Medicaid coverage exclusion for inmates in custody pending
disposition of charges.
Summary
H.R. 3074 would allow for state Medicaid programs to
provide coverage for eligible individuals who are in pre-trial
detention and are awaiting the disposition of charges. Current
law prohibits Medicaid from covering individuals who are
incarcerated, whether in pre-trial detention or post-
adjudication, thus leaving such costs up to the respective jail
or prison in question (except for a notable, bipartisan law
change from Energy and Commerce last year that now permits
Medicaid to cover children in pre-trial detention).
Legislative History
H.R. 3074 was introduced by Representative Trone (MD-D) on
May 2, 2023, and referred to the Committee on Energy and
Commerce.
On June 21, 2023, the Subcommittee on Health held a hearing
on H.R. 3074.
PREEMIE Reauthorization Act of 2023
H.R. 3226
To reauthorize the Prematurity Research Expansion and
Education for Mothers who deliver Infants Early Act.
Summary
H.R. 3226 would reauthorize the Prematurity Research
Expansion and Education for Mothers who deliver Infants Early
Act for fiscal years 2024-2028. This reauthorization would
include the renewal of research, education, and intervention
activities and programs at the Centers for Disease Control and
Prevention (CDC) and the Health Resources and Services
Administration (HRSA) that focus on preventing preterm births
and reducing infant mortality. The bill would also authorize a
new study on the financial costs of premature births to
society, among other things.
Legislative History
H.R. 3226 was introduced by Representative Eshoo (CA-D) on
May 11, 2023, and referred to the Committee on Energy and
Commerce.
On June 14, 2023, the Subcommittee on Health held a hearing
on H.R. 3226.
On July 13, 2023, the Subcommittee on Health favorably
forwarded H.R. 3226, as amended, to the full committee by a
vote of 26 to 0.
On July 19, 2023, the full committee favorably reported
H.R. 3226, as amended, to the House by a vote of 48 to 0.
On December 11, 2023, Representative Guthrie moved to
suspend the rules and pass H.R. 3226, as amended. The House
agreed to the motion by a voice vote.
On December 12, 2023, H.R. 3226 was received in the Senate,
read twice, and placed on Senate Legislative Calendar under
General Orders.
Ensuring Seniors' Access to Quality Care Act
H.R. 3227
To amend titles XVIII and XIX of the Social Security Act
with respect to nursing facility requirements.
Summary
H.R. 3227 modifies requirements that otherwise prohibit a
nursing home from running nurse aide trainings and competency
evaluations when the nursing home has been subject to civil
monetary penalties, so long as the facility has addressed
deficiencies associated with the penalties and has not been
found to have deficiencies related to patient harm or quality
of care.
Legislative History
H.R. 3227 was introduced by Representative Estes (KS-R) on
May 11, 2023, and referred to the Committee on Energy and
Commerce, and in addition to the Committee on Ways and Means.
On April 30, 2024, the Subcommittee on Health held a
hearing on H.R. 3227.
On May 16, 2024, the Subcommittee on Health favorably
forwarded H.R. 3227, as amended, to the full committee by a
vote of 13 to 12.
On September 18, 2024, the full committee favorably
reported H.R. 3227, as amended, to the House by a vote of 20 to
18.
To Amend Title XVIII of the Social Security Act to Require Each Off-
Campus Outpatient Department of a Provider To Include a Unique
Identifier on Claims for Items and Services, and To Require Providers
With a Department of a Provider To Submit to the Centers for Medicare &
Medicaid Services an Attestation With Respect to Each Such Department
H.R. 3237
To amend title XVIII of the Social Security Act to require
each off-campus outpatient department of a provider to include
a unique identifier on claims for items and services, and to
require providers with a department of a provider to submit to
the Centers for Medicare & Medicaid Services an attestation
with respect to each such department.
Summary
This legislation would require that each department of a
provider to include a unique identification number on claims
for services, and to require hospitals with an outpatient
department of a provider to submit to the Centers for Medicare
and Medicaid Services an attestation with respect to each
outpatient department.
Legislative History
H.R. 3237 was introduced by Representative Joyce (PA-R) on
May 11, 2023, and referred to the Committee on Energy and
Commerce, and in addition to the Committee on Ways and Means.
On April 26, 2023, the Subcommittee on Health held a
hearing on H.R. 3237.
The provisions of H.R. 3237 were included in H.R. 3561,
which is discussed elsewhere in this report.
Diagnostic Lab Testing Transparency Act
H.R. 3248
To amend title XVIII of the Social Security Act to increase
price transparency of clinical diagnostic laboratory tests
under the Medicare program.
Summary
This legislation would require diagnostic laboratories to
disclose three data points for clinical diagnostic laboratory
tests included on the list of shoppable services specified by
the Centers for Medicare and Medicaid Services: the discounted
cash price of each test, the de- identified minimum rate for
each test, and the de-identified maximum rate for each test.
Legislative History
H.R. 3248 was introduced by Representative Miller-Meeks
(IA-R) on May 11, 2023, and referred to the Committee on Energy
and Commerce, and in addition to the Committee on Ways and
Means.
On April 26, 2023, the Subcommittee on Health held a
hearing on H.R. 3248.
The provisions of H.R. 3248 were included in H.R. 3561,
which is discussed elsewhere in this report.
To Amend Title XI of the Social Security Act To Increase Transparency
of Certain Health-Related Ownership Information
H.R. 3262
To amend title XI of the Social Security Act to increase
transparency of certain health-related ownership information.
Summary
This legislation would require hospitals, freestanding
emergency centers, ambulatory surgical centers, physician
practices with more than 25 physicians, physician practices
owned by hospitals, insurance companies, and other entities, to
report to the Department of Health and Human Services (HHS)
upon changes in ownership. HHS would be required to use this
data to submit annual reports on trends in health care
consolidation.
Legislative History
H.R. 3262 was introduced by Representative Schakowsky (IL-
D) on May 11, 2023, and referred to the Committee on Energy and
Commerce, and in addition to the Committee on Ways and Means.
On April 26, 2023, the Subcommittee on Health held a
hearing on H.R. 3262.
The provisions of H.R. 3262 were included in H.R. 3561,
which is discussed elsewhere in this report.
Transparent Prices Required To Inform Consumer and Employers (PRICE)
Act
H.R. 3281, H.R. 2691
To promote hospital and insurer price transparency.
Summary
This legislation would require hospitals to make their
standard charges public through machine-readable files as well
as payer-specific negotiated charges, including for cash-paying
patients, for 300 shoppable services. Additionally, the
legislation would require health insurance companies to make
personalized pricing information available to enrollees and
post machine-readable files containing in-network negotiated
rates, historical prescription drug prices, and out-of-network
allowed amounts. Finally, the bill would increase penalties for
noncompliance with existing rules and implement policies to
improve the quality of data reported by hospitals and insurers
to provide actionable information for patients and employers.
Legislative History
H.R. 2691 was introduced by Representative McMorris Rodgers
(WA-R) on April 18, 2023, and referred to the Committee on
Energy and Commerce.
On April 26, 2023, the Subcommittee on Health held a
hearing on H.R. 2691.
H.R. 3281 was introduced by Representative McMorris Rodgers
(WA-R) on May 15, 2023, and referred to the Committee on Energy
and Commerce. H.R. 3281 was similar to H.R. 2691.
On May 17, 2023, the Subcommittee on Health favorably
forwarded H.R. 3281, as amended, to the full committee by a
vote of 27 to 0.
The provisions of H.R. 1613 were included in H.R. 3561,
which is discussed elsewhere in this report.
Promoting Transparency and Healthy Competition in Medicare Act
H.R. 3282
To amend title XVIII of the Social Security Act to promote
transparency of common ownership interests under parts C and D
of the Medicare program.
Summary
This legislation would increase transparency into the
effects of vertical integration in health care by requiring
Medicare Advantage Organizations and Part D plan sponsors to
report data with respect to how these companies interact with
health care providers that they share common ownership with--
like physician groups, pharmacy benefit managers (PBMs), and
pharmacies--compared to those that they do not.
Legislative History
H.R. 3282 was introduced by Representative Harshbarger (TN-
R) on May 15, 2023, and referred to the Committee on Energy and
Commerce, and in addition to the Committee on Ways and Means.
On April 26, 2023, the Subcommittee on Health held a
hearing on H.R. 3282.
The provisions of H.R. 3282 were included in H.R. 3561,
which is discussed elsewhere in this report.
Providers and Payers Compete Act
H.R. 3284
To require the Secretary of Health and Human Services to
submit an annual report on the impact of certain Medicare
regulations on provider and payer consolidation.
Summary
This legislation would require HHS, during each of its
annual hospital and other provider payment rules like those for
inpatient and outpatient care, to consider the implications
that its proposals may have on further consolidating the health
care system by studying both horizontal and vertical
consolidation among both providers and payers.
Legislative History
H.R. 3284 was introduced by Representative Burgess (TX-R)
on May 15, 2023, and referred to the Committee on Energy and
Commerce, and in addition to the Committee on Ways and Means.
On April 26, 2023, the Subcommittee on Health held a
hearing on H.R. 3284.
On May 17, 2023, the Subcommittee on Health favorably
forwarded H.R. 3284, without amendment, to the full committee
by a vote of 27 to 0.
On May 25, 2023, the full committee favorably reported H.R.
3284, as amended, to the House by a vote of 49 to 0.
The provisions of H.R. 3284 were included in H.R. 5378,
which is discussed elsewhere in this report.
Fairness for Patient Medications Act
H.R. 3285
To establish patient protections with respect to highly
rebated drugs.
Summary
This legislation would establish deductible and cost-
sharing limitations on highly rebated drugs. Specifically,
cost-sharing would be capped at the price paid by the insurer
for the drug in the previous year to ensure patients are never
paying more than the cost of the drug.
Legislative History
H.R. 3285 was introduced by Representative Griffith (VA-R)
on May 15, 2023, and referred to the Committee on Energy and
Commerce, and in addition to the Committee on Education and the
Workforce and the Committee on Ways and Means.
On April 26, 2023, the Subcommittee on Health held a
hearing on H.R. 3285.
On May 17, 2023, the Subcommittee on Health favorably
forwarded H.R. 3285 to the full committee by voice vote.
To Amend Title III of the Public Health Service Act To Ensure
Transparency and Oversight of the 340B Drug Discount Program
H.R. 3290
To amend title III of the Public Health Service Act to
ensure transparency and oversight of the 340B drug discount
program.
Summary
This legislation would establish deductible and cost-
sharing limitations on highly rebated drugs. Specifically,
cost-sharing would be capped at the price paid by the insurer
for the drug in the previous year to ensure patients are never
paying more than the cost of the drug.
Legislative History
On April 26, 2023, the Subcommittee on Health held a
hearing on a discussion draft entitled ``To amend title III of
the Public Health Service Act to ensure transparency and
oversight of the 340B drug discount program''.
H.R. 3290 was introduced by Representative Bucshon (IN-R)
on May 15, 2023, and referred to the Committee on Energy and
Commerce. H.R. 3290 was similar to the discussion draft.
On May 17, 2023, the Subcommittee on Health favorably
forwarded H.R. 3290, without amendment, to the full committee
by a vote of 16 to 12.
On May 24, 2023, the full committee favorably reported H.R.
3290, as amended, to the House by a vote of 29 to 22.
Gabriella Miller Kids First Research Act 2.0
H.R. 3391
To extend the Gabriella Miller Kids First Pediatric
Research Program at the National Institutes of Health.
Summary
H.R. 3391 reauthorizes funding for the National Institute
of Health's (NIH) Gabriella Miller Kids First Pediatric
Research Program. The bill also requires coordinating federal
efforts related to pediatric cancer research, as well as a
report detailing current federally funded programs and
initiatives, and the advancements made.
Legislative History
H.R. 3391 was introduced by Representative Wexton (VA-D) on
May 16, 2023, and referred to the Committee on Energy and
Commerce.
On June 14, 2023, the Subcommittee on Health held a hearing
on H.R. 3391.
On July 13, 2023, the Subcommittee on Health favorably
forwarded H.R. 3391, as amended, to the full committee by a
vote of 27 to 0.
On July 19, 2023, the full committee favorably reported
H.R. 3391, as amended to the House by a vote of 50 to 0.
On March 5, 2024, Representative Guthrie moved to suspend
the rules and pass H.R. 3391, as amended. The House agreed to
the motion by a vote of 384 yeas and 4 nays.
On March 6, 2024, H.R. 3391 was received in the Senate. On
March 8, 2024, H.R. 3391 was referred to the Committee on
Health, Education, Labor, and Pensions.
On December 20, 2024, the Senate passed H.R. 3391 by
unanimous consent.
Telemental Health Care Access Act of 2023
H.R. 3432
To amend title XVIII of the Social Security Act to ensure
coverage of mental and behavioral health services furnished
through telehealth.
Summary
This legislation would promote access to mental and
behavioral telehealth services by eliminating certain
geographic restrictions and in-person Medicare coverage
requirements.
Legislative History
H.R. 3432 was introduced by Representative Matsui (CA-D) on
May 17, 2023, and referred to the Committee on Energy and
Commerce, and in addition to the Committee on Ways and Means.
On April 10, 2024, the Subcommittee on Health held a
hearing on H.R. 3432.
Give Kids a Chance Act of 2024
H.R. 3433 (H.R. 7155)
To amend the Federal Food, Drug, and Cosmetic Act with
respect to molecularly targeted pediatric cancer
investigations.
Summary
H.R. 3433 provides the Food and Drug Administration (FDA)
with additional authority to require pediatric cancer trials
for combination therapies. The bill also authorizes the FDA to
take enforcement action against companies that do not conduct
required pediatric trials under the Pediatric Research Equity
Act (PREA) and requires the FDA to report on enforcement of
PREA. Additionally, the bill reauthorizes the FDA rare
pediatric disease priority review voucher (PRV) program through
fiscal year 2029, and limits orphan drug exclusivity to the
approved indication, rather than the potentially broader
designation. Lastly, the bill requires the FDA to establish an
office in an Abraham Accord country and allows the Secretary of
Health and Human Services to collect registration fees and
distribute these fees to support the operation of the Organ
Procurement and Transplantation Network (OPTN).
Legislative History
H.R. 3433 was introduced by Representative McCaul (TX-R) on
May 17, 2023, and referred to the Committee on Energy and
Commerce.
On February 29, 2024, the Subcommittee on Health held a
hearing on H.R. 3433.
On May 16, 2024, the Subcommittee on Health favorably
forwarded H.R. 3433, as amended, to the full committee by a
vote of 16 to 11.
On September 18, 2024, the full committee favorably
reported H.R. 3433, as amended, to the House by a vote of 43 to
0.
On September 23, 2024, Representative Bucshon moved to
suspend the rules and pass H.R. 3433, as amended. The House
agreed to the motion by a voice vote.
On September 24, 2024, H.R. 3433 was received in the Senate
and referred to the Committee on Health, Education, Labor, and
Pensions.
The provisions of H.R. 7155 were included in H.R. 3433,
which is discussed elsewhere in this report.
Promoting Access to Treatments and Increasing Extremely Needed
Transparency (PATIENT) Act
H.R. 3561 (H.R. 1613, H.R. 2550, H.R. 2559, H.R. 2665, H.R. 2679, H.R.
3237, H.R. 3248, H.R. 3262, H.R. 3281, H.R. 3282)
To promote hospital and insurer price transparency.
Summary
This bill expands hospital price transparency requirements
and establishes additional reporting requirements with respect
to prescription drugs and pharmacy benefit managers (PBMs). The
bill also extends funding for various programs such as the
Teaching Health Center Graduate Medical Education program,
Community Health Center program, and National Health Service
Corps.
Specifically, the bill provides statutory authority for the
requirement that hospitals publish an annual list of shoppable
services they provide, including specified pricing information.
Beginning in 2025, a hospital may not use an internet-based
price estimator tool to meet the publication requirement for
shoppable services.
The bill would modify the health insurance plan disclosure
requirements to include the rates for certain in-network
services and prescription drug payment information.
The bill would require providers of diagnostic laboratory
tests under Medicare to publish online certain price
information. Medicare Advantage (MA) organizations must report
information about payments made to providers in which the MA
organization has an ownership interest. Medicare prescription
drug plan sponsors must report certain price information for
covered drugs.
The bill would require health insurance plan issuers (or
the PBM providing services on behalf of the plan) to report to
the plan sponsor specified information about prescription drugs
dispensed under the plan. This includes rebates, fees,
alternative discounts, or other remuneration the plan receives
from drug manufacturers.
The bill would require pass-through pricing models, and
prohibits spread-pricing, for payment arrangements with PBMs
under Medicaid.
Legislative History
On April 26, 2023, the Subcommittee on Health held a
hearing on related legislative text, informing H.R. 3561.
On May 17, 2023, the Subcommittee on Health favorably
forwarded H.R. 3281, as amended by an amendment in the nature
of a substitute to the full committee by a vote of 27 to 0. The
amended bill was reintroduced as H.R. 3561, the Promoting
Access to Treatments and Increasing Extremely Needed
Transparency (PATIENT) Act of 2023.
H.R. 3561 was introduced by Representative McMorris Rodgers
(WA-R) on May 22, 2023, and referred to the Committee on Energy
and Commerce, and in addition to the Committee on Ways and
Means and the Committee on Education and the Workforce.
On May 24, 2023, the full committee favorably reported H.R.
3561, as amended, to the House by a vote of 49 to 0.
The provisions of H.R. 3561 were included in H.R. 5378,
which is discussed elsewhere in this report.
Medical and Health Stockpile Accountability Act of 2023
H.R. 3577
To require the Assistant Secretary for Preparedness and
Response to establish an automated supply chain tracking
application that provides near real-time insight into the
amount of critical medical and health supplies available in the
Strategic National Stockpile.
Summary
H.R. 3577 would establish an automated supply chain
tracking application to provide near real-time insight into the
amount of medical and health supplies available in the
Strategic National Stockpile and related entities during a
public health emergency.
Legislative History
H.R. 3577 was introduced by Representative Hudson (NC-R) on
May 22, 2023, and referred to the Committee on Energy and
Commerce.
On June 13, 2023, the Subcommittee on Health held a hearing
on H.R. 3577.
Doctors at the Ready Act
H.R. 3613
To amend title XXVIII of the Public Health Service Act to
eliminate the sunset of authority to make certain appointments
for National Disaster Medical System.
Summary
H.R. 3613 would eliminate the sunset on direct hiring
authority for the HHS Secretary to appoint personnel to the
National Disaster Medical System during a public health
emergency.
Legislative History
H.R. 3613 was introduced by Representative Schrier (WA-D)
on May 23, 2023, and referred to the Committee on Energy and
Commerce.
On June 13, 2023, the Subcommittee on Health held a hearing
on H.R. 3613.
The provisions of H.R. 3613 were included in H.R. 4421,
which is discussed elsewhere in this report.
State Strategic Stockpile Act of 2023
H.R. 3631
To amend the Public Health Service Act to extend the
authorization of appropriations for grants for State strategic
stockpiles.
Summary
H.R. 3631 would extend the authorization of appropriations
for grants for State Strategic Stockpiles from FY 2024 to FY
2028.
Legislative History
H.R. 3631 was introduced by Representative Carter (GA-R) on
May 24, 2023, and referred to the Committee on Energy and
Commerce.
On June 13, 2023, the Subcommittee on Health held a hearing
on H.R. 3631.
The provisions of H.R. 3631 were included in H.R. 4421,
which is discussed elsewhere in this report.
Providing Relief and Stability for Medicare Patients Act of 2023
H.R. 3674
To amend title XVIII of the Social Security Act to increase
the nonfacility practice expense relative value units for
specified services furnished under the Medicare program.
Summary
This legislation would increase the non-facility practice
expense relative value units for specified services furnished
under the Medicare program.
Legislative History
H.R. 3674 was introduced by Representative Bilirakis (FL-R)
on May 25, 2023, and referred to the Committee on Energy and
Commerce, and in addition to the Committee on Ways and Means.
On October 19, 2023, the Subcommittee on Health held a
hearing on H.R. 3674.
Helping Evaluate Appropriate Logistical Infrastructure for National
Government (HEALING) Response Act of 2023
H.R. 3703
To direct the Comptroller General of the United States to
conduct and complete a review examining the efforts of the
Secretary of Health and Human Services to ensure that the
United States is prepared to rapidly produce certain medical
countermeasures in the event of a public health emergency.
Summary
H.R. 3703 would require the U.S. Comptroller General to
review and issue recommendations regarding the current status
of existing efforts and programs rapidly to produce medical
countermeasures domestically, including the Centers for
Innovation and Advanced Drug Manufacturing, the National
Biopharmaceutical Manufacturing Partnership, and Industrial
Base Expansion Connect.
Legislative History
H.R. 3703 was introduced by Representative Latta (OH-R) on
May 25, 2023, and referred to the Committee on Energy and
Commerce.
On June 13, 2023, the Subcommittee on Health held a hearing
on H.R. 3703.
The provisions of H.R. 3703 were included in H.R. 4421,
which is discussed elsewhere in this report.
Extending Access to Addiction Treatment Act
H.R. 3736
To amend title XIX of the Social Security Act to extend the
requirement for State Medicaid plans to provide coverage for
medication-assisted treatment.
Summary
H.R. 3736 would permanently extend the Substance Use-
Disorder Prevention that Promotes Opioid Recovery and Treatment
(SUPPORT) Act's requirement for state Medicaid programs to
cover all forms of medication assisted treatment (MAT).
Legislative History
H.R. 3736 was introduced by Representative Tonko (NY-D) on
May 25, 2023, and referred to the Committee on Energy and
Commerce.
On June 21, 2023, the Subcommittee on Health held a hearing
on H.R. 3736.
The provisions of H.R. 3736 were included in H.R. 4531,
which is discussed elsewhere in this report.
To Direct the Comptroller General of the United States To Evaluate the
Federal Government's Collection and Sharing of Public Health Data To
Respond to Public Health Emergencies
H.R. 3742
To direct the Comptroller General of the United States to
evaluate the Federal Government's collection and sharing of
public health data to respond to public health emergencies.
Summary
H.R. 3742 would direct the U.S. Comptroller General to
review the current authorities, policies, and operational tools
used by the Secretary of HHS to collect and share public health
data, including how these authorities were used during the
COVID-19 public health emergency; how federal funds were
expended for such purposes; any challenges posed by redundant
and duplicative data reporting requirements, systems, and tools
and any publicly available resources to track how this data is
collected, shared, and utilized.
Legislative History
H.R. 3742 was introduced by Representative Peters (CA-D) on
May 26, 2023, and referred to the Committee on Energy and
Commerce.
On June 13, 2023, the Subcommittee on Health held a hearing
on H.R. 3742.
The provisions of H.R. 3742 were included in H.R. 4420,
which is discussed elsewhere in this report.
Improving Data Accessibility Through Advancements (DATA) in Public
Health Act
H.R. 3791
To amend the Public Health Service Act with respect to
public health data accessibility.
Summary
H.R. 3791 would authorize the CDC to require reporting of
public health and health care data and information from health
care providers and facilities, including pharmacies; public
health, clinical, and other laboratories and diagnostic testing
entities; state, local, and tribal health departments; and
other entities. It would also require CDC to designate certain
standards and implementation requirements for the exchange of
electronic health information and electronic reporting.
Additionally, this bill creates a Public Health Information
Sharing and Availability Advisory Committee to make
recommendations on effective health care data and information
reporting and sharing, and establishes a grant program to
develop and facilitate best practices for the collection and
use of public health data and standards.
Legislative History
H.R. 3791 was introduced by Representative Underwood (IL-D)
on June 1, 2023, and referred to the Committee on Energy and
Commerce.
On June 13, 2023, the Subcommittee on Health held a hearing
on H.R. 3791.
Ensuring Access to Lifesaving Drugs Act of 2023
H.R. 3793
To amend the Federal Food, Drug, and Cosmetic Act to
require manufacturers of life-saving drugs to submit data and
information to assess the stability of the drugs and determine
their longest supported expiration date.
Summary
H.R. 3793 would authorize the FDA to require manufacturers
of life-saving drugs to submit expiration and stability testing
studies and make labeling changes regarding its expiration date
or storage and handling of the drug based on the studies, and
include civil monetary penalties and criminal penalties if
manufacturers do not comply with the order of the FDA.
Legislative History
H.R. 3793 was introduced by Representative Slotkin (MI-D)
on June 5, 2023, and referred to the Committee on Energy and
Commerce.
On September 14, 2023, the Subcommittee on Health held a
hearing on H.R. 3793.
Fast-Track Logistics for Acquiring Supplies in a Hurry (FLASH) Act of
2023
H.R. 3794
To amend the Public Health Service Act to authorize the
Biomedical Advanced Research and Development Authority to award
follow-on production contracts or transactions, procure
supplies for experimental or test purposes, and acquire
innovative commercial products and commercial services.
Summary
H.R. 3794 would authorize certain contracting and
transaction authorities for HHS to purchase, procure, and
acquire medical countermeasures, designs, products, services,
processes, methods, and other supplies.
Legislative History
H.R. 3794 was introduced by Representative Garcia (CA-D) on
June 5, 2023, and referred to the Committee on Energy and
Commerce.
On June 13, 2023, the Subcommittee on Health held a hearing
on H.R. 3794.
To Amend the Public Health Service Act To Require the Development of a
Diagnostic Testing Preparedness Plan to be Used During Public Health
Emergencies
H.R. 3795
To amend the Public Health Service Act to require the
development of a diagnostic testing preparedness plan to be
used during public health emergencies.
Summary
H.R. 3795 would require the Administration for Strategic
Preparedness and Response (ASPR) to develop a public plan for
rapid development, authorization, scaling, procurement, and
distribution of diagnostics and clinical diagnostic laboratory
testing capacity during a public health emergency, including
opportunities to facilitate coordination and collaboration
between government agencies and private sector partners. ASPR
would be required to submit a report to Congress on the
effectiveness of activities implemented under the plan within
one year after implementation.
Legislative History
H.R. 3795 was introduced by Representative Pence (IN-R) on
June 5, 2023, and referred to the Committee on Energy and
Commerce.
On June 13, 2023, the Subcommittee on Health held a hearing
on H.R. 3795.
The provisions of H.R. 3795 were included in H.R. 4421,
which is discussed elsewhere in this report.
Drug Origin Transparency Act of 2023
H.R. 3810
To amend the Federal Food, Drug, and Cosmetic Act to
enhance drug manufacturing amount information reporting.
Summary
H.R. 3810 would expand existing active pharmaceutical
ingredients (API) reporting requirements by requiring quarterly
reporting (rather than annually) to the FDA on the identity of
API suppliers and amounts of drugs manufactured, prepared,
propagated, compounded, or processed using API and other in-
process materials from each supplier. The bill would also
require that a drug containing an API includes on its label the
name and place of business of the API supplier and the unique
facility identifier of the original manufacturer of such drug
or API.
Legislative History
H.R. 3810 was introduced by Representative Eshoo (CA-D) on
June 5, 2023, and referred to the Committee on Energy and
Commerce.
On September 14, 2023, the Subcommittee on Health held a
hearing on H.R. 3810.
CDC Leadership Accountability Act of 2023
H.R. 3813
To accelerate the applicability of the requirement that the
Director of the Centers for Disease Control and Prevention be
appointed by the President, by and with the consent of the
Senate.
Summary
H.R. 3813 would require any Director of the Centers for
Disease Control and Prevention appointed by the President on or
after June 1, 2023, to be confirmed by the Senate.
Legislative History
H.R. 3813 was introduced by Representative Guthrie (KY-R)
on June 5, 2023, and referred to the Committee on Energy and
Commerce.
On June 13, 2023, the Subcommittee on Health held a hearing
on H.R. 3813.
On July 13, 2023, the Subcommittee on Health favorably
forwarded H.R. 3813 to the full committee by a vote of 14 to
12.
On July 19, 2023, the full committee favorably reported
H.R. 3813, without amendment, to the House by a vote of 27 to
20.
The provisions of H.R. 3813 were included in H.R. 4421,
which is discussed elsewhere in this report.
To Amend the Public Health Service Act To Strike the Requirement That
the Director of the Centers for Disease Control and Prevention Be
Appointed by and With the Advice and Consent of the Senate
H.R. 3820
To amend the Public Health Service Act to strike the
requirement that the Director of the Centers for Disease
Control and Prevention be appointed by and with the advice and
consent of the Senate.
Summary
H.R. 3820 would remove the requirement for a Director of
CDC to be appointed by the President to be confirmed by the
Senate. Under current law, this requirement would take effect
January 1, 2025.
Legislative History
H.R. 3820 was introduced by Representative Pallone (NJ-D)
on June 5, 2023, and referred to the Committee on Energy and
Commerce.
On June 13, 2023, the Subcommittee on Health held a hearing
on H.R. 3820.
Disease X Act of 2023
H.R. 3832
To establish a program at BARDA for developing medical
countermeasures for viral threats with pandemic potential.
Summary
H.R. 3832 would allow the Biomedical Advanced Research and
Development Authority (BARDA) to support advanced research and
development of certain countermeasures related to emerging
viral pathogens and viral families with significant pandemic
potential (``Disease X'' threats).
Legislative History
H.R. 3832 was introduced by Representative Trahan (MA-D) on
June 5, 2023, and referred to the Committee on Energy and
Commerce.
On June 13, 2023, the Subcommittee on Health held a hearing
on H.R. 3832.
The provisions of H.R. 3832 were included in H.R. 4421,
which is discussed elsewhere in this report.
Medicaid Primary Care Improvement Act
H.R. 3836
To facilitate direct primary care arrangements under
Medicaid.
Summary
H.R. 3836 would enact a rule of construction clarifying the
permissibility of direct primary care arrangements under
Medicaid and direct the Secretary of Health and Human Services
to convene at least one virtual open-door meeting to seek input
from stakeholders and to issue guidance to States on how a
State may implement such arrangements.
Legislative History
H.R. 3836 was introduced by Representative Crenshaw (TX-R)
on June 6, 2023, and referred to the Committee on Energy and
Commerce.
On June 14, 2023, the Subcommittee on Health held a hearing
on H.R. 3836.
On July 13, 2023, the Subcommittee on Health favorably
forwarded H.R. 3836, as amended, to the full committee by a
vote of 28 to 0.
On July 19, 2023, the full committee favorably reported
H.R. 3836, as amended, to the House by a vote of 51 to 0.
On March 5, 2024, Representative Guthrie moved to suspend
the rules and pass H.R. 3836, as amended. The House agreed to
the motion by a voice vote.
On March 6, 2024, H.R. 3836 was received in the Senate and
referred to the Committee on Finance.
Improving Public Health Preparedness Act
H.R. 3837
To amend the Public Health Service Act to require the
Secretary of Health and Human Services to delegate primary
responsibility for maintaining the Strategic National Stockpile
to the Assistant Secretary for Preparedness and Response.
Summary
H.R. 3837 would require the Secretary of HHS to delegate
primary responsibility for administering and maintaining the
Strategic National Stockpile (SNS) to ASPR, further codifying
the principal responsibilities ASPR has today.
Legislative History
H.R. 3837 was introduced by Representative Miller-Meeks
(IA-R) on June 6, 2023, and referred to the Committee on Energy
and Commerce.
On June 13, 2023, the Subcommittee on Health held a hearing
on H.R. 3837.
The provisions of H.R. 3837 were included in H.R. 4421,
which is discussed elsewhere in this report.
Preventing Maternal Deaths Reauthorization Act of 2023
H.R. 3838
To amend title III of the Public Health Service Act to
reauthorize Federal support of States in their work to save and
sustain the health of mothers during pregnancy, childbirth, and
the postpartum period, to eliminate disparities in maternal
health outcomes for pregnancy-related and pregnancy-associated
deaths, to identify solutions to improve health care quality
and health outcomes for mothers.
Summary
H.R. 3838 would reauthorize federal support for states to
address disparities in maternal health outcomes and preserve
the health of mothers during pregnancy, childbirth, and the
postpartum period for fiscal years 2024 to 2028. The bill would
require the CDC to work in consultation with the Health
Resources Administration (HRSA) to disseminate best practices
relating to the prevention of maternal mortality to hospitals
and other health care providers.
Legislative History
H.R. 3838 was introduced by Representative Burgess (TX-R)
on June 6, 2023, and referred to the Committee on Energy and
Commerce.
On June 14, 2023, the Subcommittee on Health held a hearing
on H.R. 3838.
On July 13, 2023, the Subcommittee on Health favorably
forwarded H.R. 3838, as amended, to the full committee by a
vote of 28 to 0.
On July 19, 2023, the full committee favorably reported
H.R. 3838, as amended, to the House by a vote of 50 to 0.
On March 5, 2024, Representative Burgess moved to suspend
the rules and pass H.R. 3838, as amended. The House agreed to
the motion by 382 to 12.
On March 6, 2024, H.R. 3838 was received in the Senate.
Ensuring Sufficient Supply of Testing Act
H.R. 3840
To amend the Public Health Service Act to authorize certain
contracts and cooperative agreements with clinical laboratories
for purposes of delivery of medical products to the Strategic
National Stockpile.
Summary
H.R. 3840 would authorize clinical laboratories to enter
into certain contracts and cooperative agreements related to
vendor-managed inventory and warm-based surge capacity to meet
the needs of the SNS.
Legislative History
H.R. 3840 was introduced by Representative Dunn (FL-R) on
June 6, 2023, and referred to the Committee on Energy and
Commerce.
On June 13, 2023, the Subcommittee on Health held a hearing
on H.R. 3840.
The provisions of H.R. 3840 were included in H.R. 4421,
which is discussed elsewhere in this report.
Expanding Access to Diabetes Self-Management Training Act of 2023
H.R. 3842
To amend title XVIII of the Social Security Act to improve
access to diabetes outpatient self-management training
services, to require the Center for Medicare and Medicaid
Innovation to test the provision of virtual diabetes outpatient
self-management training services.
Summary
H.R. 3842 increases access to diabetes outpatient self-
management training services by specifying the conditions under
which these services are available, and by expanding the types
of care providers that can meet eligibility criteria for
furnishing these services.
Legislative History
H.R. 3842 was introduced by Representative Schrier (WA-D)
on June 6, 2023, and referred to the Committee on Energy and
Commerce, and in addition to the Committee on Ways and Means.
On September 19, 2023, the Subcommittee on Health held a
hearing on H.R. 3842.
On November 15, 2023, the Subcommittee on Health favorably
forwarded H.R. 3842, as amended, to the full committee by voice
vote.
On December 5, 2023, the full committee favorably reported
H.R. 3842, as amended, to the House by a vote of 44 to 0.
The provisions of H.R. 3842 were included in H.R. 7623,
which is discussed elsewhere in this report.
Action for Dental Health Act of 2023
H.R. 3843
To amend title III of the Public Health Service Act to
reauthorize grants to address dental workforce needs.
Summary
H.R. 3843 reauthorizes section 340G of the Public Health
Service Act for fiscal years 2024 through 2028 to address
dental workforce needs.
Legislative History
H.R. 3843 was introduced by Representative Kelly (IL-D) on
June 6, 2023, and referred to the Committee on Energy and
Commerce.
On June 14, 2023, the Subcommittee on Health held a hearing
on H.R. 3843.
On July 13, 2023, the Subcommittee on Health favorably
forwarded H.R. 3843 to the full committee by a vote of 27 to 0.
On July 19, 2023, the full committee favorably reported
H.R. 3843 to the House by a vote of 50 to 0.
On March 7, 2024, Representative Guthrie moved to suspend
the rules and pass H.R. 3843, without amendment. The House
agreed to the motion by a vote of 391 to 32.
On March 8, 2024, H.R. 3843 was received in the Senate and
referred to the Committee on Health, Education, Labor, and
Pensions.
Expanded Telehealth Access Act
H.R. 3875
To amend title XVIII of the Social Security Act to expand
the scope of practitioners eligible for payment for telehealth
services under the Medicare program.
Summary
This legislation would permanently expand practitioner
eligibility for payment for telehealth services under Medicare
to include physical therapists, speech-language pathologists,
audiologists, occupational therapists, and occupational therapy
assistants.
Legislative History
H.R. 3875 was introduced by Representative Sherrill (NJ-D)
on June 6, 2023, and referred to the Committee on Energy and
Commerce, and in addition to the Committee on Ways and Means.
On April 10, 2024, the Subcommittee on Health held a
hearing on H.R. 3875.
Sickle Cell Disease and Other Heritable Blood Disorders Research,
Surveillance, Prevention, and Treatment Act of 2023
H.R. 3884
To amend title XI of the Public Health Service Act to
reauthorize the program providing for sickle cell disease and
other heritable blood disorders research, surveillance,
prevention, and treatment.
Summary
H.R. 3884 would reauthorize the programs and activities
under the Centers for Disease Control and Prevention (CDC) and
the Health Resources and Services Administration (HRSA) aimed
to support research, prevention, and treatment for sickle cell
disease and other heritable blood disorders for fiscal years
2024 through 2028.
Legislative History
H.R. 3884 was introduced by Representative Burgess (TX-R)
on June 7, 2023, and referred to the Committee on Energy and
Commerce.
On June 14, 2023, the Subcommittee on Health held a hearing
on H.R. 3884.
On July 13, 2023, the Subcommittee on Health favorably
forwarded H.R. 3884, as amended, to the full committee by a
vote of 28 to 0.
On July 19, 2023, the full committee favorably reported
H.R. 3884, as amended, to the House by a vote of 50 to 0.
On September 23, 2024, Representative Bucshon moved to
suspend the rules and pass H.R. 3884, as amended. The House
agreed to the motion by a voice vote.
On September 24, 2024, H.R. 3884 was received in the Senate
and referred to the Committee on Health, Education, Labor, and
Pensions.
Children's Hospital GME Support Reauthorization Act of 2023
H.R. 3887
To amend title III of the Public Health Service Act to
reauthorize the program of payments to children's hospitals
that operate graduate medical education programs.
Summary
H.R. 3887 reauthorizes payments to children's hospitals
that operate Graduate Medical Education programs for fiscal
years 2024 through 2028. Additionally, the bill prohibits
payments to children's hospitals that furnish specified
procedures or drugs for minors.
Legislative History
H.R. 3887 was introduced by Representative Crenshaw (TX-R)
on June 7, 2023, and referred to the Committee on Energy and
Commerce.
On June 14, 2023, the Subcommittee on Health held a hearing
on H.R. 3887.
On July 13, 2023, the Subcommittee on Health favorably
forwarded H.R. 3887 to the full committee by a vote of 15 to
12.
On July 19, 2023, the full committee favorably reported
H.R. 3887, as amended, to the House by a vote of 27 to 17.
Certain provisions of H.R. 3887 were included in H.R.
10545.
On December 21, 2024, the House agreed to suspend the rules
and pass H.R. 10545 by a vote of 366 to 34.
On December 21, 2024 the Senate passed H.R. 10545 by a vote
of 85 to 11.
Improving Mental Health and Drug Treatment Act of 2023
H.R. 3892
To amend title XIX of the Social Security Act to make
permanent the State plan amendment option to provide medical
assistance for certain individuals who are patients in certain
institutions for mental diseases.
Summary
H.R. 3892 would permanently extend the Substance Use-
Disorder Prevention that Promotes Opioid Recovery and Treatment
(SUPPORT) Act's state plan option to lift Medicaid's
``Institutions for Mental Diseases'' Exclusion (IMD Exclusion),
which otherwise restricts Medicaid coverage for residential and
inpatient mental and behavioral health services to facilities
with fewer than 16 beds.
Legislative History
H.R. 3892 was introduced by Representative Burgess (TX-R)
on June 7, 2023, and referred to the Committee on Energy and
Commerce.
On June 21, 2023, the Subcommittee on Health held a hearing
on H.R. 3892.
The provisions of H.R. 3892 were included in H.R. 4531,
which is discussed elsewhere in this report.
Screening for Communities to Receive Early and Equitable Needed
Services (SCREENS) for Cancer Act of 2024
H.R. 3916
To amend the Public Health Service Act to reauthorize and
improve the National Breast and Cervical Cancer Early Detection
Program for fiscal years 2024 through 2028, and for other
purposes.
Summary
H.R. 3916 would reauthorize the National Breast and
Cervical Cancer Early Detection Program and makes certain
modifications and updates to the program and reporting
requirements. The legislation reauthorizes the program for five
fiscal years, from fiscal year 2025 through 2029.
Legislative History
H.R. 3916 was introduced by Representative Morelle (NY-D)
on June 7, 2023, and referred to the Committee on Energy and
Commerce.
On February 14, 2024, the Subcommittee on Health held a
hearing on H.R. 3916.
On March 12, 2024, the Subcommittee on Health favorably
forwarded H.R. 3916, as amended, to the full committee by a
vote of 24 to 0.
On March 20, 2024, the full committee favorably reported
H.R. 3916, as amended, to the House by a vote of 46 to 0.
Halting the Epidemic of Addiction and Loss (HEAL) Act of 2023
H.R. 4007
To ensure references to opioid overdose reversal agents in
grant programs of the Department of Health and Human Services
are not limited to naloxone.
Summary
H.R. 4007 would ensure that whenever the Department of
Health and Human Services issues a regulation or guidance for
any grant program addressing opioid use disorders, any
reference to an opioid overdose reversal agent is broadened to
include ``any opioid overdose reversal agent that has been
approved or otherwise authorized for use by the Food and Drug
Administration.''
Legislative History
H.R. 4007 was introduced by Representative Armstrong (ND-R)
on June 12, 2023, and referred to the Committee on Energy and
Commerce.
On June 21, 2023, the Subcommittee on Health held a hearing
on H.R. 4007.
The provisions of H.R. 4007 were included in H.R. 4531,
which is discussed elsewhere in this report.
Studying Suboxone Act
H.R. 4053
To provide for the review of the scheduling under the
Controlled Substances Act of buprenorphine-naloxone combination
products.
Summary
H.R. 4053 would require the Secretary of HHS to conduct a
review of buprenorphine-naloxone combination products and as
necessary, update the Secretary's scheduling recommendation
with respect to such products.
Legislative History
H.R. 4053 was introduced by Representative Kuster (NH-D) on
June 13, 2023, and referred to the Committee on Energy and
Commerce, and in addition to the Committee on the Judiciary.
On June 21, 2023, the Subcommittee on Health held a hearing
on H.R. 4053.
The provisions of H.R. 4053 were included in H.R. 4531,
which is discussed elsewhere in this report.
Trauma Support and Mental Health in Schools Reauthorization Act
H.R. 4054
To amend the SUPPORT for Patients and Communities Act to
reauthorize grants to improve trauma support services and
mental health care for children and youth in educational
settings.
Summary
H.R. 4054 would reauthorize grants to improve trauma
support services for children and adolescents in school
settings for fiscal years 2024 through 2028.
Legislative History
H.R. 4054 was introduced by Representative Steel (CA-R) on
June 13, 2023, and referred to the Committee on Energy and
Commerce, and in addition to the Committee on Education and the
Workforce.
On June 21, 2023, the Subcommittee on Health held a hearing
on H.R. 4054.
Ensuring Medicaid Continuity for Children in Foster Care Act of 2023
H.R. 4056
To amend title XIX of the Social Security Act to ensure
that medical assistance is available to children in foster care
who are placed in a qualified residential treatment program
under the Medicaid program.
Summary
H.R. 4056 would lift Medicaid's institutions for mental
diseases (IMD) exclusion, as it pertains to qualified
residential treatment programs (QRTPs) for foster youth. The
bill would limit the lifting of the IMD Exclusion to only QRTPs
that are compliant with the existing guardrails for QRTPs that
were established under the Families First Prevention Services
Act of 2018.
Legislative History
H.R. 4056 was introduced by Representative Bilirakis (FL-R)
on June 13, 2023, and referred to the Committee on Energy and
Commerce.
On June 21, 2023, the Subcommittee on Health held a hearing
on H.R. 4056.
On July 13, 2023, the Subcommittee on Health favorably
forwarded H.R. 4056, without amendment, to the full committee
by a vote of 17 to 9.
The provisions of H.R. 4506 were included in H.R. 4531,
which is discussed elsewhere in this report.
Keeping Kids Safe Act of 2023
H.R. 4057
To amend the SUPPORT for Patients and Communities Act to
reauthorize surveillance and data collection by the Centers for
Disease Control and Prevention for child, youth, and adult
trauma.
Summary
H.R. 4057 would reauthorize section 7131 of the Substance
Use-Disorder Prevention that Promotes Opioid Recovery and
Treatment (SUPPORT) Act for fiscal years 2024 through 2028 to
continue programs to collect and report data related to on
adverse childhood experiences.
Legislative History
H.R. 4057 was introduced by Representative Blunt Rochester
(DE-D) on June 13, 2023, and referred to the Committee on
Energy and Commerce.
On June 21, 2023, the Subcommittee on Health held a hearing
on H.R. 4057.
The provisions of H.R. 4057 were included in H.R. 4531,
which is discussed elsewhere in this report.
Federal Interventions and New Detections (FIND) Fentanyl Act of 2023
H.R. 4063
To amend the SUPPORT for Patients and Communities Act to
reauthorize a pilot program for public health laboratories to
detect fentanyl and other synthetic opioids.
Summary
H.R. 4063 would reauthorize section 7011 of the SUPPORT Act
for fiscal years 2024 through 2028 to continue a program to
support public health laboratories and laboratories operated by
law enforcement agencies to improve detection of synthetic
opioids, including fentanyl and its analogues.
Legislative History
H.R. 4063 was introduced by Representative Dingell (MI-D)
on June 13, 2023, and referred to the Committee on Energy and
Commerce.
On June 21, 2023, the Subcommittee on Health held a hearing
on H.R. 4063.
The provisions of H.R. 4063 were included in H.R. 4531,
which is discussed elsewhere in this report.
Substance Use Disorder Treatment and Recovery Loan Repayment Program
Reauthorization Act of 2023
H.R. 4079
To amend the Public Health Service Act to reauthorize a
loan repayment program for the substance use disorder treatment
workforce.
Summary
H.R. 4079 would reauthorize the Substance Use Disorder
Treatment and Recovery Loan Repayment Program for fiscal years
2024 through 2028.
Legislative History
H.R. 4079 was introduced by Representative Rogers (KY-R) on
June 13, 2023, and referred to the Committee on Energy and
Commerce.
On June 21, 2023, the Subcommittee on Health held a hearing
on H.R. 4079.
The provisions of H.R. 4079 were included in H.R. 4531,
which is discussed elsewhere in this report.
Trauma Informed Care Task Force Reauthorization Act of 2023
H.R. 4080
To amend the SUPPORT for Patients and Communities Act to
extend a task force to develop best practices for trauma-
informed identification, referral, and support.
Summary
H.R. 4080 reauthorizes section 7132 of the SUPPORT Act to
continue the Interagency Task Force on Trauma-Informed Care.
Legislative History
H.R. 4080 was introduced by Representative Ruiz (CA-D) on
June 13, 2023, and referred to the Committee on Energy and
Commerce, and in addition to the Committee on Education and the
Workforce and the Committee on the Judiciary.
On June 21, 2023, the Subcommittee on Health held a hearing
on H.R. 4080.
The provisions of H.R. 4080 were included in H.R. 4531,
which is discussed elsewhere in this report.
Comprehensive Addiction Recovery Through Effective Employment and
Reentry (CAREER) Act of 2023
H.R. 4088
To amend the SUPPORT for Patients and Communities Act to
reauthorize a program to support individuals in substance use
disorder treatment and recovery to live independently and
participate in the workforce.
Summary
H.R. 4088 reauthorizes section 7183 of the SUPPORT Act for
fiscal years 2024 through 2028 to continue a program that
supports individuals in substance use disorder treatment and
recovery to live independently and participate in the
workforce.
Legislative History
H.R. 4088 was introduced by Representative Barr (KY-R) on
June 14, 2023, and referred to the Committee on Energy and
Commerce, and in addition to the Committee on Education and the
Workforce.
On June 21, 2023, the Subcommittee on Health held a hearing
on H.R. 4088.
The provisions of H.R. 4088 were included in H.R. 4531,
which is discussed elsewhere in this report.
Safer Response Act of 2023
H.R. 4089
To amend the Public Health Service Act to reauthorize
grants for first responder training.
Summary
H.R. 4089 would reauthorize section 546 of the Public
Health Service Act for fiscal years 2024 through 2028 to
continue support for training and education related to fentanyl
and other illicit substances for first responders.
Legislative History
H.R. 4089 was introduced by Representative D'Esposito (NY-
R) on June 14, 2023, and referred to the Committee on Energy
and Commerce.
On June 21, 2023, the Subcommittee on Health held a hearing
on H.R. 4089.
The provisions of H.R. 4089 were included in H.R. 4531,
which is discussed elsewhere in this report.
To Amend the SUPPORT for Patients and Communities Act To Expand
Required Reports on T-MSIS Substance Use Disorder Data To Include
Mental Health Condition Data
H.R. 4091
To amend the SUPPORT for Patients and Communities Act to
expand required reports on T-MSIS substance use disorder data
to include mental health condition data.
Summary
H.R. 4091 would permanently extend the SUPPORT Act's
requirement for states and CMS to produce annual, comprehensive
data reports on Medicaid coverage of behavioral health care.
The bill would also expand the reports to include coverage on
mental health care.
Legislative History
H.R. 4091 was introduced by Representative Valadao (CA-R)
on June 14, 2023, and referred to the Committee on Energy and
Commerce.
On June 21, 2023, the Subcommittee on Health held a hearing
on H.R. 4091.
The provisions of H.R. 4091 were included in H.R. 4531,
which is discussed elsewhere in this report.
Protecting Moms and Infants Reauthorization Act of 2023
H.R. 4092
To amend the Public Health Service Act to reauthorize
support for residential treatment programs for pregnant and
postpartum women.
Summary
H.R. 4092 would reauthorize section 508(s) of the Public
Health Service Act to continue support for residential
substance use disorder treatment for pregnant and postpartum
women for fiscal years 2024 through 2028.
Legislative History
H.R. 4092 was introduced by Representative Perez (WA-D) on
June 14, 2023, and referred to the Committee on Energy and
Commerce.
On June 21, 2023, the Subcommittee on Health held a hearing
on H.R. 4092.
The provisions of H.R. 4092 were included in H.R. 4531,
which is discussed elsewhere in this report.
Remote Opioid Monitoring Act of 2023
H.R. 4093
To provide for a study on the effects of remote monitoring
on individuals who are prescribed opioids.
Summary
H.R. 4093 would require a Government Accountability Office
(GAO) study on the use of remote monitoring for patients who
are prescribed opioids to understand better the efficacy,
individual outcomes, and any potential cost savings.
Legislative History
H.R. 4093 was introduced by Representative Balderson (OH-R)
on June 14, 2023, and referred to the Committee on Energy and
Commerce.
On June 21, 2023, the Subcommittee on Health held a hearing
on H.R. 4093.
The provisions of H.R. 4093 were included in H.R. 4531,
which is discussed elsewhere in this report.
Save Children From Trauma Act of 2023
H.R. 4095
To amend the Public Health Service Act to reauthorize
grants to address the problems of persons who experience
violence related stress.
Summary
H.R. 4095 would reauthorize 582(j) of the Public Health
Service Act for fiscal years 2024 through 2028 to continue
grant funding to provide access to treatment and services in
communities for children, adolescents, and their families who
experience traumatic events.
Legislative History
H.R. 4095 was introduced by Representative De La Cruz (TX-
R) on June 14, 2023, and referred to the Committee on Energy
and Commerce.
On June 21, 2023, the Subcommittee on Health held a hearing
on H.R. 4095.
The provisions of H.R. 4095 were included in H.R. 4531,
which is discussed elsewhere in this report.
To Amend Title XIX of the Social Security Act To Expand the Application
of Medicaid State Programs To Monitor Antipsychotic Medications to All
Medicaid Beneficiaries
H.R. 4096
To amend title XIX of the Social Security Act to expand the
application of Medicaid State programs to monitor antipsychotic
medications to all Medicaid beneficiaries.
Summary
H.R. 4096 would expand the SUPPORT Act's requirements to
monitor potentially abusive antipsychotics prescribing for
children by requiring monitoring of such prescriptions for
seniors and people with disabilities.
Legislative History
H.R. 4096 was introduced by Representative Carter (GA-R) on
June 14, 2023, and referred to the Committee on Energy and
Commerce.
On June 21, 2023, the Subcommittee on Health held a hearing
on H.R. 4096.
The provisions of H.R. 4096 were included in H.R. 4531,
which is discussed elsewhere in this report.
Mental Health Improvement Act
H.R. 4097
To amend the Public Health Service Act to reauthorize
mental and behavioral health education and training grants.
Summary
H.R. 4097 would reauthorize 756(f) of the Public Health
Service Act for fiscal years 2024 through 2028 to continue a
grant program that helps support individuals to respond to
individuals with mental health challenges and or disorders,
particularly those with serious mental illness (SMI) and/or
serious emotional disturbances (SED).
Legislative History
H.R. 4097 was introduced by Representative Sykes (OH-D) on
June 14, 2023, and referred to the Committee on Energy and
Commerce.
On June 21, 2023, the Subcommittee on Health held a hearing
on H.R. 4097.
The provisions of H.R. 4097 were included in H.R. 4531,
which is discussed elsewhere in this report.
Communities of Recovery Reauthorization Act of 2023
H.R. 4098
To amend the Public Health Service Act to reauthorize
grants for building communities of recovery.
Summary
H.R. 4098 would reauthorize section 547(f) of the Public
Health Service Act for fiscal years 2024 through 2028 to
continue supporting community-based methods to increase the
prevalence and quality of long-term recovery support for
individuals with substance use disorders and co-occurring
substance use and mental disorders.
Legislative History
H.R. 4098 was introduced by Representative Pettersen (CO-D)
on June 14, 2023, and referred to the Committee on Energy and
Commerce.
On June 21, 2023, the Subcommittee on Health held a hearing
on H.R. 4098.
The provisions of H.R. 4098 were included in H.R. 4531,
which is discussed elsewhere in this report.
Reauthorizing the Creating Opportunities That Necessitate New and
Enhanced Connections That Improve Opioid Navigation Strategies
(RECONNECTIONS) Act of 2023
H.R. 4099
To amend the Public Health Service Act to reauthorize a
program of preventing overdoses of controlled substances.
Summary
H.R. 4099 would reauthorize section 7161 of the Substance
Use-Disorder Prevention that Promotes Opioid Recovery and
Treatment (SUPPORT) Act for fiscal years 2024 through 2028 to
continue support for the improvement of prescription drug
monitoring programs and other innovative projects related to
rapid response of controlled substance misuse, abuse, and
overdoses, as well as programs related to controlled substance
overdose data collection and reporting. The bill also
designates the fentanyl crisis as a ``new and emerging public
health crisis.''
Legislative History
H.R. 4099 was introduced by Representative Griffith (VA-R)
on June 14, 2023, and referred to the Committee on Energy and
Commerce.
On June 21, 2023, the Subcommittee on Health held a hearing
on H.R. 4099.
The provisions of H.R. 4099 were included in H.R. 4531,
which is discussed elsewhere in this report.
To Amend the Public Health Service Act To Reauthorize a Monitoring and
Education Program Regarding Infections Associated With Illicit Drug Use
and Other Risk Factors
H.R. 4100
To amend the Public Health Service Act to reauthorize a
monitoring and education program regarding infections
associated with illicit drug use and other risk factors.
Summary
H.R. 4100 would reauthorize section 7141 of the SUPPORT Act
for fiscal years 2024 through 2028 to continue programs to
support the monitoring and education of infections commonly
associated with illicit drug use.
Legislative History
H.R. 4100 was introduced by Representative Chavez-DeRemer
(OR-R) on June 14, 2023, and referred to the Committee on
Energy and Commerce.
On June 21, 2023, the Subcommittee on Health held a hearing
on H.R. 4100.
The provisions of H.R. 4100 were included in H.R. 4531,
which is discussed elsewhere in this report.
Road to Recovery Act
H.R. 4101
To amend the Public Health Service Act to reauthorize a
National Peer-Run Training and Technical Assistance Center for
Addiction Recovery Support.
Summary
H.R. 4101 would reauthorize section 547A of the Public
Health Service Act for fiscal years 2024 through 2028 to
continue support for the national peer-run training and
technical assistance center for addiction recovery support.
Legislative History
H.R. 4101 was introduced by Representative James (MI-R) on
June 14, 2023, and referred to the Committee on Energy and
Commerce.
On June 21, 2023, the Subcommittee on Health held a hearing
on H.R. 4101.
The provisions of H.R. 4101 were included in H.R. 4531,
which is discussed elsewhere in this report.
Preserving Patient Access to Home Infusion Act
H.R. 4104
To amend title XVIII of the Social Security Act to clarify
congressional intent and preserve patient access to home
infusion therapy under the Medicare program.
Summary
This legislation would allow nurse practitioners and
physician assistants to establish and review home infusion
plans of care. The bill would also require CMS to pay home
infusion providers for each day they administer drugs to
patients.
Legislative History
H.R. 4104 was introduced by Representative Buchanan (FL-R)
on June 14, 2023, and referred to the Committee on Energy and
Commerce, and in addition to the Committee on Ways and Means.
On October 19, 2023, the Subcommittee on Health held a
hearing on H.R. 4104.
Test Strip Access Act of 2023
H.R. 4106
To amend the 21st Century Cures Act to expressly authorize
the use of certain grants to implement substance use disorder
and overdose prevention activities with respect to fentanyl and
xylazine test strips.
Summary
H.R. 4106 amends section 1003(b) of the 21st Century Cures
Act to authorize the use of certain grants to purchase fentanyl
and xylazine test strips.
Legislative History
H.R. 4106 was introduced by Representative Crockett (TX-D)
on June 14, 2023, and referred to the Committee on Energy and
Commerce.
On June 21, 2023, the Subcommittee on Health held a hearing
on H.R. 4106.
The provisions of H.R. 14106 were included in H.R. 4531,
which is discussed elsewhere in this report.
Creating Opportunities Now for Necessary and Effective Care
Technologies (CONNECT) for Health Act of 2023
H.R. 4189
To amend title XVIII of the Social Security Act to expand
access to telehealth services.
Summary
This legislation would make permanent a number of
regulatory flexibilities used during the COVID-19 pandemic to
allow Medicare to reimburse for more pervasive delivery of
health care through telehealth. This includes removing the
geographic requirements for telehealth originating sites and
expanding the scope of originating sites; allowing more
practitioners to furnish telehealth services; and removing
geographic restrictions on telehealth services furnished by
Federally Qualified Health Centers (FQHCs) or Rural Health
Clinics (RHCs). Additionally, this legislation includes program
integrity guardrails, such as clarifying fraud and abuse laws
and addressing outlier telehealth billing.
Legislative History
H.R. 4189 was introduced by Representative Thompson (CA-D)
on June 15, 2023, and referred to the Committee on Energy and
Commerce, and in addition to the Committee on Ways and Means.
On April 10, 2024, the Subcommittee on Health held a
hearing on H.R. 4189.
PHE Congressional Review Act
H.R. 4381
To amend the Public Health Service Act with respect to the
determination, termination, and renewal of public health
emergencies.
Summary
H.R. 4381, the ``PHE Congressional Review Act'' would
establish a Congressional review process in which, not later
than six months after a declared Public Health Emergency (PHE),
and every six months thereafter, Congress shall meet to vote to
determine whether the PHE shall be extended or terminated.
Legislative History
On June 13, 2023, the Subcommittee on Health held a hearing
on a discussion draft entitled the ``PHE Congressional Review
Act of 2023.''
H.R. 4381 was introduced by Representative Murphy (NC-R) on
June 27, 2023, and referred to the Committee on Energy and
Commerce, and in addition to the Committee on Rules. H.R. 4381
was similar to the discussion draft.
On July 13, 2023, the Subcommittee on Health favorably
forwarded H.R. 4381 to the full committee by a vote of 14 to
12.
On July 19, 2023, the full committee favorably reported
H.R. 4381 to the House by a vote of 28 to 21.
The provisions of H.R. 4381 were included in H.R. 4421,
which is discussed elsewhere in this report.
To Amend Title XI of the Social Security Act To Clarify Manufacturer
Transparency Reporting Requirements for Certain Transfers Used for
Educational Purposes
H.R. 4402
To amend title XI of the Social Security Act to clarify
manufacturer transparency reporting requirements for certain
transfers used for educational purposes.
Summary
This legislation would clarify that manufacturers of a
covered drug, device, biological, or medical supply, will not
be required to submit information regarding educational
materials that directly benefit patients and are intended for
patient use, including peer-reviewed journals, journal
reprints, medical conference reports, and medical textbooks.
Legislative History
H.R. 4402 was introduced by Representative Burgess (TX-R)
on June 30, 2023, and referred to the Committee on Energy and
Commerce, and in addition to the Committee on Ways and Means.
On October 19, 2023, the Subcommittee on Health held a
hearing on H.R. 4402.
PHEMCE Advisory Committee Act of 2023
H.R. 4419
To amend the Public Health Service Act with respect to the
Public Health Emergency Medical Countermeasures Enterprise, and
for other purposes.
Summary
This discussion draft would establish a Public Health
Emergency Medical Countermeasures Enterprise (PHEMCE) Advisory
Committee to provide a forum for external private sector
partners and stakeholders with expertise in divergent threat
portfolios to facilitate increased communication and
transparency among stakeholders, the public, and other PHEMCE
members, as well as provide input into the existing PHEMCE
planning and decision-making processes regarding medical
countermeasures development, procurement, and distribution of
and against chemical, radiological, biological, and nuclear
threats.
Legislative History
On June 13, 2023, the Subcommittee on Health held a hearing
on a discussion draft entitled the ``PHEMCE Advisory Committee
Act.''
H.R. 4419 was introduced by Representative Hudson (NC-R) on
June 30, 2023, and referred to the Committee on Energy and
Commerce. H.R. 4419 was similar to the discussion draft.
The provisions of H.R. 4419 were included in H.R. 4421,
which is discussed elsewhere in this report.
Preparedness and Response Reauthorization Act
H.R. 4420 (H.R. 3742)
To reauthorize certain programs under the Public Health
Service Act with respect to public health security and all-
hazards preparedness and response related to the Centers for
Disease Control and Protection.
Summary
H.R. 4420 would reauthorize and make improvements to
certain programs related to public health security and all-
hazards preparedness and response activities, including efforts
at the Centers for Disease Control and Prevention to support
and improve the Public Health Emergency Preparedness Program,
the Epidemiology and Laboratory Capacity Program, and the
Federal Select Agent Program.
Legislative History
On June 13, 2023, the Subcommittee on Health held a hearing
on a discussion draft entitled ``To reauthorize certain
programs under the Public Health Service Act with respect to
public health security and all-hazards preparedness and
response, and for other purposes.''
H.R. 4420 was introduced by Representative Hudson (NC-R) on
June 30, 2023, and referred to the Committee on Energy and
Commerce. H.R. 4420 was similar to the discussion draft.
On July 13, 2023, the Subcommittee on Health favorably
forwarded H.R. 4420 to the full committee by a vote of 16 to
12.
On July 19, 2023, the full committee favorably reported
H.R. 4420, as amended, to the House by a vote of 27 to 22.
To Reauthorize Certain Programs Under the Public Health Service Act
With Respect to Public Health Security and All Hazards Preparedness and
Response Related to the Administration for Strategic Preparedness and
Response
H.R. 4421 (H.R. 2416, H.R. 3613, H.R. 3631, H.R. 3703, H.R. 3795, H.R.
3813, H.R. 3832, H.R. 3837, H.R. 3840, H.R. 4381, H.R. 4419, H.R. 4458,
H.R. 4459, H.R. 4529)
To reauthorize certain programs under the Public Health
Service Act with respect to public health security and all-
hazards preparedness and response related to the Administration
for Strategic Preparedness and Response.
Summary
H.R. 4421 would reauthorize and make improvements to
certain programs related to public health security and all-
hazards preparedness and response activities, including efforts
at the Administration for Strategic Preparedness and Response
to support and improve the National Health Security Strategy,
Strategic National Stockpile, Biomedical Advanced Research and
Development Authority, Public Health Emergency Medical
Countermeasures Enterprise, Hospital Preparedness Program, and
the National Advisory Committees on Disasters.
Legislative History
On June 13, 2023, the Subcommittee on Health held a hearing
on a discussion draft entitled ``To reauthorize certain
programs under the Public Health Service Act with respect to
public health security and all-hazards preparedness and
response, and for other purposes.''
H.R. 4421 was introduced by Representative Hudson (NC-R) on
June 30, 2023, and referred to the Committee on Energy and
Commerce. H.R. 4421 was similar to the discussion draft.
On July 13, 2023, the Subcommittee on Health favorably
forwarded H.R. 4421 to the full committee by a vote of 17 to
11.
On July 19, 2023, the full committee favorably reported
H.R. 4421, as amended, to the House by a vote of 28 to 23.
The provisions of H.R. 4458 were included in H.R. 4421,
which is discussed elsewhere in this report.
Certain provisions of H.R. 4421 were included in H.R.
10545.
On December 21, 2024, the House agreed to suspend the rules
and pass H.R. 10545 by a vote of 366 to 34.
On December 21, 2024 the Senate passed H.R. 10545 by a vote
of 85 to 11.
Improving Contract Transparency for the SNS Act
H.R. 4458
To amend title III of the Public Health Service Act to
provide for clarity with respect to the duration of contracts
for procurement of supplies for the Strategic National
Stockpile.
Summary
This discussion draft provides a 90-day notice requirement
to both Congress and the impacted vendor for any modifications,
renewals, extensions, or terminations of a procurement contract
for products, devices, and supplies for the Strategic National
Stockpile. The text also provides a base timeline for such
procurement contracts.
Legislative History
On June 13, 2023, the Subcommittee on Health held a hearing
on a discussion draft entitled ``Improving Contract
Transparency for the SNS Act.''
H.R. 4458 was introduced by Representative Griffith (VA-R)
on July 3, 2023, and referred to the Committee on Energy and
Commerce. H.R. 4458 was similar to the discussion draft.
Improving Contract transparency at BARDA Act
H.R. 4459
To amend title III of the Public Health Service Act to
specify the duration of contracts, grants, cooperative
agreements, or other transactions awarded or entered into with
the Biomedical Advanced Research and Development Authority, and
for other purposes.
Summary
H.R. 4459 would require a 90-day notice requirement to the
impacted vendor for any modifications, renewals, extensions, or
terminations of contracts, grants, cooperative agreements, or
other transactions entered into with Biomedical Advanced
Research and Development Authority (BARDA).
Legislative History
On June 13, 2023, the Subcommittee on Health held a hearing
on a discussion draft entitled ``Improving Contract
Transparency at BARDA Act.''
H.R. 4459 was introduced by Representative Griffith (VA-R)
on July 3, 2023, and referred to the Committee on Energy and
Commerce. H.R. 4459 was similar to the discussion draft.
The provisions of H.R. 4459 were included in H.R. 4421,
which is discussed elsewhere in this report.
To Amend the Public Health Service Act To Provide for the Inclusion of
a Biological Attribution Strategy, and an Early Warning Strategy and
Implementation Plan, in the National Health Security Strategy, and for
Other Purposes
H.R. 4516
To amend the Public Health Service Act to provide for the
inclusion of a biological attribution strategy, and an early
warning strategy and implementation plan, in the National
Health Security Strategy, and for other purposes.
Summary
H.R. 4516 would provide additional responsibilities and
duties to the ASPR regarding disease detection, including
requiring the ASPR to develop an annual Early Warning and
Disease Detection Strategy and Implementation Plan, as well as
a new grant program to implement the plan. It also requires the
National Health Security Strategy (NHSS) to include a
biological attribution strategy and requires the U.S.
Department of Health and Human Services (HHS) to
Legislative History
On June 13, 2023, the Subcommittee on Health held a hearing
on a discussion draft entitled ``Biosecurity Infrastructure for
Operational (BIO) Early Warning Act.''
H.R. 4516 was introduced by Representative Crenshaw (TX-R)
on July 10, 2023, and referred to the Committee on Energy and
Commerce. H.R. 4516 was similar to the discussion draft.
Public Health Guidance Transparency and Accountability Act of 2023
H.R. 4529
To amend the Public Health Service Act regarding guidance
documents of the Centers for Disease Control and Prevention.
Summary
H.R. 4529 would direct the Director of the Centers for
Disease Control and Prevention (CDC) to, through regulation,
develop and maintain good guidance practices for the issuance
and use of guidance documents. The bill establishes
requirements for public participation in the development of any
CDC guidance document and directs the Secretary to maintain
public availability of guidance documents and conduct periodic
review of such documents.
Legislative History
On June 13, 2023, the Subcommittee on Health held a hearing
on a discussion draft entitled ``Public Health Guidance
Transparency and Accountability Act.''
H.R. 4529 was introduced by Representative McMorris Rodgers
(WA-R) on July 11, 2023, and referred to the Committee on
Energy and Commerce. H.R. 4529 was similar to the discussion
draft.
On July 13, 2023, the Subcommittee on Health favorably
forwarded H.R. 4529 to the full committee by a vote of 14 to
11.
On July 19, 2023, the full committee favorably reported
H.R. 4529, as amended, to the House by a vote of 25 to 21.
The provisions of H.R. 4529 were included in H.R. 4421,
which is discussed elsewhere in this report.
Support for Patients and Communities Reauthorization Act
H.R. 4531 (H.R. 1502, H.R. 1839, H.R. 3736, H.R. 3892, H.R. 4007, H.R.
4053, H.R. 4056, H.R. 4057, H.R. 4063, H.R. 4079, H.R. 4080, H.R. 4088,
H.R. 4089, H.R. 4091, H.R. 4092, H.R. 4093, H.R. 4095, H.R. 4096, H.R.
4097, H.R. 4098, H.R. 4099, H.R. 4100, H.R. 4101, H.R. 4106)
To reauthorize certain programs that provide for opioid use
disorder prevention, recovery, and treatment.
Summary
H.R. 4531 would reauthorize public health programs focused
on prevention, treatment, and recovery for patients with
substance use disorder, permanently places xylazine in schedule
III of the Controlled Substances Act, and includes a permanent
extension of Medicaid's required coverage of medication-
assisted treatments.
Legislative History
On June 9, 2023, the Subcommittee on Health held a hearing
that informed the drafting of H.R. 4531.
H.R. 4531 was introduced by Representative Guthrie (KY-R)
on July 11, 2023, and referred to the Committee on Energy and
Commerce, and in addition to the Committee on the Judiciary and
the Committee on Education and the Workforce.
On July 19, 2023, the full committee favorably reported
H.R. 4531, as amended, to the House by a vote of 49 to 0.
On December 11, 2023, Representative Guthrie moved to
suspend the rules and pass H.R. 4531, as amended. The House
agreed to the motion by a vote of 386 to 37.
On December 13, 2023, H.R. 4531 was received in the Senate
and referred to the Committee on Health, Education, Labor, and
Pensions.
Women and Lung Cancer Research and Preventive Services Act of 2024
H.R. 4534
To require a review of women and lung cancer, and for other
purposes.
Summary
H.R. 4534 would require The Department of Health and Human
Services (HHS) to conduct an interagency review on the status
of, and identify research related to, women and underserved
populations with lung cancer. The review would include
assessments of current research and access to prevention
services, the availability of research opportunities regarding
prevention, detection, and treatment, and recommendations for
national public education and screening strategies.
Legislative History
H.R. 4534 was introduced by Representative Boyle (PA-D) on
July 11, 2023, and referred to the Committee on Energy and
Commerce.
On February 14, 2024, the Subcommittee on Health held a
hearing on H.R. 4534.
On May 16, 2024, the Subcommittee on Health favorably
forwarded H.R. 4534, as amended, to the full committee by a
vote of 21 to 0.
On June 12, 2024, the full committee favorably reported
H.R. 4534, as amended, to the House by a vote of 44 to 0.
On December 16, 2024, Representative Bucshon moved to
suspend the rules and pass H.R. 4534, as amended. The House
agreed to the motion by voice vote.
Laws Ensuring Safe Shrimp Act
H.R. 4547
To establish a fund to promote the inspection and
consumption of shrimp and products containing shrimp or shrimp
parts.
Summary
This legislation would provide funding to the FDA and the
Department of Agriculture to inspect imported shrimp and shrimp
products in accordance with certain health and safety standards
and encourage domestic consumption of shrimp.
Legislative History
H.R. 4547 was introduced by Representative Graves (LA-R) on
July 11, 2023, and referred to the Committee on Energy and
Commerce, and in addition to the Committee on Agriculture.
On September 10, 2024, the Subcommittee on Health held a
hearing on H.R. 4547.
Accelerating Kids' Access to Care Act
H.R. 4758
To amend title XIX of the Social Security Act to streamline
enrollment under the Medicaid program of certain providers
across State lines, and to prevent the use of abusive spread
pricing in Medicaid.
Summary
H.R. 4758 would streamline Medicaid and Children's Health
Insurance Program (CHIP) out-of-state pediatric provider
enrollment requirements to promote timely access to care for
children needing to travel out-of-state for care.
Legislative History
H.R. 4758 was introduced by Representative Trahan (MA-D) on
July 19, 2023, and referred to the Committee on Energy and
Commerce.
On February 29, 2024, the Subcommittee on Health held a
hearing on H.R. 4758.
On May 16, 2024, the Subcommittee on Health favorably
forwarded H.R. 4758 to the full committee by voice vote.
On June 12, 2024, the full committee favorably reported
H.R. 4758, as amended, to the House by a vote of 43 to 0.
On September 17, 2024, Representative Miller-Meeks moved to
suspend the rules and pass H.R. 4758, as amended. The House
agreed to the motion by a voice vote.
On September 18, 2024, H.R. 4758 was received in the Senate
and referred to the Committee on Finance.
Honey Identification Verification and Enforcement Act
H.R. 4764
To establish a standard of identity for honey.
Summary
This legislation would require the FDA to establish a
standard of identity for honey and report to Congress on
enforcement actions taken with respect to adulterated or
misbranded honey.
Legislative History
H.R. 4764 was introduced by Representative Armstrong (ND-R)
on July 20, 2023, and referred to the Committee on Energy and
Commerce, and in addition to the Committee on Agriculture.
On September 10, 2024, the Subcommittee on Health held a
hearing on H.R. 4764.
Treat and Reduce Obesity Act
H.R. 4818
To amend title XVIII of the Social Security Act to provide
for the coordination of programs to prevent and treat obesity,
and for other purposes.
Summary
This legislation would expand Medicare Part D coverage of
obesity medications and allow additional health care providers
to offer the Intensive Behavioral Therapy benefit.
Additionally, the bill would require the Secretary of Health
and Human Services (HHS) to submit a report to Congress on
steps taken to implement the provisions of this Act, along with
recommendations to improve Federal coordination to treat,
reduce, and prevent obesity.
Legislative History
H.R. 4818 was introduced by Representative Wenstrup (OH-R)
on July 20, 2023, and referred to the Committee on Energy and
Commerce, and in addition to the Committee on Ways and Means.
On September 19, 2023, the Subcommittee on Health held a
hearing on H.R. 4818.
Enabling More of the Physical and Occupational Workforce To Engage in
Rehabilitation (EMPOWER) Act
H.R. 4878
To amend title XVIII of the Social Security Act to ensure
appropriate supervision requirements for outpatient physical
therapy and outpatient occupational therapy.
Summary
This legislation would remove direct supervision
requirements for physical therapy assistants and occupational
therapy assistants and require the U.S. Government
Accountability Office (GAO) to analyze how the Medicare Part B
15 percent payment differential for services provided by
occupational therapy assistants and physical therapy assistants
has impacted access to physical and occupational therapy
services.
Legislative History
H.R. 4878 was introduced by Representative Lesko (AZ-R) on
July 25, 2023, and referred to the Committee on Energy and
Commerce, and in addition to the Committee on Ways and Means.
On October 19, 2023, the Subcommittee on Health held a
hearing on H.R. 4878.
To Amend Title XVIII of the Social Security Act To Limit Cost Sharing
for Drugs Under the Medicare Program
H.R. 4881
To amend title XVIII of the Social Security Act to limit
cost sharing for drugs under the Medicare program.
Summary
H.R. 4881 would limit patient cost-sharing for drugs under
Medicare Part D starting in 2027 by providing that patients
would not be required to pay more than the insurance company is
paying for highly rebated drugs once all the discounts are
accounted for.
Legislative History
H.R. 4881 was introduced by Representative Malliotakis (NY-
R) on July 25, 2023, and referred to the Committee on Energy
and Commerce, and in addition to the Committee on Ways and
Means.
On September 19, 2023, the Subcommittee on Health held a
hearing on H.R. 4881.
On November 15, 2023, the Subcommittee on Health favorably
forwarded H.R. 4881 to the full committee by voice vote.
On December 5, 2023, the full committee favorably reported
H.R. 4881, as amended, to the House by a vote of 45 to 0.
Stillbirth Health Improvement and Education (SHINE) for Autumn Act
H.R. 5012
To improve research and data collection on stillbirths, and
for other purposes.
Summary
H.R. 5012 allows the Department of Health and Human
Services (HHS) to award grants for data collection and
reporting related to still births and requires HHS to issue
guidelines regarding proper training and processes for
collection of data, as well as disseminate educational
materials, related to stillbirth. In addition, this legislation
requires HHS to incorporate a perinatal pathology fellowship
program or related program within an existing training program.
This legislation also requires HHS to issue public educational
guidelines and reports on the progress of the described
programs.
Legislative History
H.R. 5012 was introduced by Representative Kim (CA-R) on
July 27, 2023, and referred to the Committee on Energy and
Commerce.
On February 14, 2024, the Subcommittee on Health held a
hearing on H.R. 5012.
On March 12, 2024, the Subcommittee on Health favorably
forwarded H.R. 5012 to the full committee by voice vote.
On June 12, 2024, the full committee favorably reported
H.R. 5012 to the House by a vote of 45 to 0.
Kidney Patient Access to Technologically Innovative and Essential
Nephrology Treatments (PATIENT) Act of 2023
H.R. 5074
To amend the America Taxpayer Relief Act of 2012 to delay
implementation of the inclusion of oral-only ESRD-related drugs
in the Medicare ESRD prospective payment system.
Summary
H.R. 5074 would maintain Medicare Part D coverage of oral
medications that treat end-stage renal disease (ESRD), by
delaying the transfer of reimbursement for oral-only ESRD
medications from the Part D ESRD prospective payment system to
Medicare Part B. In addition, the Kidney PATIENT Act of 2024
requires the Department of Health and Human Services to issue a
report to Congress that would inform any future deliberation on
delaying the change to ESRD oral-only medication reimbursement.
Legislative History
H.R. 5074 was introduced by Representative Carter (GA-R) on
July 28, 2023, and referred to the Committee on Energy and
Commerce, and in addition to the Committee on Ways and Means.
On September 19, 2023, the Subcommittee on Health held a
hearing on H.R. 5074.
On March 12, 2024, the Subcommittee on Health favorably
forwarded H.R. 5074 to the full committee by a vote of 16 to
10.
On March 20, 2024, the full committee favorably reported
H.R. 5074, as amended, to the House by a vote of 36 to 10.
Choices for Increased Mobility Act of 2023
H.R. 5371
To amend title XVIII of the Social Security Act to clarify
payment rules for manual wheelchairs under Part B of the
Medicare program.
Summary
H.R. 5371 would clarify payment rules for manual
wheelchairs under part B of the Medicare program by requiring
HHS to establish two or more Healthcare Common Procedure Coding
System (HCPCS) codes depending on wheelchair construction
material.
Legislative History
H.R. 5371 was introduced by Representative Joyce (PA-R) on
September 8, 2023, and referred to the Committee on Energy and
Commerce, and in addition to the Committee on Ways and Means.
On September 19, 2023, the Subcommittee on Health held a
hearing on H.R. 5371.
On November 15, 2023, the Subcommittee on Health favorably
forwarded H.R. 5371 to the full committee by voice vote.
On December 5, 2023, the full committee favorably reported
H.R. 5371, as amended, to the House by a vote of 41 to 0.
Expanding Seniors' Access to Lower Cost Medicines Act of 2023
H.R. 5372
To amend Title XVIII of the Social Security Act to
facilitate midyear formulary changes for biosimilars.
Summary
This legislation would encourage greater patient access to
biosimilar products by allowing for mid-year changes in
insurance plan formularies for certain biosimilar products
starting in 2025.
Legislative History
H.R. 5372 was introduced by Representative Joyce (PA-R) on
September 8, 2023, and referred to the Committee on Energy and
Commerce, and in addition to the Committee on Ways and Means.
On September 19, 2023, the Subcommittee on Health held a
hearing on H.R. 5372.
On November 15, 2023, the Subcommittee on Health favorably
forwarded H.R. 5372 to the full committee by voice vote.
On December 5, 2023, the full committee favorably reported
H.R. 5372, as amended, to the House by a vote of 48 to 0.
Share the Savings With Seniors Act
H.R. 5376
To amend title XVIII of the Social Security Act to ensure
appropriate cost-sharing for chronic care drugs under Medicare
Part D.
Summary
This legislation would require full rebate pass-through for
chronic condition medicines within the deductible, or when
patients owe coinsurance.
Legislative History
H.R. 5376 was introduced by Representative Miller-Meeks
(IA-R) on September 8, 2023, and referred to the Committee on
Energy and Commerce, and in addition to the Committee on Ways
and Means.
On September 19, 2023, the Subcommittee on Health held a
hearing on H.R. 5376.
Lower Costs, More Transparency Act
H.R. 5378 (H.R. 1613, H.R. 2547, H.R. 2550, H.R. 2559, H.R. 2665, H.R.
2679, H.R. 3237, H.R. 3248, H.R. 3282, H.R. 3284, H.R. 3561)
To promote price transparency in the health care sector,
and for other purposes.
Summary
H.R. 5378 seeks to lower health care costs by: Requiring
hospitals, insurance companies, labs, imaging providers, and
ambulatory surgical centers to publicly list prices, allowing
patients and employers better shop for health care; Requiring
health insurers and pharmacy benefit managers (PBMs) to
disclose negotiated drug rebates and discounts, revealing the
true costs of prescription drugs; Lowering out-of-pocket costs
for seniors who receive medication at a hospital-owned
outpatient facility or doctor's office; and Expanding access to
more affordable generic drugs.
Legislative History
H.R. 5378 was introduced by Representative McMorris Rodgers
(WA-R) on September 8, 2023, and referred to the Committee on
Energy and Commerce, and in addition to the Committee on Ways
and Means and the Committee on Education and the Workforce.
On April 26, 2023, the Subcommittee on Health held a
hearing on H.R. 5378.
On December 11, 2023, Representative McMorris Rodgers moved
to suspend the rules and pass H.R. 5378, as amended. The House
agreed to the motion by a vote of 320 to 71, and 1 present.
To Amend Title XVIII of the Social Security Act To Increase Data
Transparency for Supplemental Benefits Under Medicare Advantage
H.R. 5380
To amend title XVIII of the Social Security Act to increase
data transparency for supplemental benefits under Medicare
Advantage.
Summary
H.R. 5380 requires enrollee-level utilization reporting of
supplemental benefits by Medicare Advantage plans.
Legislative History
H.R. 5380 was introduced by Representative Sarbanes (MD-D)
on September 8, 2023, and referred to the Committee on Ways and
Means, and in addition to the Committee on Energy and Commerce.
On September 19, 2023, the Subcommittee on Health held a
hearing on H.R. 5380.
On November 15, 2023, the Subcommittee on Health favorably
forwarded H.R. 5380 to the full committee by voice vote.
On December 5, 2023, the full committee favorably reported
H.R. 5380, as amended, to the House by a vote of 43 to 0.
Medicare PBM Accountability Act
H.R. 5385
To amend title XVIII of the Social Security Act to
establish pharmacy benefit manager reporting requirements with
respect to prescription drug plans and MA-PD plans under
Medicare Part D.
Summary
H.R. 5385 creates enhanced PBM reporting requirements,
including annual reporting of drug pricing and other
information to the Secretary of HHS including information about
Part D drugs, drug dispensing, drug costs and pricing, generic
and biosimilar formulary placement, PBM affiliates, financial
arrangements with consultants, and potential PBM conflicts of
interest. The information submitted would not be publicly
disclosed except in limited circumstances. The legislation
would stipulate an audits and enforcement process by which
prescription drug plans (PDPs) can audit their PBM for
compliance.
Legislative History
H.R. 5385 was introduced by Representative Landsman (OH-D)
on September 12, 2023, and referred to the Committee on Energy
and Commerce, and in addition to the Committee on Ways and
Means.
On September 19, 2023, the Subcommittee on Health held a
hearing on H.R. 5385.
On November 15, 2023, the Subcommittee on Health favorably
forwarded H.R. 5385 to the full committee by voice vote.
On December 5, 2023, the full committee favorably reported
H.R. 5385, as amended, to the House by a vote of 44 to 0.
Cutting Copays Act
H.R. 5386
To amend title XVIII of the Social Security Act to provide
for adjustments to the Medicare Part D cost-sharing reductions
for low-income individuals.
Summary
H.R. 5386 bill would clarify Medicare Part D cost-sharing
for generic drugs for low-income patients in the Low-Income
Subsidy (LIS) program by setting generic drug co-pays at $0.
Legislative History
H.R. 5386 was introduced by Representative McGarvey (KY-D)
on September 12, 2023, and referred to the Committee on Energy
and Commerce, and in addition to the Committee on Ways and
Means.
On September 19, 2023, the Subcommittee on Health held a
hearing on H.R. 5386.
On November 15, 2023, the Subcommittee on Health favorably
forwarded H.R. 5386 to the full committee by voice vote.
On December 5, 2023, the full committee favorably reported
H.R. 5386, as amended, to the House by a vote of 41 to 1.
Supporting Innovation for Seniors Act
H.R. 5388
To amend title XVIII of the Social Security Act to provide
coverage of certain technologies and medical devices under the
Medicare program.
Summary
This bill would expand a flexibility offered through the
Medicare Advantage Value-Based Insurance Design (VBID) Model to
allow all Medicare Advantage plans to increase access to
innovative medical devices and technologies using their
existing supplemental benefit funds.
Legislative History
H.R. 5388 was introduced by Representative Balderson (OH-R)
on September 12, 2023, and referred to the Committee on Ways
and Means, and in addition to the Committee on Energy and
Commerce.
On September 19, 2023, the Subcommittee on Health held a
hearing on H.R. 5388.
On November 15, 2023, the Subcommittee on Health favorably
forwarded H.R. 5388 to the full committee by voice vote.
On December 5, 2023, the full committee favorably reported
H.R. 5388, as amended, to the House by a vote of 43 to 0.
National Coverage Determination Transparency Act
H.R. 5389
To amend title XVIII of the Social Security Act to ensure
transparency in the national coverage determination process
under the Medicare program.
Summary
This bill would require the Secretary of HHS to determine
whether a request for a National Coverage Determination (NCD)
is complete within 30 days of receiving the request. The bill
would also allow the Secretary to work directly with the entity
who submitted the request to update and resubmit the request if
the Secretary finds that the application is incomplete.
Additionally, the Secretary would be required to make all
complete NCD applications publicly available on Centers for
Medicare and Medicaid Services' (CMS's) website. Finally, the
bill would clarify that the timeline for making a NCD begins on
the date the Secretary receives an NCD application.
Legislative History
H.R. 5389 was introduced by Representative Guthrie (KY-R)
on September 12, 2023, and referred to the Committee on Ways
and Means, and in addition to the Committee on Energy and
Commerce.
On September 19, 2023, the Subcommittee on Health held a
hearing on H.R. 5389.
On November 15, 2023, the Subcommittee on Health favorably
forwarded H.R. 5389, as amended, to the full committee by voice
vote.
On December 5, 2023, the full committee favorably reported
H.R. 5389, as amended, to the House by a vote of 46 to 0.
Timely Access to Coverage Decisions Act of 2023
H.R. 5392
To amend title XVIII of the Social Security Act to ensure
timely review of local coverage determination requests under
the Medicare program.
Summary
This legislation would require that LCD requests received
by Medicare administrative contractors (MACs) be reviewed and
determined whether complete or not within 30 days of a request.
In the case of incomplete requests, the MAC must transmit the
additional information needed to complete the request within 60
days of the receipt. The legislation would also standardize a
9-month timeline for issuing a coverage decision after a
request is determined to be complete.
Legislative History
H.R. 5392 was introduced by Representative Dunn (FL-R) on
September 12, 2023, and referred to the Committee on Ways and
Means, and in addition to the Committee on Energy and Commerce.
On September 19, 2023, the Subcommittee on Health held a
hearing on H.R. 5392.
Transparency and Fairness for Pharmacies Act
H.R. 5393
To amend title XVIII of the Social Security Act to ensure
fair assessment of pharmacy performance and quality under
Medicare part D, and for other purposes.
Summary
This bill would standardize pharmacy performance measures
in the Medicare Part D program that assess network pharmacy
performance by requiring that prescription drug plans (PDPs)
only use pharmacy performance measures that are established by
the Secretary of the Department of Health and Human Services
(HHS) and are relevant to a particular pharmacy. The
legislation would require an HHS Office of the Inspector
General (OIG) report studying the implementation of these
performance measures. The legislation would also establish a
process by which PDPs provide their network pharmacies with
comprehensive information about pricing prescription drug
claims.
Legislative History
H.R. 5393 was introduced by Representative Griffith (VA-R)
on September 12, 2023, and referred to the Committee on Energy
and Commerce, and in addition to the Committee on Ways and
Means.
On September 19, 2023, the Subcommittee on Health held a
hearing on H.R. 5393.
On November 15, 2023, the Subcommittee on Health favorably
forwarded H.R. 5393 to the full committee by voice vote.
On December 5, 2023, the full committee favorably reported
H.R. 5393 to the House by a vote of 44 to 0.
Expanding Remote Monitoring Access Act
H.R. 5394
To ensure appropriate access to remote monitoring services
furnished under the Medicare program.
Summary
This legislation would provide for Medicare coverage of
remote monitoring services if such services collect data for a
minimum of 2 days over a 30-day period, a decrease from 16 days
in current law. The legislation also requires a study of remote
monitoring services that will help inform reimbursement and
coverage policies of remote monitoring services.
Legislative History
H.R. 5394 was introduced by Representative Balderson (OH-R)
on September 12, 2023, and referred to the Committee on Energy
and Commerce, and in addition to the Committee on Ways and
Means.
On September 19, 2023, the Subcommittee on Health held a
hearing on H.R. 5394.
On May 16, 2024, the Subcommittee on Health favorably
forwarded H.R. 5394, as amended, to the full committee by voice
vote.
Coverage Parity for Medicare Patients Act
H.R. 5395
To amend title XVIII of the Social Security Act to
establish a demonstration program relating to medical necessity
determinations under the Medicare program.
Summary
This legislation would establish a demonstration program
for Medicare patients in a number of states or regions to
provide for coverage for items and services that are otherwise
safe and effective and not experimental or investigational, if
commercial insurance plans already cover these items or
services for patients. This policy would test commercial
coverage parity for Medicare patients to provide that seniors
do not lose access to innovative medical products and services
by enrolling in the Medicare program.
Legislative History
H.R. 5395 was introduced by Representative Harshbarger (TN-
R) on September 12, 2023, and referred to the Committee on Ways
and Means, and in addition to the Committee on Energy and
Commerce.
On September 19, 2023, the Subcommittee on Health held a
hearing on H.R. 5395.
Coverage Determination Clarity Act of 2023
H.R. 5396
To amend title XVIII of the Social Security Act to prohibit
Medicare local coverage determinations from restricting access
to care, and for other purposes.
Summary
H.R. 5396 would prohibit Local Coverage Determinations
(LCDs) from being more restrictive than National Coverage
Determinations (NCDs).
Legislative History
H.R. 5396 was introduced by Representative Bucshon (IN-R)
on September 12, 2023, and referred to the Committee on Ways
and Means, and in addition to the Committee on Energy and
Commerce.
On September 19, 2023, the Subcommittee on Health held a
hearing on H.R. 5396.
On November 15, 2023, the Subcommittee on Health favorably
forwarded H.R. 5396 to the full committee by voice vote.
On December 5, 2023, the full committee favorably reported
H.R. 5396, as amended, to the House by a vote of 44 to 0.
Joe Fiandra Access to Home Infusion Act of 2023
H.R. 5397
To amend title XVIII of the Social Security Act to provide
coverage of external infusion pumps and non-self-administrable
home infusion drugs under the Medicare program.
Summary
This legislation would codify a proposed CMS durable
medical equipment (DME) policy that clarifies coverage of an
external infusion pump under the Medicare DME benefit by
clarifying the definition of external infusion pumps as
``appropriate for use in the home'' for individuals who are
unable to self-administer drugs that meet certain criteria.
Legislative History
H.R. 5397 was introduced by Representative Fitzpatrick (PA-
R) on September 12, 2023, and referred to the Committee on
Energy and Commerce, and in addition to the Committee on Ways
and Means.
On September 19, 2023, the Subcommittee on Health held a
hearing on H.R. 5397.
On November 15, 2023, the Subcommittee on Health favorably
forwarded H.R. 5397, as amended, to the full committee by voice
vote.
On December 5, 2023, the full committee favorably reported
H.R. 5397, as amended, to the House by a vote of 46 to 0.
The provisions of H.R. 5397 were included in H.R. 5526,
which is discussed elsewhere in this report.
Seniors' Access to Critical Medications Act
H.R. 5526 (H.R. 5397)
To amend title XVIII of the Social Security Act to clarify
the application of the in-office ancillary services exception
to the physician self-referral prohibition for covered
outpatient drugs furnished under the Medicare program, and to
provide coverage of external infusion pumps and non-self-
administrable home infusion drugs under such program.
Summary
H.R. 5526 would amend the physician self-referral law to
permit Medicare patients to receive prescription drugs via
caregivers picking up drugs on the patient's behalf or via mail
or couriers delivering the drug to the patient in instances
when a provider prescribes a drug to be dispensed by a pharmacy
that falls under the self-referral law's definition of an in-
office ancillary service. Current law prohibits such
arrangements for Medicare beneficiaries.
Legislative History
H.R. 5526 was introduced by Representative Harshbarger (TN-
R) on September 18, 2023, and referred to the Committee on
Energy and Commerce, and in addition to the Committee on Ways
and Means.
On October 19, 2023, the Subcommittee on Health held a
hearing on H.R. 5526.
On March 12, 2024, the Subcommittee on Health favorably
forwarded H.R. 5526 to the full committee by a vote of 19 to 6.
On June 12, 2024, the full committee favorably reported
H.R. 5526, as amended, to the House by a vote of 41 to 0.
On September 23, 2024, Representative Bucshon moved to
suspend the rules and pass H.R. 5526, as amended. The House
agreed to the motion by a voice vote.
On September 24, 2024, H.R. 5526 was received in the
Senate, read twice, and referred to the Committee on Finance.
No further action was taken on the bill.
Optimizing Research Progress Hope and New (ORPHAN) Cures Act
H.R. 5539
To amend title XI of the Social Security Act to expand and
clarify the exclusion for orphan drugs under the Drug Price
Negotiation Program.
Summary
This legislation would expand and clarify the exclusion for
orphan drugs under the Drug Price Negotiation Program, allowing
drugs that treat more than one rare disease to maintain their
orphan drug status and exemption from price setting through the
Drug Price Negotiation Program.
Legislative History
H.R. 5539 was introduced by Representative Joyce (PA-R) on
September 18, 2023, and referred to the Committee on Energy and
Commerce, and in addition to the Committee on Ways and Means.
On February 29, 2024, the Subcommittee on Health held a
hearing on H.R. 5539.
To Provide Temporary Licensing Reciprocity for Telehealth and
Interstate Health Care Treatment
H.R. 5541
To provide temporary licensing reciprocity for telehealth
and interstate health care treatment.
Summary
This legislation would temporarily allow authorized health
care professionals to provide mental health telehealth services
across state lines during a declared national emergency.
Legislative History
H.R. 5541 was introduced by Representative Latta (OH-R) on
September 18, 2023, and referred to the Committee on Energy and
Commerce.
On April 10, 2024, the Subcommittee on Health held a
hearing on H.R. 5541.
Maintaining Investments in New Innovation Act
H.R. 5547
To amend title XI of the Social Security Act to protect
access to genetically targeted technologies.
Summary
This legislation would modify the criteria for certain
single source drugs to qualify for the Drug Price Negotiation
Program after being approved for 11 years, instead of 7 years,
given their similarity to larger, biological products that are
subject to the 11-year timeframe under the Inflation Reduction
Act (IRA).
Legislative History
H.R. 5547 was introduced by Representative Nickel (NC-D) on
September 18, 2023, and referred to the Committee on Energy and
Commerce, and in addition to the Committee on Ways and Means.
On February 29, 2024, the Subcommittee on Health held a
hearing on H.R. 5547.
DMEPOS Relief Act of 2023
H.R. 5555
To direct the Secretary of Health and Human Services to
provide for certain adjustments to Medicare payment for items
of durable medical equipment that were formerly included in
round 2021 of the DMEPOS competitive bidding program.
Summary
H.R. 5555 would require the Secretary of the Department of
Health and Human Services (HHS) to temporarily maintain certain
adjustments to the blended Medicare payment rates for durable
medical equipment, prosthetics, orthotics, and supplies
(DMEPOS) that are furnished in non-competitive bidding areas
under the Medicare program.
Legislative History
H.R. 5555 was introduced by Representative Miller-Meeks
(IA-R) on September 19, 2023, and referred to the Committee on
Energy and Commerce, and in addition to the Committee on Ways
and Means.
On October 19, 2023, the Subcommittee on Health held a
hearing on H.R. 5555.
On November 15, 2023, the Subcommittee on Health favorably
forwarded H.R. 5555 to the full committee by a vote of 16 to
12.
On December 5, 2023, the full committee favorably reported
H.R. 5555, as amended, to the House by voice vote.
Helping Ensure Access to Local TeleHealth (HEALTH) Act of 2023
H.R. 5611
To amend title XVIII of the Social Security Act to provide
for permanent payments for telehealth services furnished by
Federally qualified health centers and rural health clinics
under the Medicare program.
Summary
This legislation would allow Medicare coverage of
telehealth services to include audio-only communications. This
legislation would also implement a permanent payment system for
telehealth services furnished by Rural Health Clinics (RHCs)
and Federally Qualified Health Centers (FQHCs), in addition to
eliminating originating site requirements for telehealth
services furnished by RHCs and FQHCs.
Legislative History
H.R. 5611 was introduced by Representative Thompson (PA-R)
on September 20, 2023, and referred to the Committee on Energy
and Commerce, and in addition to the Committee on Ways and
Means.
On April 10, 2024, the Subcommittee on Health held a
hearing on H.R. 5611.
ALS Better Care Act
H.R. 5663
To amend title XVIII of the Social Security Act to provide
coverage of ALS-related services under the Medicare program for
individuals diagnosed with amyotrophic lateral sclerosis.
Summary
This legislation would expand Medicare coverage to include
relevant services for people diagnosed with ALS. The
supplemental facility-based payment system established by this
bill would cover outpatient services administered by a
qualified provider.
Legislative History
H.R. 5663 was introduced by Representative Schakowsky (IL-
D) on September 21, 2023, and referred to the Committee on
Energy and Commerce, and in addition to the Committee on Ways
and Means.
On February 29, 2024, the Subcommittee on Health held a
hearing on H.R. 5663.
Honor Our Living Donors Act
H.R. 6020
To amend the Public Health Service Act to eliminate
consideration of the income of organ recipients in providing
reimbursement of expenses to donating individuals.
Summary
H.R. 6020 would prevent an organ recipient's income from
being considered when providing reimbursement for qualifying
expenses incurred by a living organ donor during the donation
process.
Legislative History
H.R. 6020 was introduced by Representative Obernolte (CA-R)
on October 26, 2023, and referred to the Committee on Energy
and Commerce.
On February 29, 2024, the Subcommittee on Health held a
hearing on H.R. 6020.
On May 16, 2024, the Subcommittee on Health favorably
forwarded H.R. 6020, as amended, to the full committee by a
vote of 24 to 0.
On June 12, 2024, the full committee favorably reported
H.R. 6020, as amended, to the House by a vote of 42 to 0.
On December 16, 2024, Representative Bucshon moved to
suspend the rules and pass H.R. 6020. The House agreed to the
motion by voice vote.
Supporting Patient Education and Knowledge (SPEAK) Act of 2024
H.R. 6033
To require the Secretary of Health and Human Services to
establish a task force to improve access to health care
information technology for non-English speakers.
Summary
H.R. 6033 would require the Secretary of Health and Human
Services to, in consultation with stakeholders, to issue and
disseminate best practices for delivering quality care via
telehealth to beneficiaries with limited English language
proficiency.
Legislative History
H.R. 6033 was introduced by Representative Steel (CA-R) on
October 26, 2023, and referred to the Committee on Energy and
Commerce.
On April 10, 2024, the Subcommittee on Health held a
hearing on H.R. 6033.
On May 16, 2024, the Subcommittee on Health favorably
forwarded H.R. 6033, as amended, to the full committee by a
vote of 23 to 0.
On June 12, 2024, the full committee favorably reported
H.R. 6033, as amended, to the House by a vote of 40 to 0.
On September 17, 2024, Representative McMorris Rodgers
moved to suspend the rules and pass H.R. 6033, as amended. The
House agreed to the motion by a voice vote.
On September 18, 2024, H.R. 6033 was received in the Senate
and referred to the Committee on Health, Education, Labor, and
Pensions.
The provisions of H.R. 6033 were included in H.R. 7623,
which is discussed elsewhere in this report.
Providing Realistic Opportunity to Equal and Comparable Treatment for
Rare Act
H.R. 6094
To amend titles XVIII and XIX of the Social Security Act
and title XXVII of the Public Health Service Act to refine the
set of information sources for determining coverage of certain
drugs and biologicals used in the treatment or management of a
rare disease or condition.
Summary
This legislation would expand the definition of medically
accepted indications in Medicare Part D and Medicaid to include
treatments for rare diseases that are supported in peer-
reviewed literature and clinical guidelines and do not
otherwise have unfavorable reviews in the United States
Pharmacopoeia or other similar compendia. Additionally, the
bill would require expedited processes for private health
insurers to similarly review coverage for such treatments.
Legislative History
H.R. 6094 was introduced by Representative Matsui (CA-D) on
October 26, 2023, and referred to the Committee on Energy and
Commerce, and in addition to the Committee on Ways and Means.
On February 29, 2024, the Subcommittee on Health held a
hearing on H.R. 6094.
To Amend the Public Health Service Act to Reauthorize a Lifespan
Respite Care Program
H.R. 6160
To amend the Public Health Service Act to reauthorize a
lifespan respite care program.
Summary
H.R. 6160 would reauthorize the lifespan respite care
program for five years.
Legislative History
H.R. 6160 was introduced by Representative Molinaro (NY-R)
on November 1, 2023, and referred to the Committee on Energy
and Commerce.
On February 14, 2024, the Subcommittee on Health held a
hearing on H.R. 6160.
On March 12, 2024, the Subcommittee on Health favorably
forwarded H.R. 6160, as amended, to the full committee by a
vote of 25 to 0.
On March 20, 2024, the full committee favorably reported
H.R. 6160, as amended, to the House by a vote of 46 to 0.
On September 17, 2024, Representative McMorris Rodgers
moved to suspend the rules and pass H.R. 6160, as amended. The
House agreed to the motion by a voice vote.
On September 18, 2024, H.R. 6160 was received in the Senate
and referred to the Committee on Health, Education, Labor, and
Pensions.
Medicare Telehealth Privacy Act of 2023
H.R. 6364
To amend title XVIII of the Social Security Act to maintain
certain telehealth flexibilities relating to provider privacy
under the Medicare program.
Summary
H.R. 6364 would maintain certain telehealth flexibilities
regarding provider privacy under the Medicare program. To
protect providers, the Department of HHS is prohibited from
publicly disclosing the addresses of physicians or
practitioners who elect to furnish telehealth services from
their home addresses.
Legislative History
On October 19, 2023, the Subcommittee on Health held a
hearing on a discussion draft entitled ``Telehealth Privacy Act
of 2023.''
H.R. 6364 was introduced by Representative Balderson (OH-R)
on November 13, 2023, and referred to the Committee on Energy
and Commerce, and in addition to the Committee on Ways and
Means. H.R. 6364 was similar to the discussion draft.
On November 15, 2023, the Subcommittee on Health favorably
forwarded H.R. 6364 to the full committee by voice.
On December 5, 2023, the full committee favorably reported
H.R. 6364, as amended, to the House by a vote of 44 to 0.
To Amend Title XVIII of the Social Security Act With Respect to the
Work Geographic Index for Physician Payments Under the Medicare
Program, and To Revise the Phase-In of Clinical Laboratory Test Payment
Changes Under Such Program
H.R. 6366
To amend title XVIII of the Social Security Act with
respect to the work geographic index for physician payments
under the Medicare program, and to revise the phase-in of
clinical laboratory test payment changes under such program.
Summary
This bill would extend for one year a policy to increase
the work geographic index to 1.00 for any locality where the
index would be less than 1.00, which is otherwise set to expire
January 1, 2024. The bill would also delay cuts and reporting
under the clinical lab fee schedule.
Legislative History
H.R. 6366 was introduced by Representative Hudson (NC-R) on
November 13, 2023, and referred to the Committee on Energy and
Commerce, and in addition to the Committee on Ways and Means.
On October 19, 2023, the Subcommittee on Health held a
hearing on H.R. 6366.
On November 15, 2023, the Subcommittee on Health favorably
forwarded H.R. 6366 to the full committee by voice.
Certain provisions of H.R. 6366 were included in H.R.
10545.
On December 21, 2024, the House agreed to suspend the rules
and pass H.R. 10545 by a vote of 366 to 34.
On December 21, 2024 the Senate passed H.R. 10545 by a vote
of 85 to 11.
To Amend Title XVIII of the Social Security Act To Extend Incentive
Payments for Participation in Eligible Alternative Payment Models
H.R. 6369
To amend title XVIII of the Social Security Act to extend
incentive payments for participation in eligible alternative
payment models.
Summary
This bill would extend incentive payments for participation
in eligible alternative payment models (APMs) for one year and
tiers the size of the bonus according to how long a provider
has participated in an APM to better account for increased up-
front costs of APM participation.
Legislative History
H.R. 6369 was introduced by Representative Schrier (WA-D)
on November 13, 2023, and referred to the Committee on Energy
and Commerce, and in addition to the Committee on Ways and
Means.
On October 19, 2023, the Subcommittee on Health held a
hearing on H.R. 6369.
On November 15, 2023, the Subcommittee on Health favorably
forwarded H.R. 6369 to the full committee by voice.
Provider Reimbursement Stability Act of 2023
H.R. 6371
To provide for certain adjustments to the physician fee
schedule under the Medicare program.
Summary
This discussion draft would increase the Physician Fee
Schedule (PFS) budget neutrality threshold and provide for a
lookback period to reconcile overestimates and underestimates
of pricing adjustments for individual services. The draft also
requires that the Secretary update prices and rates for direct
cost inputs for practice expense relative value units no less
than every 5 years. Finally, the draft sets a limitation on
year-to-year conversion fact (CF) variance.
Legislative History
H.R. 6371 was introduced by Representative Murphy (NC-R) on
November 13, 2023, and referred to the Committee on Energy and
Commerce, and in addition to the Committee on Ways and Means.
On October 19, 2023, the Subcommittee on Health held a
hearing on H.R. 6371.
On November 15, 2023, the Subcommittee on Health favorably
forwarded H.R. 6371 to the full committee by voice.
Preserving Life Saving Access to Specialty Medicines in America
(PLASMA) Act
H.R. 6465
To amend title XVIII of the Social Security Act to provide
a phase-in for plasma-derived products under the manufacturer
discount program.
Summary
This legislation would modify how plasma derived medicinal
products are treated in relation to changes to the Part D cost-
sharing structure. This change would phase-in the increase in
manufacturer rebates over 5 years under the existing pathway
for small biotechnology manufacturers.
Legislative History
H.R. 6465 was introduced by Representative Hudson (NC-R) on
November 21, 2023, and referred to the Committee on Energy and
Commerce, and in addition to the Committee on Ways and Means.
On February 29, 2024, the Subcommittee on Health held a
hearing on H.R. 6465.
Stephen Hacala Poppy Seed Safety Act
H.R. 6512
To prohibit the sale of food that is, or contains, unsafe
poppy seeds.
Summary
This legislation would prohibit the sale of food that is,
or contains, unsafe levels of morphine, codeine, or other
alkaloid compounds in poppy seeds.
Legislative History
H.R. 6512 was introduced by Representative Womack (AR-R) on
November 29, 2023, and referred to the Committee on Energy and
Commerce.
On September 10, 2024, the Subcommittee on Health held a
hearing on H.R. 6512.
Physician Fee Schedule Update and Improvements Act
H.R. 6545
To amend title XVIII of the Social Security Act to make
improvements to the physician fee schedule under the Medicare
program.
Summary
This bill would extend for one year a policy to increase
the work geographic index to 1.00 for any locality where the
index would be less than 1.00, which is otherwise set to expire
January 1, 2024. It would also increase the Medicare physician
fee schedule conversion factor from 1.25 percent to 3 percent
for calendar year 2024 and extend incentive payments for
participation in eligible alternative payment models (APMs) for
one year and tiers the size of the bonus according to how long
a provider has participated in an APM to better account for
increased up-front costs of APM participation.
Legislative History
H.R. 6545 was introduced by Representative Miller-Meeks
(IA-R) on December 1, 2023, and referred to the Committee on
Energy and Commerce, and in addition to the Committee on Ways
and Means.
On October 19, 2023, the Subcommittee on Health held a
hearing on H.R. 6545.
On December 5, 2023, the full committee favorably reported
H.R. 6545, as amended, to the House by a vote of 46 to 0.
Innovation in Pediatric Drugs Act of 2023
H.R. 6664
To encourage innovation in the development of pediatric
drugs.
Summary
This legislation would remove the existing exemption for
orphan drugs to be studied in children before approval and
authorize the FDA to penalize companies that have not completed
required pediatric studies on time. Additionally, the bill
would reauthorize and increases funding for the National
Institutes of Health Best Pharmaceuticals for Children's Act
(BPCA) program, currently authorized at $25 million through
FY2027, to $50 million from FY2023 to FY2027.
Legislative History
H.R. 6664 was introduced by Representative Eshoo (CA-D) on
December 7, 2023, and referred to the Committee on Energy and
Commerce.
On February 29, 2024, the Subcommittee on Health held a
hearing on H.R. 6664.
Effective Screening and Testing for Tuberculosis Act
H.R. 6705
To require the Secretary of Health and Human Services to
treat certain tests for tuberculosis as breakthrough devices
eligible for expedited development and priority review, to
require certain establishments that perform donor screening or
testing to screen or test for active and latent tuberculosis.
Summary
This legislation would require the Secretary of Health and
Human Services (HHS) to treat certain tests for tuberculosis as
breakthrough devices eligible for expedited development and
priority review. It would also require certain establishments
that perform donor screening or testing to screen or test for
active and latent tuberculosis.
Legislative History
H.R. 6705 was introduced by Representative Moolenaar (MI-R)
on December 11, 2023, and referred to the Committee on Energy
and Commerce.
On February 29, 2024, the Subcommittee on Health held a
hearing on H.R. 6705.
Improving Newborns' Food and Nutrition Testing Safety (Infants) Act of
2023
H.R. 6770
To amend the Federal Food, Drug, and Cosmetic Act to ensure
the safety of infant and toddler food.
Summary
This legislation would require food facilities that
manufacture or process food for infants and toddlers to test
food samples for toxins such as lead, cadmium, mercury, and
arsenic. The bill would also require manufacturers of powdered
infant formula to implement an environmental monitoring program
for Cronobacter spp. and Salmonella. Manufacturers would be
required to report any contamination to the FDA within 24 hours
of discovery.
Legislative History
H.R. 6770 was introduced by Representative Sykes (OH-D) on
December 13, 2023, and referred to the Committee on Energy and
Commerce.
On September 10, 2024, the Subcommittee on Health held a
hearing on H.R. 6770.
Cardiomyopathy Health Education, Awareness, and Research, and AED
Training (Hearts) in the Schools Act of 2024
H.R. 6829
To amend the Public Health Service Act to authorize and
support the creation and dissemination of cardiomyopathy
education, awareness, and risk assessment materials and
resources to identify more at-risk families, to authorize
research and surveillance activities relating to
cardiomyopathy.
Summary
H.R. 6829 would direct the Department of Health and Human
Services (HHS) to develop and distribute certain educational
materials and resources regarding cardiomyopathy, automated
external defibrillators (AEDs), and cardiopulmonary
resuscitation (CPR), to school administrators, educators,
school health professionals, coaches, families, guardians,
caregivers, State and local health departments, certain health
professionals, and other relevant individuals. In addition,
this bill would require the Secretary to submit a report to
Congress on the Centers for Disease Control and Prevention's
(CDC's) existing activities related to cardiomyopathy, as well
as develop a risk assessment for individuals at risk of
cardiomyopathy. This bill would also allow the Secretary, in
consultation with the Director of the National Institutes of
Health (NIH), to expand and coordinate research with respect to
cardiomyopathy and requires a report on NIH's ongoing research
efforts. The bill also includes a program to promote student
access to AEDs and CPR in schools, including educational
materials, training programs, and equipment.
Legislative History
H.R. 6829 was introduced by Representative Pallone (NJ-D)
on December 14, 2023, and referred to the Committee on Energy
and Commerce.
On February 14, 2024, the Subcommittee on Health held a
hearing on H.R. 6829.
On March 12, 2024, the Subcommittee on Health favorably
forwarded H.R. 6829, as amended, to the full committee by a
vote of 24 to 0.
On March 20, 2024, the full committee favorably reported
H.R. 6829, as amended, to the House by a vote of 42 to 0.
On September 23, 2024, Representative Bucshon moved to
suspend the rules and pass H.R. 6829, as amended. The House
agreed to the motion by a voice vote.
On September 24, 2024, H.R. 6829 was received in the Senate
and referred to the Committee on Health, Education, Labor, and
Pensions.
On December 10, 2024, the HEARTS in the Schools Act of 2024
passed the Senate, without amendment, by unanimous consent.
On December 17, 2024, H.R. 6829 was presented to the
President.
Emergency Medical Services for Children Reauthorization Act of 2024
H.R. 6960
To amend the Public Health Service Act to reauthorize the
Emergency Medical Services for Children program.
Summary
H.R. 6960 would reauthorize the Emergency Medical Services
for Children program for five years.
Legislative History
H.R. 6960 was introduced by Representative Carter (GA-R) on
January 11, 2024, and referred to the Committee on Energy and
Commerce.
On February 14, 2024, the Subcommittee on Health held a
hearing on H.R. 6960.
On March 12, 2024, the Subcommittee on Health favorably
forwarded H.R. 6960 to the full committee by a vote of 23 to 0.
On March 20, 2024, the full committee favorably reported
H.R. 6960 to the House by a vote of 48 to 0.
On May 15, 2024, Representative Bucshon moved to suspend
the rules and pass H.R. 6960, without amendment. The House
agreed to the motion by a vote of 399 to 13.
On May 16, 2024, H.R. 6960 was received in the Senate and
referred to the Committee on Health, Education, Labor, and
Pensions.
On December 10, 2024, the Emergency Medical Services for
Children Reauthorization Act of 2024 passed the Senate, without
amendment, by unanimous consent.
On December 17, 2024, H.R. 6960 was presented to the
President.
Equal Access to Specialty Care Everywhere (EASE) Act of 2024
H.R. 7149
To amend title XI of the Social Security Act to require the
Center for Medicare and Medicaid Innovation to test a model to
improve access to specialty health services for certain
Medicare and Medicaid beneficiaries.
Summary
This legislation would require the Center for Medicare and
Medicaid Innovation (CMMI) to conduct a pilot program that
would assess the impact of furnishing certain specialty health
care services through telehealth and other remote technologies.
Legislative History
H.R. 7149 was introduced by Representative Steel (CA-R) on
January 30, 2024, and referred to the Committee on Energy and
Commerce, and in addition to the Committee on Ways and Means.
On April 10, 2024, the Subcommittee on Health held a
hearing on H.R. 7149.
Dr. Lorna Breen Health Care Provider Protection Reauthorization Act
H.R. 7153
To reauthorize the Dr. Lorna Breen Health Care Provider
Protection Act, and for other purposes.
Summary
H.R. 7153 reauthorizes the Dr. Lorna Breen Health Care
Provider Protection Act, which directs the Secretary of Health
and Human Services (HHS) to allocate resources to health care
entities for programs that promote the utilization of mental
health and substance use disorder services among health care
professionals.
Legislative History
H.R. 7153 was introduced by Representative Wild (PA-D) on
January 30, 2024, and referred to the Committee on Energy and
Commerce.
On February 14, 2024, the Subcommittee on Health held a
hearing on H.R. 7153.
On March 12, 2024, the Subcommittee on Health favorably
forwarded H.R. 7153, without amendment, to the full committee
by a vote of 23 to 0.
On March 20, 2024, the full committee favorably reported
H.R. 7153 to the House by a vote of 48 to 0.
United States Abraham Accords Cooperation and Security Act of 2024
H.R. 7155
To provide for the establishment, within the Food and Drug
Administration, of an Abraham Accords Bureau to promote and
facilitate cooperation between the Food and Drug Administration
and entities in Abraham Accords countries wishing to work with
the agency in order to develop and sell products in the United
States, and for other purposes.
Summary
This legislation would require the FDA to establish an
office in an Abraham Accord nation.
Legislative History
H.R. 7155 was introduced by Representative Harshbarger (TN-
R) on January 31, 2024, and referred to the Committee on Energy
and Commerce.
The provisions of H.R. 7155 were included in H.R. 3433,
which is discussed elsewhere in this report.
Shandra Eisenga Human Cell and Tissue Product Safety Act
H.R. 7188
To require the Secretary of Health and Human Services to
conduct a national, evidence-based education campaign to
increase public and health care provider awareness regarding
the potential risks and benefits of human cell and tissue
products transplants.
Summary
H.R. 7188 requires the Secretary of Health and Human
Service (HHS) to conduct a national, evidence-based education
campaign to increase public and health care provider awareness
regarding the potential risks and benefits of human cell and
tissue products transplants. The Secretary would also be
required to report any actions that could be taken to improve
the safety of human cell and tissue products and update
existing donor eligibility guidance accordingly. The bill also
establishes civil monetary penalties for any person who
violates human cell and tissue product requirements established
in section 361 of the Public Health Service Act.
Legislative History
H.R. 7188 was introduced by Representative Moolenaar (MI-R)
on February 1, 2024, and referred to the Committee on Energy
and Commerce.
On February 29, 2024, the Subcommittee on Health held a
hearing on H.R. 7188.
On May 16, 2024, the Subcommittee on Health favorably
forwarded H.R. 7188, as amended, to the full committee by a
vote of 27 to 0.
On September 18, 2024, the full committee favorably
reported H.R. 7188, as amended, to the House by a vote of 40 to
0.
On December 16, 2024, Representative Bucshon moved to
suspend the rules and pass H.R. 7188. The House agreed to the
motion by voice vote.
Dennis John Benigno Traumatic Brain Injury Program Reauthorization Act
of 2024
H.R. 7208
To reauthorize the Traumatic Brain Injury program.
Summary
H.R. 7208 would reauthorize Traumatic Brain Injuries (TBI)
programs at the Department of Health and Human Services (HHS).
The programs reauthorized in this bill allocate resources for
TBI prevention, improving access to TBI rehabilitation, and TBI
patient advocacy systems. The bill reauthorizes the program for
five fiscal years from 2025 through 2029.
Legislative History
H.R. 7208 was introduced by Representative Pascrell (NJ-D)
on February 1, 2024, and referred to the Committee on Energy
and Commerce.
On February 14, 2024, the Subcommittee on Health held a
hearing on H.R. 7208.
On March 12, 2024, the Subcommittee on Health favorably
forwarded H.R. 7208 to the full committee by voice vote.
On March 20, 2024, the full committee favorably reported
H.R. 7208, as amended, to the House by a vote of 44 to 0.
On September 17, 2024, Representative Miller-Meeks moved to
suspend the rules and pass H.R. 7208, as amended. The House
agreed to the motion by a voice vote.
On September 18, 2024, H.R. 7208 was received in the Senate
and placed on Senate Legislative Calendar under General Orders.
Autism Collaboration, Accountability, Research, Education, and Support
(CARES) Act of 2024
H.R. 7213
To amend the Public Health Service Act to enhance and
reauthorize activities and programs relating to autism spectrum
disorder, and for other purposes.
Summary
H.R. 7213 would reauthorize and make improvements to
certain programs related to autism spectrum disorder, including
the Developmental Disabilities Surveillance and Research
Program; Autism education, early detection, and intervention;
and the Interagency Autism Coordination Committee at currently
appropriated levels for fiscal years 2025 through 2029.
Legislative History
H.R. 7213 was introduced by Representative Smith (NJ-R) on
February 1, 2024, and referred to the Committee on Energy and
Commerce.
On February 14, 2024, the Subcommittee on Health held a
hearing on H.R. 7213.
On May 16, 2024, the Subcommittee on Health favorably
forwarded H.R. 7213, as amended, to the full committee by a
vote of 22 to 0.
On June 12, 2024, the full committee favorably reported
H.R. 7213, as amended, to the House by a vote of 42 to 0.
On September 17, 2024, Representative McMorris Rodgers
moved to suspend the rules and pass H.R. 7213, as amended. The
House agreed to the motion by a vote of 402 to 13.
On September 19, 2024, H.R. 7213 was received in the
Senate.
On November 21, 2024, the Autism CARES Act passed the
Senate, as amended, by voice vote.
On December 16, 2024, H.R. 7213, Representative Bucshon
moved to suspend the rules and concur with the Senate amendment
to H.R. 7213. The House agreed to the motion by a vote of 374
to 15.
To Amend the Public Health Service Act To Reauthorize the Stop,
Observe, Ask, and Respond to Health and Wellness Training Program
H.R. 7224
To amend the Public Health Service Act to reauthorize the
Stop, Observe, Ask, and Respond to Health and Wellness Training
Program.
Summary
This legislation would reauthorize the Stop, Observe, and
Respond (SOAR) to Health and Wellness training program for five
years.
Legislative History
H.R. 7224 was introduced by Representative Cohen (TN-D) on
February 5, 2024, and referred to the Committee on Energy and
Commerce.
On February 14, 2024, the Subcommittee on Health held a
hearing on H.R. 7224.
On March 12, 2024, the Subcommittee on Health favorably
forwarded H.R. 7224 to the full committee by a vote of 24 to 0.
On March 20, 2024, the full committee favorably reported
H.R. 7224 to the House by a vote of 45 to 0.
On December 16, 2024, Representative Bucshon moved to
suspend the rules and pass H.R. 7224. The House agreed to the
motion by voice vote.
FDA Modernization Act 3.0
H.R. 7248
To amend the Federal Food, Drug, and Cosmetic Act to
establish a process for the qualification of nonclinical
testing methods to reduce and replace the use of animals in
nonclinical research, improve the predictivity of nonclinical
testing methods, and reduce development time for a biological
product or other drug.
Summary
This legislation would establish a process for the
qualification of nonclinical testing methods to replace the use
of animals in nonclinical research. Specifically, the FDA would
prequalify non-animal testing methods before the technologies
are integrated into an application.
Legislative History
H.R. 7248 was introduced by Representative Carter (GA-R) on
February 6, 2024, and referred to the Committee on Energy and
Commerce.
On February 29, 2024, the Subcommittee on Health held a
hearing on H.R. 7248.
Family-to-Family Reauthorization Act of 2024
H.R. 7300
To amend title V of the Social Security Act to extend
funding for the family-to-family health information centers.
Summary
This legislation reauthorizes the funding for family-to-
family health information centers through fiscal year 2029.
Legislative History
H.R. 7300 was introduced by Representative Sherrill (NJ-D)
on February 7, 2024, and referred to the Committee on Energy
and Commerce.
On February 14, 2024, the Subcommittee on Health held a
hearing on H.R. 7300.
The provisions of H.R. 7300 were included in H.R. 7623,
which is discussed elsewhere in this report.
Certain provisions of H.R. 7300 were included in H.R.
10545.
On December 21, 2024, the House agreed to suspend the rules
and pass H.R. 10545 by a vote of 366 to 34.
On December 21, 2024 the Senate passed H.R. 10545 by a vote
of 85 to 11.
Retaining Access and Restoring Exclusivity (RARE) Act
H.R. 7383
To amend the Federal Food, Drug, and Cosmetic Act to set
forth limitations on exclusive approval or licensure of drugs
designated for rare diseases or conditions.
Summary
This legislation would clarify the FDA's interpretation of
limiting orphan drug exclusivity to the approved indication
rather than the potentially broader designation.
Legislative History
H.R. 7383 was introduced by Representative Matsui (CA-D) on
February 15, 2024, and referred to the Committee on Energy and
Commerce.
On February 29, 2024, the Subcommittee on Health held a
hearing on H.R. 7383.
Creating Hope Reauthorization Act of 2024
H.R. 7384
To amend the Federal Food, Drug, and Cosmetic Act to extend
the authority of the Secretary of Health and Human Services to
issue priority review vouchers to encourage treatments for rare
pediatric diseases.
Summary
This legislation would extend the FDA priority review
voucher program from FY2024 through FY2028 to incentivize the
development of drugs for rare pediatric diseases.
Legislative History
H.R. 7384 was introduced by Representative McCaul (TX-R) on
February 15, 2024, and referred to the Committee on Energy and
Commerce.
On February 29, 2024, the Subcommittee on Health held a
hearing on H.R. 7384.
DeOndra Dixon INCLUDE Project Act of 2024
H.R. 7406
To amend the Public Health Service Act to authorize the
Secretary of Health and Human Services to carry out a program
of research, training, and investigation related to Down
syndrome.
Summary
H.R. 7406 would reauthorize the INCLUDE (Investigation of
Co-occurring conditions across the Lifespan to Understand Down
syndromE) Project at the National Institutes of Health (NIH),
which is currently funded to promote the scientific
understanding of Down syndrome and co-occurring conditions and
improve the quality of life of individuals with Down syndrome
and their families. This bill would also require reporting to
Congress on the program's progress and related research. The
legislation reauthorizes the program for five fiscal years from
2025 to 2029.
Legislative History
H.R. 7406 was introduced by Representative McMorris Rodgers
(WA-R) on February 16, 2024, and referred to the Committee on
Energy and Commerce.
On February 14, 2024, the Subcommittee on Health held a
hearing on H.R. 7406.
On March 12, 2024, the Subcommittee on Health favorably
forwarded H.R. 7406, as amended, to the full committee by voice
vote.
On March 20, 2024, the full committee favorably reported
H.R. 7406, as amended, to the House by a vote of 45 to 0.
On September 17, 2024, Representative McMorris Rodgers
moved to suspend the rules and pass H.R. 7406, as amended. The
House agreed to the motion by a voice vote.
On September 18, 2024, H.R. 7406 was received in the Senate
and referred to the Committee on Health, Education, Labor, and
Pensions.
Sickle Cell Disease Comprehensive Care Act
H.R. 7432
To amend title XIX of the Social Security Act to enable
State Medicaid programs to provide comprehensive, coordinated
care through a health home to individuals with sickle cell
disease.
Summary
H.R. 7432 would allow State Medicaid programs to establish
health homes for eligible beneficiaries with sickle cell
disease.
Legislative History
H.R. 7432 was introduced by Representative Burgess (TX-R)
on February 23, 2024, and referred to the Committee on Energy
and Commerce.
On February 29, 2024, the Subcommittee on Health held a
hearing on H.R. 7432.
Antimicrobial Resistance Research Assessment Act of 2024
H.R. 7436
To direct the Comptroller General of the United States to
prepare a report on Federal efforts to address antimicrobial
resistance.
Summary
This legislation would require the Government
Accountability Office (GAO) to report on the efforts of the
federal government to address antimicrobial resistance,
including the roles of each federal program in these efforts
and recommendations to improve coordination.
Legislative History
H.R. 7436 was introduced by Representative Griffith (VA-R)
on February 23, 2024, and referred to the Committee on Energy
and Commerce.
On February 29, 2024, the Subcommittee on Health held a
hearing on H.R. 7436.
Real-Time Benefit Tool Implementation Act
H.R. 7512
To amend title XVIII of the Social Security Act to ensure
implementation of real-time benefit tools under Part D of the
Medicare program.
Summary
This discussion draft would clarify implementation of the
Medicare Part D real-time benefit tools (RTBT) requirements by
requiring prescription drug plan (PDP) sponsors provide
patients real-time information related to formularies and
benefit information (including cost and utilization management
policies) within 1-year of enactment.
Legislative History
H.R. 7512 was introduced by Representative Arrington (TX-R)
on March 1, 2024, and referred to the Committee on Ways and
Means, and in addition to the Committee on Energy and Commerce.
On October 19, 2023, the Subcommittee on Health held a
hearing on H.R. 7512.
To Prohibit the Secretary of Health and Human Services From Finalizing
a Proposed Rule Regarding Minimum Staffing for Nursing Facilities, And
To Establish an Advisory Panel on the Skilled Nursing Facility
Workforce
H.R. 7513
To prohibit the Secretary of Health and Human Services from
finalizing a proposed rule regarding minimum staffing for
nursing facilities, and to establish an advisory panel on the
skilled nursing facility workforce
Summary
This legislation would prohibit the Secretary of HHS from
finalizing regulations that would require long-term care
facilities to adhere to minimum staffing standards.
Legislative History
H.R. 7513 was introduced by Representative Fischbach (MN-R)
on March 1, 2024, and referred to the Committee on Ways and
Means, and in addition to the Committee on Energy and Commerce.
On April 30, 2024, the Subcommittee on Health held a
hearing on H.R. 7513.
Food Traceability Enhancement Act
H.R. 7563
To strengthen compliance with the FDA Food Traceability
Rule, to enhance the FDA foodborne illness outbreak
investigation process.
Summary
This legislation would require the FDA to conduct pilot
projects with restaurants, retail food establishments, and
warehouses on the effectiveness and use of traceability lot
codes before the compliance date of the ``Requirements for
Additional Traceability Records for Certain Foods'' final rule.
Legislative History
H.R. 7563 was introduced by Representative Franklin (FL-R)
on March 6, 2024, and referred to the Committee on Energy and
Commerce.
On September 10, 2024, the Subcommittee on Health held a
hearing on H.R. 7563.
Stop Unfair Medicaid Recoveries Act
H.R. 7573
To amend title XIX of the Social Security Act to repeal the
requirement that States establish a Medicaid Estate Recovery
Program and to limit the circumstances in which a State may
place a lien on a Medicaid beneficiary's property.
Summary
This legislation would repeal the requirement for States to
engage in estate recovery practices and limit the ability of
States to place liens on a Medicaid beneficiary's property.
Legislative History
H.R. 7573 was introduced by Representative Schakowsky (IL-
D) on March 6, 2024, and referred to the Committee on Energy
and Commerce.
On April 30, 2024, the Subcommittee on Health held a
hearing on H.R. 7573.
Telehealth Modernization Act of 2024
H.R. 7623 (H.R. 134, H.R. 1110, H.R. 1406, H.R. 2679, H.R. 3842, H.R.
6033, H.R. 7300)
To amend title XVIII of the Social Security Act to make
certain permanent telehealth flexibilities under the Medicare
program.
Summary
H.R. 7623 would make certain telehealth flexibilities
permanent under Medicare. The telehealth flexibilities that are
extended by this legislation include: removing geographic
restrictions, expanding eligibility for practitioners to
furnish telehealth services, retaining the waiver process for
modifying telehealth services covered under Medicare,
implementing a permanent payment system for telehealth services
furnished by rural health clinics (RHCs) and federally
qualified health centers (FQHCs), allowing clinically
appropriate use of telehealth for hospice care and home
dialysis, and allowing the use of audio-only telecommunications
technology.
Legislative History
H.R. 7623 was introduced by Representative Carter (GA-R) on
March 12, 2024, and referred to the Committee on Energy and
Commerce, and in addition to the Committee on Ways and Means.
On April 10, 2024, the Subcommittee on Health held a
hearing on H.R. 7623.
On May 16, 2024, the Subcommittee on Health favorably
forwarded H.R. 7623, as amended, to the full committee by a
vote of 21 to 0.
On September 18, 2024, the full committee favorably
reported H.R. 7623, as amended, to the House by a vote of 41 to
0.
Certain provisions of H.R. 7623 were included in H.R.
10545.
On December 21, 2024, the House agreed to suspend the rules
and pass H.R. 10545 by a vote of 366 to 34.
On December 21, 2024 the Senate passed H.R. 10545 by a vote
of 85 to 11.
Advancing Access to Telehealth Act
H.R. 7711
To amend title XVIII of the Social Security Act to make
permanent certain telehealth flexibilities under the Medicare
program.
Summary
This legislation would make certain telehealth
flexibilities permanent under Medicare. The flexibilities cited
in this legislation include, removing geographic restrictions,
allowing for the use of audio-only telecommunications
technology, and eliminating in-person requirements for certain
services furnished through telehealth.
Legislative History
H.R. 7711 was introduced by Representative Dingell (MI-D)
on March 19, 2024, and referred to the Committee on Energy and
Commerce, and in addition to the Committee on Ways and Means.
On April 10, 2024, the Subcommittee on Health held a
hearing on H.R. 7711.
Promoting Responsible and Effective Virtual Experiences Through Novel
Technology (PREVENT) To Deliver Improved Access and Better Engagement
With Tested and Evidence-Based Strategies (DIABETES) Act
H.R. 7856
To amend title XVIII of the Social Security Act to provide
for coverage of the Medicare Diabetes Prevention program, and
for other purposes.
Summary
This legislation would establish a diabetes prevention
program under Medicare that furnishes structured behavioral
health change services, for the purpose of preventing or
delaying the onset of type II diabetes. In addition, this
legislation would sunset the Medicare Diabetes Prevention
Program Expanded Model.
Legislative History
H.R. 7856 was introduced by Representative DeGette (CO-D)
on April 2, 2024, and referred to the Committee on Energy and
Commerce, and in addition to the Committee on Ways and Means.
On April 10, 2024, the Subcommittee on Health held a
hearing on H.R. 7856.
On May 16, 2024, the Subcommittee on Health favorably
forwarded H.R. 7856, as amended, to the full committee by voice
vote.
Telehealth Enhancement for Mental Health Act of 2024
H.R. 7858
To amend title XVIII of the Social Security Act to
establish a Medicare incident to modifier for mental health
services furnished through telehealth and other telehealth
services.
Summary
This legislation would direct the Secretary of HHS to
implement a coding modifier to identify telehealth claims for
services that are key components of the care process and are
furnished by non-physician clinicians or support staff.
Legislative History
H.R. 7858 was introduced by Representative James (MI-R) on
April 2, 2024, and referred to the Committee on Energy and
Commerce, and in addition to the Committee on Ways and Means.
On April 10, 2024, the Subcommittee on Health held a
hearing on H.R. 7858.
On May 16, 2024, the Subcommittee on Health favorably
forwarded H.R. 7858, as amended, to the full committee by a
vote of 22 to 0.
On June 12, 2024, the full committee favorably reported
H.R. 7858, as amended, to the House by a vote of 40 to 0.
On September 17, 2024, Representative McMorris Rodgers
moved to suspend the rules and pass H.R. 7858, as amended. The
House agreed to the motion by a voice vote.
On September 18, 2024, H.R. 7858 was received in the Senate
and referred to the Committee on Finance.
To Require the Secretary of HHS To Issue Guidance on Furnishing
Behavioral Health Services Via Telehealth to Individuals With Limited
English Proficiency Under Medicare Program
H.R. 7863
To require the Secretary of HHS to issue guidance on
furnishing behavioral health services via telehealth to
individuals with limited English proficiency under Medicare
program.
Summary
This legislation would require the Secretary of HHS to
issue guidance for providers on best practices for furnishing
behavioral health services via telehealth to Medicare
beneficiaries with limited English proficiency.
Legislative History
H.R. 7863 was introduced by Representative Steel (CA-R) on
April 2, 2024, and referred to the Committee on Energy and
Commerce.
On April 10, 2024, the Subcommittee on Health held a
hearing on H.R. 7863.
Leveraging Integrity and Verification of Eligibility (LIVE) for
Beneficiaries Act
H.R. 8084
To amend title XIX of the Social Security Act to require
States to verify certain eligibility criteria for individuals
enrolled for medical assistance quarterly, and for other
purposes.
Summary
H.R. 8084 would require States to screen the Social
Security Administration's Death Master File (DMF) to identify
currently enrolled Medicaid beneficiaries who are deceased and
remove identified deceased beneficiaries from enrollment in
Medicaid.
Legislative History
H.R. 8084 was introduced by Representative Bilirakis (FL-R)
on April 19, 2024, and referred to the Committee on Energy and
Commerce.
On April 30, 2024, the Subcommittee on Health held a
hearing on H.R. 8084.
On May 16, 2024, the Subcommittee on Health favorably
forwarded H.R. 8084 to the full committee by a vote of 18 to 0.
On June 12, 2024, the full committee favorably reported
H.R. 8084, as amended, to the House by a vote of 46 to 0.
On September 17, 2024, Representative McMorris Rodgers
moved to suspend the rules and pass H.R. 8084, as amended. The
House agreed to the motion by a voice vote.
On September 18, 2024, H.R. 8084 was received in the Senate
and referred to the Committee on Finance.
Medicare and Medicaid Fraud Prevention Act of 2024
H.R. 8089
To amend title XIX of the Social Security Act to require
certain additional provider screening under the Medicaid
program.
Summary
H.R. 8089 would require State Medicaid agencies to check
the Social Security Administration's Death Master File (DMF) to
determine--as part of a provider's enrollment (or reenrollment
or revalidation of enrollment) in the Medicaid program--that
the provider is not deceased.
Legislative History
H.R. 8089 was introduced by Representative Garcia (CA-R) on
April 19, 2024, and referred to the Committee on Energy and
Commerce.
On April 30, 2024, the Subcommittee on Health held a
hearing on H.R. 8089.
On May 16, 2024, the Subcommittee on Health favorably
forwarded H.R. 8089, as amended, to the full committee by a
vote of 22 to 0.
On June 12, 2024, the full committee favorably reported
H.R. 8089, as amended, to the House by a vote of 45 to 0.
On September 17, 2024, Representative McMorris Rodgers
moved to suspend the rules and pass H.R. 8089, as amended. The
House agreed to the motion by a voice vote.
On September 18, 2024, H.R. 8089 was received in the Senate
and referred to the Committee on Finance.
To Amend Title XIX of the Social Security Act To Modify Certain Asset
Recovery Rules
H.R. 8094
To amend title XIX of the Social Security Act to modify
certain asset recovery rules.
Summary
This legislation would modify asset recovery under a State
plan, so that States may choose to not pursue adjustments or
recoveries of medical assistance through a property lien if,
after the death of an individual, that individual's home would
be transferred to another individual who is eligible for
Medicaid or has an income that is 138 percent of the Federal
Poverty Level or below.
Legislative History
H.R. 8094 was introduced by Representative Kean (NJ-R) on
April 19, 2024, and referred to the Committee on Energy and
Commerce.
On April 30, 2024, the Subcommittee on Health held a
hearing on H.R. 8094.
To Amend Title XIX of the Social Security Act To Increase Transparency
and Expand Coverage Options With Respect to Home and Community-Based
Services Under a Medicaid Waiver
H.R. 8106
To amend title XIX of the Social Security Act to increase
transparency and expand coverage options with respect to home
and community-based services under a Medicaid waiver.
Summary
This legislation would amend Medicaid's section 1915(c)
waivers to allow States to provide home and community-based
services to beneficiaries who do not meet an institutional
level of care. Additionally, this legislation would require
States to report on the state of waiting lists for HCBS care.
Legislative History
H.R. 8106 was introduced by Representative McMorris Rodgers
(WA-R) on April 23, 2024, and referred to the Committee on
Energy and Commerce.
On April 30, 2024, the Subcommittee on Health held a
hearing on H.R. 8106.
Ensuring Access to Medicaid Buy-In Programs Act of 2024
H.R. 8107
To amend title XIX of the Social Security Act to remove
certain age restrictions on Medicaid eligibility for working
adults with disabilities
Summary
H.R. 8107 amends the Medicaid buy-in program to repeal the
eligibility pathway's age limit of 65 to allow current
beneficiaries to continue to be able to retain coverage through
the program. Additionally, it would authorize a demonstration
where up to five States could opt to provide home and
community-based services in Medicaid for individuals who do not
otherwise need an institutional level of care for 5 years.
Legislative History
H.R. 8107 was introduced by Representative Ciscomani (AZ-R)
on April 23, 2024, and referred to the Committee on Energy and
Commerce.
On April 30, 2024, the Subcommittee on Health held a
hearing on H.R. 8107.
On September 18, 2024, the full committee favorably
reported H.R. 8107, as amended, to the House by a vote of 43 to
0.
To Amend Title XIX of the Social Security Act To Add a Medicaid State
Plan Requirement With Respect to the Determination of Residency of
Certain Individuals Serving in the Armed Forces
H.R. 8108
To amend title XIX of the Social Security Act to add a
Medicaid State plan requirement with respect to the
determination of residency of certain individuals serving in
the Armed Forces.
Summary
H.R. 8108 would require States to continue to provide
Medicaid coverage for (or retain waiting list placement for)
active-duty military families who are receiving home and
community-based services (or are on the waitlist to receive
such services) in the event that the family moves out of state
for military relocation.
Legislative History
H.R. 8108 was introduced by Representative Kiggans (VA-R)
on April 23, 2024, and referred to the Committee on Energy and
Commerce.
On April 30, 2024, the Subcommittee on Health held a
hearing on H.R. 8108.
On September 18, 2024, the full committee favorably
reported H.R. 8108, as amended, to the House by a vote of 42 to
0.
On September 23, 2024, Representative Bucshon moved to
suspend the rules and pass H.R. 8108, as amended. The House
agreed to the motion by a voice vote.
On September 24, 2024, H.R. 8108 was received in the Senate
and referred to the Committee on Finance.
Money Follows the Person Permanency Act of 2024
H.R. 8109
To amend the Deficit Reduction Act of 2005 to make
permanent the Money Follows the Person rebalancing
demonstration.
Summary
This legislation would permanently extend the Money Follows
the Person rebalancing demonstration, which supports the
transition from living in an inpatient facility to home and
community based services (HCBS) for long term services and
supports (LTSS) eligible individuals.
Legislative History
H.R. 8109 was introduced by Representative Dingell (MI-D)
on April 23, 2024, and referred to the Committee on Energy and
Commerce.
On April 30, 2024, the Subcommittee on Health held a
hearing on H.R. 8109.
Protecting Married Seniors From Impoverishment Act of 2024
H.R. 8110
To amend title XIX of the Social Security Act to make
permanent the State option to extend protection against spousal
impoverishment for recipients of home and community-based
services under Medicaid.
Summary
This legislation would permanently extend spousal
impoverishment protections for beneficiaries receiving home and
community-based services, akin to current protections for
beneficiaries receiving institutional care.
Legislative History
H.R. 8110 was introduced by Representative Dingell (MI-D)
on April 23, 2024, and referred to the Committee on Energy and
Commerce.
On April 30, 2024, the Subcommittee on Health held a
hearing on H.R. 8110.
Medicaid Program Improvement Act
H.R. 8111
To amend title XIX of the Social Security Act to ensure the
reliability of address information provided under the Medicaid
program.
Summary
H.R. 8111 would require States to regularly obtain
beneficiary address information from reliable sources,
including (where applicable) Medicaid managed care plans, to
promote the State's ability to contact the beneficiary, and to
confirm a Medicaid beneficiary's residence is within the state.
Legislative History
H.R. 8111 was introduced by Representative Miller-Meeks
(IA-R) on April 23, 2024, and referred to the Committee on
Energy and Commerce.
On April 30, 2024, the Subcommittee on Health held a
hearing on H.R. 8111.
On May 16, 2024, the Subcommittee on Health favorably
forwarded H.R. 8111, as amended, to the full committee by a
vote of 22 to 0.
On June 12, 2024, the full committee favorably reported
H.R. 8111, as amended, to the House by a vote of 46 to 0.
On September 17, 2024, Representative Miller-Meeks moved to
suspend the rules and pass H.R. 8111, as amended. The House
agreed to the motion by a voice vote.
On September 18, 2024, H.R. 8111 was received in the Senate
and referred to the Committee on Finance.
To Amend Title XIX of the Social Security Act to Further Require
Certain Additional Provider Screening Under the Medicaid Program
H.R. 8112
To amend title XIX of the Social Security Act to further
require certain additional provider screening under the
Medicaid program.
Summary
H.R. 8112 would require States to regularly check the Data
Exchange System (DEX) to determine as part of a provider's
enrollment (or reenrollment or revalidation of enrollment) in
the Medicaid program that the provider is not prohibited from
participating in the Medicare program.
Legislative History
H.R. 8112 was introduced by Representative D'Esposito (NY-
R) on April 23, 2024, and referred to the Committee on Energy
and Commerce.
On April 30, 2024, the Subcommittee on Health held a
hearing on H.R. 8112.
On May 16, 2024, the Subcommittee on Health favorably
forwarded H.R. 8112, as amended, to the full committee by a
vote of 23 to 0.
On June 12, 2024, the full committee favorably reported
H.R. 8112, as amended, to the House by a vote of 44 to 0.
On September 17, 2024, Representative McMorris Rodgers
moved to suspend the rules and pass H.R. 8112, as amended. The
House agreed to the motion by a voice vote.
On September 18, 2024, H.R. 8112 was received in the Senate
and referred to the Committee on Finance.
Transparency Into State Directed Payments Act of 2024
H.R. 8113
To amend title XIX of the Social Security Act to require
reporting on certain directed payments under the Medicaid
program.
Summary
This legislation would require States to report on provider
level data from amounts paid by the State through State
Directed Payments.
Legislative History
H.R. 8113 was introduced by Representative Griffith (VA-R)
on April 23, 2024, and referred to the Committee on Energy and
Commerce.
On April 30, 2024, the Subcommittee on Health held a
hearing on H.R. 8113.
To Prohibit the Secretary of Health and Human Services From Finalizing
a Rule Proposed by the Centers for Medicare & Medicaid Services To
Place Certain Limitations on Medicaid Payments for Home or Community-
Based Services
H.R. 8114
To prohibit the Secretary of Health and Human Services from
finalizing a rule proposed by the Centers for Medicare &
Medicaid Services to place certain limitations on Medicaid
payments for home or community-based services.
Summary
This legislation would prohibit the Secretary of HHS from
finalizing regulations that would require pass-through payment
requirements for home and community-based services.
Legislative History
H.R. 8114 was introduced by Representative Cammack (FL-R)
on April 23, 2024, and referred to the Committee on Energy and
Commerce.
On April 30, 2024, the Subcommittee on Health held a
hearing on H.R. 8114.
To Amend Title XIX of the Social Security Act To Allow for the Deferral
or Disallowance of Portions of Payments for Certain Managed Care
Violations Under Medicaid
H.R. 8115
To amend title XIX of the Social Security Act to allow for
the deferral or disallowance of portions of payments for
certain managed care violations under Medicaid.
Summary
This legislation would establish enforcement mechanisms for
the Secretary of HHS to make partial deferrals of payments to
Medicaid managed care organizations, in addition to other
existing enforcement tools, for purposes of ensuring compliance
with federal laws.
Legislative History
H.R. 8115 was introduced by Representative Sarbanes (MD-D)
on April 23, 2024, and referred to the Committee on Energy and
Commerce.
On April 30, 2024, the Subcommittee on Health held a
hearing on H.R. 8115.
Improving Seniors' Timely Access to Care Act of 2024
H.R. 8702
To amend title XVIII of the Social Security Act to
establish requirements with respect to the use of prior
authorization under Medicare Advantage plans.
Summary
This discussion draft would require Medicare Advantage
plans with prior authorization requirements to establish an
electronic prior authorization program that meets certain
enrollee protection standards and transparency requirements.
Legislative History
H.R. 8702 was introduced by Representative Kelly (PA-R) on
June 12, 2024, and referred to the Committee on Ways and Means,
and in addition to the Committee on Energy and Commerce.
On October 19, 2023, the Subcommittee on Health held a
hearing on H.R. 8702.
Physician Led and Rural Access to Quality Care Act
H.R. 9001
To amend title XVIII of the Social Security Act to revise
certain physician self-referral exemptions relating to
physician-owned hospitals.
Summary
H.R. 9001 would modify the physician self-referral
exemptions related to Physician-Owned Hospitals (POHs) for
certain rural hospitals that are located a certain distance
from an existing hospital or critical access hospital.
Legislative History
On October 19, 2023, the Subcommittee on Health held a
hearing on a discussion draft entitled ``To amend title XVIII
of the Social Security Act to revise certain physician self-
referral exemptions relating to physician-owned hospitals.''
H.R. 9001 was introduced by Representative Burgess (TX-R)
on July 11, 2024, and referred to the Committee on Energy and
Commerce, and in addition to the Committee on Ways and Means.
H.R. 9001 was similar to the discussion draft.
Building America's Health Care Workforce Act
H.R. 9067, H.R. 468
To amend titles XVIII and XIX of the Social Security Act to
establish a waiver of certain training and certification
requirements for specified skilled nursing facilities and
nursing facilities.
Summary
H.R. 9067 would permit States and nursing homes to pursue
waivers to let temporary nurse aides to practice in nursing
homes for more than 120 days.
Legislative History
H.R. 468 was introduced by Representative Guthrie (KY-R) on
January 24, 2023, and referred to the Committee on Energy and
Commerce, and in addition to the Committee on Ways and Means.
On April 30, 2024, the Subcommittee on Health held a
hearing on H.R. 468.
On May 16, 2024, the Subcommittee on Health favorably
forwarded H.R. 468, as amended, to the full committee by a vote
of 14 to 8.
H.R. 9067 was introduced by Representative Guthrie (KY-R)
on September 18, 2024, and referred to the Committee on Ways
and Means, and in addition to the Committee on Energy and
Commerce. H.R. 9067 was similar to H.R. 468.
On September 18, 2024, the full committee favorably
reported H.R. 9067, as amended, to the House by a vote of 23 to
17.
Patient Access Act of 2024
H.R. 9184
To amend title XI of the Social Security Act to exclude
from anti kickback an do ther sanctions certain travel and
lodging arrangements between manufacturers of drugs and
individuals being administered such drugs, and for other
purposes.
Summary
H.R. 9184 would prevent antikickback penalties from being
applied to certain travel and lodging arrangements, made
between a drug manufacturer and an individual who is prescribed
such drug, as a means to improve access to treatments that may
otherwise require traveling to centers of excellence to receive
necessary care.
Legislative History
On February 29, 2024, the Subcommittee on Health held a
hearing on a discussion draft entitled ``Patient Access Act.''
H.R. 9184 was introduced by Representative Guthrie (KY-R)
on July 30, 2024, and referred to the Committee on Energy and
Commerce, and in addition to the Committee on Ways and Means.
H.R. 9184 was similar to the discussion draft.
Tobacco User Fee Modernization Act of 2024
H.R. 9425
To amend the Federal Food, Drug, and Cosmetic Act to
authorize tobacco user fee assessments for all regulated
tobacco products, and for other purposes.
Summary
This legislation would increase the amount of fees
collected by CTP and increase the amount by inflation in
perpetuity. It also requires additional data to be submitted
the FDA and authorizes tobacco user fee assessments for all
regulated tobacco products, including ``deemed'' products.
Legislative History
H.R. 9425 was introduced by Representative McClellan (VA-D)
on August 30, 2024, and referred to the Committee on Energy and
Commerce.
On September 10, 2024, the Subcommittee on Health held a
hearing on H.R. 9425.
Federal and State Food Safety Information Sharing Act of 2024
H.R. 9443
To amend the Federal Food, Drug, and Cosmetic Act to
authorize the Secretary of Health and Human Services to share
food safety information with State, local, Tribal, and
Territorial authorities, and for other purposes.
Summary
This legislation would authorize the Secretary of Health
and Human Services to share unredacted information related to
foodborne illness surveillance, laboratory sampling testing
information, inspection information, distribution lists,
consumer complaints, and any other information the Secretary
determines will assist in protecting the public with state,
local, tribal, and territorial authorities.
Legislative History
H.R. 9443 was introduced by Representative Ross (NC-D) on
August 30, 2024, and referred to the Committee on Energy and
Commerce.
On September 10, 2024, the Subcommittee on Health held a
hearing on H.R. 9443.
Providing for Congressional Disapproval Under Chapter 8 of Title 5,
United States Code, of the Rule Submitted by the Centers for Medicare &
Medicaid Services Relating to ``Medicare and Medicaid Programs: Minimum
Staffing Standards for Long-Term Care Facilities and Medicaid
Institutional Payment Transparency Reporting''
H.J. RES. 139
To Providing for congressional disapproval under chapter 8
of title 5, United States Code, of the rule submitted by the
Centers for Medicare & Medicaid Services relating to ``Medicare
and Medicaid Programs: Minimum Staffing Standards for Long-Term
Care Facilities and Medicaid Institutional Payment Transparency
Reporting''.
Summary
H.J. Res. 139 would overturn the Medicare and Medicaid
Programs: Minimum Staffing Standards for Long-Term Care
Facilities and Medicaid Institutional Payments Transparency
Reporting final rule that was finalized by the Centers for
Medicare and Medicaid Services on May 10, 2024.
Legislative History
H.J. Res. 139 was introduced by Representative Fischbach
(MN-R) on May 10, 2024, and referred to the Committee on Energy
and Commerce, and in addition to the Committee on Ways and
Means.
On October 25, 2023, the Subcommittee on Health held a
hearing on H.J. Res. 139.
On September 18, 2024, the full committee favorably
reported H.J. Res. 139, without amendment, to the House by a
vote of to 18.
Fewer Burdens for Better Care Act of 2023
DISCUSSION DRAFT
To amend title XVIII of the Social Security Act to provide
for multi-stakeholder input on removal of quality and
efficiency measures, and for other purposes.
Summary
This discussion draft would require the Secretary of Health
and Human Services to provide a 30-day public comment period
for stakeholders to provide feedback on quality and efficiency
measures that could be considered for removal.
Legislative History
On October 19, 2023, the Subcommittee on Health held a
hearing on a discussion draft entitled ``Fewer Burdens for
Better Care Act of 2023.''
Stop Drug Shortages Act
DISCUSSION DRAFT
To address drug shortages, and for other purposes.
Summary
The discussion draft would address drug shortages through a
number of provisions to increase reimbursement for sterile
generic injectable drugs in shortage or those made by multiple
manufacturers indicated for a serious disease or condition.
Specifically, the bill would suspend additional inflationary
rebates for sterile, injectable, generics and generic drugs at
risk of or in shortage, exempt certain generic, sterile,
injectables from 340B rebates, and require the Centers for
Medicare and Medicaid Services (CMS) to phase-out the rebate
reduction in Medicare Part D and Part B for drugs exiting a
shortage. Specifically, the bill would suspend additional
inflationary rebates for sterile, injectable, generics and
generic drugs at risk of or in shortage, exempt certain
generic, sterile, injectables from 340B rebates, and require
CMS to phase-out the rebate reduction in Medicare Part D and
Part B for drugs exiting a shortage.
Legislative History
On September 14, 2023, the Subcommittee on Health held a
hearing on a discussion draft entitled ``Stop Drug Shortages
Act.''
To Amend the Public Health Service Act With Respect to the Covered
Countermeasure Process Fund
DISCUSSION DRAFT
To amend the Public Health Service Act with respect to the
Covered Countermeasure Process Fund.
Summary
The discussion draft would require the Secretary to make
reasonable efforts to inform the public about the availability
of the Fund, require the Secretary to release the covered
countermeasure injury table within 180 days after making a
declaration under 319F 3(b), and provide rationale for denied
claims.
Legislative History
On April 19, 2023, the Subcommittee on Health held a
hearing on a discussion draft entitled ``to amend the Public
Health Service Act with respect to the Covered Countermeasure
Process Fund.''
To Amend Title XVIII of the Social Security Act To Allow for the Use of
Alternative Measures of Performance Under the Merit-Based Incentive
Payment System Under the Medicare Program
DISCUSSION DRAFT
To amend title XVIII of the Social Security Act to allow
for the use of alternative measures of performance under the
Merit-based Incentive Payment System under the Medicare
program.
Summary
This discussion draft would allow MIPS reporting
flexibility for physicians who perform the majority of their
work in a facility-based setting by allowing physicians to
choose to use quality or value-based program measures used
under their respective sites of care.
Legislative History
On October 19, 2023, the Subcommittee on Health held a
hearing on a discussion draft entitled ``To amend title XVIII
of the Social Security Act to allow for the use of alternative
measures of performance under the Merit-based Incentive Payment
System under the Medicare program.''
To Amend Title XVIII of the Social Security Act To Provide for Parity
in Medicare Payments for Hospital Outpatient Department Services
Furnished Off Campus
DISCUSSION DRAFT
To amend title XVIII of the Social Security Act to provide
for parity in Medicare payments for hospital outpatient
department services furnished off campus.
Summary
The discussion draft equalizes the amount Medicare and
Medicare beneficiaries pay for physician-administered drugs
across outpatient settings.
Legislative History
On April 26, 2024, the Subcommittee on Health held a
hearing on a discussion draft entitled ``To amend title XVIII
of the Social Security Act to provide for parity in Medicare
payments for hospital outpatient department services furnished
off-campus.''
To Amend Title XVIII of the Social Security Act To Provide for Site
Neutral Payments Under the Medicare Program for Certain Services
Furnished in Ambulatory Settings
DISCUSSION DRAFT
To amend title XVIII of the Social Security Act to provide
for site neutral payments under the Medicare program for
certain services furnished in ambulatory settings.
Summary
This discussion draft implements a proposal designed by the
Medicare Payment Advisory Commission (MedPAC) to ensure that
for certain services performed safely in multiple care
settings, patients and Medicare pay the same amount for the
same services regardless of where they are furnished. The
discussion draft limits Medicare revenue reductions at safety
net hospitals to 4.1 percent annually, but the Secretary has
discretion to set a lower amount.
Legislative History
On April 26, 2024, the Subcommittee on Health held a
hearing on a discussion draft entitled ``To amend XVIII of the
Social Security Act to provide for site neutral payments under
the Medicare program for certain services furnished in
ambulatory settings.''
To Amend Title XVIII of the Social Security Act To Require Payment for
All Hospital-Owned Physician Offices Located Off-Campus be Paid in
Accordance With the Applicable Payment System for the Items and
Services Furnished
DISCUSSION DRAFT
To amend title XVIII of the Social Security Act to require
payment for all hospital-owned physician offices located off-
campus be paid in accordance with the applicable payment system
for the items and services furnished.
Summary
The discussion draft would expand upon the 2015 Bipartisan
Budget Act, which required that new outpatient departments of
hospitals be paid by Medicare and Medicare beneficiaries at the
same rate as other outpatient providers (physician offices,
non-hospital outpatient surgical centers) for the same services
performed safely at such facilities. The discussion draft would
apply this policy to off-campus outpatient hospital departments
that existed prior to 2015 and currently get reimbursed at a
higher rate than other providers for providing the same
services.
Legislative History
On April 26, 2024, the Subcommittee on Health held a
hearing on a discussion draft entitled ``To amend title XVIII
of the Social Security Act to require payment for all hospital-
owned physician offices located off-campus be paid in
accordance with the applicable payment system for the items and
services furnished.''
To Phase Out Certain Services Designated as Inpatient-Only Services
Under the Medicare Program
DISCUSSION DRAFT
To amend the Public Health Service Act with respect to the
Covered Countermeasure Process Fund.
Summary
This discussion draft would phase out certain
musculoskeletal services that Medicare, through a regulatory
policy known as the ``Inpatient Only List,'' has required to be
conducted in an inpatient care setting, rather than allowing
for doctors and patients to decide if the procedure could be
safely conducted in a potentially lower-cost outpatient
setting. The draft would also require the Secretary of HHS to
conduct a study and report on clinical outcomes and patient
safety as well as patient cost-sharing and the financial impact
of the inpatient-only service list on Medicare.
Legislative History
On April 26, 2024, the Subcommittee on Health held a
hearing on a discussion draft entitled ``To phase out certain
services designated as inpatient-only services under the
Medicare program.''
OVERSIGHT ACTIVITIES
Restoring a Healthy Nation: Addressing the Fentanyl Crisis, Protecting
Critical Lifelines, and Ending Discrimination Against Those With
Disabilities
On February 1, 2023, the Subcommittee on Health held a
hearing entitled ``Restoring a Healthy Nation: Addressing The
Fentanyl Crisis, Protecting Critical Lifelines, and Ending
Discrimination Against Those with Disabilities.'' The purpose
of the hearing was to examine how we can advance solutions that
will help people in need of hope and healing in our
communities. The Subcommittee received testimony from Kemp
Chester, Senior Advisor, International Relations and Supply
Reduction, Office of National Drug Control Policy; Neerja
Gandotra, Chief Medical Officer, Substance Abuse and Mental
Health Services Administration; Jon C. DeLena, Associate
Administrator, Business Operations, Drug Enforcement
Administration; Kandi Pickard, President and CEO, National Down
Syndrome Society; Frederick Isasi, Executive Director, Families
USA; Molly Cain, Parent Advocate; Stephen Loyd, Chief Medical
Officer, Cedar Recovery; and, Timothy Westlake, Emergency
Medicine Physician.
The Federal Response to COVID-19
On February 8, 2023, the Subcommittees on Health and on
Oversight and Investigations held a hearing entitled ``The
Federal Response to COVID-19.'' The purpose of the hearing was
to questions surrounding the federal government's response to
COVID-19. The Subcommittee received testimony from Lawrence A.
Tabak, Senior Official Performing the Duties of the Director,
National Institutes of Health; Rochelle P. Walensky, Director,
Centers for Disease Control and Prevention; and Robert Califf,
Commissioner of Food and Drugs, U.S. Food and Drug
Administration. Dawn O'Connell, Assistant Secretary for
Preparedness and Response, was invited and scheduled to attend.
However, she had to cancel due to a personal emergency.
President Biden's Border Crisis is a Public Health Crisis
On February 15, 2023, the Subcommittees on Health and on
Oversight and Investigations held a hearing entitled
``President Biden's Border Crisis is a Public Health Crisis.''
The purpose of the hearing was to discuss the policies that led
to the crisis at the southern border and help inform any future
actions needed to secure the border, reduce the amount of
illicit fentanyl flowing into the United States, and address
the public health impacts of the border crisis. The
Subcommittee received testimony from Urbino Martinez, Brooks
County Sheriff; Stuart Archer, CEO, Oceans Health Care;
Rochelle M. Garza, President, Texas Civil Rights Project; and
Brandon Judd, President, National Border Patrol Council.
Lowering Unaffordable Costs: Examining Transparency and Competition in
Health Care
On March 28, 2023, the Subcommittee on Health held a
hearing entitled ``Lowering Unaffordable Costs: Examining
Transparency and Competition in Health Care.'' The purpose of
the hearing was to discuss how improving price transparency and
promoting competition in our health care system can drive down
costs. The Subcommittee received testimony from Chris Severn,
Co-Founder and Chief Executive Officer, Turquoise Health;
Matthew Forge, Chief Executive Officer, Pullman Regional
Hospital; Marilyn Bartlett, Senior Policy Fellow, National
Association of State Health Policy; Sophia Tripoli, Director of
Health Care Innovation, Families USA; and Benedic Ippolito,
Senior Fellow in Economic Policy Studies, American Enterprise.
Fiscal Year 2024 Department of Health and Human Services Budget
On March 29, 2023, the Subcommittee on Health held a
hearing entitled ``Fiscal Year 2024 Department of Health and
Human Services Budget.'' The purpose of the hearing was to
review the Fiscal Year 2024 budget request for the Department
of Health and Human Services. The Subcommittee received
testimony from Xavier Becerra, Secretary, U.S. Department of
Health and Human Services.
Reauthorization of the Animal Drug User Fee Programs
On March 30, 2023, the Subcommittee on Health held a
hearing entitled ``Reauthorization of the Animal Drug User Fee
Programs.'' The purpose of the hearing was to consider
legislation that reauthorizes the Animal Drug User Fee
Amendments and the Animal Generic Drug User Fee Amendments. The
Subcommittee received testimony from Tracey Forfa, Director,
Center for Veterinary Medicine, Food and Drug Administration;
Rachel Cumberbatch, Director, Regulatory Affairs, Animal Drugs,
Animal Health Institute; Stephanie Batliner, Chair, Generic
Animal Drug Alliance; and Lori Teller, President, American
Veterinary Medical Association.
Examining Existing Federal Programs To Build a Stronger Health
Workforce and Improve Primary Care
On April 19, 2023, the Subcommittee on Health held a
hearing entitled ``Examining Existing Federal Programs to Build
a Stronger Health Workforce and Improve Primary Care.'' The
purpose of the hearing was to discuss several existing federal
programs and proposed legislation related to health care
workforce, primary care services, organ procurement
competition, countermeasure injury compensation transparency,
and diabetes research and treatment. The Subcommittee received
testimony from Carole Johnson, Administrator, Health Resources
and Services Administration, U.S. Department of Health and
Human Services.
Lowering Unaffordable Costs: Legislative Solutions To Increase
Transparency and Competition in Health Care
On April 26, 2023, the Subcommittee on Health held a
hearing entitled ``Lowering Unaffordable Costs: Legislative
Solutions to Increase Transparency and Competition in Health
Care.'' The purpose of the hearing was to hear from
Administrator Brooks-LaSure and relevant stakeholders on
proposals to lower the costs of health care for Americans
through increased transparency and competition. The
Subcommittee received testimony from Chiquita Brooks-LaSure,
Administrator, U.S. Centers for Medicare and Medicaid Services;
Ashley Thompson, Senior Vice President, Public Policy Analysis
and Development, American Hospital Association; Kristin Bass,
Chief Policy and External Affairs Officer, Pharmaceutical Care
Management Association; Brian Connell, Executive Director,
Federal Affairs, The Leukemia and Lymphoma Society; Sean
Cavanaugh, Chief Policy Officer, Aledade, Inc.; Ilyse Schuman,
Senior Vice President, Health Policy, American Benefits
Council; and Loren Adler, Fellow and Associate Director, USC
Brookings Initiative for Health Policy, Economic Studies
Program, Brookings Institution.
Preparing for and Responding to Future Public Health Security Threats
On May 11, 2023, the Subcommittee on Health held a hearing
entitled ``Preparing for and Responding to Future Public Health
Security Threats. .'' The purpose of the hearing was to examine
the authorities from PAHPA that are set to expire and build
upon lessons from the COVID-19 pandemic to ensure effective
preparation, response, and recovery from future emerging
threats. The Subcommittee received testimony from Dawn
O'Connell, Assistant Secretary for Preparedness and Response,
Administration for Strategic Preparedness and Response;
Rochelle P. Walensky, Director, U.S. Centers for Disease
Control and Prevention, and Administrator, Agency for Toxic
Substances and Disease Registry ; Robert M. Califf,
Commissioner, U.S. Food and Drug Administration; Tom Inglesby,
Director, Johns Hopkins Center for Health Security, Bloomberg
School of Public Health; Randall Lutter, Senior Fellow,
Manhattan Institute for Policy Research; Erik Decker, Chair,
Cybersecurity Working Group, Health Sector Coordinating
Council; and Mary Denigan-Macauley, Director, Health Care, U.S.
Government Accountability Office.
Addressing the Opioid Crisis: Examining the Support Act Five Years
Later
On June 9, 2023, the Subcommittee on Health held a hearing
entitled ``Addressing the Opioid Crisis: Examining the SUPPORT
Act Five Years Later.'' The purpose of the hearing was to
examine the SUPPORT Act and discuss the policy solutions that
have successfully addressed gaps within substance use disorder
treatment and recovery. The Subcommittee received testimony
from Emily Keller, Special Secretary of Opioid Response, Opioid
Operational Command Center, Office of Governor Wes Moore; Mike
Straley, Founder, Leah's Legacy Foundation; Mitchell Crawford,
Medical Director, Specialized Treatment and Recovery, WellSpan
Health, Director, Addiction Services, WellSpan Health; and
Chief William Ceravola, Reading Township Police Department.
Legislative Solutions To Bolster Preparedness and Response for All
Hazards and Public Health Security Threats
On June 13, 2023, the Subcommittee on Health held a hearing
entitled ``Legislative Solutions to Bolster Preparedness and
Response for All Hazards and Public Health Security Threats.''
The purpose of the hearing was to consider several pieces of
legislation that are critical to our national public health
security. The Subcommittee received testimony from Gerald
Parker, Associate Dean for Global One Health and Director for
the Pandemic and Biosecurity Policy Program, Texas A&M
University; Raynard Washington, Director, Public Health
Department, Mecklenburg, County Health and Human Services
Agency Mecklenburg County, North Carolina; Phyllis Arthur,
Senior Vice President, Infectious Disease and Emerging Science
Policy, Biotechnology Innovation Organization; Julie R. Gralow,
Chief Medical Officer and Executive Vice President, American
Society of Clinical Oncology; and Ted Okon, Executive Director,
Community Oncology Alliance.
Examining Proposals That Provide Access To Care for Patients and
Support Research for Rare Diseases
On June 14, 2023, the Subcommittee on Health held a hearing
entitled ``Examining Proposals that Provide Access to Care for
Patients and Support Research for Rare Diseases.'' The purpose
of the hearing was to evaluate where gaps exist, identify any
potential duplication or redundant efforts, and reveal any
improvements needed as Congress considers reauthorizations. The
Subcommittee received testimony from Elizabeth Cherot, Senior
Vice President and Chief Medical Health Officer, March of
Dimes; Alexis A. Thompson, Chief of Division of Hematology,
Elias Schwartz Endowed Chair in Hematology, Children's Hospital
of Philadelphia, Professor of Pediatrics, University of
Pennsylvania Perelman School of Medicine; Meredithe McNamara,
Assistant Professor, Yale School of Medicine; Miriam Grossman,
Child, Adolescent, and Adult Psychiatrist; George Manahan,
Parkinson's Advocate and Patient; and Kevin O'Connor, Assistant
to the General President for Government Affairs and Political
Action, International Association of Fire Fighters.
Responding to America's Overdose Crisis: An Examination of Legislation
to Build Upon the SUPPORT Act
On June 21, 2023, the Subcommittee on Health held a hearing
entitled ``Responding to America's Overdose Crisis: An
Examination of Legislation to Build Upon the SUPPORT Act.'' The
purpose of the hearing was to examine key provisions of the
SUPPORT Act that were set to expire, as well as consider
policies that are relevant to addressing challenges associated
with opioid use disorders and substance use disorders. The
Subcommittee received testimony from Matthew Strait, Deputy
Assistant Administrator, Office of Diversion Control for the
Drug Enforcement Administration; Christopher Jones, Director of
the National Center for Injury Prevention and Control for the
Centers for Disease Control and Prevention; Tom Coderre, Acting
Deputy Assistant Secretary for Mental Health and Substance Use;
Diana Espinosa, Principal Deputy Administrator of the Health
Resources and Services Administration, Acting Deputy Assistant
Secretary for Mental Health and Substance Use; and Jonathan
Blum, Principal Deputy Administrator and Chief Operating
Officer for the Centers for Medicare and Medicaid Services.
Innovation Saves Lives: Evaluating Medicare Coverage Pathways for
Innovative Drugs, Medical Devices, and Technology
On July 18, 2023, the Subcommittee on Health held a hearing
entitled ``Innovation Saves Lives: Evaluating Medicare Coverage
Pathways for Innovative Drugs, Medical Devices, and
Technology.'' The purpose of the hearing was to examine
challenges and opportunities to improve Medicare coverage
processes in order to encourage innovation and increase access
to care. The Subcommittee received testimony from Natalia Rost,
President Elect, American Academy of Neurology; Thomas
MacGillivray, President, Society of Thoracic Surgeons; Lishan
Aklog, Chairman and Chief Executive Officer, PAVmed; Todd
Brinton, Corporate Vice President, Advanced Technology Chief
Scientific Officer, Edwards Lifesciences; Sue Wronsky,
Alzheimer's Association Advocate; and Brian Miller, Nonresident
Fellow, American Enterprise Institute, Assistant Professor of
Medicine, Johns Hopkins University School of Medicine.
Legislative Proposals To Prevent and Respond to Generic Drug Shortages
On September 14, 2023, the Subcommittee on Health held a
hearing entitled ``Legislative Proposals to Prevent and Respond
to Generic Drug Shortages.'' The purpose of the hearing was to
consider policy solutions aimed at addressing the underlying
causes of shortages and the public health risks posed by these
supply disruptions. The Subcommittee received testimony from
Michael Ganio, Senior Director, Pharmacy Practice and Quality,
American Society of Health System Pharmacists; Todd Ebert,
President and CEO, Healthcare Supply Chain Association; Chester
``Chip'' Davis, Jr., President and Chief Executive Officer,
Healthcare Distribution Alliance; Melissa Barber, Postdoctoral
fellow at the Yale School of Medicine, Yale Law School, and
Yale Collaboration for Regulatory Rigor, Integrity, and
Transparency; Allan Coukell, Senior Vice President, Public
Policy, Civica; and David Gaugh, Interim President and CEO,
Association for Accessible Medicines.
Examining Policies To Improve Seniors' Access to Innovative Drugs,
Medical Devices, and Technology
On September 19, 2023, the Subcommittee on Health held a
hearing entitled ``Examining Policies to Improve Seniors'
Access to Innovative Drugs, Medical Devices, and Technology.''
The purpose of the hearing was to discuss the root causes of
drug shortages and listen to stakeholder feedback on proposed
legislative solutions. The Subcommittee received testimony from
Dora Hughes, Acting Director, Center for Clinical Standards and
Quality, Acting Chief Medical Officer, U.S. Centers for
Medicare and Medicaid Services; and John Dicken, Director,
Health Care--Public Health and Private Markets, U.S. Government
Accountability Office.
What's the Prognosis?: Examining Medicare Proposals To Improve Patient
Access to Care & Minimize Red Tape for Doctors
On October 19, 2023, the Subcommittee on Health held a
hearing entitled ``What's the Prognosis?: Examining Medicare
Proposals to Improve Patient Access to Care & Minimize Red Tape
for Doctors.'' The purpose of the hearing was to examine
policies focused on physician payment, beneficiary access to
care, and furthering the goals of the Medicare Access and CHIP
Reauthorization Act of 2015. The Subcommittee received
testimony from Meena Seshamani, Director, Center for Medicare,
Centers for Medicare & Medicaid Services; Leslie Gordon,
Director, Health Care, U.S. Government Accountability Office;
Paul Masi, Executive Director, Medicare Payment Advisory
Commission; Steven Furr, President-Elect, American Academy of
Family Physicians; Debra Patt, Executive Vice President, Texas
Oncology; Joe Albanese, Senior Policy Analyst, Paragon Health
Institute; and Matthew Fiedler, Joseph A. Pechman Senior Fellow
in Economic Studies, Brookings Schaeffer Initiative on Health
Policy, The Brookings Institution.
Supporting Access to Long-Term Services and Supports: An Examination of
the Impacts of Proposed Regulations on Workforce and Access to Care
On October 25, 2023, the Subcommittee on Health held a
hearing entitled ``Supporting Access to Long-Term Services and
Supports: An Examination of the Impacts of Proposed Regulations
on Workforce and Access to Care.'' The purpose of the hearing
was to examine the current state of the long-term services and
supports workforce and the proposed regulations to better
understand the challenges ahead and ways to preserve access to
care. The Subcommittee received testimony from Sarah Schumann,
Vice President of Operations, Brookside Inn; Mary Killough,
Vice President of Operations and Government Relations,
AccentCare; Shelly Hughes, Certified Nurse Aide; Lori Smetanka,
Executive Director, The National Consumer Voice for Quality
Long-Term Care; and Patti Killingsworth, Former Chief of LTSS,
TennCare, Chief Strategy Officer, CareBridge Health.
Understanding How AI is Changing Health Care
On November 29, 2023, the Subcommittee on Health held a
hearing entitled ``Understanding How AI is Changing Health
Care.'' The purpose of the hearing was to discuss AI
integration in medical devices and hospital settings, as well
as to consider the role of Congress as AI in health care
evolves. The Subcommittee received testimony from Michael
Schlosser, Senior Vice President of Care Transformation and
Innovation, HCA Healthcare; Benjamin Nguyen, Senior Product
Manager, Transcarent; Peter Shen, Head of Digital Health--North
America, Siemens Healthineers; Christopher Longhurst, Chief
Medical Officer, Chief Digital Officer, and Association Dean,
UC San Diego Health; and David Newman-Toker, Director, Division
of Neuro-Visual and Vestibular Disorders, Department of
Neurology, Professor of Neurology, Johns Hopkins University
School of Medicine.
Health Care Spending in the United States: Unsustainable for Patients,
Employers, and Taxpayers
On January 31, 2024, the Subcommittee on Health held a
hearing entitled ``Health Care Spending in the United States:
Unsustainable for Patients, Employers, and Taxpayers.'' The
purpose of the hearing was to examine spending within the
health care system and discuss solutions to lower costs. The
Subcommittee received testimony from Chapin White, Director of
Health Analysis, Congressional Budget Office; Sophia Tripoli,
Senior Director of Health Policy, Families USA; Kevin Lyons,
Plan Administrator, New Jersey State Policemen's Benevolent
Association, Inc.; Benedic Ippolito, Senior Fellow, American
Enterprise Institute; and Katie Martin, President and CEO,
Health Care Cost Institute.
Legislative Proposals To Support Patients and Caregivers
On February 14, 2024, the Subcommittee on Health held a
hearing entitled ``Legislative Proposals to Support Patients
and Caregivers.'' The purpose of the hearing was to examine
proposals to help improve our understanding of various
diseases, disabilities, chronic conditions, and stillbirths.
The Subcommittee received testimony from Andy Shih, Chief
Science Officer, Autism Speaks; Corey Feist, Co-Founder and
CEO, Dr. Lorna Breen Heroes' Foundation; Joanne Pike, President
and CEO, Alzheimer's Association; Gordon Tomaselli, Former
President, American Heart Association, Marilyn and Stanley M.
Katz Dean, Emeritus and Professor of Medicine, Albert Einstein
College of Medicine, Adjunct Professor of Medicine, Johns
Hopkins University School of Medicine; Michelle Whitten,
President, CEO, and Co-Founder, Global Down Syndrome
Foundation; Randy Strozyk, President, American Ambulance
Association; and Christina Annunziata, Senior Vice President of
Extramural Discovery Science, American Cancer Society.
Legislative Proposals To Support Patients with Rare Diseases
On February 29, 2024, the Subcommittee on Health held a
hearing entitled ``Legislative Proposals to Support Patients
with Rare Diseases.'' The purpose of the hearing was to examine
every aspect of the rare disease treatment pipeline and discuss
bipartisan solutions to strengthen patient access to care. The
Subcommittee received testimony from Terence Flotte, Provost
and Dean of UMass Chan Medical School, Vice President of
American Society of Gene and Cell Therapy; Alexander Bassuk,
Physician-in-Chief, University of Iowa Stead Family Children's
Hospital, Chair and Professor, Stead Family Department of
Pediatrics; Aaron Kesselheim, Professor of Medicine, Harvard
Medical School, Director, Program On Regulation, Therapeutics,
And Law (PORTAL) at Brigham and Women's Hospital; Jeromie
Ballreich, Associate Research Professor, Johns Hopkins
Bloomberg School of Public Health; Alice Chen, Senior Fellow,
USC Schaeffer Center for Health Policy and Economics; Associate
Professor and Vice Dean for Research, USC Sol Price School of
Public Policy; and Khrystal Davis, Founding President, Texas
Rare Alliance.
Evaluating Approaches to Diagnostic Test Regulation and the Impact of
the FDA's Proposed Rule
On March 21, 2024, the Subcommittee on Health held a
hearing entitled ``Evaluating Approaches to Diagnostic Test
Regulation and the Impact of the FDA's Proposed Rule.'' The
purpose of the hearing was to examine the Food and Drug
Administration's proposed rule that allows for laboratory
developed test regulation under medical device authorities. The
Subcommittee received testimony from Susan Van Meter,
President, American Clinical Laboratory Association; Zach
Rothstein, Executive Director, AdvaMedDx; Donald S. Karcher,
President of the College of American Pathologists; Jeff Allen,
President and CEO, Friends of Cancer Research; and Dara L.
Aisner, Medical Director, Colorado Molecular Correlates
Laboratory, Professor of Pathology, University of Colorado,
Representative of the Academic Coalition for Effective
Laboratory Developed Tests.
Legislative Proposals To Support Patient Access to Telehealth Services
On April 10, 2024, the Subcommittee on Health held a
hearing entitled ``Legislative Proposals to Support Patient
Access to Telehealth Services.'' The purpose of the hearing was
to examine legislative proposals that maintain access to vital
telehealth services under Medicare, while ensuring appropriate
guardrails are in place to protect against fraud and abuse. The
Subcommittee received testimony from Jeanette Ashlock, Patient
Advocate, National Multiple Sclerosis Society; Fred Riccardi
President, Medicare Rights Center; Lee Schwamm, Associate Dean
for Digital Strategy and Transformation, Yale School of
Medicine, Senior Vice President and Chief Digital Health
Officer, Yale New Haven Health System; Eve Cunningham, Group
Vice President and Chief of Virtual Care and Digital Health,
Providence; and Ateev Mehrotra, Professor of Health Care Policy
and Medicine, Harvard Medical School, Hospitalist, Beth Israel
Deaconess Medical Center.
Examining Health Sector Cybersecurity in the Wake of the Change
Healthcare Attack
On April 16, 2024, the Subcommittee on Health held a
hearing entitled ``Examining Health Sector Cybersecurity in the
Wake of the Change Healthcare Attack.'' The purpose of the
hearing was to discuss cybersecurity in health care and the
Change Healthcare cyberattack. The Subcommittee received
testimony from Greg Garcia, Executive Director for
Cybersecurity, Healthcare Sector Coordinating Council; Robert
Sheldon, Senior Director of Public Policy and Strategy,
CrowdStrike; John Riggi, National Advisor for Cybersecurity and
Risk, American Hospital Association; Scott MacLean, Board
Chair, College of Healthcare Information Management Executives;
and Adam Bruggeman, Orthopedic Surgeon, Texas Spine Center.
Fiscal Year 2025 Department of Health and Human Services Budget
On April 17, 2024, the Subcommittee on Health held a
hearing entitled ``Fiscal Year 2025 Department of Health and
Human Services Budget.'' The purpose of the hearing was to
review the Fiscal Year 2025 budget request for the Department
of Health and Human Services. The Subcommittee received
testimony from Xavier Becerra, Secretary, U.S. Department of
Health and Human Services.
Legislative Proposals To Increase Medicaid Access and Improve Program
Integrity
On April 30, 2024, the Subcommittee on Health held a
hearing entitled ``Legislative Proposals to Increase Medicaid
Access and Improve Program Integrity.'' The purpose of the
hearing was to examine legislative solutions to support
beneficiaries who rely on long-term care, in addition to
promoting accountable Medicaid spending. The Subcommittee
received testimony from Daniel Tsai, Deputy Administrator and
Director, Center for Medicaid and CHIP Services.
Check Up: Examining FDA Regulation of Drugs, Biologics, and Devices
On May 22, 2024, the Subcommittee on Health held a hearing
entitled ``Check Up: Examining FDA Regulation of Drugs,
Biologics, and Devices.'' The purpose of the hearing was to
discuss how Congress can help the FDA streamline operations and
provide clear, consistent scientific and regulatory information
to innovators and drug manufacturers. The Subcommittee received
testimony from Patrizia Cavazzoni, Director, Center for Drug
Evaluation and Research; Peter Marks, Director, Center for
Biologics Evaluation and Research; and Jeff Shuren, Director,
Center for Devices and Radiological Health.
Checking In on CMMI: Assessing the Transition to Value Based Care
On June 13, 2024, the Subcommittee on Health held a hearing
entitled ``Checking In on CMMI: Assessing the Transition to
Value-Based Care.'' The purpose of the hearing was to hear from
the head of CMMI about the challenges to achieving their
intended mission. The Subcommittee received testimony from
Elizabeth Fowler, Deputy Administrator and Director, Center for
Medicare and Medicaid Innovation.
Are CDC'S Priorities Restoring Public Trust and Improving the Health of
the American People?
On July 23, 2024, the Subcommittee on Health held a hearing
entitled ``Are CDC's Priorities Restoring Public Trust and
Improving the Health of the American People?.'' The purpose of
the hearing was to hear from CDC officials on efforts regain
public trust and protect the health and wellbeing of the
American people. The Subcommittee received testimony from Henry
Walke, Director, CDC Office of Readiness and Response; Jennifer
Layden, Director, CDC Office of Public Health Data,
Surveillance, and Technology; Daniel Jernigan, Director, CDC
National Center for Emerging and Zoonotic Infectious Diseases;
Karen Hacker, Director, CDC National Center for Chronic Disease
Prevention and Health Promotion; Demetre Daskalakis, Director,
CDC National Center for Immunization and Respiratory Diseases;
and Allison Arwady, Director, CDC National Center for Injury
Prevention and Control.
Evaluating FDA's Human Foods and Tobacco Programs
On September 10, 2024, the Subcommittee on Health held a
hearing entitled ``Evaluating FDA's Human Foods and Tobacco
Programs.'' The purpose of the hearing was to examine how the
FDA is supporting smoking cessation, regulating illegal
products, and ensuring a safe food supply. The Subcommittee
received testimony from James Jones, Deputy Commissioner for
Human Foods, U.S. Food and Drug Administration; and Brian King,
Director, Center for Tobacco Products, U.S. Food and Drug
Administration.
Subcommittee on Oversight and Investigations
Challenges and Opportunities To Investigating the Origins of Pandemics
and Other Biological Events
On Wednesday, February 1, 2023, the Subcommittee on
Oversight and Investigations held a hearing entitled
``Challenges and Opportunities to Investigating the Origins of
Pandemics and Other Biological Events.'' The purpose of the
hearing was to examine the conclusions of a recent GAO report
on technology assessment on pandemic origins. The Subcommittee
received testimony from Karen L. Howard, PhD, Acting Chief
Scientist, Director of Science and Technology Assessment
Science, Technology Assessment, and Analytics, Government
Accountability Office (GAO); Tom Inglesby, MD, Director, Center
for Health Security, Johns Hopkins Bloomberg School of Public
Health; Asha M. George, DrPH, Executive Director, Bipartisan
Commission on Biodefense; Gerald Parker, DVM, PhD, Associate
Dean, College of Veterinary Medicine & Biomedical Services,
Texas A&M University; and Michael Imperiale, PhD, Arther F.
Thurnau Professor, University of Michigan Medical School.
Follow the Money: Oversight of President Biden's Massive Spending Spree
On March 29, 2023, the Subcommittee on Oversight and
Investigations held a hearing entitled ``Follow the Money:
Oversight of President Biden's Massive Spending Spree.'' The
purpose of the hearing was to learn more about challenges
selected federal agencies face in managing the large infusion
of funding they received from recent major legislation such as
the Infrastructure Investment and Jobs Act, Creating Helpful
Incentives to Produce Semiconductors and Science Act of 2002,
and the Inflation Reduction Act. The Subcommittee received
testimony from The Honorable Teri L. Donaldson, Inspector
General, Office of the Inspector General, Department of Energy;
The Honorable Peggy E. Gustafson, Inspector General, Office of
the Inspector General, Department of Commerce; The Honorable
Sean O'Donnell, Inspector General, Office of the Inspector
General, Environmental Protection Agency; and Mark Gaffigan,
Managing Director, Natural Resources and Environment,
Government Accountability Office.
Insights From the HHS Inspector General on Oversight of Unaccompanied
Minors, Grant Management, and CMS
On April 18, 2023, the Subcommittee on Oversight and
Investigations held a hearing entitled ``Insights from the HHS
Inspector General on Oversight of Unaccompanied Minors, Grant
Management, and CMS.'' The purpose of the hearing was to hear
from Inspector General for the Department of Health and Human
Services regarding the Office of Refugee Resettlement's
management of the unaccompanied alien children program; grant
management by the National Institutes of Health and the Centers
for Disease Control and Prevention; and oversight of the
Centers for Medicare and Medicaid Services. The Subcommittee
received testimony from the Honorable Christi A. Grimm,
Inspector General, Office of Inspector General, U.S. Department
of Health and Human Services.
Who is Selling Your Data: A Critical Examination of the Role of Data
Brokers in the Digital Economy
On April 19, 2023, the Subcommittee on Oversight and
Investigations held a hearing entitled ``Who is Selling Your
Data: A Critical Examination of the Role of Data Brokers in the
Digital Economy.'' The purpose of the hearing was to build upon
previous hearings and continue to learn about the harms of the
data broker ecosystems. Subcommittee received testimony from
Justin Sherman, Senior Fellow & Research Lead Data Brokerage
Project, Duke University Sanford School of Public Policy;
Marshall Erwin, Vice President and Chief Security Officer,
Mozilla Corporation; and Laura Moy, Faculty Director, Center on
Privacy & Technology, Georgetown Law Center.
Biosafety and Risky Research: Examining if Science is Outpacing Policy
and Safety
On April 27, 2023, the Subcommittee on Oversight and
Investigations held a hearing entitled ``Biosafety and Risk
Research: Examining if Science is Outpacing Policy and
Safety.'' The purpose of the hearing was to examine the need
for virus research to be conducted more safely by strengthening
standards and obtaining more data about laboratory accidents.
Subcommittee received testimony from Rocco Casagrande,
Chairman, Gryphon Scientific; Gregory Koblentz, Associate
Professor and Director, Biodefense Graduate Programs, George
Mason University; Andy Pekosz, Professor of Molecular
Microbiology and Immunology, Johns Hopkins University,
Bloomberg School of Public Health; and Robert Hawley, Former of
Chief of Safety and Radiation Protection Division, U.S. Army
Medical Research Institute, Fort Detrick.
Antimicrobial Resistance: Examining an Emerging Public Health Threat
On April 28, 2023, the Subcommittee on Oversight and
Investigations held a hearing entitled ``Antimicrobial
Resistance: Examining an Emerging Public Health Threat.'' The
purpose of the hearing was to gain a better understanding of
the ongoing concerns about antimicrobial resistance.
Subcommittee received testimony from Amanda Jezek, Senior Vice
President, Public Policy and Government Relations, Infectious
Diseases Society of America; Kevin Outterson, Professor of Law
and Executive Director of CARB X, Boston University; Mary
Denigan-Macauley, Director, Health Care, Government
Accountability Office; and Amy J. Mathers, Associate Professor,
Infectious Diseases and International Health, University of
Virginia School of Medicine.
Closing the Digital Divide: Overseeing Federal Funds for Broadband
Deployment
On May 10, 2023, the Subcommittee on Oversight and
Investigations held a hearing entitled ``Closing the Digital
Divide: Overseeing Federal Funds for Broadband Deployment.''
The purpose of the hearing was to provide an opportunity for
Members to learn more about the broadband programs across the
federal government. Subcommittee received testimony from Andrew
Von Ah, Director of Physical Infrastructure, Government
Accountability Office; Dr. George Ford, PhD, Chief Economist,
Phoenix Center for Advanced Legal & Economic Public Policy
Studies; and Angela Siefer, Executive Director, National
Digital Inclusion Alliance.
Examining the Root Causes of Drug Shortages: Challenges in
Pharmaceutical Drug Supply Chains
On May 11, 2023, the Subcommittee on Oversight and
Investigations held a hearing entitled ``Examining the Root
Causes of Drug Shortages: Challenges in Pharmaceutical Drug
Supply Chains.'' The purpose of the hearing was to investigate
the recent rise in the number of pharmaceutical drugs with
shortages and ways the United States and improve the resilience
of its current drug supply chain. Subcommittee received
testimony from Dr. Alex Oshmyansky, MD, PhD, CEO and Founder of
the Mark Cuban Cost Plus Drug Company; Anthony Sardella,
Adjunct Lecturer and Senior Research Advisor, Center for
Analytics and Business Insights, Washington University in St.
Louis; Laura Bray, Founder, Angels for Change; and Dr. Fernando
Muzzio, PhD, Distinguished Professor of Chemical and
Biochemical Engineering, Rutgers University.
Protecting Critical Infrastructure From Cyberattacks: Examining
Expertise of Sector Specific Agencies
On May 16, 2023, the Subcommittee on Oversight and
Investigations held a hearing entitled ``Protecting Critical
Infrastructure from Cyberattacks: Examining Expertise of Sector
Specific Agencies.'' The purpose of the hearing was to examine
federal agencies' efforts to secure critical infrastructure
against cybersecurity threats, assess agencies' responses to
emerging threats, and learn more about the role of the
represented agencies in the federal cybersecurity enterprise.
Subcommittee received testimony from Puesh Kumar, Director,
Office of Cybersecurity, Energy Security, and Emergency
Response, Department of Energy; David Travers, Director, Water
Infrastructure and Cyber Resilience Division, Office of
Groundwater and Drinking Water, Office of Water, Environmental
Protection Agency; and Dr. Brian Mazanec, PhD, Deputy Director,
Office of Preparedness, Administration for Strategic
Preparedness and Response, Department of Health and Human
Services.
Growing the Domestic Energy Sector Supply Chain and Manufacturing Base:
Are Federal Efforts Working?
On May 23, 2023, the Subcommittee on Oversight and
Investigations held a hearing entitled ``Growing the Domestic
Energy Sector Supply Chain and Manufacturing Base: Are Federal
Efforts Working?'' The purpose of the hearing was to learn more
about vulnerabilities created by an energy sector supply chain
reliant on international and examine opportunities to address
this threat. Subcommittee received testimony from Diana
Furchtgott-Roth, Director, Center for Energy, Climate, and
Environment, The Heritage Foundation, and Adjunct Professor,
George Washington University; Jeremy Harrell, Chief Strategy
Officer, ClearPath; Ellen Hughes-Cromwick, Senior Resident
Fellow for Climate and Energy Program, Third Way; and Kenny
Stein, Vice President for Policy, Institute for Energy
Research.
Looking Back Before Moving Forward: Assessing CDC's Failures in
Fulfilling its Mission
On June 7, 2023, the Subcommittee on Oversight and
Investigations held a hearing entitled ``Looking Back Before
Moving Forward: Assessing CDC's Failures in Fulfilling its
Mission.'' The purpose of the hearing was to examine what
reforms are needed to improve ability for the Centers for
Disease Control and Prevention to respond to public health
crisis' in the future. Subcommittee received testimony from Dr.
Charity Dean, MD, MPH & TM, CEO and Founder, The Public Health
Company; Dr. Mary Denigan-Macauley, PhD, Director of Public
Health, Government Accountability Office; Dr. Tracy Beth Hoeg,
MD, PhD, Epidemiologist, Department of Epidemiology and
Biostatistics, University of California at San Francisco.
Microvast and More: Oversight of President Biden's Energy Spending
Spree
On June 21, 2023, the Subcommittee on Oversight and
Investigations held a hearing entitled ``Microvast and More:
Oversight of President Biden's Energy Spending Spree.'' The
purpose of the hearing was to learn about the new Office of
Manufacturing and Energy Supply Chains within the Department of
Energy and its efforts to manage its financial awards programs
and responsibly administer federal funds. Subcommittee received
testimony from David Howell, Principal Deputy Director, Office
of Manufacturing and Energy Supply Chains, Department of
Energy.
MACRA Checkup: Assessing Implementation and Challenges That Remain for
Patients and Doctors
On June 22, 2023, the Subcommittee on Oversight and
Investigations held a hearing entitled ``MACRA Checkup:
Assessing Implementation and Challenges that Remain for
Patients and Doctors.'' The purpose of the hearing was to
assess the implementation and effectiveness of the Medicare
Access and CHIP Reauthorization Act of 2015. Subcommittee
received testimony from Joe Albanese, Policy Analyst, Paragon
Institute; Aisha Pittman, Senior Vice President, National
Association of ACOs; Dr. Anas Daghestani, M.D., Chair of the
Board of America's Physician Groups and Chief Executive Officer
of the Austin Regional Clinic in Texas; Dr. J. Michael
McWilliams M.D., PhD, Warren Alpert Foundation Professor of
Health Care Policy and Professor of Medicine, Harvard Medical
School.
Examining Emerging Threats to Electric Energy Infrastructure
On July 18, 2023, the Subcommittee on Oversight and
Investigations held a hearing entitled ``Examining Emerging
Threats to Electric Energy Infrastructure.'' The purpose of the
hearing was to hear from industry experts about the various
threats to the United States electricity operation and delivery
system and valuate their strategies for prevention and
response. Subcommittee received testimony from Manny Cancel,
Chief Executive Officer, Electric Information Sharing and
Analysis Center and Senior Vice President, North American
Electric Reliability Corporation; Sam Chanoski, Technical
Relationship Manager, Idaho National Laboratory; The Honorable
Paul N. Stockton, Ph.D., Senior Fellow, Johns Hopkins
University Applied Physics Laboratory; The Honorable Bruce
Walker, President and Chief Security Office, Alliance for
Critical Infrastructure Security Incorporated.
Stopping the Exploitation of Migrant Children: Oversight of HHS' Office
of Refugee Resettlement
On July 26, 2023, the Subcommittee on Oversight and
Investigations held a hearing entitled ``Stopping the
Exploitation of Migrant Children: Oversight of HHS' Office of
Refugee Resettlement.'' The purpose of the hearing was to
examine the ability of the Office of Refugee Resettlement to
safely discharge unaccompanied migrant children from their
care. Subcommittee received testimony from the Honorable Xavier
Becerra, Secretary, United States Department of the Health and
Human Services.
Making the Grade?: Audit of the Environmental Protection Agency's Clean
School Bus Program
On September 13, 2023, the Subcommittee on Oversight and
Investigations held a hearing entitled ``Making the Grade?:
Audit of the Environmental Protection Agency's Clean School Bus
Program.'' The purpose of the hearing was to examine the
effectiveness of the new program created from the
Infrastructure Investment and Jobs Act for zero emission school
busses. Subcommittee received testimony from the Honorable Sean
O'Donnell, Inspector General, Office of the Inspector General,
United States Environmental Protection Agency.
At What Cost: Oversight of How the IRA's Price Setting Scheme Means
Fewer Cures for Patients
On September 20, 2023, the Subcommittee on Oversight and
Investigations held a hearing entitled ``At What Cost:
Oversight of How the IRA's Price Setting Scheme Means Fewer
Cures for Patients.'' The purpose of the hearing was to learn
more about how Center for Medicare and Medicaid Services'
implementation of the Drug Price Negotiation Program,
established by the Inflation Reduction Act, will result in
fewer lifesaving cures and treatments and negative outcomes for
patients battling serious and life-threatening diseases.
Subcommittee received testimony from John Czwartacki, Founder.
Survivors for Solutions; Dr. Steve Potts, Ph.D., Chair, Drug
Development Council, International Cancer Advocacy Network;
John Crowley, Executive Chairman, Amicus Therapeutics,
Incorporated, Dr. Aaron S. Kesselheim, M.D., J.D., M.P.H.,
Professor of Medicine at Harvard Medical School.
Investigating the Role of Electric Infrastructure in the Catastrophic
Maui Fire
On September 28, 2023, the Subcommittee on Oversight and
Investigations held a hearing entitled ``Investigating the Role
of Electric Infrastructure in the Catastrophic Maui Fire.'' The
purpose of the hearing was to learn more about the events
leading up the fires in the area of Lahaina on the island of
Maui and examine the potential role of electric infrastructure.
Subcommittee received testimony from Panel Leodoloff R.
Asuncion, Jr. Chairman, Hawai'i Public Utilities Commission;
Mark B. Glick, Chief Energy Officer, Hawai'i State Energy
Office; Shelee Kimura, President and Chief Executive Officer,
Hawaiian Electric on Panel 1 and Representative Ed Case (HI-01)
and Representative Jill Tokuda (HI-02) on Panel 2.
Investigating the Role of Electric Infrastructure in the Catastrophic
Maui Fire
On September 28, 2023, the Subcommittee on Oversight and
Investigations held a hearing entitled ``Investigating the Role
of Electric Infrastructure in the Catastrophic Maui Fire.'' The
purpose of the hearing was to learn more about the events
leading up the fires in the area of Lahaina on the island of
Maui and examine the potential role of electric infrastructure.
Subcommittee received testimony from Panel Leodoloff R.
Asuncion, Jr., Chairman, Hawai'i Public Utilities Commission;
Mark B. Glick, Chief Energy Officer, Hawai'i State Energy
Office; Shelee Kimura, President and Chief Executive Officer,
Hawaiian Electric on Panel 1 and Representative Ed Case (HI-01)
and Representative Jill Tokuda (HI-02) on Panel 2.
Unmasking Challenges CDC Faces in Rebuilding Public Trust Amid
Respiratory Illness Season
On November 30, 2023, the Subcommittee on Oversight and
Investigations held a hearing entitled ``Unmasking Challenges
CDC Faces in Rebuilding Public Trust Amid Respiratory Illness
Season.'' The purpose of the hearing was to evaluate the
agency's readiness and preparedness plans for the respiratory
disease season, as well as future public health crises.
Subcommittee received testimony from Dr. Mandy Cohen, Director,
Centers for Disease Control and Prevention.
Threat to Every Community: Assessing the Safety, Health, and Economic
Consequences of President Biden's Border Policies
On January 17, 2024, the Subcommittee on Oversight and
Investigations held a hearing entitled ``Threat to Every
Community: Assessing the Safety, Health, and Economic
Consequences of President Biden's Border Policies.'' The
purpose of the hearing was to examine the crisis at the
southern border and help inform future actions needed to secure
the border, stop illicit fentanyl from flowing into the United
States, address the public health impacts of the border crisis,
and mitigate the social and economic impact of a breakdown at
the southern border. Subcommittee received testimony from
Robert Rector, Senior Research Fellow, the Heritage Foundation;
Ammon Blair, Senior Fellow, Texas Public Policy Foundation;
Inna Vernikov, Councilwoman, New York City.
Fighting the Misuse of Biden's Green Bank Giveaway
On January 30, 2024, the Subcommittee on Oversight and
Investigations held a hearing entitled ``Fighting the Misuse of
Biden's Green Bank Giveaway.'' The purpose of the hearing was
to provide the Environmental Protection Agency with a chance to
update the Committee on its efforts to administer the new
Greenhouse Gas Reduction Fund grants to States, municipalities,
Tribal governments, and eligible nonprofits to provide loans,
other financial assistance, and technical assistance to deploy
zero-emission technologies in low-income and disadvantaged
communities. Subcommittee received testimony from Zealan
Hoover, Senior Advisor to the Administrator, Environmental
Protection Agency.
Protecting American Health Security: Oversight of Shortcomings in the
FDA's Foreign Drug INSpection Program
On February 6, 2024, the Subcommittee on Oversight and
Investigations held a hearing entitled ``Protecting American
Health Security: Oversight of Shortcomings in the FDA's Foreign
Drug Inspection Program.'' The purpose of the hearing was to
provide an opportunity for members to understand the FDA's
foreign inspection program and to explore opportunities to
address challenges to protect and promote the public health.
Subcommittee received testimony from Dinesh S. Thakur, Public
Health Activist, Thakur Family Foundation, Incorporated; John
W.M. Claud, Counsel, Hyman, Phelps & McNamara; Mary Denigan-
Macauley, Director of Public Health, Government Accountability
Office.
Timeout: Evaluating Safety Measures Implemented To Protect Athletes
On March 21, 2024, the Subcommittee on Oversight and
Investigations held a hearing entitled ``Timeout: Evaluating
Safety Measures Implemented to Protect Athletes.'' The purpose
of the hearing was to provide an opportunity for Members to ask
how best to safeguard athletes in youth leagues not within the
United States Center for SafeSport jurisdiction and ask
witnesses how best to fix the identifiable shortcomings.
Subcommittee received testimony from Ju'Riese Colon, Chief
Executive Officer, United States Center for SafeSport; Craig
Cress, Chief Executive Officer, USA Softball; Mana Shim, Chair,
U.S. Soccer Federation Participant Safety Task Force; Nicole
Deal, Senior Vice President for Security and Athlete Safety,
United States Olympic and Paralympic Committee.
Examining How Improper Payments Cost Taxpayers Billions and Weaken
Medicare and Medicaid
On April 16, 2024, the Subcommittee on Oversight and
Investigations held a hearing entitled ``Examining How Improper
Payments Cost Taxpayers Billions and Weaken Medicare and
Medicaid.'' The purpose of the hearing was to provide an
opportunity for Members to better understand the rise in
improper payments within both the Medicare and Medicaid
programs under the Biden administration. Subcommittee received
testimony from the Honorable Gene Dodaro, Comptroller General,
Government Accountability Office; the Honorable Christi Grimm,
Inspector General, the Department of Health and Human Service;
Timothy Hill, MPA, MACPAC Commission Member; Dr. Michael
Chernew, PH.D., MEDPAC Commission Chair.
Examining the Change Healthcare Cyberattack
On May 1, 2024, the Subcommittee on Oversight and
Investigations held a hearing entitled ``Examining the Change
Healthcare Cyberattack.'' The purpose of the hearing was to
provide an opportunity for Members to establish a timeline of
events and be updated directly by UnitedHealth on the February
21, 2024 cyberattack on Change Healthcare. Subcommittee
received testimony from Sir Andrew Witty, Chief Executive
Officer, UnitedHealth Group Incorporated.
Examining Accusations of Ideological Bias at NPR, a Taxpayer Funded
News Entity
On May 8, 2024, the Subcommittee on Oversight and
Investigations held a hearing entitled ``Examining Accusations
of Ideological Bias at NPR, a Taxpayer Funded News Entity.''
The purpose of the hearing was to investigates how federal
dollars are being used at NPR and what reforms may be
necessary. Subcommittee received testimony from Howard Husock,
Senior Fellow, American Enterprise Institute; James Erwin,
Federal Affairs Manager for Telecommunications, Americans for
Tax Reform; Tim Graham, Executive Editor, NewsBusters.org,
Media Research Center; Craig Aaron, Co-CEO, Free Press.
Oversight of 340B Drug Pricing Program
On June 4, 2024, the Subcommittee on Oversight and
Investigations held a hearing entitled ``Oversight of 340B Drug
Pricing Program.'' The purpose of the hearing was to provide
members the opportunity to examine the current challenges and
growth affecting the 340B Drug Discount Program, second-largest
government pharmaceutical program. Subcommittee received
testimony from Dr. Anthony DiGiorgio, Neurosurgeon, University
of California San Francisco Health; Sue Veer, President and
CEO, Carolina Health Center; Dr. William Smith, PhD, Senior
Fellow and Director of Pioneer Life Sciences Initiative,
Pioneer Institute; Matthew Perry, President and CEO, Genesis
Healthcare System.
Examining Anti-Doping Measures in Advance of the 2024 Olympics
On June 25, 2024, the Subcommittee on Oversight and
Investigations held a hearing entitled ``Examining Anti-Doping
Measures in Advance of the 2024 Olympics.'' The purpose of the
hearing was to provide members the opportunity to understand
the various preventative measures taken by anti-doping
officials to protect athletes ahead of the Paris Olympics and
investigate the alleged shortcomings of the World Anti-Doping
Agency following the Chinese swimming scandal. Subcommittee
received testimony from Michael Phelps, American swimmer and
Olympic gold medalist; Travis Tygart, Chief Executive Officer,
United States Anti-Doping Agency; Allison Schmitt, American
swimmer and Olympic gold medalist.
A Year Removed: Oversight of Securing the U.S. Organ Procurement and
Transplantation Network Act Implementation
On September 11, 2024, the Subcommittee on Oversight and
Investigations held a hearing entitled ``A Year Removed:
Oversight of Securing the U.S. Organ Procurement and
Transplantation Network Act Implementation.'' The purpose of
the hearing was to conduct oversight on the implementation of
the Securing the U.S. Organ Procurement and Transplantation
Network Act (the Act), which was enacted one year prior to
modernize and improve the nation's organ procurement and
transplantation system. Subcommittee received testimony from
Greg Segal, Founder & Chief Executive Officer, Organize; Dr.
Robert Cannon, M.D., Associate Professor of Surgery and
Surgical Director for Liver Transplant, University of Alabama
at Birmingham; Dr. Seth Karp, M.D., Surgeon-in-Chief,
Vanderbilt University Medical Center; Dr. Jesse Roach, Senior
Vice President of Government Relations, National Kidney
Foundation.
Authorization and Oversight Plan
(Adopted January 31, 2023)
This is the oversight plan of the Committee on Energy and
Commerce for the 118th Congress. It includes areas where the
Committee expects to conduct oversight during the 118th
Congress, subject to staff and resource limitations, but does
not preclude oversight or investigation of additional matters.
The Committee will continue to consult with other committees
that have jurisdiction over the same or related laws, programs,
or agencies with the objective of ensuring maximum coordination
and cooperation. Specifically, the Committee will continue to
work with other committees to facilitate expiring programs,
coordinate with the Congressional Budget Office regarding
lapsed authorizations and upcoming expirations, and hold member
and staff-level meetings with relevant committees and House and
Senate conferences.
During the 118th Congress, the Committee on Energy and
Commerce will hold hearings and conduct rigorous oversight over
matters within its jurisdiction. The Committee will conduct
thorough oversight, reach conclusions based on an objective
review of the facts, and treat witnesses fairly. The Committee
will request information in a responsible manner that is
calculated to be helpful to the Committee in its oversight
responsibilities. The Committee's oversight functions will
focus on 1) cutting government spending through the elimination
of waste, fraud, and abuse; and 2) ensuring laws are adequate
to protect the public interest or are being implemented in a
manner that protects the public interest, without stifling
economic growth. The Committee will use the information it
collects through its oversight to inform the reauthorization of
certain lapsed programs within its jurisdiction.
HEALTH AND HEALTH CARE ISSUES
Covid-19 Pandemic Origins and Response and Pandemic Prevention
The Committee will examine the roles and actions taken by
Federal agencies involved in insuring and protecting the public
health during the Covid-19 pandemic.
The National Institutes of Health (NIH) and other federal
agencies have invested heavily over the last decade-plus in a
pandemic preparedness strategy based on, among other things,
the notion that pandemics could be predicted through intensive
virus hunting in the field. However, even though these efforts
were focused on coronaviruses in bats located in China and
southeast Asia, virus hunting failed to predict the Covid-19
pandemic. The Committee will conduct oversight of the federal
government's policies and procedures relating to pandemic
prediction and prevention.
The Committee will investigate the government's role in
Gain-of-Function research and the adequacy of the HHS Potential
Pandemic Pathogen Care and Oversight (P3CO) framework used to
oversee research projects involving experiments that could make
dangerous viruses more transmissible or more lethal.
The Committee will conduct oversight of the NIH grantmaking
policies and procedures as it relates to approving and
monitoring its grants and subgrantees, including the use of
indirect costs, to ensure the safe, appropriate, and efficient
use of Federal tax dollars.
The Committee will also examine issues related to the
Centers for Disease Control and Prevention (CDC), which put out
opaque, politically influenced guidance and data that was then
used by other Federal agencies, states, and localities as
rationale for mandates and lockdowns that has led to increased
mental health issues, especially in children. CDC has never
been authorized, and many of its authorities and programs are
broad or out of date.
In addition, many of the authorities used by the Federal
government to prepare and respond to chemical, biological,
radiological, or nuclear threats expire at the end of fiscal
year (FY) 2023. The Committee intends to examine those
authorities and reauthorize those necessary with appropriate
changes to reflect the abuse of power and lack of transparency
in scientific recommendations witnessed during the COVID-19
pandemic. The Committee also plans to examine the overarching
pandemic and biodefense leadership structure, and how it could
be strengthened to ensure we are best prepared for future
bioterrorism threats.
The Illicit Fentanyl Crisis
U.S. drug overdose deaths are at record highs, and
approximately two thirds of those deaths can be attributed to
fentanyl and other synthetic opioids. Oversight of the Drug
Enforcement Administration (DEA) and the Office of National
Drug Control Policy (ONDCP) is necessary to gain insight into
the fentanyl trafficking problem, including both precursor
production in Mexico that has migrated from China, and
trafficking in the U.S. Additionally, the Committee will
conduct oversight of the role of social medias in facilitating
fentanyl distribution throughout the U.S., particularly in
transactions involving minors.
It has been 5 years since the SUPPORT Act passed, and
provisions around how Medicaid can pay for treatment for those
with substance use disorders expire at the end of FY2023. The
committee will conduct oversight of the SUPPORT Act and
reauthorize those expiring authorities with any changes
necessary if such authorities should be reauthorized.
Health Care Costs
The Committee will continue to examine issues related to
the affordability of health care, including areas where federal
government intervention has contributed to increased costs for
patients and families. The Department of Health and Human
Services (HHS) regulates significant portions of the commercial
health insurance market, promulgates Medicare payment rules
that encourage health care provider consolidation, issues
Medicaid regulations that make it more difficult for states to
design Medicaid programs to function as a true safety net, and
implements provisions of the Consolidated Appropriations Act
(CAA) related to ending surprise medical billing and improving
health cost transparency, including with respect to pharmacy
benefit managers. It is critical that the Committee identify
provisions within the troves of HHS regulations contributing to
dynamics--such as provider consolidation--that are increasing
health care costs. Similarly, the committee will be closely
scrutinizing areas where the current administration is actively
seeking to limit competition and choice for families, including
through the first ever federal ban on private health insurance
options. Furthermore, the Committee will keenly oversee
implementation of the CAA provisions related to surprise
medical billing and health care price transparency. Ensuring
that these protections are implemented in line with
congressional intent will result in lower costs for families,
employers, and taxpayers alike.
ENTITLEMENT PROGRAMS
The Committee will review Medicare and Medicaid, two of the
most significant drivers of the federal budget deficit and
resulting debt. The total number of beneficiaries and the
average spending per beneficiary in each program have grown
significantly over the past decade, with major increases
occurring in the past three years, and making sure taxpayer
dollars are spent wisely is imperative to ensuring the long-
term sustainability of each program. The Committee will examine
and review Medicare and Medicaid management and activity as it
relates to ongoing Committee efforts to prevent bias, waste,
fraud, and abuse in Federal health care programs. Ensuring
responsible stewardship of each program can also help protect
beneficiaries from unscrupulous actors seeking to defraud the
program rather than improve the health of their enrollees.
In addition, with the granting of sweeping authority for
CMS to forcibly set the prices for drugs for seniors, the
Committee will continue to inform the public of the
consequences of this authority on critical medical innovation,
Part D plan design and patient choice, access to lower cost
generic and biosimilar alternatives, and if patients will be
able to have a meaningful voice in the process CMS uses to set
drug prices. The Committee will also continue to monitor CMS's
process and decisions with respect to Medicare coverage policy,
including National Coverage Determinations, and take action, if
necessary, to ensure seniors and people with disabilities can
access drugs that their doctors determine are best for them.
Food and Drug Administration
The Committee will review whether the Food and Drug
Administration (FDA) is fulfilling its mission after recent
failures to quickly identify and respond to infant formula
production issues and no clear plan to restart necessary
inspections overseas delayed or stopped during the COVID-19
pandemic. The Committee will also awork to ensure that FDA is
fulfilling its mission to ensure that regulated drugs and
medical devices are safe, effective, and available to American
patients in an expeditious fashion. The Committee will examine
whether FDA's reorganization efforts are improving the
effectiveness of FDA regulation, or worsening delays and
inefficiency in decision-making.
The animal drug and generic drug user fee programs expire
at the end of FY2023 and must be reauthorized for FY2024-2028.
The Committee will consider the proposed agreements for the
Animal Drug User Fee Act (ADUFA) and the Animal Generic Drug
User Fee Act (AGDUFA) for timely reauthorization of these
authorities and examine how these programs are working to
ensure that pet owners and farmers may continue to rely on safe
and effective medications for companion animals and food-
producing animals alike.
Mental Health Crisis
The Committee will conduct oversight of the implementation
of and work done by the Assistant Secretary for Mental Health
and Substance Use, an agency responsible for mental health and
substance use disorder programs and policies at HHS, following
passage of the mental health reauthorization in the
Consolidated Appropriations Act, 2023. The Committee will also
examine regulations drafted to implement the 21st Century Cures
Act, CARES Act, Consolidated Appropriations Act of 2021, and
Consolidated Appropriations of 2023 to ensure they comport with
the intent of Congress, and will monitor funding provided by
the legislation to ensure that it is appropriately spent.
ENERGY AND ENVIRONMENT ISSUES
National Energy Policy
During the 118th Congress, the Committee will examine
issues relating to national energy policy, including U.S.
policies that relate to the exploration, production,
distribution, and consumption of electricity, oil and natural
gas, coal, hydroelectric power, nuclear power, and renewable
energy. The Committee will examine the impact of government
policies and programs on the efficient exploration, production,
storage, supply, marketing, pricing, and regulation of domestic
energy resources, including issues relating to the nation's
energy infrastructure. The Committee will continue to examine
safety and security issues relating to energy exploration,
production, distribution, and the Strategic Petroleum Reserve.
The Committee will conduct oversight over the impact the
administration's energy policies are having on supply chains,
increasing dependence on China and the Chinese Communist Party
(CCP), and domestic production of energy.
Electricity System and Electric Utility Markets
During the 118th Congress, the Committee will undertake a
review of the nation's electricity system. This effort will
include a review of the federal electricity policies of the
Department of Energy (DOE) and the Federal Energy Regulatory
Commission (FERC) relating to competitive wholesale power
markets, transmission, generation infrastructure upgrades, and
compliance with relevant statutes. It will also examine the
activities of the DOE and FERC relating to electric industry
restructuring, protection of consumers, and the development of
wholesale markets for electricity. It will also continue to
examine the activities of the DOE and FERC with respect to
Environmental Protection Agency (EPA) regulations affecting the
electricity sector, including regulatory requirements that may
impact consumer prices and reliability of the electricity grid.
Energy Efficiency
The Committee will continue to assess federal programs
setting energy efficiency standards for motor vehicles, crafted
by EPA and the National Highway Traffic Safety Administration
(NHTSA), and home appliances and other products, crafted by
DOE, to ensure that the programs are implemented in a manner
that maximizes the benefit to consumers. In the case of motor
vehicle standards, the Committee will also assess the merit of
having two federal agencies operating parallel efficiency
programs. The Committee will continue to promote energy
efficiency initiatives in order to create jobs, save businesses
and consumers money, and improve our nation's energy security.
This may include federal programs setting energy efficiency
standards for motor vehicles and appliances, to ensure that the
programs are implemented in a manner that rewards innovation,
ensures benefits for consumers and businesses, enhances U.S.
energy security, and protects the environment. In addition, the
Committee will continue its oversight of waivers under the
Clean Air Act in connection with motor vehicle emissions
standards, to ensure that a national marketplace of affordable
vehicles is available to consumers.
Management of the Department of Energy and its National Laboratories
The Committee will oversee the governance, management, and
operations at DOE, including oversight, management, and
operations of the National Nuclear Security Administration
(NNSA) and the national laboratories. The Committee's oversight
work will include the continuing review of security and safety
reforms at NNSA and DOE facilities, ongoing safety and security
matters, and the Office of Environmental Management's cleanup
program. This work will also include the Committee's special
oversight functions over programs and activities relating to
nonmilitary energy research and development, and including
programs across DOE to safeguard technology and intellectual
property from transfer to foreign adversaries.
Yucca Mountain
The Committee will continue to examine the actions of DOE
and the Nuclear Regulatory Commission (NRC) in connection with
obligations of these agencies under the Nuclear Waste Policy
Act, including licensing activities for the Yucca Mountain
repository.
DOE Energy Grant and Loan Programs
The Committee will continue to review management and
implementation of clean energy and advanced technology grant
and loan programs authorized under the Energy Policy Act of
2005, the Infrastructure Investment and Jobs Act (IIJA), the
Inflation Reduction Act, and other statutes; the development of
new technologies, products, and businesses including clean
energy, advanced coal, nuclear, and other technologies; and the
impact of DOE grant, cost-sharing, and loan spending on the
domestic supply, manufacture, and commercial deployment of
clean and advanced energy products and other technologies. The
Committee will also conduct oversight over DOE's grant and loan
programs that fund production in foreign jurisdiction,
particularly in facilities controlled by China and the CCP.
The Nuclear Regulatory Commission
The Committee will continue to review the activities of the
NRC. The Committee will examine NRC's budget requests and
conduct oversight of the manner in which the Commission
discharges its various responsibilities, including its
statutory responsibilities, licensing activity, the safety and
security of nuclear power facilities and nuclear materials
licensees, and the Commission's regulatory actions.
Clean Air Act
The Committee will continue to review significant
rulemakings under the Clean Air Act and the potential economic
and job impacts of those rulemakings on the energy,
manufacturing, industrial, and construction industries, and
other critical sectors of the U.S. economy, as well as any
public health and environmental benefits of the regulations.
The Committee's review will include oversight of the EPA's
decisions, strategies, and actions to meet Clean Air Act
standards, and the current role of cost, employment and
feasibility considerations in Clean Air Act rulemakings. The
Committee will also continue to review EPA's implementation of
the Renewable Fuel Standard.
Climate Change
The Committee will continue to monitor international
negotiations on efforts to control greenhouse gas emissions in
connection with concerns about global climate change. In
addition, the Committee will examine the EPA's efforts to
regulate domestic greenhouse gas emissions under the Clean Air
Act based on its endangerment findings. The Committee will
consider whether such agreements and regulatory efforts are
scientifically and statutorily well grounded. The Committee
will also review the activities undertaken in this area by DOE,
HHS, and other agencies within the Committee's jurisdiction,
including efforts to prepare for and respond to weather events
and natural disasters in the future.
EPA MANAGEMENT AND OPERATIONS
The Committee will conduct general oversight of the EPA,
including review of the agency's funding decisions, resource
allocation, grants, research activities, enforcement actions,
relations with State and local governments, public
transparency, implementation of new statutory authorities
including under the IIJA and Inflation Reduction Act, and
respect for economic, procedural, public health, and
environmental standards in regulatory actions. In addition, the
Committee will review the government's activities in hydraulic
fracturing research and regulation.
ASSESSMENT AND MANAGEMENT OF CHEMICAL SUBSTANCES
The Committee will monitor EPA implementation of reforms
made to title I of the Toxic Substances Control Act. These
efforts will include program management and the use of chemical
risk analysis in environmental assessment programs. The
Committee will also review deadline management and consistency
of implementation, ensuring that confidential business
information is protected from unwarranted disclosure, and make
certain that EPA provides the appropriate consideration of
risks and the societal impacts of trade-offs during the
evaluation and regulatory process.
DRINKING WATER INFRASTRUCTURE AND REGULATION
The Committee will conduct oversight of the operation of
the Drinking Water State Revolving Loan Fund program authorized
under section 1452 of the Safe Drinking Water Act. Included
will be an examination of EPA involvement in State functions
and State funding uses, efficiencies that could be realized in
managing this funding that maximize its effectiveness, and the
use of this funding for leveraging other investments. In
addition, the Committee will conduct oversight of EPA
regulatory actions under section 1412 of the Safe Drinking
Water Act and the protocol it uses to issue health advisories
under the same section of law.
Solid and Hazardous Waste Management
The Committee will review EPA implementation of various
regulatory programs established under the most recent
administration, including regulations regarding the definition
of solid waste and coal ash.
CERCLA (Superfund) and Brownfields
The Committee will monitor EPA implementation of the
Comprehensive Environmental Response Compensation and Liability
Act (CERCLA). These efforts will include an examination of
State cleanup programs and a comprehensive analysis regarding
whether cleanup under State programs would result in greater
efficiency in the process. The Committee will also conduct
oversight of EPA regulatory actions under CERCLA, including any
designations made by EPA under CERCLA. The Committee will also
examine the EPA brownfields program, including statutory
implementation, the challenges of program operation, and
whether changes to the program would result in more effective
and efficient cleanup and redevelopment of abandoned and
blighted properties.
COMMUNICATIONS AND TECHNOLOGY ISSUES
A Modern Communications Framework for the Innovation Age
The Committee will continue to exercise its jurisdiction
over wired and wireless communications to ensure our nation's
policies governing voice, video, audio, and data services are
promoting investment, innovation, and job creation. The
country's current regulatory regime takes a siloed approach in
which different technological platforms--such as wireline,
wireless, broadcast, cable, and satellite--are regulated
differently based on regulations that may be decades old. As we
move deeper into the Internet era, however, providers are
increasingly using these platforms to offer the same or similar
services. The Committee will examine whether these regulations
should be updated to better meet the communications needs of
the country and to ensure its citizens enjoy cutting edge
services and the economic benefits they bring.
Federal Communications Commission
During the 118th Congress, the Committee will conduct
oversight of the Federal Communications Commission (FCC),
including the efforts to reverse the reclassification of
Broadband Internet Access Service as a telecommunications
service subject to Title II of the Communications Act of 1934
and efforts to bring transparency and accountability to the
Commission's processes. The Committee will also continue to
conduct oversight of the FCC's decisions and their impact on
innovation and the U.S. economy. Among other things, the
Committee will evaluate the impact generally of FCC actions on
voice, video, audio, and data services, public safety,
broadband mapping, and security of our networks. The Committee
will also focus its oversight efforts on the Commission's
administration of funding for the Affordable Connectivity
Program (ACP) and the Emergency Connectivity Fund (ECF), and
investigate and cases of waste, fraud, and abuse. The Committee
will pay particular attention to whether the FCC conducts cost-
benefit and market analyses before imposing regulations.
National Telecommunications and Information Administration
During the 118th Congress, the Committee will conduct
oversight of the National Telecommunications and Information
Administration (NTIA), including its administration of
broadband grant programs created in the IIJA and efforts to
bring transparency and accountability to NTIA's processes. The
Committee will also look into NTIA's authorities and determine
whether NTIA needs additional authorities to keep pace with the
advancement of modern technology and the advancement of the
communications marketplace.
Spectrum Management
The Committee will conduct oversight of the Federal
Communications Commission's and the NTIA management and
allocation of the nation's spectrum for commercial and
government use. Spectrum is increasingly being used to provide
voice, video, audio, and data services to consumers and to
serve the needs of our nation's government agencies. The
Committee will evaluate spectrum-management policies to ensure
efficient use of the public airwaves for innovative
communications services. The Committee will also examine
whether plans for allocating spectrum maximizes broadband
deployment and encourages investment. The Committee will pay
particular attention to FCC and NTIA implementation of the
IIJA, which included provisions intended to make more spectrum
available for commercial wireless services.
Availability of Broadband
The Committee will investigate whether regulatory policies
are helping or hindering broadband deployment. In particular,
the Committee will examine the need for reforms to State and
Federal permitting processes to speed the deployment of fiber
optic systems and 5G wireless services. Additionally, the
Committee will conduct oversight of funding mechanisms for
broadband deployment and adoption, including the $9 billion per
year Universal Service Fund, the $42 billion Broadband Equity,
Access, and Deployment (BEAD) grant program created in the
IIJA, and other federal grant programs that could be awarded
for broadband deployment. Specifically, the Committee will
examine what procedures are in place to control waste, fraud,
and abuse, whether the funds are appropriately targeted, and
the impact of the funding on jobs and the economy.
Internet
The Committee will exercise its jurisdiction over wired and
wireless communications to ensure continued growth and
investment in the Internet. In particular, the Committee will
monitor efforts to employ the multi-stakeholder model of
Internet governance--in which governmental and non-governmental
entities develop best practices for the management of Internet
networks and content. The Committee will also monitor
international efforts to replace multistakeholder governance
with domestic regulation and international multilateral
institutions, and will continue to support U.S. leadership in
these international standards setting bodies.
Public Safety Communications
The Committee will examine whether the communications needs
of first responders are being met. The Committee will examine
the progress being made to ensure that first responders have
interoperable communications capabilities with local, State,
and Federal public safety officials. The Committee will also
examine the progress being made by the First Responder Network
Authority (FirstNet) in carrying out the mandates of the Middle
Class Tax Relief and Job Creation Act of 2012. In addition, the
Committee will conduct oversight regarding the implementation
of legacy 911 and Next Generation 911 (NG911) services. The
Committee will review efforts to promote deployment of these
advanced systems and challenges to realizing ubiquitous NG911.
INNOVATION, DATA, AND COMMERCE
Consumer Privacy and Data Security
In the 118th Congress, the Committee will examine issues
relating to the privacy and data security of information
collected by businesses and service providers about Americans
and the potential for improving protection and security of such
data, without undercutting innovative uses that benefit
Americans and the economy, such as artificial intelligence and
machine learning. Further, the Committee will continue to
review the manner in which fraud and other criminal activities
affect e-commerce. The Committee will also explore privacy and
cybersecurity policies surrounding the Internet of Things and
blockchain technologies.
The Committee will investigate the impact of social media
on mental health, including the algorithms used by social media
companies to cause ever increasing use and dependence of these
platforms, particularly by children. Additionally, the
Committee will conduct oversight of social media and technology
companies' policies and procedures regulating publication,
appeals processes regarding censorship and deplatforming,
censorship, handling of-claimed misinformation, and the
government's role in these policies and procedures.
The Committee will investigate and conduct oversight of the
collection and use of data by social media, technology
companies, and data brokers. This will include TikTok and the
relationship to its parent company ByteDance, and other
similarly positioned companies with close ties to the Chinese
Communist Party.
Autonomous Vehicles
The Committee will examine the policy framework being
developed for autonomous vehicles. Autonomous vehicles hold the
promise to reduce traffic fatalities greatly, while at the same
time expanding mobility options for senior citizens and
Americans living with disabilities, as tight labor markets
continue to fail them for such services. The U.S. must lead in
setting the standards for this technology, its deployment, and
ensure that the potential of revolutionary change to the sector
is not damaged by frivolous litigation and unnecessary
regulation with no benefit to Americans.
Manufacturing
The Committee will explore the state of manufacturing in
the U.S. to identify factors that are hampering or furthering
U.S. competitiveness. The Committee will review the issues
presented by the globalization of production and manufacturing
networks, the availability and resiliency of supply chains, the
integrity of products and components assembled overseas, and
the impact on national security.
Trade
The Committee will examine trade negotiations to ensure
that foreign governments are not imposing non-tariff trade
barriers, such as regulations or requirements, that harm U.S.
businesses, their competitiveness, and their ability to support
jobs in the U.S., especially as it relates to the flow of data
across borders and a successor agreement to EU-U.S. Privacy
Shield.
Department of Commerce Management and Operations
The Committee will conduct oversight of the Department of
Commerce and complementary or conflicting Federal efforts to
promote U.S. manufacturing, including but not limited to
semiconductors and microelectronics, emerging technologies,
such as artificial intelligence and blockchain technologies.
This also includes export and trade-related efforts to lower or
eliminate non-tariff barriers and harmonize regulation of
products sold internationally, such as cross border data flows,
where other countries share our health, safety, and consumer
protection goals. The Committee will also be reviewing reports
required to be delivered to Congress under, section XV, the
American COMPETE Act, of Public Law 116-260.
Consumer Product Safety Commission Management and Operations
The Committee will continue oversight of the Consumer
Product Safety Commission and its implementation and
enforcement of laws and regulations, the effectiveness of the
agency's structure, research activities, investigations, import
surveillance, and enforcement actions relating to the safety of
consumer products. The Committee will examine the agency's
execution of its current authorities and process obligations,
so as not to divert from its mission to also promote consensus
industry standards while efficiently and effectively protecting
Americans.
NHTSA Management and Operations
The Committee will continue oversight of NHTSA, including
the effectiveness of the agency's structure, regulations,
research activities, investigations, and enforcement actions
pertaining to motor vehicle safety. The committee will examine
how NHTSA is working on requirements established in the IIJA,
as well as their Standing Government Orders, and will be
particularly concerned with the way the Administration
processes information and its ability to oversee ever advancing
safety technologies effectively.
Federal Trade Commission Management and Operations
The Committee will conduct oversight of the Federal Trade
Commission's (FTC) management and operations, including the
impact of its decisions and actions on the general public and
the business community, with a particular focus on how the FTC
conducts its business while not creating undue burdens for
legitimate businesses, its determination of priorities, and the
need, if any, for refinement of its authorities. The Committee
will explore the FTC's role relative to emerging technologies
and sectors of the economy. Additionally, the Committee will
examine how the agency is utilizing specific bureaus, or lack
thereof, including the Bureau of Economics, while pursuing
enforcement and regulatory action. The Committee will also be
reviewing reports required to be delivered to Congress under,
section XV, the American COMPETE Act, of Public Law 116-260.
MISCELLANEOUS
Cybersecurity
The Committee will exercise its jurisdiction over
cybersecurity to ensure the country is well protected while at
the same time avoiding one-size-fits all approaches that hinder
the flexibility of commercial and governmental actors to combat
the rapidly evolving threats. The Committee will also review
the efforts of agencies within its jurisdiction to secure their
networks. In doing so, the Committee will explore current
cybersecurity threats and strategies to address those threats.
The Committee will also examine government initiatives to
improve cybersecurity both in the public and private sectors,
and review efforts at agencies within the Committee's
jurisdiction to regulate cybersecurity. The Committee will also
examine the security of the Internet of Things, discovery and
disclosure of cybersecurity vulnerabilities, and the National
Institute of Standards and Technology (NIST) Cybersecurity
Framework.
Bioterrorism Preparedness and Response
The Committee will continue its examination of the roles of
HHS agencies in assisting the nation's detection, warning
capability, and response to potential biological attacks. In
addition, the Committee will evaluate the potential impact and
preparedness of the nation's public health system. The
Committee will continue to review the implementation of the
Public Health Security and Bioterrorism Preparedness and
Response Act of 2002 by HHS, and the extent of the coordination
between HHS and the Department of Homeland Security (DHS),
especially as it relates to Project BioShield.
Federal Oversight of High-Containment Bio Laboratories
The Committee will examine issues related to high-
containment bio laboratories, which handle some of the world's
most exotic and dangerous diseases, including anthrax,
smallpox, foot and mouth disease, and Ebola virus. Among the
issues under review are the adequacy of the security and
practices of high-containment bio laboratories, Federal efforts
to oversee the laboratories, and whether some of these efforts
are duplicative and overlapping. The Committee will continue
its oversight into issues raised by the improper storage and
handling of Federal select agents at CDC, NIH, and FDA labs.
Anti-Terrorism Security for Chemical Facilities
The Committee will continue its oversight of DHS's
implementation of the Chemical Facilities Anti-Terrorism
Program, originally authorized in Section 550 of Public Law
109-295, the Homeland Security Appropriations Act of 2007--now
in Title XXI of the Homeland Security Act. The Committee will
continue to examine whether taxpayer funds are spent prudently
and the extent to which DHS is advancing the purpose of
securing chemical facilities against terrorist threats.
Government Scientific and Risk Assessment Programs
During the 118th Congress, the Committee will examine
issues relating to the numerous Federal science programs
assessing public health risks, including the Integrated Risk
Information System at the EPA, the Report on Carcinogens
produced by the National Toxicology Program at HHS, and
assessments proposed or ongoing in other Federal departments
and agencies. The Committee will review programs to assess the
objectives, transparency, objectivity, validity, and integrity
of scientific assessments that inform regulatory and public
health policies.
Controlling Spending
The Committee will examine Departments and agencies under
its jurisdiction to assure adequate and prompt implementation
of recommendations from the Administration, the Offices of
Inspectors General, the Government Accountability Office, and
other sources to achieve cost savings or eliminate wasteful
spending.
Critical Infrastructure
In June 2006, the Bush administration issued a National
Infrastructure Protection Plan. This plan created a process by
which DHS is to identify critical assets and assess their
vulnerabilities and risks due to loss or natural disaster.
During the 118th Congress, the Committee will review the
Department's activities with respect to identifying high-
priority assets and implementing plans to protect these assets
in areas within the Committee's jurisdiction. The Committee
will also examine the statutory and other activities of DOE,
FERC, EPA, and other Federal agencies related to the physical
and cybersecurity of the nation's critical infrastructure
within the jurisdiction of the Committee. Further, the
Committee will examine the roles and responsibilities of the
private sector, which owns and operates the bulk of the
nation's critical infrastructure assets.
Nuclear Smuggling
The Committee will continue to monitor Federal government
and private sector efforts at border crossings, seaports, and
mail facilities. The Committee's review will analyze and assess
U.S. Customs and Border Protection and the Department of
Energy's efforts, including international efforts, aimed at
detecting and preventing the smuggling of dangerous commerce,
particularly nuclear and radiological weapons of mass
destruction.
AUTHORIZATION OF PROGRAMS WITHIN THE JURISDICTION OF THE COMMITTEE ON
ENERGY AND COMMERCE
During the 118th Congress, as part of both its oversight
and legislative agenda, the Committee on Energy and Commerce
will review the authorizations of agencies and programs within
its jurisdiction and, specifically with regard to lapsed
authorizations, determine whether the program should be
reauthorized or terminated. Each subcommittee will conduct
oversight of these programs and offices, including hearings,
outreach to the Executive Branch, and requests for information
in order to gather the necessary information to support these
determinations.
The Committee's authorization work will include, but not be
limited to, the following departments, agencies, and statutes:
Animal Drug User Fee and Generic Drug User
Fee Agreements
Brownfields Program
Centers for Disease Control and Prevention
Chemical Facility Anti-Terrorism Standards
Childhood Cancer STAR Act
Children's Health Graduate Medical Education
Program
Consumer Protection Safety Commission
Department of Energy
Environmental Protection Agency
Federal Communications Commission
Federal Energy Regulatory Commission
Federal Trade Commission
National Highway and Traffic Safety
National Institutes of Health
National Telecommunications and Information
Administration
Nuclear Regulatory Commission
Pandemic All-Hazards Preparedness Act
Pipeline and Hazardous Materials
Administration
SUPPORT for Patients and Communities Act
[all]